{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "toc_visible": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "source": [
        "!sudo apt-get update\n",
        "!apt-get install poppler-utils"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "iucQZFDkrixb",
        "outputId": "413f45d2-f0d6-4899-db5e-5ce886db543a"
      },
      "execution_count": 75,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Get:1 https://cloud.r-project.org/bin/linux/ubuntu jammy-cran40/ InRelease [3,632 B]\n",
            "Hit:2 http://archive.ubuntu.com/ubuntu jammy InRelease\n",
            "Get:3 http://security.ubuntu.com/ubuntu jammy-security InRelease [129 kB]\n",
            "Get:4 https://r2u.stat.illinois.edu/ubuntu jammy InRelease [6,555 B]\n",
            "Hit:5 https://developer.download.nvidia.com/compute/cuda/repos/ubuntu2204/x86_64  InRelease\n",
            "Get:6 http://archive.ubuntu.com/ubuntu jammy-updates InRelease [128 kB]\n",
            "Hit:7 https://ppa.launchpadcontent.net/deadsnakes/ppa/ubuntu jammy InRelease\n",
            "Hit:8 https://ppa.launchpadcontent.net/graphics-drivers/ppa/ubuntu jammy InRelease\n",
            "Get:9 https://r2u.stat.illinois.edu/ubuntu jammy/main amd64 Packages [2,747 kB]\n",
            "Get:10 http://archive.ubuntu.com/ubuntu jammy-backports InRelease [127 kB]\n",
            "Hit:11 https://ppa.launchpadcontent.net/ubuntugis/ppa/ubuntu jammy InRelease\n",
            "Get:12 http://security.ubuntu.com/ubuntu jammy-security/universe amd64 Packages [1,253 kB]\n",
            "Get:13 https://r2u.stat.illinois.edu/ubuntu jammy/main all Packages [9,053 kB]\n",
            "Get:14 http://security.ubuntu.com/ubuntu jammy-security/main amd64 Packages [3,024 kB]\n",
            "Get:15 http://archive.ubuntu.com/ubuntu jammy-updates/universe amd64 Packages [1,561 kB]\n",
            "Get:16 http://security.ubuntu.com/ubuntu jammy-security/restricted amd64 Packages [4,532 kB]\n",
            "Get:17 http://archive.ubuntu.com/ubuntu jammy-updates/main amd64 Packages [3,340 kB]\n",
            "Get:18 http://archive.ubuntu.com/ubuntu jammy-updates/restricted amd64 Packages [4,703 kB]\n",
            "100% [18 Packages store 0 B]^C\n",
            "^C\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install pdfplumber spacy pdf2image mistralai pydantic pytesseract asyncio pymupdf nest_asyncio"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "kIxiWfX1eFEH",
        "outputId": "7b2a4536-5fa7-48e9-a5d3-33fbec7ab20a"
      },
      "execution_count": 1,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: pdfplumber in /usr/local/lib/python3.11/dist-packages (0.11.7)\n",
            "Requirement already satisfied: spacy in /usr/local/lib/python3.11/dist-packages (3.8.7)\n",
            "Requirement already satisfied: pdf2image in /usr/local/lib/python3.11/dist-packages (1.17.0)\n",
            "Requirement already satisfied: mistralai in /usr/local/lib/python3.11/dist-packages (1.8.2)\n",
            "Requirement already satisfied: pydantic in /usr/local/lib/python3.11/dist-packages (2.11.7)\n",
            "Requirement already satisfied: pytesseract in /usr/local/lib/python3.11/dist-packages (0.3.13)\n",
            "Requirement already satisfied: asyncio in /usr/local/lib/python3.11/dist-packages (3.4.3)\n",
            "Requirement already satisfied: pymupdf in /usr/local/lib/python3.11/dist-packages (1.26.1)\n",
            "Requirement already satisfied: nest_asyncio in /usr/local/lib/python3.11/dist-packages (1.6.0)\n",
            "Requirement already satisfied: pdfminer.six==20250506 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (20250506)\n",
            "Requirement already satisfied: Pillow>=9.1 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (11.2.1)\n",
            "Requirement already satisfied: pypdfium2>=4.18.0 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (4.30.1)\n",
            "Requirement already satisfied: charset-normalizer>=2.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20250506->pdfplumber) (3.4.2)\n",
            "Requirement already satisfied: cryptography>=36.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20250506->pdfplumber) (43.0.3)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.0.13)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.0.11)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.0.10)\n",
            "Requirement already satisfied: thinc<8.4.0,>=8.3.4 in /usr/local/lib/python3.11/dist-packages (from spacy) (8.3.6)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.5.1)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (0.16.0)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (4.67.1)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.0.2)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.32.3)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.1.6)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.11/dist-packages (from spacy) (75.2.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.5.0)\n",
            "Requirement already satisfied: eval-type-backport>=0.2.0 in /usr/local/lib/python3.11/dist-packages (from mistralai) (0.2.2)\n",
            "Requirement already satisfied: httpx>=0.28.1 in /usr/local/lib/python3.11/dist-packages (from mistralai) (0.28.1)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.11/dist-packages (from mistralai) (2.9.0.post0)\n",
            "Requirement already satisfied: typing-inspection>=0.4.0 in /usr/local/lib/python3.11/dist-packages (from mistralai) (0.4.1)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.11/dist-packages (from pydantic) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.33.2 in /usr/local/lib/python3.11/dist-packages (from pydantic) (2.33.2)\n",
            "Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.11/dist-packages (from pydantic) (4.14.0)\n",
            "Requirement already satisfied: anyio in /usr/local/lib/python3.11/dist-packages (from httpx>=0.28.1->mistralai) (4.9.0)\n",
            "Requirement already satisfied: certifi in /usr/local/lib/python3.11/dist-packages (from httpx>=0.28.1->mistralai) (2025.6.15)\n",
            "Requirement already satisfied: httpcore==1.* in /usr/local/lib/python3.11/dist-packages (from httpx>=0.28.1->mistralai) (1.0.9)\n",
            "Requirement already satisfied: idna in /usr/local/lib/python3.11/dist-packages (from httpx>=0.28.1->mistralai) (3.10)\n",
            "Requirement already satisfied: h11>=0.16 in /usr/local/lib/python3.11/dist-packages (from httpcore==1.*->httpx>=0.28.1->mistralai) (0.16.0)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.11/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy) (1.3.0)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.11/dist-packages (from python-dateutil>=2.8.2->mistralai) (1.17.0)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2.4.0)\n",
            "Requirement already satisfied: blis<1.4.0,>=1.3.0 in /usr/local/lib/python3.11/dist-packages (from thinc<8.4.0,>=8.3.4->spacy) (1.3.0)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.11/dist-packages (from thinc<8.4.0,>=8.3.4->spacy) (0.1.5)\n",
            "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (8.2.1)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.11/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.11/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (0.21.1)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.11/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.11/dist-packages (from jinja2->spacy) (3.0.2)\n",
            "Requirement already satisfied: cffi>=1.12 in /usr/local/lib/python3.11/dist-packages (from cryptography>=36.0.0->pdfminer.six==20250506->pdfplumber) (1.17.1)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.11/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy) (1.2.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (2.19.1)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.11/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy) (1.17.2)\n",
            "Requirement already satisfied: sniffio>=1.1 in /usr/local/lib/python3.11/dist-packages (from anyio->httpx>=0.28.1->mistralai) (1.3.1)\n",
            "Requirement already satisfied: pycparser in /usr/local/lib/python3.11/dist-packages (from cffi>=1.12->cryptography>=36.0.0->pdfminer.six==20250506->pdfplumber) (2.22)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.11/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (0.1.2)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "##Testing"
      ],
      "metadata": {
        "id": "JW3LZwJgqDwS"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Do not run when executing main workflow"
      ],
      "metadata": {
        "id": "wwpzXOKfRsJ1"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import pdfplumber\n",
        "from google import genai\n",
        "import io\n",
        "import httpx\n",
        "from google.colab import userdata\n",
        "import pathlib\n",
        "import types\n",
        "import base64\n",
        "import os\n",
        "from mistralai import Mistral\n",
        "import asyncio\n",
        "from pydantic import BaseModel\n",
        "import fitz\n",
        "import nest_asyncio\n",
        "from IPython.display import display\n",
        "import difflib"
      ],
      "metadata": {
        "id": "fCspLeKvecTG"
      },
      "execution_count": 2,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import cv2\n",
        "from PIL import Image, ImageEnhance, ImageFilter\n",
        "# grayscale\n",
        "img = Image.open(\"page_0.png\").convert(\"L\")\n",
        "MAX_DIM = 2000\n",
        "if img.width > MAX_DIM or img.height > MAX_DIM:\n",
        "    scale = MAX_DIM / max(img.width, img.height)\n",
        "    img = img.resize((int(img.width * scale), int(img.height * scale)), Image.BICUBIC)\n",
        "\n",
        "img = ImageEnhance.Contrast(img).enhance(2.0)\n",
        "\n",
        "img = img.filter(ImageFilter.MedianFilter(size=3))\n",
        "img = img.resize((img.width * 2, img.height * 2), Image.BICUBIC)\n",
        "\n",
        "img.save(\"soft_cleaned_fax_safe.png\")\n",
        "\n",
        "from PIL import Image\n",
        "from transformers import TrOCRProcessor, VisionEncoderDecoderModel\n",
        "\n",
        "# Load TrOCR\n",
        "processor = TrOCRProcessor.from_pretrained(\"microsoft/trocr-large-handwritten\")\n",
        "model = VisionEncoderDecoderModel.from_pretrained(\"microsoft/trocr-large-handwritten\")\n",
        "\n",
        "image = Image.open(\"soft_cleaned_fax_safe.png\").convert(\"RGB\")\n",
        "pixel_values = processor(images=image, return_tensors=\"pt\").pixel_values\n",
        "generated_ids = model.generate(pixel_values, max_length=256)\n",
        "text = processor.batch_decode(generated_ids, skip_special_tokens=True)[0]\n",
        "\n",
        "print(\"OCR result:\", text)\n"
      ],
      "metadata": {
        "id": "zvPG72CaAR69"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "#Referral Extraction"
      ],
      "metadata": {
        "id": "jQ9nMbza797L"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "page_num = 0\n",
        "with pdfplumber.open(\"referral_package.pdf\") as pdf:\n",
        "    page_num = len(pdf.pages)\n",
        "\n",
        "print(page_num)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-iGworl4SMld",
        "outputId": "42057a0d-cd8a-4bd9-d637-7c5e5630a340"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "15\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def page_to_img(path, page_number):\n",
        "    with pdfplumber.open(path) as pdf:\n",
        "        image = pdf.pages[page_number].to_image(resolution=150).original  # PIL Image\n",
        "        filename = f\"page_{page_number}.png\"\n",
        "        image.save(filename)\n",
        "        return filename  # Return the filename"
      ],
      "metadata": {
        "id": "9sgoXXc1_FdB"
      },
      "execution_count": 4,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def process_image(image_path):\n",
        "    \"\"\"Encode the image to base64.\"\"\"\n",
        "    try:\n",
        "        with open(image_path, \"rb\") as image_file:\n",
        "            return base64.b64encode(image_file.read()).decode('utf-8')\n",
        "    except FileNotFoundError:\n",
        "        print(f\"Error: The file {image_path} was not found.\")\n",
        "        return None\n",
        "    except Exception as e:  # Added general exception handling\n",
        "        print(f\"Error: {e}\")\n",
        "        return None"
      ],
      "metadata": {
        "id": "YI8lEYyA33n0"
      },
      "execution_count": 5,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#Testing on handwriting page\n",
        "image_path = \"page_0.png\"\n",
        "base64_image = process_image(image_path)\n",
        "\n",
        "api_key = userdata.get(\"MISTRALAI_API_KEY\")\n",
        "client = Mistral(api_key=api_key)\n",
        "\n"
      ],
      "metadata": {
        "id": "4jW59gRaFPZk"
      },
      "execution_count": 6,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def encode_pdf(pdf_path):\n",
        "    \"\"\"Encode the pdf to base64.\"\"\"\n",
        "    try:\n",
        "        with open(pdf_path, \"rb\") as pdf_file:\n",
        "            return base64.b64encode(pdf_file.read()).decode('utf-8')\n",
        "    except FileNotFoundError:\n",
        "        print(f\"Error: The file {pdf_path} was not found.\")\n",
        "        return None\n",
        "    except Exception as e:  # Added general exception handling\n",
        "        print(f\"Error: {e}\")\n",
        "        return None\n",
        "\n",
        "base64_pdf = encode_pdf(\"referral_package.pdf\")\n",
        "\n",
        "test_response2 = client.ocr.process(\n",
        "    model=\"mistral-ocr-latest\",\n",
        "    document={\n",
        "        \"type\": \"document_url\",\n",
        "        \"document_url\": f\"data:application/pdf;base64,{base64_pdf}\"\n",
        "    },\n",
        "    include_image_base64=True\n",
        ")"
      ],
      "metadata": {
        "id": "5LZbqirZ9KJ5"
      },
      "execution_count": 7,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "test_response2"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6nHIGVI-9N7k",
        "outputId": "2a0e9b83-9de8-494c-d5e0-0d2f4cb3aefe"
      },
      "execution_count": 8,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "OCRResponse(pages=[OCRPageObject(index=0, markdown='04/22/2024 WED 11:32 FAX\\n\\n001/028\\n\\n# FAX TRANSMISSION\\n\\n**Better Life Multiple Sclerosis Center**\\n\\n3320 Montgomery Dr. Nashville, TN 37361\\n\\n**BetterLife**\\n\\nF 615-562-4820 P: 615-562-4848\\n\\nDr. Asriel Han | Dr. Aetya Shan\\n\\n---\\n\\n**TO:**\\n\\nGolden Gate Infusion Center\\n\\n**Fax:** 614-225-3355 **Phone:** 614-295-7655\\n\\n**From:** Erran Rostami, BSN, RN\\n\\n**P:** 615-343-1176\\n\\n**F:** 615-343-1219\\n\\n---\\n\\n**Page**\\n\\n(including cover sheet)\\n\\n---\\n\\n**Comments:**\\n\\n- Arabic - spoken / English - written\\n- Rituxen (Truxima) TP\\n- MRI Reports\\n- Hospital DIC Make\\n- Demographics\\n\\n---\\n\\nThe documents accompanying this transmission may contain health information that is legally protected. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless permitted by law or regulation.\\n\\nIf you are not the intended recipient, you are hereby notified that any use, disclosure, copying or distribution of these documents is strictly prohibited. If you have received this information in error, please notify the sender immediately and arrange for the return or destruction of these documents.', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=1, markdown=\"05/22/2024 WED 11:32 FAX\\n\\n5/22/24, 11:10 AM\\n\\n# Abdulla, Shakh\\n\\n**MRN: 041152153**\\n\\n**Communication** 5/16/2024\\n\\n**Provider:** Erfan Rostami, RN\\n\\n**Status:** Open\\n\\n**Reason for call:** Truxima Second Initial Dose Needed Week of June 3\\n\\n**Better Life Multiple Sclerosis**\\n\\n**Center**\\n\\n## All Conversations: Truxima Second Initial Dose Needed Week of June 3\\n\\n*(Newest Message First)*\\n\\n**May 21, 2024**\\n\\n**Jha, Vedant**\\n\\n**to Erfan Rostami, RN**\\n\\n**Hi Erfan**\\n\\n**5/21/24 4:44 PM**\\n\\nThe only way Extraordinary Care could see his Medicaid plan would be at home if he is able to be seen at a hospital based infusion center closer to home?\\n\\nWe will hold off on this one for now—let me know if you're not able to find a provider who can see him in the infusion suite and we will re-open the referral.\\n\\n**Vedant**\\n\\nErfan Rostami, RN routed this conversation to Jha, Vedant\\n\\n**5/21/24 2:32 PM**\\n\\n**May 20, 2024**\\n\\n**Gu, Hao H, MD**\\n\\n**to Erfan Rostami, RN**\\n\\n**Note**\\n\\n**5/20/24 5:13 PM**\\n\\n**Hi**\\n\\n**No home infusion**\\n\\nHer first dose is scheduled may 23\\n\\nSecond dos 2 weeks from may 23 first\\n\\nErfan Rostami, RN routed this conversation to Gu, Hao H, MD\\n\\n**5/20/24 3:41 PM**\\n\\nJha, Vedant to Erfan Rostami, RN\\n\\n**Hi**\\n\\n**Is Dr. Gu comfortable with this patient being seen for home infusion?**\\n\\n**5/20/24 2:54 PM**\\n\\n**Thanks,**\\n\\n1/3\", images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=2, markdown='05/22/2024 WED 11:33 FAX\\n\\n5/22/24, 10:33 AM\\n\\n003/028\\n\\nAbdulla, Shakh (MR # 041152153) DOB: 04/01/2001\\n\\n# Shakh Abdulla\\n\\n**Therapy Plan 1 Summary**\\n\\nMRN: 041152153 Description: male DOB: 4/1/2001\\n\\n## Patient Demographics\\n\\n|  Patient Name | Legal | DOB | Address | Phone  |\\n| --- | --- | --- | --- | --- |\\n|  Abdulla, Shakh | Sex | 4/1/2001 | 425 Sherman Ave | 865-395-3958 (Home)  |\\n|   | male |  |  | 865-395-0481 (Mobile)  |\\n|   |  |  | Nashville TN 37995 | *Preferred*  |\\n\\n## Medication\\n\\nRituximab Or Biosimilar Days 1, 15 Load Then Once Every 24 Weeks\\n\\n## Associated Problems\\n\\n- **Problem**\\n- **Selected Diagnosis**\\n- Multiple sclerosis in pediatric patient (CMS/HCC) [G35]\\n- Multiple sclerosis in pediatric patient (CMS/HCC) [G35]\\n\\n## Infusion Orders\\n\\n## All Current Orders\\n\\n|  **Nursing Orders** | **Interval** | **Duration** | **Due**  |\\n| --- | --- | --- | --- |\\n|  ☑ IV access | Every visit |  | Every visit  |\\n|  Care Instructions: Obtain IV access (PIV, PORT, etc.) and start NS 0.9% @ KVO |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ Monitor pt for hypersensitivity reaction | Every visit |  | Every visit  |\\n|  Once Starting when released for 1 occurrence |  |  |   |\\n|  If allergic reaction or infusion related reaction occurs, initiate adult hypersensitivity reaction protocol or pediatric guideline and CALL MD for additional orders. |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ NURSING COMMUNICATION | Every visit |  | Every visit  |\\n|  Care Instructions: Ensure that patient has not taken antihypertensive medications in the 12 hours prior to infusion |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ NURSING COMMUNICATION | Every visit |  | Every visit  |\\n|  Care Instructions: For Hypotension, place patient in Trendelenberg position, support with NS, and call MD |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=3, markdown='05/22/2024 WED 11:33 FAX\\n\\n004/028\\n\\n5/22/24, 10:33 AM\\n\\nAbduia, Shakh (MR # 041152153) DOB: 04/01/2001\\n\\n|  |   |   |\\n| --- | --- | --- |\\n|  Last released: Never | Interval | Duration  |\\n|   |  | Signed By: Gu, Hao MD on 5/15/2024 5:11 PM  |\\n|  Labs |  |   |\\n|  IgG |  | Every 24 weeks  |\\n|  Clinic Collect, Blood |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  CBC w/ Differential |  | Every visit  |\\n|  Once Starting when released, Blood |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Flow Lymphocytes Subsets (TBNK) |  | Every visit  |\\n|  Once Starting when released, Blood |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Vitals |  |   |\\n|  Vital Signs |  | Every visit  |\\n|  Care Instructions: Obtain VS prior to start therapy, Q30 minutes with each dose increase and at the end of treatment. |  |   |\\n|  As needed Starting when released Until Specified |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024  |\\n|  Hydration |  |   |\\n|  heparin, porcine (PF) 100 unit/mL syringe 5 |  | PRN  |\\n|  mL |  |   |\\n|  5 mL, intraVENOUS, As needed, For flushing Ports/ PICC lines/ Central Lines IF NEEDED, Starting when released, Until Discontinued |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Pre-Medications |  |   |\\n|  acetaminophen (TYLENOL) tablet 650 mg |  | Every visit  |\\n|  650 mg, oral, Once, Starting when released |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  diphenhydramine (BENADRYL) 50 mg in 50 |  | Every visit  |\\n|  mL NS |  |   |\\n|  50 mg, intraVENOUS, Once, Starting when released |  |   |\\n|  Administer 30 minutes before starting infusion. |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  methylprednisolone sod succinate (SOLU-Medrol) (20 mg/mL) 125 mg in NS 6.2 mL |  | Every visit  |\\n\\n2/4', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=4, markdown='05/22/2024 WED 11:33 FAX\\n\\n005/028\\n\\n5/22/24, 10:33 AM\\n\\nAbduinabi, Noor (MR # 048182163) DOB: 01/01/2008\\n\\n|  |   |   |\\n| --- | --- | --- |\\n|  125 mg, intraVENOUS, Once, Starting when released |  |   |\\n|  Administer 30 minutes before starting infusion. |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Infusion Therapy |  |   |\\n|  ✔ NURSING COMMUNICATION | Every visit | Every visit  |\\n|  Until discontinued Starting when released Until Specified |  |   |\\n|  Infusion rate (standard only) |  |   |\\n|  1st infusion - initiate at 50mg/hr and if no infusion toxicity reaction, may increase by 50mg/hr ever 30 minutes; Max Rate 400mg/hr |  |   |\\n|  Subsequent infusions - initiate at 100mg/hr and if no infusion toxicity reaction, may increase by 100mg/hr every 30 min; Max Rate 400mg/hr |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Infusion Therapy - Initial Dose |  |   |\\n|  ✔ riTUXimab-abbs (TRUXIMA) IVPB | Every 2 weeks | 2/2 remaining Week of 5/19/2024  |\\n|  694 mg (rounded from 693.75 mg = 375 mg/m2 x 1.85 m2 - BSA might be out of date), intraVENOUS, Once, Starting 30 minutes after treatment start time |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Infusion Therapy - Maintenance Dose |  |   |\\n|  ✔ riTUXimab-abbs (TRUXIMA) IVPB | Every 24 weeks | Mon 11/4/2024  |\\n|  Defer until: Mon 11/4/2024 |  |   |\\n|  694 mg (rounded from 693.75 mg = 375 mg/m2 x 1.85 m2 - BSA might be out of date), intraVENOUS, Once, Starting when released |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  PRN Medications |  |   |\\n|  ✔ diphenhydramine (BENADRYL) injection 25 mg | PRN | PRN  |\\n|  25 mg, intraVENOUS, As needed, chills, Starting when released, for 2 doses |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  ✔ meperidine (DEMEROL) injection 25 mg | PRN | PRN  |\\n|  25 mg, intraVENOUS, As needed, rigors, Starting when released, for 2 doses |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  ✔ ondansetron (ZOFRAN) injection 4 mg | PRN | PRN  |\\n|  4 mg, intraVENOUS, As needed, nausea, vomiting, Starting when released, for 2 doses |  |   |\\n|  Doses up to 4 mg may be administered undiluted. Inject over at least 30 seconds, but preferably over 2-5 minutes. |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n\\neSignature Information\\n\\nAll order signatures are valid for 1 (one) year from the signature date.\\n\\nProvider Contact Information\\n\\n3/4', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=5, markdown='05/22/2024 WED 11:34 FAX\\n\\n5/22/24, 10:33 AM\\n\\nAbduinabi, Noor (MR # 048152153) DOB: 01/01/2008\\n\\nHao H Gu, MD (NPI: 1154611523)\\n\\nBetter Life Multiple Sclerosis Center\\n\\n3320 Montgomery Dr NASHVILLE TN 37361\\n\\n614-936-0065\\n\\n4/4', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=6, markdown='05/22/2024 WED 11:34 FAX\\n\\n007/028\\n\\n# Better Life\\nMultiple Sclerosis\\nCenter\\n\\nPatient: Shakh Abdulta\\n\\nHospital A/C:\\n\\nCare Everywhere ID#: VDJ-TKR2-484T-LGF8\\n\\nENCOUNTER\\nPatient Class:\\nAdmission Date/Time:5/17/2024\\nAdmission User:\\nAdmitting Provider:\\nAttending Provider:\\nAdm Diagnosis:\\nMyHealth Bundle Status:\\n\\nPATIENT\\nName: Shakh Abdulta\\nAddress: 425 Sherman Aves APT D\\nCity: A/ashvitie TN 37923\\nPrimary Care Provider: James David, PNP\\nMarital Status: Single\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nName: Shakh Abdulta\\nAddress: 425 Sherman Aves APT D\\nCity: A/ashvitie TN 37923\\nPrimary Care Provider: James David, PNP\\nMarital Status: Single\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nName Phone Work Phone\\n1. Sina, Amin\\n2. Mohammedraza, Musiala\\nYes\\nYes\\nHume Phone\\nMother\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR EMPLOYER\\nTHERE IS NO GUARANTER INFORMATION ENTERED FOR THIS ENCOUNTER.\\nTHERE IS NO GUARANTER INFORMATION ENTERED FOR THIS ENCOUNTER.\\nTHERE IS NO\\nTO\\nDATE: 10/29/1979\\nSex: Female\\n\\nTO\\nDATE: 10/29/1979\\nHume Phone:\\nMobile Phone:\\nWork Phone:\\nGUARANTOR EMPLOYER\\nTHERE IS NO GUARANTER INFORMATION ENTERED FOR THIS ENCOUNTER.\\nTO\\nSTATE: NOT EMPLO*\\n\\nCOVERAGE\\nPRIMARY INSURANCE\\nPayor:\\nGroup Number:\\nSubscriber Name:\\nSubscriber ID:\\nPat. Rel. to Subscriber:\\nPlan: TC BLUE CARE NO COPAY\\nInsurance Type:\\nSubscriber DOB:\\nFinancial Class:\\nPRIMARY INSURANCE\\nPayor:\\nGroup Number:\\nSubscriber Name:\\nSubscriber ID:\\nPat. Rel. to Subscriber:\\nPlan:\\nInsurance Type:\\nSubscriber DOB:\\n\\nMay 22, 2024 Hospital Face Sheet', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=7, markdown='05/22/2024 WED 11:34 FAX 5/22/24, 10:37 AM\\n\\nAbduinabi, Noor (MRN: 041152153) DOB: 4/1/2001\\n\\nPrimary Coverage\\n\\n|  Payer | Plan | Sponsor Code | Group Number | Group Name  |\\n| --- | --- | --- | --- | --- |\\n|  BC TENNCARE | TC BLUE CARE NO COPAY |  | 435000 | TENNCARE/BLUECARE  |\\n\\nPrimary Subscriber\\n\\n|  ID | Name | SSN | Address  |\\n| --- | --- | --- | --- |\\n|  LAJM14345116 | ABDULLA, SHAKH | xxx-xx-8143 | 8327 BROADWAY LN  |\\n|   |  |  | APT D  |\\n|   |  |  | KNOXVILLE, TN 37923  |\\n\\n1/1', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=8, markdown=\"05/22/2024 WED 11:34 FAX\\n\\n009/028\\n\\n6/22/24, 10:39 AM\\n\\n# Abdulla, Shakh\\n\\n**MRN: 048152153**\\n\\n## ED to Hosp-Admission\\n\\n**Last attending:** Harry, Tom, MD · with Treatment\\n\\n**5/14/2024 - 5/17/2024 (3 days)**\\n\\n**Status:** Discharged\\n\\nMonroe Carell Jr. Children's Hospital\\n\\n## Discharge Summary\\n\\n**Kaine, Adam Jason. MD (Resident Physician) · Pediatric Neurology**\\n\\n**Cosigned by:** Gu, Hao H, MD at 5/17/2024 1:56 PM\\n\\nAttestation signed by Gu, Hao H, MD at 5/17/2024 1:56 PM (Updated)\\n\\nI saw the patient on: 5/17/2024 with Dr Kaine, I discussed the care with Dr Kaine, patient and his father at bedside and agree with the findings and plan as documented in the attached note.\\n\\nI personally spent more than 30 minutes on the patient's care unit in the preparation and execution of the hospital discharge.\\n\\n**S/p 4 days of high dose IVMP (1g/dose) today:**\\n\\n- Discharge home with oral decadron 180mg (equivalent to 1000mg IVMP) x 1 to round out 5 days of high dose steroid treatment for active demyelinating lesion (family wishes to be discharged today instead of Saturday)\\n- He will then start oral prednisone taper: Instructions provided +PPI\\n- First dose of Rituximab or biosimilar scheduled for May 22 at 9am; second dose of first course of Rituximab within 2 weeks after, we are working with local infusion facility in Knoxville to get this set up for her moving forward to minimize travel\\n- He will follow up with ophthalmologist in Knoxville\\n- School note for this week and next week\\n- PT/OT locally\\n- Continue vitamin D\\n- I will see her tentatively 3 months after completion of 1st course of Rituximab with same day\\n- MRI (she does not need sedation): looking at early or mid September. Will update family once we have that arranged\\n\\nHao Gu MD\\n\\n## Neurology Discharge Summary\\n\\n**Patient Name:** Shakh Abdulla\\n\\n**DOB:** 4/1/2001\\n\\n**Service:** Pediatric Neurology\\n\\n**Attending:** Harry, Tom, MD\\n\\n**Date of Admission:** 5/14/2024\", images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=9, markdown='05/22/2024 WED 11:34 FAX\\n\\n010/028\\n\\n5/22/24, 10:39 AM\\n\\n**Date of Discharge:** 5/17/2024\\n\\n**Diagnosis:**\\n\\n**Principal Problem:**\\n\\nAbnormal MRI\\n\\n**Resolved Problems:**\\n\\n* No resolved hospital problems. *\\n\\n**Procedures:**\\n\\n**Bedside Procedures:**\\n\\nNo orders of the defined types were placed in this encounter.\\n\\n**OR Procedures:**\\n\\n* Cannot find OR case *\\n\\n**Synopsis:**\\n\\nShakh Abdulla is a 23 year old male who established care with VCH neurology; with MRI brain and spine demonstrating multiple lesions consistent with atypical pediatric MS.\\n\\n**Hospital Course:**\\n\\nShakh Abdulla is a 23 year old male with history of optic neuritis and abnormal MRI brain concerning for MS who presented for admission following clinic visit and neuroimaging today. History from primary neurologist, clinic visit and patient and father at bedside. Patient referred to Dr. Gu by Dr. Fazal in East Bay. Confirms predominant symptoms since April of numbness in his right hand and urinary hesitancy/urgency. Additionally reporting right eye pain since time of clinic visit this morning. MRI brain and spine obtained following clinic visit and multiple lesions noted on brain and spine suggestive of pediatric MS. Presents for admission for IVMP.\\n\\n**Per clinic visit earlier today with Dr. Gu and confirmed with family at bedside:**\\n\\nShakh is a 23 years old male, previously healthy who has been referred to neuroimmunology clinic for diagnosis of optic neuritis and abnormal brain MRI concerning for MS. He is referred by Dr Fazal-pediatric neurology in East Bay.\\n\\nHe is here with dad; patient himself is an excellent historian and provided the following information- I do not have CSF results nor clinic note- I do have MRI report from Jan 21 2024 (no actual images)- with father and his permission, I reached out to Dr Shane- Dr Fazal\\'s colleague on service who can help assist with quick access to Shakh\\'s chart.\\n\\nToday, Shakh tells me that around early Oct 2023- he started to notice in right eye \"neon bright color\" fuzzy vision, and eye pain with movement and perhaps right side of his face in discomfort triggered by physical activities. Symptoms improved once he rested. By end of Oct 2023, he brought this up to parents and was brought to local eye doctor and recalled being told that \"right eye being inflamed\" and he recalled visual field deficits appreciated during exam.\\n\\nHe was referred to UT ophthalmology Dr Derrek in Jan this year, per report negative MOG and AQP4 [While waiting on this appt, he thought some improvement but not back to baseline entirely - \"not completely normal\"].\\n\\nWhen he saw UT ophthalmology clinic, recommended brain and orbit and noted WM changes and MS was mentioned. He was treated with 5 days of IVMP and referred to see Dr Kosentka ped neurology.\\n\\nMRI report from Jan 21 2024- \"Diffuse T2 hyperintensity and decreased volume throughout the right optic nerve is similar to prior examination however associated abnormal enhancement seen on prior study has resolved, presumably secondary to interveal treatment.\\n\\nLeft optic nerve is subtle but diffusely small in caliber without significant change from last exam. Several intracranial WM lesions, stable from last\"\\n\\nHe saw Dr Fazal in Feb 2024-who obtained LP and had markers of MS and referred to MS clinic today. Below are information provided by Dr Shane. Per note recommended referral to our MS center for\\n\\nPrinted by O\\'Rourke, Cydnie B. RN at 5/22/2024 10:39 AM\\n\\n2/9', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=10, markdown='05/22/2024 WED 11:35 FAX\\n\\n6/22/24, 10:39 AM\\n\\nfurther evaluation and treatment.\\n\\nCSF ?WBC, 837 rbc, IgG Index 0.87 (elevated), +OCB\\n\\nPrior to appt today May 14- he noted that in April of this year, started to have involvement of LEFT eye again similar with \"neon colors appearance\", some eye discomfort; it happened several times during the day for a few days and has since resolved\\n\\nSince April he has had intermittent numbness in his right hand (dominant hand)+ along with muscle twitch in his hands and shoulder like tics\\n\\nHe has noticed a change with urinary hesitancy- taking a long time to empty his bladder and in addition urinary urgency\\n\\nHe has not noticed weakness but noted intermittent drifting to right side, bumping in to things\\n\\nHe does note that at times when he laughs, bends his neck, does note electrical sensation\\n\\nAcademically doing very well, no difficulty\\n\\nSleeps well\\n\\nFamily history: parents and brothers are healthy\\n\\nFloor course (05/14 -\\n\\nPatient was admitted to the wards in a stable condition.\\n\\nPatient was initiated on high dose steroids for 5 days and tolerated well. MRI consistent with lesions in the brain and spinal cord consistent with atypical MS. ANA was positive as well as SSB so rheumatology was consulted but felt she did not have evidence of another systemic autoimmune disease. PT/OT evaluated his and he will follow outpatient. He was dc with Decadron and then steroid taper with Pepcid prophylaxis. He was arranged to have outpatient rituximab and Dr. Gu will follow his in clinic.\\n\\nPhysical Exam:\\n\\nTemp: [36.5 °C (97.7 °F)-36.7 °C (98.1 °F)] 36.7 °C (98 °F)\\n\\nPulse: [81-99] 84\\n\\nResp: [16-18] 16\\n\\nBP: (122-136)/(63-99) 126/63\\n\\nSpO2: [98 %] 98 %\\n\\nPhysical Exam:\\n\\nTemp: [36.5 °C (97.7 °F)-36.7 °C (98.1 °F)] 36.7 °C (98 °F)\\n\\nPulse: [81-99] 84\\n\\nResp: [16-18] 16\\n\\nBP: (122-136)/(63-99) 126/63\\n\\nSpO2: [98 %] 98 %\\n\\n-Well appearing; NAD\\n\\nCV:\\n\\n-RRR\\n\\nHIGHER INTEGRATIVE FUNCTIONS:\\n\\n-Attention & concentration: Normal\\n\\n-Orientation: Oriented to person, place & time\\n\\n-Memory: Recent and remote memory intact\\n\\n-Language: Normal\\n\\n-Fund of Knowledge: Normal\\n\\nCRANIAL NERVES:\\n\\n-CN 2: Visual fields full\\n\\n-CN 2.3: PERRL; rAPD\\n\\n-CN 3,4,6: EOMI\\n\\n-CN 5: Facial sensation intact\\n\\n-CN 7: Facial strength/movement intact bilaterally\\n\\nPrinted by O\\'Rourke, Cydnie B, RN at 5/22/2024 10:39 AM\\n\\n3/9', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=11, markdown=\"05/22/2024 WED 11:35 FAX\\n\\n5/22/24, 10:39 AM\\n\\n- CN 8: Hearing normal bilaterally\\n- CN 9,10: Palate elevates symmetrically\\n- CN 11: Normal shoulder shrug and head turn\\n- CN 12: Tongue protrudes midline\\n\\nMOTOR:\\n- Muscle tone normal in upper and lower extremities\\n- Muscle strength 5/5 in upper and lower extremities; RLE 4+ proximally\\n\\nSENSATION:\\n- Intact to light touch in upper and lower extremities bilaterally\\n\\nCOORDINATION:\\n- Finger/nose intact bilaterally\\n\\nGAIT:\\n- Normal gait\\n\\nImmunizations/Injections Administered for This Admission\\n\\nNo immunizations on file.\\n\\nAllergies:\\nNo Known Allergies\\n\\nDiagnostic Studies:\\nRecent Results (from the past 24 hour(s))\\nCBC w/ Differential\\nCollection Time: 05/14/24 10:47 AM\\nResult\\nValue\\nRef Range\\nWhite Blood Cells 7.7\\n3.4 - 10.2\\nx10(3)/mcL\\nRed Blood Cells 4.63\\n3.80 - 5.50\\nx10(6)/mcL\\nHemoglobin 13.0\\n12.0 - 16.0\\ngm/dL\\nHematocrit 40\\n35 - 49 %\\nMean Cell Volume 86\\n76 - 96 fL\\nMean Cell 28.1\\n25.0 - 35.0\\nHemoglobin pg\\nMean Cell 32.7\\n32.0 - 37.0\\nHemoglobin gm/dL\\nConcentration\\nRDW SD 38.4\\n37.4 - 52.4\\nfL\\nRDW CV 12.3\\n11.1 - 14.3\\n%\\nPlatelet 300\\n150 - 400\\nx10(3)/mcL\\n\\nPrinted by O'Rourke, Cydnie B. RN at 5/22/2024 10:39 AM\\n\\n4/9\", images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=12, markdown='05/22/2024 WED 11:35 FAX\\n\\n5/22/24, 10:39 AM\\n\\n|  |   |   |\\n| --- | --- | --- |\\n|  Mean Platelet | 10.0 | 9.3 - 12.8 fL  |\\n|  Volume |  |   |\\n|  Nucleated RBC | 0 | 0 - 0/100  |\\n|   |  | WBC  |\\n|  Nucleated RBC | 0.00 | 0.00 - 0.00  |\\n|  Abs |  | x10(3)/mcL  |\\n|  Auto Neutrophil | 4.52 | 1.80 - 7.70  |\\n|  Absolute |  | x10(3)/mcL  |\\n|  CMP |  |   |\\n|  Collection Time: 05/14/24 10:47 AM |  |   |\\n|  Result | Value | Ref Range  |\\n|  Sodium Level | 139 | 138 - 145  |\\n|   |  | mmol/L  |\\n|  Potassium Level | 3.8 | 3.3 - 4.8  |\\n|   |  | mmol/L  |\\n|  Chloride Level | 101 | 98 - 107  |\\n|   |  | mmol/L  |\\n|  Carbon Dioxide | 22 | 17 - 28  |\\n|   |  | mmol/L  |\\n|  Anion Gap | 16 | mmol/L  |\\n|  Glucose Level | 95 | 60 - 99  |\\n|   |  | mg/dL  |\\n|  Blood Urea | 13 | 7 - 18  |\\n|  Nitrogen |  | mg/dL  |\\n|  Creatinine Level | 0.67 | 0.50 - 0.90  |\\n|   |  | mg/dL  |\\n|  Calcium Level | 9.9 | 8.4 - 10.2  |\\n|  Total |  | mg/dL  |\\n|  Bilirubin Total | 0.4 | 0.0 - 0.7  |\\n|   |  | mg/dL  |\\n|  Albumin Level | 4.7 | 4.0 - 5.3  |\\n|   |  | gm/dL  |\\n|  Protein Total | 8.4 (H) | 6.3 - 7.8  |\\n|   |  | gm/dL  |\\n|  Alkaline | 55 | 50 - 117  |\\n|  Phosphatase |  | unit/L  |\\n|  Aspartate | 25 | 21 - 34  |\\n|  Aminotransferase |  | unit/L  |\\n|  Alanine | <6 | 0 - 17 unit/L  |\\n|  Aminotransferase |  |   |\\n|  Hepatitis B Pnl |  |   |\\n|  Collection Time: 05/14/24 10:47 AM |  |   |\\n|  Result | Value | Ref Range  |\\n|  Hepatitis B Surface | Negative | Negative  |\\n|  Antigen |  |   |\\n|  Hep B Core Ab | Negative | Negative  |\\n|  Total |  |   |\\n|  Hepatitis B Surface | 44.7 (H) | <=10.0  |\\n|  Ab Unit |  | mlU/mL  |\\n|  Hep Bs Ab Interp | Positive (A) | Negative  |\\n|  IgG |  |   |\\n|  Collection Time: 05/14/24 10:47 AM |  |   |\\n|  Result | Value | Ref Range  |\\n|  IgG Quantitative | 1,355 (H) | 600 - 1,310  |\\n|   |  | mg/dL  |\\n\\n5/9', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=13, markdown='05/22/2024 WED 11:35 FAX\\n\\n014/028\\n\\n5/22/24, 10:39 AM\\n\\nIgA\\n\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult | Value | Ref Range\\n--- | --- | ---\\nIgA Quantitative | 279 | 40 - 290 mg/dL\\n\\nAuto Diff\\n\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult | Value | Ref Range\\n--- | --- | ---\\nNeutrophils | 58.3 | %\\nAbsolute | 4.52 | 1.80 - 7.70\\nNeutrophils | | x10(3)/mcL\\nLymphs | 33.6 | %\\nAbsolute | 2.60 | 1.70 - 4.50\\nLymphocytes | | x10(3)/mcL\\nMonocytes | 6.5 | %\\nAbsolute | 0.50 | 0.20 - 1.00\\nMonocytes | | x10(3)/mcL\\nEosinophils | 0.5 | %\\nAbsolute | 0.04 | 0.00 - 0.50\\nEosinophils | | x10(3)/mcL\\nBasophils | 0.8 | %\\nAbsolute Basophils | 0.06 | 0.01 - 0.08\\nImm Gran | 0.3 | x10(3)/mcL\\nAutomated | | %\\nAbsolute Imm | 0.02 | 0.00 - 0.03\\nGran Automated | | x10(3)/mcL\\n\\nConsultations Obtained:\\n\\nOrders Placed This Encounter\\n\\nProcedures\\n\\n- Inpatient Consult to Pediatric Ophthalmology\\n- Inpatient Consult to Pediatric Rheumatology\\n- Inpatient consult to Case Management\\n\\nCondition at Discharge:\\n\\nStable\\n\\nDisposition:\\n\\nHome or Self Care\\n\\nPatient Instructions:\\n\\nDischarge Medications\\n\\nNew Medications\\n\\ndexamethasone 4 mg/mL CONCENTRATED solution\\n\\nfamotidine 40 mg tablet\\n\\nCommonly known as: PEPCID\\n\\nSig\\n\\nTake 45 mL (180 mg total) by mouth daily for 1 dose. See comment\\n\\nTake 1 tablet (40 mg total) by mouth daily.\\n\\n6/9', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822)), OCRPageObject(index=14, markdown='05/22/2024 WED 11:35 FAX\\n\\n015/028\\n\\n8/22/24, 10:39 AM\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n', images=[], dimensions=OCRPageDimensions(dpi=111, height=3694, width=2822))], model='mistral-ocr-2505-completion', usage_info=OCRUsageInfo(pages_processed=15, doc_size_bytes=8285754), document_annotation=None)"
            ]
          },
          "metadata": {},
          "execution_count": 8
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def extract_page_contents(ocr_response):\n",
        "    pages = ocr_response.pages\n",
        "    return [\n",
        "        {\n",
        "            \"page\": page.index,\n",
        "            \"page_content\": page.markdown.strip() if hasattr(page, \"markdown\") else \"\"\n",
        "        }\n",
        "        for page in pages\n",
        "    ]\n"
      ],
      "metadata": {
        "id": "0zsVBNkwCI-b"
      },
      "execution_count": 9,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "referral_pack_response = extract_page_contents(test_response2)"
      ],
      "metadata": {
        "id": "0ErLbeYyCJ6a"
      },
      "execution_count": 10,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "referral_pack_response"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-YB5rs_S2Two",
        "outputId": "f251795a-1572-40bd-9dfd-22a414862e35"
      },
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[{'page': 0,\n",
              "  'page_content': '04/22/2024 WED 11:32 FAX\\n\\n001/028\\n\\n# FAX TRANSMISSION\\n\\n**Better Life Multiple Sclerosis Center**\\n\\n3320 Montgomery Dr. Nashville, TN 37361\\n\\n**BetterLife**\\n\\nF 615-562-4820 P: 615-562-4848\\n\\nDr. Asriel Han | Dr. Aetya Shan\\n\\n---\\n\\n**TO:**\\n\\nGolden Gate Infusion Center\\n\\n**Fax:** 614-225-3355 **Phone:** 614-295-7655\\n\\n**From:** Erran Rostami, BSN, RN\\n\\n**P:** 615-343-1176\\n\\n**F:** 615-343-1219\\n\\n---\\n\\n**Page**\\n\\n(including cover sheet)\\n\\n---\\n\\n**Comments:**\\n\\n- Arabic - spoken / English - written\\n- Rituxen (Truxima) TP\\n- MRI Reports\\n- Hospital DIC Make\\n- Demographics\\n\\n---\\n\\nThe documents accompanying this transmission may contain health information that is legally protected. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless permitted by law or regulation.\\n\\nIf you are not the intended recipient, you are hereby notified that any use, disclosure, copying or distribution of these documents is strictly prohibited. If you have received this information in error, please notify the sender immediately and arrange for the return or destruction of these documents.'},\n",
              " {'page': 1,\n",
              "  'page_content': \"05/22/2024 WED 11:32 FAX\\n\\n5/22/24, 11:10 AM\\n\\n# Abdulla, Shakh\\n\\n**MRN: 041152153**\\n\\n**Communication** 5/16/2024\\n\\n**Provider:** Erfan Rostami, RN\\n\\n**Status:** Open\\n\\n**Reason for call:** Truxima Second Initial Dose Needed Week of June 3\\n\\n**Better Life Multiple Sclerosis**\\n\\n**Center**\\n\\n## All Conversations: Truxima Second Initial Dose Needed Week of June 3\\n\\n*(Newest Message First)*\\n\\n**May 21, 2024**\\n\\n**Jha, Vedant**\\n\\n**to Erfan Rostami, RN**\\n\\n**Hi Erfan**\\n\\n**5/21/24 4:44 PM**\\n\\nThe only way Extraordinary Care could see his Medicaid plan would be at home if he is able to be seen at a hospital based infusion center closer to home?\\n\\nWe will hold off on this one for now—let me know if you're not able to find a provider who can see him in the infusion suite and we will re-open the referral.\\n\\n**Vedant**\\n\\nErfan Rostami, RN routed this conversation to Jha, Vedant\\n\\n**5/21/24 2:32 PM**\\n\\n**May 20, 2024**\\n\\n**Gu, Hao H, MD**\\n\\n**to Erfan Rostami, RN**\\n\\n**Note**\\n\\n**5/20/24 5:13 PM**\\n\\n**Hi**\\n\\n**No home infusion**\\n\\nHer first dose is scheduled may 23\\n\\nSecond dos 2 weeks from may 23 first\\n\\nErfan Rostami, RN routed this conversation to Gu, Hao H, MD\\n\\n**5/20/24 3:41 PM**\\n\\nJha, Vedant to Erfan Rostami, RN\\n\\n**Hi**\\n\\n**Is Dr. Gu comfortable with this patient being seen for home infusion?**\\n\\n**5/20/24 2:54 PM**\\n\\n**Thanks,**\\n\\n1/3\"},\n",
              " {'page': 2,\n",
              "  'page_content': '05/22/2024 WED 11:33 FAX\\n\\n5/22/24, 10:33 AM\\n\\n003/028\\n\\nAbdulla, Shakh (MR # 041152153) DOB: 04/01/2001\\n\\n# Shakh Abdulla\\n\\n**Therapy Plan 1 Summary**\\n\\nMRN: 041152153 Description: male DOB: 4/1/2001\\n\\n## Patient Demographics\\n\\n|  Patient Name | Legal | DOB | Address | Phone  |\\n| --- | --- | --- | --- | --- |\\n|  Abdulla, Shakh | Sex | 4/1/2001 | 425 Sherman Ave | 865-395-3958 (Home)  |\\n|   | male |  |  | 865-395-0481 (Mobile)  |\\n|   |  |  | Nashville TN 37995 | *Preferred*  |\\n\\n## Medication\\n\\nRituximab Or Biosimilar Days 1, 15 Load Then Once Every 24 Weeks\\n\\n## Associated Problems\\n\\n- **Problem**\\n- **Selected Diagnosis**\\n- Multiple sclerosis in pediatric patient (CMS/HCC) [G35]\\n- Multiple sclerosis in pediatric patient (CMS/HCC) [G35]\\n\\n## Infusion Orders\\n\\n## All Current Orders\\n\\n|  **Nursing Orders** | **Interval** | **Duration** | **Due**  |\\n| --- | --- | --- | --- |\\n|  ☑ IV access | Every visit |  | Every visit  |\\n|  Care Instructions: Obtain IV access (PIV, PORT, etc.) and start NS 0.9% @ KVO |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ Monitor pt for hypersensitivity reaction | Every visit |  | Every visit  |\\n|  Once Starting when released for 1 occurrence |  |  |   |\\n|  If allergic reaction or infusion related reaction occurs, initiate adult hypersensitivity reaction protocol or pediatric guideline and CALL MD for additional orders. |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ NURSING COMMUNICATION | Every visit |  | Every visit  |\\n|  Care Instructions: Ensure that patient has not taken antihypertensive medications in the 12 hours prior to infusion |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ NURSING COMMUNICATION | Every visit |  | Every visit  |\\n|  Care Instructions: For Hypotension, place patient in Trendelenberg position, support with NS, and call MD |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |'},\n",
              " {'page': 3,\n",
              "  'page_content': '05/22/2024 WED 11:33 FAX\\n\\n004/028\\n\\n5/22/24, 10:33 AM\\n\\nAbduia, Shakh (MR # 041152153) DOB: 04/01/2001\\n\\n|  |   |   |\\n| --- | --- | --- |\\n|  Last released: Never | Interval | Duration  |\\n|   |  | Signed By: Gu, Hao MD on 5/15/2024 5:11 PM  |\\n|  Labs |  |   |\\n|  IgG |  | Every 24 weeks  |\\n|  Clinic Collect, Blood |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  CBC w/ Differential |  | Every visit  |\\n|  Once Starting when released, Blood |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Flow Lymphocytes Subsets (TBNK) |  | Every visit  |\\n|  Once Starting when released, Blood |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Vitals |  |   |\\n|  Vital Signs |  | Every visit  |\\n|  Care Instructions: Obtain VS prior to start therapy, Q30 minutes with each dose increase and at the end of treatment. |  |   |\\n|  As needed Starting when released Until Specified |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024  |\\n|  Hydration |  |   |\\n|  heparin, porcine (PF) 100 unit/mL syringe 5 |  | PRN  |\\n|  mL |  |   |\\n|  5 mL, intraVENOUS, As needed, For flushing Ports/ PICC lines/ Central Lines IF NEEDED, Starting when released, Until Discontinued |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Pre-Medications |  |   |\\n|  acetaminophen (TYLENOL) tablet 650 mg |  | Every visit  |\\n|  650 mg, oral, Once, Starting when released |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  diphenhydramine (BENADRYL) 50 mg in 50 |  | Every visit  |\\n|  mL NS |  |   |\\n|  50 mg, intraVENOUS, Once, Starting when released |  |   |\\n|  Administer 30 minutes before starting infusion. |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  methylprednisolone sod succinate (SOLU-Medrol) (20 mg/mL) 125 mg in NS 6.2 mL |  | Every visit  |\\n\\n2/4'},\n",
              " {'page': 4,\n",
              "  'page_content': '05/22/2024 WED 11:33 FAX\\n\\n005/028\\n\\n5/22/24, 10:33 AM\\n\\nAbduinabi, Noor (MR # 048182163) DOB: 01/01/2008\\n\\n|  |   |   |\\n| --- | --- | --- |\\n|  125 mg, intraVENOUS, Once, Starting when released |  |   |\\n|  Administer 30 minutes before starting infusion. |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Infusion Therapy |  |   |\\n|  ✔ NURSING COMMUNICATION | Every visit | Every visit  |\\n|  Until discontinued Starting when released Until Specified |  |   |\\n|  Infusion rate (standard only) |  |   |\\n|  1st infusion - initiate at 50mg/hr and if no infusion toxicity reaction, may increase by 50mg/hr ever 30 minutes; Max Rate 400mg/hr |  |   |\\n|  Subsequent infusions - initiate at 100mg/hr and if no infusion toxicity reaction, may increase by 100mg/hr every 30 min; Max Rate 400mg/hr |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Infusion Therapy - Initial Dose |  |   |\\n|  ✔ riTUXimab-abbs (TRUXIMA) IVPB | Every 2 weeks | 2/2 remaining Week of 5/19/2024  |\\n|  694 mg (rounded from 693.75 mg = 375 mg/m2 x 1.85 m2 - BSA might be out of date), intraVENOUS, Once, Starting 30 minutes after treatment start time |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  Infusion Therapy - Maintenance Dose |  |   |\\n|  ✔ riTUXimab-abbs (TRUXIMA) IVPB | Every 24 weeks | Mon 11/4/2024  |\\n|  Defer until: Mon 11/4/2024 |  |   |\\n|  694 mg (rounded from 693.75 mg = 375 mg/m2 x 1.85 m2 - BSA might be out of date), intraVENOUS, Once, Starting when released |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  PRN Medications |  |   |\\n|  ✔ diphenhydramine (BENADRYL) injection 25 mg | PRN | PRN  |\\n|  25 mg, intraVENOUS, As needed, chills, Starting when released, for 2 doses |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  ✔ meperidine (DEMEROL) injection 25 mg | PRN | PRN  |\\n|  25 mg, intraVENOUS, As needed, rigors, Starting when released, for 2 doses |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n|  ✔ ondansetron (ZOFRAN) injection 4 mg | PRN | PRN  |\\n|  4 mg, intraVENOUS, As needed, nausea, vomiting, Starting when released, for 2 doses |  |   |\\n|  Doses up to 4 mg may be administered undiluted. Inject over at least 30 seconds, but preferably over 2-5 minutes. |  |   |\\n|  Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n\\neSignature Information\\n\\nAll order signatures are valid for 1 (one) year from the signature date.\\n\\nProvider Contact Information\\n\\n3/4'},\n",
              " {'page': 5,\n",
              "  'page_content': '05/22/2024 WED 11:34 FAX\\n\\n5/22/24, 10:33 AM\\n\\nAbduinabi, Noor (MR # 048152153) DOB: 01/01/2008\\n\\nHao H Gu, MD (NPI: 1154611523)\\n\\nBetter Life Multiple Sclerosis Center\\n\\n3320 Montgomery Dr NASHVILLE TN 37361\\n\\n614-936-0065\\n\\n4/4'},\n",
              " {'page': 6,\n",
              "  'page_content': '05/22/2024 WED 11:34 FAX\\n\\n007/028\\n\\n# Better Life\\nMultiple Sclerosis\\nCenter\\n\\nPatient: Shakh Abdulta\\n\\nHospital A/C:\\n\\nCare Everywhere ID#: VDJ-TKR2-484T-LGF8\\n\\nENCOUNTER\\nPatient Class:\\nAdmission Date/Time:5/17/2024\\nAdmission User:\\nAdmitting Provider:\\nAttending Provider:\\nAdm Diagnosis:\\nMyHealth Bundle Status:\\n\\nPATIENT\\nName: Shakh Abdulta\\nAddress: 425 Sherman Aves APT D\\nCity: A/ashvitie TN 37923\\nPrimary Care Provider: James David, PNP\\nMarital Status: Single\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nName: Shakh Abdulta\\nAddress: 425 Sherman Aves APT D\\nCity: A/ashvitie TN 37923\\nPrimary Care Provider: James David, PNP\\nMarital Status: Single\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nDEPENDENT\\nName Phone Work Phone\\n1. Sina, Amin\\n2. Mohammedraza, Musiala\\nYes\\nYes\\nHume Phone\\nMother\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR\\nGUARANTOR EMPLOYER\\nTHERE IS NO GUARANTER INFORMATION ENTERED FOR THIS ENCOUNTER.\\nTHERE IS NO GUARANTER INFORMATION ENTERED FOR THIS ENCOUNTER.\\nTHERE IS NO\\nTO\\nDATE: 10/29/1979\\nSex: Female\\n\\nTO\\nDATE: 10/29/1979\\nHume Phone:\\nMobile Phone:\\nWork Phone:\\nGUARANTOR EMPLOYER\\nTHERE IS NO GUARANTER INFORMATION ENTERED FOR THIS ENCOUNTER.\\nTO\\nSTATE: NOT EMPLO*\\n\\nCOVERAGE\\nPRIMARY INSURANCE\\nPayor:\\nGroup Number:\\nSubscriber Name:\\nSubscriber ID:\\nPat. Rel. to Subscriber:\\nPlan: TC BLUE CARE NO COPAY\\nInsurance Type:\\nSubscriber DOB:\\nFinancial Class:\\nPRIMARY INSURANCE\\nPayor:\\nGroup Number:\\nSubscriber Name:\\nSubscriber ID:\\nPat. Rel. to Subscriber:\\nPlan:\\nInsurance Type:\\nSubscriber DOB:\\n\\nMay 22, 2024 Hospital Face Sheet'},\n",
              " {'page': 7,\n",
              "  'page_content': '05/22/2024 WED 11:34 FAX 5/22/24, 10:37 AM\\n\\nAbduinabi, Noor (MRN: 041152153) DOB: 4/1/2001\\n\\nPrimary Coverage\\n\\n|  Payer | Plan | Sponsor Code | Group Number | Group Name  |\\n| --- | --- | --- | --- | --- |\\n|  BC TENNCARE | TC BLUE CARE NO COPAY |  | 435000 | TENNCARE/BLUECARE  |\\n\\nPrimary Subscriber\\n\\n|  ID | Name | SSN | Address  |\\n| --- | --- | --- | --- |\\n|  LAJM14345116 | ABDULLA, SHAKH | xxx-xx-8143 | 8327 BROADWAY LN  |\\n|   |  |  | APT D  |\\n|   |  |  | KNOXVILLE, TN 37923  |\\n\\n1/1'},\n",
              " {'page': 8,\n",
              "  'page_content': \"05/22/2024 WED 11:34 FAX\\n\\n009/028\\n\\n6/22/24, 10:39 AM\\n\\n# Abdulla, Shakh\\n\\n**MRN: 048152153**\\n\\n## ED to Hosp-Admission\\n\\n**Last attending:** Harry, Tom, MD · with Treatment\\n\\n**5/14/2024 - 5/17/2024 (3 days)**\\n\\n**Status:** Discharged\\n\\nMonroe Carell Jr. Children's Hospital\\n\\n## Discharge Summary\\n\\n**Kaine, Adam Jason. MD (Resident Physician) · Pediatric Neurology**\\n\\n**Cosigned by:** Gu, Hao H, MD at 5/17/2024 1:56 PM\\n\\nAttestation signed by Gu, Hao H, MD at 5/17/2024 1:56 PM (Updated)\\n\\nI saw the patient on: 5/17/2024 with Dr Kaine, I discussed the care with Dr Kaine, patient and his father at bedside and agree with the findings and plan as documented in the attached note.\\n\\nI personally spent more than 30 minutes on the patient's care unit in the preparation and execution of the hospital discharge.\\n\\n**S/p 4 days of high dose IVMP (1g/dose) today:**\\n\\n- Discharge home with oral decadron 180mg (equivalent to 1000mg IVMP) x 1 to round out 5 days of high dose steroid treatment for active demyelinating lesion (family wishes to be discharged today instead of Saturday)\\n- He will then start oral prednisone taper: Instructions provided +PPI\\n- First dose of Rituximab or biosimilar scheduled for May 22 at 9am; second dose of first course of Rituximab within 2 weeks after, we are working with local infusion facility in Knoxville to get this set up for her moving forward to minimize travel\\n- He will follow up with ophthalmologist in Knoxville\\n- School note for this week and next week\\n- PT/OT locally\\n- Continue vitamin D\\n- I will see her tentatively 3 months after completion of 1st course of Rituximab with same day\\n- MRI (she does not need sedation): looking at early or mid September. Will update family once we have that arranged\\n\\nHao Gu MD\\n\\n## Neurology Discharge Summary\\n\\n**Patient Name:** Shakh Abdulla\\n\\n**DOB:** 4/1/2001\\n\\n**Service:** Pediatric Neurology\\n\\n**Attending:** Harry, Tom, MD\\n\\n**Date of Admission:** 5/14/2024\"},\n",
              " {'page': 9,\n",
              "  'page_content': '05/22/2024 WED 11:34 FAX\\n\\n010/028\\n\\n5/22/24, 10:39 AM\\n\\n**Date of Discharge:** 5/17/2024\\n\\n**Diagnosis:**\\n\\n**Principal Problem:**\\n\\nAbnormal MRI\\n\\n**Resolved Problems:**\\n\\n* No resolved hospital problems. *\\n\\n**Procedures:**\\n\\n**Bedside Procedures:**\\n\\nNo orders of the defined types were placed in this encounter.\\n\\n**OR Procedures:**\\n\\n* Cannot find OR case *\\n\\n**Synopsis:**\\n\\nShakh Abdulla is a 23 year old male who established care with VCH neurology; with MRI brain and spine demonstrating multiple lesions consistent with atypical pediatric MS.\\n\\n**Hospital Course:**\\n\\nShakh Abdulla is a 23 year old male with history of optic neuritis and abnormal MRI brain concerning for MS who presented for admission following clinic visit and neuroimaging today. History from primary neurologist, clinic visit and patient and father at bedside. Patient referred to Dr. Gu by Dr. Fazal in East Bay. Confirms predominant symptoms since April of numbness in his right hand and urinary hesitancy/urgency. Additionally reporting right eye pain since time of clinic visit this morning. MRI brain and spine obtained following clinic visit and multiple lesions noted on brain and spine suggestive of pediatric MS. Presents for admission for IVMP.\\n\\n**Per clinic visit earlier today with Dr. Gu and confirmed with family at bedside:**\\n\\nShakh is a 23 years old male, previously healthy who has been referred to neuroimmunology clinic for diagnosis of optic neuritis and abnormal brain MRI concerning for MS. He is referred by Dr Fazal-pediatric neurology in East Bay.\\n\\nHe is here with dad; patient himself is an excellent historian and provided the following information- I do not have CSF results nor clinic note- I do have MRI report from Jan 21 2024 (no actual images)- with father and his permission, I reached out to Dr Shane- Dr Fazal\\'s colleague on service who can help assist with quick access to Shakh\\'s chart.\\n\\nToday, Shakh tells me that around early Oct 2023- he started to notice in right eye \"neon bright color\" fuzzy vision, and eye pain with movement and perhaps right side of his face in discomfort triggered by physical activities. Symptoms improved once he rested. By end of Oct 2023, he brought this up to parents and was brought to local eye doctor and recalled being told that \"right eye being inflamed\" and he recalled visual field deficits appreciated during exam.\\n\\nHe was referred to UT ophthalmology Dr Derrek in Jan this year, per report negative MOG and AQP4 [While waiting on this appt, he thought some improvement but not back to baseline entirely - \"not completely normal\"].\\n\\nWhen he saw UT ophthalmology clinic, recommended brain and orbit and noted WM changes and MS was mentioned. He was treated with 5 days of IVMP and referred to see Dr Kosentka ped neurology.\\n\\nMRI report from Jan 21 2024- \"Diffuse T2 hyperintensity and decreased volume throughout the right optic nerve is similar to prior examination however associated abnormal enhancement seen on prior study has resolved, presumably secondary to interveal treatment.\\n\\nLeft optic nerve is subtle but diffusely small in caliber without significant change from last exam. Several intracranial WM lesions, stable from last\"\\n\\nHe saw Dr Fazal in Feb 2024-who obtained LP and had markers of MS and referred to MS clinic today. Below are information provided by Dr Shane. Per note recommended referral to our MS center for\\n\\nPrinted by O\\'Rourke, Cydnie B. RN at 5/22/2024 10:39 AM\\n\\n2/9'},\n",
              " {'page': 10,\n",
              "  'page_content': '05/22/2024 WED 11:35 FAX\\n\\n6/22/24, 10:39 AM\\n\\nfurther evaluation and treatment.\\n\\nCSF ?WBC, 837 rbc, IgG Index 0.87 (elevated), +OCB\\n\\nPrior to appt today May 14- he noted that in April of this year, started to have involvement of LEFT eye again similar with \"neon colors appearance\", some eye discomfort; it happened several times during the day for a few days and has since resolved\\n\\nSince April he has had intermittent numbness in his right hand (dominant hand)+ along with muscle twitch in his hands and shoulder like tics\\n\\nHe has noticed a change with urinary hesitancy- taking a long time to empty his bladder and in addition urinary urgency\\n\\nHe has not noticed weakness but noted intermittent drifting to right side, bumping in to things\\n\\nHe does note that at times when he laughs, bends his neck, does note electrical sensation\\n\\nAcademically doing very well, no difficulty\\n\\nSleeps well\\n\\nFamily history: parents and brothers are healthy\\n\\nFloor course (05/14 -\\n\\nPatient was admitted to the wards in a stable condition.\\n\\nPatient was initiated on high dose steroids for 5 days and tolerated well. MRI consistent with lesions in the brain and spinal cord consistent with atypical MS. ANA was positive as well as SSB so rheumatology was consulted but felt she did not have evidence of another systemic autoimmune disease. PT/OT evaluated his and he will follow outpatient. He was dc with Decadron and then steroid taper with Pepcid prophylaxis. He was arranged to have outpatient rituximab and Dr. Gu will follow his in clinic.\\n\\nPhysical Exam:\\n\\nTemp: [36.5 °C (97.7 °F)-36.7 °C (98.1 °F)] 36.7 °C (98 °F)\\n\\nPulse: [81-99] 84\\n\\nResp: [16-18] 16\\n\\nBP: (122-136)/(63-99) 126/63\\n\\nSpO2: [98 %] 98 %\\n\\nPhysical Exam:\\n\\nTemp: [36.5 °C (97.7 °F)-36.7 °C (98.1 °F)] 36.7 °C (98 °F)\\n\\nPulse: [81-99] 84\\n\\nResp: [16-18] 16\\n\\nBP: (122-136)/(63-99) 126/63\\n\\nSpO2: [98 %] 98 %\\n\\n-Well appearing; NAD\\n\\nCV:\\n\\n-RRR\\n\\nHIGHER INTEGRATIVE FUNCTIONS:\\n\\n-Attention & concentration: Normal\\n\\n-Orientation: Oriented to person, place & time\\n\\n-Memory: Recent and remote memory intact\\n\\n-Language: Normal\\n\\n-Fund of Knowledge: Normal\\n\\nCRANIAL NERVES:\\n\\n-CN 2: Visual fields full\\n\\n-CN 2.3: PERRL; rAPD\\n\\n-CN 3,4,6: EOMI\\n\\n-CN 5: Facial sensation intact\\n\\n-CN 7: Facial strength/movement intact bilaterally\\n\\nPrinted by O\\'Rourke, Cydnie B, RN at 5/22/2024 10:39 AM\\n\\n3/9'},\n",
              " {'page': 11,\n",
              "  'page_content': \"05/22/2024 WED 11:35 FAX\\n\\n5/22/24, 10:39 AM\\n\\n- CN 8: Hearing normal bilaterally\\n- CN 9,10: Palate elevates symmetrically\\n- CN 11: Normal shoulder shrug and head turn\\n- CN 12: Tongue protrudes midline\\n\\nMOTOR:\\n- Muscle tone normal in upper and lower extremities\\n- Muscle strength 5/5 in upper and lower extremities; RLE 4+ proximally\\n\\nSENSATION:\\n- Intact to light touch in upper and lower extremities bilaterally\\n\\nCOORDINATION:\\n- Finger/nose intact bilaterally\\n\\nGAIT:\\n- Normal gait\\n\\nImmunizations/Injections Administered for This Admission\\n\\nNo immunizations on file.\\n\\nAllergies:\\nNo Known Allergies\\n\\nDiagnostic Studies:\\nRecent Results (from the past 24 hour(s))\\nCBC w/ Differential\\nCollection Time: 05/14/24 10:47 AM\\nResult\\nValue\\nRef Range\\nWhite Blood Cells 7.7\\n3.4 - 10.2\\nx10(3)/mcL\\nRed Blood Cells 4.63\\n3.80 - 5.50\\nx10(6)/mcL\\nHemoglobin 13.0\\n12.0 - 16.0\\ngm/dL\\nHematocrit 40\\n35 - 49 %\\nMean Cell Volume 86\\n76 - 96 fL\\nMean Cell 28.1\\n25.0 - 35.0\\nHemoglobin pg\\nMean Cell 32.7\\n32.0 - 37.0\\nHemoglobin gm/dL\\nConcentration\\nRDW SD 38.4\\n37.4 - 52.4\\nfL\\nRDW CV 12.3\\n11.1 - 14.3\\n%\\nPlatelet 300\\n150 - 400\\nx10(3)/mcL\\n\\nPrinted by O'Rourke, Cydnie B. RN at 5/22/2024 10:39 AM\\n\\n4/9\"},\n",
              " {'page': 12,\n",
              "  'page_content': '05/22/2024 WED 11:35 FAX\\n\\n5/22/24, 10:39 AM\\n\\n|  |   |   |\\n| --- | --- | --- |\\n|  Mean Platelet | 10.0 | 9.3 - 12.8 fL  |\\n|  Volume |  |   |\\n|  Nucleated RBC | 0 | 0 - 0/100  |\\n|   |  | WBC  |\\n|  Nucleated RBC | 0.00 | 0.00 - 0.00  |\\n|  Abs |  | x10(3)/mcL  |\\n|  Auto Neutrophil | 4.52 | 1.80 - 7.70  |\\n|  Absolute |  | x10(3)/mcL  |\\n|  CMP |  |   |\\n|  Collection Time: 05/14/24 10:47 AM |  |   |\\n|  Result | Value | Ref Range  |\\n|  Sodium Level | 139 | 138 - 145  |\\n|   |  | mmol/L  |\\n|  Potassium Level | 3.8 | 3.3 - 4.8  |\\n|   |  | mmol/L  |\\n|  Chloride Level | 101 | 98 - 107  |\\n|   |  | mmol/L  |\\n|  Carbon Dioxide | 22 | 17 - 28  |\\n|   |  | mmol/L  |\\n|  Anion Gap | 16 | mmol/L  |\\n|  Glucose Level | 95 | 60 - 99  |\\n|   |  | mg/dL  |\\n|  Blood Urea | 13 | 7 - 18  |\\n|  Nitrogen |  | mg/dL  |\\n|  Creatinine Level | 0.67 | 0.50 - 0.90  |\\n|   |  | mg/dL  |\\n|  Calcium Level | 9.9 | 8.4 - 10.2  |\\n|  Total |  | mg/dL  |\\n|  Bilirubin Total | 0.4 | 0.0 - 0.7  |\\n|   |  | mg/dL  |\\n|  Albumin Level | 4.7 | 4.0 - 5.3  |\\n|   |  | gm/dL  |\\n|  Protein Total | 8.4 (H) | 6.3 - 7.8  |\\n|   |  | gm/dL  |\\n|  Alkaline | 55 | 50 - 117  |\\n|  Phosphatase |  | unit/L  |\\n|  Aspartate | 25 | 21 - 34  |\\n|  Aminotransferase |  | unit/L  |\\n|  Alanine | <6 | 0 - 17 unit/L  |\\n|  Aminotransferase |  |   |\\n|  Hepatitis B Pnl |  |   |\\n|  Collection Time: 05/14/24 10:47 AM |  |   |\\n|  Result | Value | Ref Range  |\\n|  Hepatitis B Surface | Negative | Negative  |\\n|  Antigen |  |   |\\n|  Hep B Core Ab | Negative | Negative  |\\n|  Total |  |   |\\n|  Hepatitis B Surface | 44.7 (H) | <=10.0  |\\n|  Ab Unit |  | mlU/mL  |\\n|  Hep Bs Ab Interp | Positive (A) | Negative  |\\n|  IgG |  |   |\\n|  Collection Time: 05/14/24 10:47 AM |  |   |\\n|  Result | Value | Ref Range  |\\n|  IgG Quantitative | 1,355 (H) | 600 - 1,310  |\\n|   |  | mg/dL  |\\n\\n5/9'},\n",
              " {'page': 13,\n",
              "  'page_content': '05/22/2024 WED 11:35 FAX\\n\\n014/028\\n\\n5/22/24, 10:39 AM\\n\\nIgA\\n\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult | Value | Ref Range\\n--- | --- | ---\\nIgA Quantitative | 279 | 40 - 290 mg/dL\\n\\nAuto Diff\\n\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult | Value | Ref Range\\n--- | --- | ---\\nNeutrophils | 58.3 | %\\nAbsolute | 4.52 | 1.80 - 7.70\\nNeutrophils | | x10(3)/mcL\\nLymphs | 33.6 | %\\nAbsolute | 2.60 | 1.70 - 4.50\\nLymphocytes | | x10(3)/mcL\\nMonocytes | 6.5 | %\\nAbsolute | 0.50 | 0.20 - 1.00\\nMonocytes | | x10(3)/mcL\\nEosinophils | 0.5 | %\\nAbsolute | 0.04 | 0.00 - 0.50\\nEosinophils | | x10(3)/mcL\\nBasophils | 0.8 | %\\nAbsolute Basophils | 0.06 | 0.01 - 0.08\\nImm Gran | 0.3 | x10(3)/mcL\\nAutomated | | %\\nAbsolute Imm | 0.02 | 0.00 - 0.03\\nGran Automated | | x10(3)/mcL\\n\\nConsultations Obtained:\\n\\nOrders Placed This Encounter\\n\\nProcedures\\n\\n- Inpatient Consult to Pediatric Ophthalmology\\n- Inpatient Consult to Pediatric Rheumatology\\n- Inpatient consult to Case Management\\n\\nCondition at Discharge:\\n\\nStable\\n\\nDisposition:\\n\\nHome or Self Care\\n\\nPatient Instructions:\\n\\nDischarge Medications\\n\\nNew Medications\\n\\ndexamethasone 4 mg/mL CONCENTRATED solution\\n\\nfamotidine 40 mg tablet\\n\\nCommonly known as: PEPCID\\n\\nSig\\n\\nTake 45 mL (180 mg total) by mouth daily for 1 dose. See comment\\n\\nTake 1 tablet (40 mg total) by mouth daily.\\n\\n6/9'},\n",
              " {'page': 14,\n",
              "  'page_content': '05/22/2024 WED 11:35 FAX\\n\\n015/028\\n\\n8/22/24, 10:39 AM\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**\\n\\n**Graduates**'}]"
            ]
          },
          "metadata": {},
          "execution_count": 11
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pytesseract\n",
        "from PIL import Image"
      ],
      "metadata": {
        "id": "6sVgPd2tEMLj"
      },
      "execution_count": 12,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "img = Image.open(\"page_14.png\")\n",
        "#TEST\n",
        "# Run OCR with Tesseract or any other visual OCR engine\n",
        "text = pytesseract.image_to_string(img)\n",
        "\n",
        "print(text)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GDqkqQncELSu",
        "outputId": "f14ea000-3326-4a03-ef35-e58fbc39e564"
      },
      "execution_count": 13,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "05/22/2024 WED 11:35 FAX MIVLI/V29\n",
            "5/22/24, 10:39 AM\n",
            "\n",
            "ae : , cs « ‘a\n",
            "predniSONE 20 mg tablet Taka 3 tablets (60 mg total) by mouth daily for 7\n",
            "\n",
            "Commonly known as: DELTASONE days, THEN 2 tablets (40 mg total) daily for 7\n",
            "\n",
            "Start taking on: May'16, 2024 days, THEN 1 tablet (20 mg total) dally for 7\n",
            "days, THEN 0,5 tablets (10 mg total) daily for 7\n",
            "days, Then stop.\n",
            "\n",
            "Activity instructions\n",
            "\n",
            "Discharge activity - Normal Activity\n",
            "\n",
            "Some medications such as for example pain medications and sleeping or anti-anxiety agents may affect your\n",
            "abllity to operate heavy machinery including driving. Please always carefully read the labels on the medications\n",
            "that you take, If you have experienced confusion, seizures, lightheadedness or blackouts then it may not be safe\n",
            "or even Jegal for you to operate heavy machinery (Including driving). Please act in the interest of your own safety\n",
            "and that of others. Speak to a physician If you ara not sure whether it Ie safe or legal for you to drive,\n",
            "Care Instructions: You should engages In exercise as tolerated to improve your health. You may go to the website\n",
            "of the American Heart Association for additional information and tips an how to exercise right\n",
            "\n",
            "(WWW. americanheart.org).\n",
            "Scheduled Appointments\n",
            "May 22, 2024 10:30 AM 2211 Broad Way\n",
            "Pads Infusion (Leantaas) with PEDS INF UMBRELLA, Tower 4th FL, Suite 6102\n",
            "PEDS 241+ MIN INFUSION Nashville TN 37232\n",
            "Childran’s Hematology - Oncology (Peds DOT 6) 615-936-1762\n",
            "\n",
            "7/9\n",
            "\f\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def extract_page_contents_fallback(pages):\n",
        "  pages_content = []\n",
        "  for i in range(pages):\n",
        "    img = Image.open(f\"page_{i}.png\")\n",
        "    text = pytesseract.image_to_string(img)\n",
        "    content = {\n",
        "        \"page\": i,\n",
        "        \"page_content\": text\n",
        "    }\n",
        "    pages_content.append(content)\n",
        "  return pages_content"
      ],
      "metadata": {
        "id": "RWeVGWxLRkKr"
      },
      "execution_count": 14,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "pytes_results = extract_page_contents_fallback(page_num)\n",
        "pytes_results"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "dWh27jLzS-pW",
        "outputId": "62ac1dc1-24ff-49fc-a6d3-c03577f6872f"
      },
      "execution_count": 15,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[{'page': 0,\n",
              "  'page_content': \"04/22/2024 WRD 11:32 FAX KIVULAU Sd\\n\\nFAX TRANSMISSION\\n\\nBetter Lie Multiple Sclerosis Center\\n3320 Montgomery Dr> Nashville, TN 37364\\nF 618-662-4820 P: 615-562-4848\\nDr. Asriel Han | Dr. Aditya Shan\\n\\nBetterLife\\n\\nTO: Golden Gate Infusion Center\\n\\nFax: ~G/4—-2-75-5 35S Phone Orazge 57 ONT\\n\\nFrom: Erfan Rostami, BSN, RN\\n\\nPages P: 618-343-1176\\n\\n(including cover sheet)\\nF: 615-343-1219\\n\\nComments:\\n“7 OS ) . +r\\n(Arav'e — Seoten / Sng bsin ~ aa ~)\\n7 i baxter (Truse, ma ) TY?\\n\\n~ mee pout\\n- Hos | dé cM be\\n\\n- Demonnogh« 9\\n\\nThe documents accompanying this transmission may contain health information that Is legally protected. This information ia intanded only\\nfor the use of the Individual or entity named above, The authorized recipient of this information ts prohibited from disclosing this\\nInformation to any other party unless permitted by law or regulation.\\n\\nIf you ara not the intended recipient, you are hereby notified that any use, dlaclosura, copying or distribution of thease dacumeants ls strictly\\nprohibited. If you have received this Information tn error, please notify tha sender Immediately and arrange for the return or destruction of\\nthese documents.\\n\\n \\n\\x0c\"},\n",
              " {'page': 1,\n",
              "  'page_content': \"05/22/2024 WED 11:32 FAX BywWe/ Vee\\n\\n§/22/24, 11:10 AM\\n\\nAbdulla, Shakh MRN: 041152153\\n!\\n\\nCommunication 5/16/2024 provider: Etfen Rostsmi, rN\\n\\nStatus: Open Reason for call: Truxima Second Initial Dose Needed Week of June 3\\n\\nBetter Life Multiple Sclerosis\\n\\nCenter\\n\\nAll Conversations: Truxima Second Initial Dose Needed Week of June 3 _\\n\\nMay 21, 2024\\nJha, Vedant to Erfan Rostami, RN\\n\\nHi Erfan 5/21/24 4:44 PM\\nThe only way Extraodinary Care could sea his Medicaid plan would be at hore :( I'm not sure\\n\\nif he is able to be seen at a hospital based infusion center closer to home?\\n\\n(Newest Message First)\\n\\nWe will hold off on this one for now- let me know if you're not able to find a provider who can see\\nhim in the infusion suite and we will re-open the referral.\\n\\n| Vedant\\nErfan Rostami, RN routed this conversation to ina, Vedant $/21/24 2:32 PM\\nMay 20, 2024\\nGu, Hao H, MD to Erfan Rostami, RN\\n4 Note 5/20/24 5:13 PM\\nHl\\n\\nSecond dos 2 waeks from may 23 first\\nErfan Rostami, RN routed this conversation te Gu, Hao H, MD 5/20/24 3:41 PM\\nJha, Vedant to Erfan Rostami, RN\\n\\nHi\\n\\n5/20/24 2:54 PM\\nls Dr, Gu camfortable with this patient being seen for home Infusion?\\n\\nThanks,\\n\\n1/3\\n\\x0c\"},\n",
              " {'page': 2,\n",
              "  'page_content': '05/22/2024 WED 11:33 FAX KIVVo/ Vad\\n§/22/24, 10:33 AM Abdulla, Shakh (MR # 041162163) DOB: 04/01/2001\\n\\nShakh Abdulla Therapy Plan 1 Summary\\n\\nMRN: 041182153 Description male DOB: 4/1/2001\\n\\nNf oP ea <meta see eer ee eT eee errr rrr at ro ec re re ee Yer eee ee ee eee ee pet, YONA L sD feewmgedyenpeom cman enemees aston meet\\n\\n \\n\\nPatient Demographics\\nPatient Name Legal DOB Address Phone\\nAbdulla, Shakh SEX 4/1/2001 425 Sherman Ave 865-395... 3958(Home)\\nmale 865-395... 0481 Mobile)\\nNashville TN 37995 *Preferrad* |\\nMedication\\nRituximab Or Biosimilar Days 1, 15 Load Then Once Eva 24 Weeks\\n® Associated Problems\\nProblem Selected Diagnosis\\nMultiple sclerosis in pediatric patient (CMS/HCC) [G35] Multiple sclerosis in pediatric patient (CMS/HCC) [G35]\\nInfusion Orders i\\nla) All Current Orders\\nInterval Duration Due\\nNursing Orders iam MT TUS aespatinemmmsiiiahtass. nue Retinitis tation,” <n 6 besmmsneesnist\\nwf iD IV access — Every visit Every visit\\n\\nCare Instructions: Obtain IV access (PIV, PORT, ete.) and start NS 0.9% @ KVO\\n\\nUntil discontinued Starting when released Until Specified\\n\\nLast released: Never Electronically Signed By: Gu, Hao H, MD on 5/15/2024\\nS:1 1PM\\n\\nwf mm Monitor pt for hypersensitivity reaction Every visit Every visit\\n\\nOnce Starting when released for 1 occurrence\\n\\nIf allergic reaction or infusion related reaction occurs, initiate adult hypersensitivity reaction protacol or\\n\\npediatric guideline and CAUL MD for additional orders,\\n\\nLast released: Never Electronically Signed By: Gu, Hae H, MD on 5/15/2024 :\\nwv @ NURSING COMMUNICATION ery visit. Every visit 7\\nCare Instructions: Ensure that patient has not taken antihypertensive medications in the 12 hours prior to 7\\ninfusion\\nUntil discontinued Starting when released Until Specified\\nLast released: Never Electronically Signed By: Gu, Hae H, MD on 5/15/2024\\n_ 11 PM\\nwf NURSING COMMUNICATION Every visit | ~ Every visit\\n\\nCare Instructions: For hypotension, place patient in Trendelenberg position, support with NS, and call MD\\nUntil discontinued Starting when released Until Specified\\n\\n \\n\\n114\\n\\n \\n\\x0c'},\n",
              " {'page': 3,\n",
              "  'page_content': '05/22/2024 WED 11:33 FAX KIvve/ Vad\\n\\n6/22/24, 10:33 AM Abdulla, Shakh (MR # 041152153) DOB: 04/01/2001\\non oo ‘Interval Duration ~ \"Due Electronically\\n\\nLast released: Never Signed By: Gu, hao MD on 5/15/2024 5:11 PM\\n\\nwv th IgG Every 24 weeks Week of 5/19/2024\\nClinle Callect, Blood\\nLast released: Never Electronically Slgned By: Gu, Hao H, MD on 5/15/2024\\n\\n111 Monet aipstomens rege ry bm r eel NESE MAE AUET IY MCT non nee Sng 00 A YP OND RAN aU AN A ABA Na, ae mt net mH PTY 3 11 PM sap daonte AEP PM ADRD AN AADAC PORE MATURE MMU A Fetes teem yaaa tee Amnesia\\n\\nWw we CBC w/ Differential ‘Every visi t Every visit.\\nOnce Starting when released, Blood\\nLast released: Never Electronically Signed By: Gu, Hao H, MD on 5/15/2024\\n\\n5:17 PM.\\n\\n“? um’ Blow Lymphocytes Subsets (TBNK) Every visit Every visit\\nOnce Starting when released, Blood\\nLast reteased: Never Electronically Signed By: Gu, Hao H, MD on 5/18/2024\\n\\n5:11 PM\\n\\nof of Vital Signs | Every visit Every visit\\nCare Instructions: Obtain VS prior to start therapy, Q30 minutes with each dose increase and at the end of\\ntreatment.\\nAs needed Starting when released Until Specifled\\nLast released: Never Elactronically Signed By: Gu, Hao H, MD on 5/18/2024\\n\\n1 rep Ar eee Ae ROMA Ni MPAA gs era et i my Ard pun AP A RPE A ARN AEN Pe a ea tm a ep\\n\\nHydration\\nmL\\n\\n5 mL, intraVENOUS, As needed, For flushing Ports/ PICC lines/ Central Lines IF NEEDED, Starting when\\nreleased, Until Discontinued\\n\\nMedral} (20 mg/mL) 125 mg in NS 6.2 mL\\n\\n \\n\\nwo a ‘heparin, porcine (PF) 100 ‘unit/mL “syringe 5 5 “PRN ELS PRN oe\\n\\nLast released: Never Seen Signed By: Gu, Hao H, MO on 5/15/2024\\nPre-Medications ld meee errrtreona lS se over eerste mm Faexschieo\\n\\nowe acetaminophen (T YLENOL) tablet 650 mg Every visit Every visit\\n\\n650 mg, oral, Once, Starting when released\\n\\nLast released: Never Blectienlesily Signed By: Gu, Hao H, MD on 5/15/2024\\n“fo diphenhydrAMINE (BENADRYL) 50 mg in 50 Ean) visi t Every visit\\n\\nmL NS\\n\\n50 mg, intraVENOUS, Once, Starting when released\\n\\nAdminister 30 minutes before starting infusion.\\n\\nLast released; Never Electronically Signed By: Gu, Hao H, MD on 5/15/2024\\n\\nie omeqee =: os apweeg a 1 1 PM sisting ninininieniinienpr niente ne nape ee\\n\\n/ m methylPREDNiSolone sod suceinate (SOLU- “Every visit. Every visit\\n\\nai4\\n\\x0c'},\n",
              " {'page': 4,\n",
              "  'page_content': \"05/22/2024 WED 11:33 FAX KVQ9/028\\n5/22/24, 10:33 AM Abdulnabl, Noor (MR # 0481521 63) Dos: 01/01/2008\\n\\ninterval ‘Duration Due\\n125 mg, intraVENOUS, Once, Starting when released\\nAdminister 30 minutes before starting infusion.\\n\\nLast released: Never Elactronically Signed By: Gu, Hao H, MD on 5/18/2024 5:11\\nPM\\nInfusion Therapy ean daca nad eee aooeene noe\\n” & NURSING COMMUNICATION ~ Every visit Every visit\\n\\nUntil discontinued Starting when released Until Specified\\nInfusion rate (standard only)\\nist infusion - initiate at SOmg/hr and if no infusion toxicity reaction, may increase by SOmag/hr ever 30\\nminutes; Max Rate 400mg/hr\\nSubsequent infusions - initiate at 100mg/hr and if no infusion toxicity reaction, may increase by 100mg/hr\\nevery 30 min; Max Rate 400mg/hr\\nLast released: Never Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11\\nPM\\nInfusion Therapy - Initial Dose | Be\\nwf St riTUXimab-abbs (TRUXIMA) IVPB Every 2 weeks 2/2remaining Week of 5/19/2024\\n694 mg (rounded from 693,75 mg = 375 mg/mé x 1.85 me - BSA might be out of date), intraVENOUS, Once,\\nStarting 30 minutes after treatment start time\\nLast released: Never Electronically Signed By: Gu, Hao H, MD on 5/15/2024\\n5:11 PM\\nInfusion Therapy - Maintenance Dose situa inccnaiale mairiiataaCIET. Ii So PURE eee:\\nwv M@ riTUXImab-abbs (TRUXIMA) IVPB Every 24 weeks Mon 11/4/2024\\nDefer until; Mon 11/4/2024\\n694 mg (rounded from 693.75 mg = 375 mg/m2 « 1.85 m2 - BSA might be out of date), intraVENOUS, Once,\\nStarting when released\\n\\nLast released: Never Electronically Signed By: Gu, Had H, MD on 5/13/2024 5:11\\nPM\\naS a diphenhydrAMINE (BENADRYL) injection 25 PRN PRN\\nmg\\n25 mg, intraVENOUS, As needed, chills, Starting when released, for 2 dases\\nLast released: Never Electronically Signed By: Gu, Hao H, MD an $/15/2024\\nTe igpauiue Simei a ccm iat yeaa ato ous ge 5:11 PM : ‘ (seta) ipl eed rns\\nw «' meperidine (DEMERQL) injection 25 mg PRN PRN\\n25 mg, intraVENOUS, As needed, rigors, Starting when released, for 2 doses\\nLast released: Never Electronically Signed By: Gu, Hae H, MD on 5/15/2024\\n5:17 PM\\now i ondansetron (ZOFRAN) injection 4 mg PRN PRN\\n\\n4 mq, intraVENOUS, As needed, nausea, vomiting, Starting when released, for 2 doses\\n\\nDoses up to 4 mg may be administered undiluted. Inject aver at least 30 seconds, but preferably over 2-5\\n\\nminutes,\\n\\nLast released: Never Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11\\nPM\\n\\n \\n\\neSignature Information\\nAll order signatures are valid for 1 (ane) year fram the signature date.\\nProvider Contact Information\\n\\n3/4\\n\\x0c\"},\n",
              " {'page': 5,\n",
              "  'page_content': '05/22/2024 WED 11:34 FAX\\nS/22/24, 10:33 AM\\n\\nHao H Gu, MD (NPI: 1154641523)\\n\\nBatter Lifa Multiple Sclerosis Center\\n\\nAbdultabl, Noor (MR # 048162153) DOB: 01/01/2008\\n\\n3320 Montgomeny Dr NASHVILLE TN 37361\\n\\n614-936-0065\\n\\nKIVVO/U Ad\\n\\n4/4\\n\\x0c'},\n",
              " {'page': 6,\n",
              "  'page_content': \"0§/22/2024 WED 11:3@ FAX\\n\\nBetter Life\\nMultiple Sclerosis\\n\\nCenter\\n\\nENCOUNTER\\n\\nPatiant Class:\\nAdmission User:\\nAdmitting Provider:\\nAttending Provider:\\n\\nKJQO7/ 028\\n\\nPatient: Shakh Abdulla\\n\\nHospital A/C:\\n\\nVO0J-7KR2-484T91.GFA\\n\\n \\n\\nCare Everywhere IDA;\\n\\nAdmixsion Qate/T'ime:8/1 7/2024\\nReforring Physician:\\n\\n \\n\\nAdin Diagnosis: Mylfeulth Bundle Status:\\nPATIENT\\nName: = Shakh Abdulla\\nAddress: 428 Sherman Aves APT D\\n\\nCity:  Avashvitte TN 37923\\n\\names David, PNP\\nMarital Status: Single\\n\\n-BMERGENCY CONTACT\\n\\nContact Name .eaal, Guardian?\\n1, Sina, Amin Yes\\n2. Mohammedreza, Musiala «= Yos\\n\\nPrimary Care Provider:\\n\\nFather\\nMother\\n\\nGuarantor\\nAddress:\\n\\nRelation ta Patient:\\n\\nGuarantor 1D:\\n\\nGUARANTOR EMPLOYER\\nThere Is no Quarantar Information entered for this encounter,\\nCOVERAGE\\nPRIMARY INSURANCE\\nPayor:\\nGroup Number:\\nSubsertbar Name;\\nStubseriber ID;\\nPat. Rel, to Subsorlber:\\nSBCONDARY INSURANGE 9 oop\\nPayor!\\nGroup Number:\\n\\nSubscriber Name:\\nSubscriber 17):\\nPat. Rel. to Subseriber:\\n\\nMay 22, 2024\\n\\n \\n\\nDOB:  4/1/200) (23 yrs)\\nSex: malo\\nProf Lang: Arable\\nPrimary Fhone: §68-839-7458\\nMobile Phone: 865-839-7458\\n\\nHom Phong Work Phone\\n\\nDOB: 10/29/1979\\n\\nSex: Female\\n\\nHome Phone:\\nMohile Phone:\\nWork Phone:\\n\\nStaius;s NOT EMPLO*\\n\\nPian; TC BLUE CARE NO COPAY\\nInsurance Type:\\nSubseriber DOB:\\nFinancial Class:\\n\\nPlatt:\\nInaurance Type:\\nSubscriber DOB:\\n\\n \\n\\nHospital Face Sheet\\n\\x0c\"},\n",
              " {'page': 7,\n",
              "  'page_content': '05/22/2024 wed 11:34\\n5/22/24, 10:37 AM\\n\\nPrimary Coverage\\nBC TENNCARE\\n\\nPrimary Subscriber\\n\\nID\\nLAJM14345116\\n\\nFAX\\nAbdulnabi, Noor (MRN: 041162163) DOB: 4/1/2001\\n\\nPlan... Spensor Code... Group Number Group Name\\nTC BLUE CARE NO 435000 TENNCARE/BLUECARE\\n\\nCOPAY\\n\\nVale TE a” GRE! weosa\\nABDULLA,SHAKH Kxx-XH~8 143 8327 BROADWAY LN\\nAPT D\\nKNOXVILLE, TN 37923\\n\\nWYVS/ 049\\n\\n4/4\\n\\x0c'},\n",
              " {'page': 8,\n",
              "  'page_content': \"05/22/2024 WED 11:34 FAX Vs as\\n6/22/24, 10:39 AM\\n\\n \\n\\nAbdulla, Shakh MRN: 048152153\\n\\nER ta Hosp-Admission Last attending: Marry, Tom, MD + with Treatment\\n§/14/2024 ~ 5/17/2024 (3 days) team Principal problem: Abnormal MRI\\n\\nStatus: Discharged\\n\\nMonroe Carell Jr. Children's\\n\\nHospital\\n\\n \\n\\nDischarge Summary Kaine, Adam Jason, MD (Resident Physician) + Pediatric Neurology —\\nGosigned by: Gu,Hao H, MD at 5/17/2024 1:56 PM\\n\\nAttestation signed by Gu, Hao H, MD at 5/17/2024 1:5%@ PM (Updated)\\n\\n| saw the patient on: 5/17/2024 with Dr Kaine, | discussed the care with Dr Kaine, patient and\\nhis father at bedside and agree with the findings and plan as documented in the attached\\nnote.\\n\\n| personally spent more than 30 minutes on the patient's care unit In the preparation and\\nexacution of the hospital discharge.\\n\\nS/p 4 days of high dose IVMP (1g/dose) today-\\n\\nDischarge home with oral decadron 180mg (equivalent to 1000mg IVMP) x1 to round out §\\ndays of high dose steroid treatment for active demyelinating leslon (family wishes to be\\ndischarged today instead of Saturday)\\n\\nhe will then start oral prednisone taper- Instructions provided +PP!\\n\\nFirst dose of Rituximab or biosimilar scheduled for May 22 at 9am; second dose of first course\\nof Rituximab within 2 weeks after, we are working with local infusion facility in Knoxville to\\nget this set up for her moving forward to minimize travel\\n\\nhe will follow up with ophthalmologist in Knoxville |\\nSchool note for this week and next week |\\nPT/OT locally |\\nContinue vitamin D |\\n( will see her tentatively 3 months after completion of ist course of Rituximab -with same day\\n\\nMRI (she does not need sedation)- looking at early or mid September. Will update family once\\nwe have that arranged\\n\\n' ao Gu MD\\n\\nNeurology Discharge Summary\\n\\nPatient Name: Shakh Abdulla\\nDOB; 4/1/2001\\n\\nService: Pediatric Neurology\\nAttending: Harry, Tom, MD\\nDate of Admission: 5/14/2024\\n\\x0c\"},\n",
              " {'page': 9,\n",
              "  'page_content': '05/22/2024 WED 11:34 Fax KIVLO/VZs\\n\\n5/22/24, 10:39 AM\\nDate of Discharge: 5/17/2024\\n\\nDiagnosis:\\nPrinelpal Problem:\\nAbnormal MRI\\nResolved Problems:\\n* No resolved hospital problems. *\\n\\nProcedures: |\\nBedside Procedures:\\nNo orders of the defined types were placed in this encounter.\\n\\nOR Procedures:\\n\\n* Cannot find OR case *\\n\\nSynopsis:\\n\\nShakh Abdulla is a 23 year old male who established care with VCH neurology ; with MRI brain and spine\\ndemonstrating multipla lasions consistent with atypical pediatric MS.\\n\\nHospital Course:\\n\\nShakh Abdulla is a 23 year old male with history of optic neuritis and abnormal MRI brain concerning for\\nMS who presented for admission following clinic visit and neuroimaging today, History from primary\\nneurologist, clinic visit and patient and father at bedside, Patient referred to Or. Gu by Dr. Fazal in East\\nBay Confirms predominant symptoms since April of numbness in his right hand and urinary\\nhesitaney/urgency. Additionally reporting right eye pain since tire of clinic visit this morning. MRI brain and\\nspine obtained following clinic visit and multiple lesions noted on brain and spine suggestive of pediatric\\nMS. Presents for admission for IVMP.\\n\\nPer. clinic visit sarller today with Or Gu.and confirmed with family at bedside:\\n\\nShakh /s a 23 years old male, previously healthy who has been referred to neuroimmunology clinic for\\ndiagnosis of optic neuritis and abnormal brain MRI concerning for MS. He is referred by Dr Fazal-pediatric\\nneurology in East Bay\\n\\nhe /s here with dad; patient himself is an excellent historian and provided the following informations | do\\nnot have CSF results nor clinic note- / do have MRI report from Jan 21 2024 (no actual images)- with\\nfather and his permission, | reached out to Or Shane- Dr Fazal\\'s colleague on service who can help assist\\nwith quick access to Shakh\\'s chart.\\n\\nToday, Shakh tells me that around early Oct 2023- he started to notice In right eye \"nean bright color”\\nfuzzy vision, and eye pain with movement and perhaps right side of his face in discomfort triggered by\\nphysicel activities . Symptoms improved once he rested. By end of Qet 2023, he brought this up to\\nparents and was brought to local eye doctor and recalled being told that’right eye being inflamed\" and he\\nrecalled visual field deficits appreciated during exam.\\n\\nHe was referred to UT ophthalmology Dr Derrek in Jan this year, per raport negative MOG and AQP4\\n[While waiting on this appt, he thought some Improvernent but not back to baseline entirely -\"not\\ncompletely normal\")\\n\\nWhen he saw UT ophthalmology clinic, recommended brain and orbit and noted WM changes and MS\\nwas mentioned. He was treated with &§ days of |\\\\VMP and referred to see Dr Kosentka ped neurology.\\n\\nMRI report from Jan 21 2024- \"Diffuse T2 hyperintensity and decreased volume throughout the right optic\\nnerve is similar to prior examination however assocaited abnormal enhancement seen on prior study has\\nrasoved, presumably secondary to interveal treatment.\\n\\nLeft optic nerve | subtle but diffusely small in caliber without significant change from last exam,\\n\\nSeveral intracranial WM lesions, stable from last\"\\n\\nHe saw Or Fazal in Feb 2024-who obtained LP and had markers of MS and referred to MS clinic today.\\nBelow ara information provided by Dr Shane. Per note recommended referral to our MS center for\\nPrinted by O\\'Rourke, Cvdale 8. RN at 8/22/2024 10:39 AM 2/9\\n\\x0c'},\n",
              " {'page': 10,\n",
              "  'page_content': '05/22/2024 WED 11:35 FAX Biiwats Vv\\n\\nO/2e/e4, 10:39 AM\\n\\nfurther evaluation and treatment.\\nCSF ?WBC, 837 rbc, IgG Index 0.87 (elavated), +OCB\\n\\nPrior to appt today May 14- he nated that in April of this year, started to have invalvement of LEFT eye -\\nagain similar with \"neon colors appearance\", some eye discomfort; it happened several times during the\\n\\nday for a faw days and has since resovied\\n\\nSince April he has had intermittent numbness Ih his right hand (dominant hand)+ along with muscle\\ntwitch in his hands and shoulder like tics\\n\\nHe has noticed a change with urinary hesitancy- taking a long time to empty his bladder and in addition\\nurinary urgency\\n\\nHe has not noticed weakness but noted intermittent drifting to right side, burping in to things\\n\\nHe does nate that at times when he laughs, bands his neck, does note alactrical sensation\\nAcademically doing very well, no difficulty\\n\\nSleeps well\\n\\nFamily history: parents and brothers are healthy\\nFloor course (05/14 -\\n\\nPatient was admitted to the wards in a stable condition.\\n\\nPatient was initiated on high dose sterolds for § days and tolerated well. MRI consistent with lesions in\\nthe brain and spinal cord consistent with atypical MS. ANA was positive as well as SSB so rhaumatology\\nwas consulted but felt she did not have evidence of another systemic autolmmune disease. PT/OT\\nevaluated his and he will follaw outpationt. He was de with Decadron and then steroid taper with Pepcid\\nprophylaxis. Ha was arranged to have outpatient rituximab and Dr. Gu will follow his in clinic.\\n\\nPhysical Exam:\\nTemp: (36.5 °C A 7 °F)-36.7 °C (98.1 °F)] 36.7 °C (98 °F)\\nPulse: [81-99] 84\\nResp: [16-18] 16\\nBP: ( 122-1 Tos 126/63\\nSpO2: (88 %] 98 %\\n\\nPhysical Exami\\n\\nTamp: [36.5 °C (97.7 °F)-38.7 °C (98.1 °F)] 36.7 °C (98 °F)\\nPulse: [81-99] 84\\n\\nResp: [16-18] 16\\n\\nBP: (122-136)/(63-99) 126/63\\n\\nSpO2; (98 %] 98 %\\n\\n-Well appearing; NAD\\n\\nCV!\\n-RRR\\n\\nHIGHER INTEGRATIVE FUNCTIONS:\\n-Attentlon & concentration; Normal\\n-Orlentation: Orlanted to person, place & time\\n-Memory: Recent and remote mamory Intact\\n-Language: Normal\\n\\n-Fund of Knowledge: Normal\\n\\nCRANIAL NERVES:\\n\\n“CN 2: Visual flelds full\\n\\n«GN 2,3: PERRL; rAPD\\n\\n“ON 3,4,6: EOMI\\n\\n-CN &: Faclal sensation intact\\n\\n-ON 7: Facial strength/movement Intact bilaterally\\n\\nPrinted by O\\'Rourka. Cydnie B. RN at 5/22/2024 10:39 AM\\n\\x0c'},\n",
              " {'page': 11,\n",
              "  'page_content': \"05/22/2024 WED 11:35 FAX YyVle/ Vas\\n\\n5/22/24, 10:38 AM\\n-CN 8; Hearing normal bilaterally\\n“GN 9,10: Palate elavates symmetrically\\n“CN 14: Normal shoulder shrug and head turn\\n-CN 12: Tongue protrudes midiine\\n\\nMOTOR:\\n-Muscla tone normal In upper and lower extremities\\n-Muscle strangth 5/5 In upper and lower extremities; RLE 4+ proximally\\n\\nSENSATION:\\n-Intact to light touch in upper and lower extremities bilaterally\\n\\nCOORDINATION:\\n-Finger/nose intact bilaterally\\n\\nGAIT:\\n«Normal gait\\n\\nImmunizations/Injections Administered for This Admission\\n\\nNo immunizations on file.\\n\\nAllergies:\\nNo Known Allergies\\nDiagnostic Studies:\\nRecent Results (from the past 24 hour(s)\\nCBC wi Differential\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult Value Ref Range\\nWhite Blood Cells 7.7 3.4 - 10,2\\nX10(3)/meL\\nRed Blood Celis 4,63 3.80 - 5.50\\nx10(6)/meL\\nHemoglobin 13.0 12,0 » 16.0\\ngm/d.\\nHematocrit 40 35 - 49 %\\nMean Cell Volume 86 76 - 96 fl\\nMean Cell 28.1 29.0 = 35.0\\nHemoglobin pg\\nMean Cell 32.7 32.0 + 37.0\\nHemoglobin gm/dL.\\nConcentration\\nRDW SD 38.4 ae ~ 52.4\\nRDW CV 12.3 Ne - 14.3\\n0\\nPlatelet 300 150 - 400\\nx10(3)/mel\\n\\nPrinted by O'Rourké. Cvdala B, RN at §/22/2024 10:39 AM 4/9\\n\\x0c\"},\n",
              " {'page': 12,\n",
              "  'page_content': '05/22/2024 wed 11:35\\n\\n6/22/24, 10:38 AM\\n\\nFAX\\n\\nMean Platelet 10,0 9.3» 12.8 fl.\\nVolume\\nNucleated RBC 0) 0-0/100\\nWBC\\nNucleated RBC 0.00 0.00 - 0.00\\nAbs X10(3)/moL\\nAuto Neutrophil 4.52 1,80 - 7.70\\nAbsolute x10(3)/mel.\\nCMP\\nCallaction Time: 05/14/24 10:47 AM\\nResult Value Ref Range\\nSodium Level 139 138 - 145\\nmmol/L\\nPotasslum Level 3.8 3,3 - 4.8\\nmmol/L\\nChloride Level 101 98 - 107\\nmmol/L.\\nCarbon Dioxide 22 17 - 28\\nmmol/L\\nAnion Gap 16 mmol/L\\nGlucose Level 95 60 - 99\\nmg/dL.\\nBlood Urea 13 7-18\\nNitrogen mg/dl.\\nCreatinine Level 0.67 0.50 - 0.90\\nmg/dl\\nCalcium Level 9.9 8.4 - 10,2\\nTotal mg/dL\\nBillrubin Total 0.4. 0.0 - 0,7\\nmg/dL\\nAlbumin Level 4.7 4.0+5.3\\ngm/dt.\\nProtein Total 8.4 (fH) 6.3-7.8\\ngm/dL\\nAlkaline 55 50-117\\nPhosphatase unit/L\\nAspartate 25 21-34\\nAminotransferase Unit/L,\\nAlanine <6 0-17 univ/L\\nAminotransferase\\nHopatitis B Pn\\nCollection Time: 05/14/24 10:47 AM\\nResult Value Raf Range\\nHepatitis B Surface Negative Negative\\nAntigen\\nHep B Core Ab Negative Negative\\nTotal\\nHepatitis B Surface 44.7 (H) <=10.0\\nAb Unit mlU/mb\\n\\nHep Bs Ab Interp Positive (A) Negative\\n\\nResult\\n\\nIgG Quantitative\\n\\nVale\\n\\n1,355 (A)\\n\\nyG\\nCollaction Time: 05/14/24 10:47 AM\\n\\nRef Range\\n600 - 1,310\\nmg/dL\\n\\nIVI S/ 29\\n\\x0c'},\n",
              " {'page': 13,\n",
              "  'page_content': '05/22/2024 WED 11:35 FAX KVLe/Qag\\n6/22/24, 10:38 AM\\n\\nIgA\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult Value Ref Range\\nIgA Quantitative 279 40 - 290\\n\\nmg/dl.\\n\\nAuto Diff\\nCollection Time: 05/14/24 10:47 AM\\n\\nResuit Value Ref Range\\nNeutrophils 58.3 %\\nAbsolute 4.52 1,80 - 7.70\\nNeutrophils x10(3)/mel.\\nLymphs 33.6 %\\nAbsolute 2.60 1.70 «4.50\\nLymphocytes x10(3)/mel.\\nMonacytes 6.5 %\\nAbsolute 0.60 0.20 - 1.00\\nMonocytes %10(3)/meL\\nEosinophils 0,5 %\\nAbsolute 0.04 0.00 - 0.50\\nEosinophils x10(3)/mcL.\\nBasophils 0.8 %\\nAbsolute Basaphils 0.06 0,01 - 0.08\\n\\nx10(3)/meL\\n\\nImm Gran 0.3 %\\nAutomated\\nAbsolute Imm 0.02 0.00 - 0.03\\nGran Automated x10(3)/meL\\n\\nConsultations Obtained:\\n\\nOrders Placed This Encounter\\n\\nProceduras\\n* Inpatient Consult to Pediatric Ophthalmolagy\\n* Inpatient Consult to Pediatric Rheumatology\\n* Inpatient consult to Case Management :\\n\\nCondition at Discharge:\\nStable\\n\\nDisposition:\\nHome or Salf Care\\n\\nPatient Instructions:\\n\\nDischarge Medications\\n\\nNew Medications\\n\\ndexamethasone 4 mg/mL CONCENTRATED Take 45 mL (180 mg total) by mouth daily for 1\\n\\nsolution dose, See comment\\nfamotidine 40 mg tablet Take 1 tablet (40 mg total) by mouth daily.\\n\\nCommonly known 8: PEPCID\\n\\n6/9\\n\\x0c'},\n",
              " {'page': 14,\n",
              "  'page_content': \"05/22/2024 WED 11:35 FAX MIVLI/V29\\n5/22/24, 10:39 AM\\n\\nae : , cs « ‘a\\npredniSONE 20 mg tablet Taka 3 tablets (60 mg total) by mouth daily for 7\\n\\nCommonly known as: DELTASONE days, THEN 2 tablets (40 mg total) daily for 7\\n\\nStart taking on: May'16, 2024 days, THEN 1 tablet (20 mg total) dally for 7\\ndays, THEN 0,5 tablets (10 mg total) daily for 7\\ndays, Then stop.\\n\\nActivity instructions\\n\\nDischarge activity - Normal Activity\\n\\nSome medications such as for example pain medications and sleeping or anti-anxiety agents may affect your\\nabllity to operate heavy machinery including driving. Please always carefully read the labels on the medications\\nthat you take, If you have experienced confusion, seizures, lightheadedness or blackouts then it may not be safe\\nor even Jegal for you to operate heavy machinery (Including driving). Please act in the interest of your own safety\\nand that of others. Speak to a physician If you ara not sure whether it Ie safe or legal for you to drive,\\nCare Instructions: You should engages In exercise as tolerated to improve your health. You may go to the website\\nof the American Heart Association for additional information and tips an how to exercise right\\n\\n(WWW. americanheart.org).\\nScheduled Appointments\\nMay 22, 2024 10:30 AM 2211 Broad Way\\nPads Infusion (Leantaas) with PEDS INF UMBRELLA, Tower 4th FL, Suite 6102\\nPEDS 241+ MIN INFUSION Nashville TN 37232\\nChildran’s Hematology - Oncology (Peds DOT 6) 615-936-1762\\n\\n7/9\\n\\x0c\"}]"
            ]
          },
          "metadata": {},
          "execution_count": 15
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "client = genai.Client(api_key=userdata.get(\"GOOGLE_API_KEY\"))"
      ],
      "metadata": {
        "id": "_4X5tjjJ3Fm5"
      },
      "execution_count": 16,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def evaluate_page(page_num, mistral_text, pytess_text):\n",
        "    prompt = f\"\"\"\n",
        "You are comparing two OCR outputs from page {page_num} of a medical document.\n",
        "\n",
        "Choose the output that is:\n",
        "- More accurate and complete\n",
        "- Less likely to include hallucinated or repeated content\n",
        "- Reflective of a medical fax or discharge summary\n",
        "\n",
        "Do NOT answer with just \"A\" or \"B\".\n",
        "Do NOT describe your reasoning.\n",
        "Instead, return the full content of the better OCR output below.\n",
        "\n",
        "### OCR Output A (Mistral):\n",
        "{mistral_text}\n",
        "\n",
        "### OCR Output B (Tesseract):\n",
        "{pytess_text}\n",
        "\n",
        "Respond with a strict JSON object ONLY, containing the better content:\n",
        "{{\n",
        "  \"page\": {page_num},\n",
        "  \"content\": \"<<<full better OCR text here>>>\"\n",
        "}}\n",
        "No markdown, no extra text — just JSON.\n",
        "\"\"\"\n",
        "\n",
        "    response = client.models.generate_content(\n",
        "        model=\"models/gemini-2.0-flash\",\n",
        "        contents=prompt\n",
        "    )\n",
        "\n",
        "    return response.text if hasattr(response, \"text\") else str(response)\n",
        "\n",
        "\n",
        "import asyncio\n",
        "from concurrent.futures import ThreadPoolExecutor\n",
        "\n",
        "executor = ThreadPoolExecutor()\n",
        "\n",
        "async def evaluate_all_pages(mistral_pages, pytess_pages):\n",
        "    loop = asyncio.get_event_loop()\n",
        "    tasks = []\n",
        "    for i in range(len(mistral_pages)):\n",
        "        m_text = mistral_pages[i][\"page_content\"]\n",
        "        p_text = pytess_pages[i][\"page_content\"]\n",
        "        tasks.append(loop.run_in_executor(executor, evaluate_page, i, m_text, p_text))\n",
        "    return await asyncio.gather(*tasks)\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ePG0uqQBwC0o",
        "outputId": "20a76612-24ab-4d34-f9d0-8091c2cee65b"
      },
      "execution_count": 21,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/lib/python3.11/tokenize.py:529: RuntimeWarning: coroutine 'evaluate_all_pages' was never awaited\n",
            "  pseudomatch = _compile(PseudoToken).match(line, pos)\n",
            "RuntimeWarning: Enable tracemalloc to get the object allocation traceback\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "results = await evaluate_all_pages(referral_pack_response, pytes_results)"
      ],
      "metadata": {
        "id": "8R91MSAIxQDi"
      },
      "execution_count": 23,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def extract_clean_json(responses):\n",
        "    import re\n",
        "    import json\n",
        "\n",
        "    parsed = []\n",
        "    for r in responses:\n",
        "        # Remove markdown-style formatting\n",
        "        cleaned = re.sub(r\"^```json|```$\", \"\", r.strip(), flags=re.MULTILINE).strip()\n",
        "\n",
        "        # Try parsing it\n",
        "        try:\n",
        "            parsed.append(json.loads(cleaned))\n",
        "        except Exception as e:\n",
        "            print(f\"Failed to parse JSON: {e}\")\n",
        "            parsed.append(None)\n",
        "    return parsed\n",
        "\n",
        "parsed_results = extract_clean_json(results)\n",
        "parsed_results"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RsiKGM189m-D",
        "outputId": "82d4214c-b5d0-4aca-971e-433f50ad2071"
      },
      "execution_count": 24,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[{'page': 0,\n",
              "  'content': '04/22/2024 WED 11:32 FAX\\n\\n001/028\\n\\n# FAX TRANSMISSION\\n\\n**Better Life Multiple Sclerosis Center**\\n\\n3320 Montgomery Dr. Nashville, TN 37361\\n\\n**BetterLife**\\n\\nF 615-562-4820 P: 615-562-4848\\n\\nDr. Asriel Han | Dr. Aetya Shan\\n\\n---\\n\\n**TO:**\\n\\nGolden Gate Infusion Center\\n\\n**Fax:** 614-225-3355 **Phone:** 614-295-7655\\n\\n**From:** Erran Rostami, BSN, RN\\n\\n**P:** 615-343-1176\\n\\n**F:** 615-343-1219\\n\\n---\\n\\n**Page**\\n\\n(including cover sheet)\\n\\n---\\n\\n**Comments:**\\n\\n- Arabic - spoken / English - written\\n- Rituxen (Truxima) TP\\n- MRI Reports\\n- Hospital DIC Make\\n- Demographics\\n\\n---\\n\\nThe documents accompanying this transmission may contain health information that is legally protected. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless permitted by law or regulation.\\n\\nIf you are not the intended recipient, you are hereby notified that any use, disclosure, copying or distribution of these documents is strictly prohibited. If you have received this information in error, please notify the sender immediately and arrange for the return or destruction of these documents.'},\n",
              " {'page': 1,\n",
              "  'content': \"05/22/2024 WED 11:32 FAX\\n\\n5/22/24, 11:10 AM\\n\\n# Abdulla, Shakh\\n\\n**MRN: 041152153**\\n\\n**Communication** 5/16/2024\\n\\n**Provider:** Erfan Rostami, RN\\n\\n**Status:** Open\\n\\n**Reason for call:** Truxima Second Initial Dose Needed Week of June 3\\n\\n**Better Life Multiple Sclerosis**\\n\\n**Center**\\n\\n## All Conversations: Truxima Second Initial Dose Needed Week of June 3\\n\\n*(Newest Message First)*\\n\\n**May 21, 2024**\\n\\n**Jha, Vedant**\\n\\n**to Erfan Rostami, RN**\\n\\n**Hi Erfan**\\n\\n**5/21/24 4:44 PM**\\n\\nThe only way Extraordinary Care could see his Medicaid plan would be at home if he is able to be seen at a hospital based infusion center closer to home?\\n\\nWe will hold off on this one for now—let me know if you're not able to find a provider who can see him in the infusion suite and we will re-open the referral.\\n\\n**Vedant**\\n\\nErfan Rostami, RN routed this conversation to Jha, Vedant\\n\\n**5/21/24 2:32 PM**\\n\\n**May 20, 2024**\\n\\n**Gu, Hao H, MD**\\n\\n**to Erfan Rostami, RN**\\n\\n**Note**\\n\\n**5/20/24 5:13 PM**\\n\\n**Hi**\\n\\n**No home infusion**\\n\\nHer first dose is scheduled may 23\\n\\nSecond dos 2 weeks from may 23 first\\n\\nErfan Rostami, RN routed this conversation to Gu, Hao H, MD\\n\\n**5/20/24 3:41 PM**\\n\\nJha, Vedant to Erfan Rostami, RN\\n\\n**Hi**\\n\\n**Is Dr. Gu comfortable with this patient being seen for home infusion?**\\n\\n**5/20/24 2:54 PM**\\n\\n**Thanks,**\\n\\n1/3\"},\n",
              " {'page': 2,\n",
              "  'content': '05/22/2024 WED 11:33 FAX\\n\\n5/22/24, 10:33 AM\\n\\n003/028\\n\\nAbdulla, Shakh (MR # 041152153) DOB: 04/01/2001\\n\\n# Shakh Abdulla\\n\\n**Therapy Plan 1 Summary**\\n\\nMRN: 041152153 Description: male DOB: 4/1/2001\\n\\n## Patient Demographics\\n\\n|  Patient Name | Legal | DOB | Address | Phone  |\\n| --- | --- | --- | --- | --- |\\n|  Abdulla, Shakh | Sex | 4/1/2001 | 425 Sherman Ave | 865-395-3958 (Home)  |\\n|   | male |  |  | 865-395-0481 (Mobile)  |\\n|   |  |  | Nashville TN 37995 | *Preferred*  |\\n\\n## Medication\\n\\nRituximab Or Biosimilar Days 1, 15 Load Then Once Every 24 Weeks\\n\\n## Associated Problems\\n\\n- **Problem**\\n- **Selected Diagnosis**\\n- Multiple sclerosis in pediatric patient (CMS/HCC) [G35]\\n- Multiple sclerosis in pediatric patient (CMS/HCC) [G35]\\n\\n## Infusion Orders\\n\\n## All Current Orders\\n\\n|  **Nursing Orders** | **Interval** | **Duration** | **Due**  |\\n| --- | --- | --- | --- |\\n|  ☑ IV access | Every visit |  | Every visit  |\\n|  Care Instructions: Obtain IV access (PIV, PORT, etc.) and start NS 0.9% @ KVO |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ Monitor pt for hypersensitivity reaction | Every visit |  | Every visit  |\\n|  Once Starting when released for 1 occurrence |  |  |   |\\n|  If allergic reaction or infusion related reaction occurs, initiate adult hypersensitivity reaction protocol or pediatric guideline and CALL MD for additional orders. |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ NURSING COMMUNICATION | Every visit |  | Every visit  |\\n|  Care Instructions: Ensure that patient has not taken antihypertensive medications in the 12 hours prior to infusion |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |\\n|  Last released: Never |  |  |   |\\n|  Electronically Signed By: Gu, Hao H, MD on 5/15/2024 |  |  |   |\\n|  5:11 PM |  |  |   |\\n|  ☑ NURSING COMMUNICATION | Every visit |  | Every visit  |\\n|  Care Instructions: For Hypotension, place patient in Trendelenberg position, support with NS, and call MD |  |  |   |\\n|  Until discontinued Starting when released Until Specified |  |  |   |'},\n",
              " {'page': 3,\n",
              "  'content': '05/22/2024 WED 11:33 FAX\\n\\n004/028\\n\\n5/22/24, 10:33 AM\\n\\nAbduia, Shakh (MR # 041152153) DOB: 04/01/2001\\n\\n|  |   |   |\\n| --- | --- | --- |\\n| Last released: Never | Interval | Duration  |\\n|   |  | Signed By: Gu, Hao MD on 5/15/2024 5:11 PM  |\\n| Labs |  |   |\\n| IgG |  | Every 24 weeks  |\\n| Clinic Collect, Blood |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n| CBC w/ Differential |  | Every visit  |\\n| Once Starting when released, Blood |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n| Flow Lymphocytes Subsets (TBNK) |  | Every visit  |\\n| Once Starting when released, Blood |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n| Vitals |  |   |\\n| Vital Signs |  | Every visit  |\\n| Care Instructions: Obtain VS prior to start therapy, Q30 minutes with each dose increase and at the end of treatment. |  |   |\\n| As needed Starting when released Until Specified |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024  |\\n| Hydration |  |   |\\n| heparin, porcine (PF) 100 unit/mL syringe 5 |  | PRN  |\\n| mL |  |   |\\n| 5 mL, intraVENOUS, As needed, For flushing Ports/ PICC lines/ Central Lines IF NEEDED, Starting when released, Until Discontinued |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n| Pre-Medications |  |   |\\n| acetaminophen (TYLENOL) tablet 650 mg |  | Every visit  |\\n| 650 mg, oral, Once, Starting when released |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n| diphenhydramine (BENADRYL) 50 mg in 50 |  | Every visit  |\\n| mL NS |  |   |\\n| 50 mg, intraVENOUS, Once, Starting when released |  |   |\\n| Administer 30 minutes before starting infusion. |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM  |\\n| methylprednisolone sod succinate (SOLU-Medrol) (20 mg/mL) 125 mg in NS 6.2 mL |  | Every visit  |\\n\\n2/4'},\n",
              " {'page': 4,\n",
              "  'content': '05/22/2024 WED 11:33 FAX\\n\\n005/028\\n\\n5/22/24, 10:33 AM\\n\\nAbduinabi, Noor (MR # 048182163) DOB: 01/01/2008\\n\\n|  |   |   |\\n| --- | --- | --- |\\n| 125 mg, intraVENOUS, Once, Starting when released |  |   |\\n| Administer 30 minutes before starting infusion. |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM |\\n| Infusion Therapy |  |   |\\n| ✔ NURSING COMMUNICATION | Every visit | Every visit  |\\n| Until discontinued Starting when released Until Specified |  |   |\\n| Infusion rate (standard only) |  |   |\\n| 1st infusion - initiate at 50mg/hr and if no infusion toxicity reaction, may increase by 50mg/hr ever 30 minutes; Max Rate 400mg/hr |  |   |\\n| Subsequent infusions - initiate at 100mg/hr and if no infusion toxicity reaction, may increase by 100mg/hr every 30 min; Max Rate 400mg/hr |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM |\\n| Infusion Therapy - Initial Dose |  |   |\\n| ✔ riTUXimab-abbs (TRUXIMA) IVPB | Every 2 weeks | 2/2 remaining Week of 5/19/2024  |\\n| 694 mg (rounded from 693.75 mg = 375 mg/m2 x 1.85 m2 - BSA might be out of date), intraVENOUS, Once, Starting 30 minutes after treatment start time |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM |\\n| Infusion Therapy - Maintenance Dose |  |   |\\n| ✔ riTUXimab-abbs (TRUXIMA) IVPB | Every 24 weeks | Mon 11/4/2024  |\\n| Defer until: Mon 11/4/2024 |  |   |\\n| 694 mg (rounded from 693.75 mg = 375 mg/m2 x 1.85 m2 - BSA might be out of date), intraVENOUS, Once, Starting when released |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM |\\n| PRN Medications |  |   |\\n| ✔ diphenhydramine (BENADRYL) injection 25 mg | PRN | PRN  |\\n| 25 mg, intraVENOUS, As needed, chills, Starting when released, for 2 doses |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM |\\n| ✔ meperidine (DEMEROL) injection 25 mg | PRN | PRN  |\\n| 25 mg, intraVENOUS, As needed, rigors, Starting when released, for 2 doses |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM |\\n| ✔ ondansetron (ZOFRAN) injection 4 mg | PRN | PRN  |\\n| 4 mg, intraVENOUS, As needed, nausea, vomiting, Starting when released, for 2 doses |  |   |\\n| Doses up to 4 mg may be administered undiluted. Inject over at least 30 seconds, but preferably over 2-5 minutes. |  |   |\\n| Last released: Never |  | Electronically Signed By: Gu, Hao H, MD on 5/15/2024 5:11 PM |\\n\\neSignature Information\\n\\nAll order signatures are valid for 1 (one) year from the signature date.\\n\\nProvider Contact Information\\n\\n3/4'},\n",
              " {'page': 5,\n",
              "  'content': '05/22/2024 WED 11:34 FAX\\n\\n5/22/24, 10:33 AM\\n\\nAbduinabi, Noor (MR # 048152153) DOB: 01/01/2008\\n\\nHao H Gu, MD (NPI: 1154611523)\\n\\nBetter Life Multiple Sclerosis Center\\n\\n3320 Montgomery Dr NASHVILLE TN 37361\\n\\n614-936-0065\\n\\n4/4'},\n",
              " {'page': 6,\n",
              "  'content': \"0§/22/2024 WED 11:3@ FAX\\n\\nBetter Life\\nMultiple Sclerosis\\n\\nCenter\\n\\nENCOUNTER\\n\\nPatiant Class:\\nAdmission User:\\nAdmitting Provider:\\nAttending Provider:\\n\\nKJQO7/ 028\\n\\nPatient: Shakh Abdulla\\n\\nHospital A/C:\\n\\nVO0J-7KR2-484T91.GFA\\n\\n \\n\\nCare Everywhere IDA;\\n\\nAdmixsion Qate/T'ime:8/1 7/2024\\nReforring Physician:\\n\\n \\n\\nAdin Diagnosis: Mylfeulth Bundle Status:\\nPATIENT\\nName: = Shakh Abdulla\\nAddress: 428 Sherman Aves APT D\\n\\nCity:  Avashvitte TN 37923\\n\\names David, PNP\\nMarital Status: Single\\n\\n-BMERGENCY CONTACT\\n\\nContact Name .eaal, Guardian?\\n1, Sina, Amin Yes\\n2. Mohammedreza, Musiala «= Yos\\n\\nPrimary Care Provider:\\n\\nFather\\nMother\\n\\nGuarantor\\nAddress:\\n\\nRelation ta Patient:\\n\\nGuarantor 1D:\\n\\nGUARANTOR EMPLOYER\\nThere Is no Quarantar Information entered for this encounter,\\nCOVERAGE\\nPRIMARY INSURANCE\\nPayor:\\nGroup Number:\\nSubsertbar Name;\\nStubseriber ID;\\nPat. Rel, to Subsorlber:\\nSBCONDARY INSURANGE 9 oop\\nPayor!\\nGroup Number:\\n\\nSubscriber Name:\\nSubscriber 17):\\nPat. Rel. to Subseriber:\\n\\nMay 22, 2024\\n\\n \\n\\nDOB:  4/1/200) (23 yrs)\\nSex: malo\\nProf Lang: Arable\\nPrimary Fhone: §68-839-7458\\nMobile Phone: 865-839-7458\\n\\nHom Phong Work Phone\\n\\nDOB: 10/29/1979\\n\\nSex: Female\\n\\nHome Phone:\\nMohile Phone:\\nWork Phone:\\n\\nStaius;s NOT EMPLO*\\n\\nPian; TC BLUE CARE NO COPAY\\nInsurance Type:\\nSubseriber DOB:\\nFinancial Class:\\n\\nPlatt:\\nInaurance Type:\\nSubscriber DOB:\\n\\n \\nHospital Face Sheet\\n\"},\n",
              " {'page': 7,\n",
              "  'content': '05/22/2024 WED 11:34 FAX 5/22/24, 10:37 AM\\n\\nAbduinabi, Noor (MRN: 041152153) DOB: 4/1/2001\\n\\nPrimary Coverage\\n\\n|  Payer | Plan | Sponsor Code | Group Number | Group Name  |\\n| --- | --- | --- | --- | --- |\\n|  BC TENNCARE | TC BLUE CARE NO COPAY |  | 435000 | TENNCARE/BLUECARE  |\\n\\nPrimary Subscriber\\n\\n|  ID | Name | SSN | Address  |\\n| --- | --- | --- | --- |\\n|  LAJM14345116 | ABDULLA, SHAKH | xxx-xx-8143 | 8327 BROADWAY LN  |\\n|   |  |  | APT D  |\\n|   |  |  | KNOXVILLE, TN 37923  |\\n\\n1/1'},\n",
              " {'page': 8,\n",
              "  'content': \"05/22/2024 WED 11:34 FAX\\n\\n009/028\\n\\n6/22/24, 10:39 AM\\n\\n# Abdulla, Shakh\\n\\n**MRN: 048152153**\\n\\n## ED to Hosp-Admission\\n\\n**Last attending:** Harry, Tom, MD · with Treatment\\n\\n**5/14/2024 - 5/17/2024 (3 days)**\\n\\n**Status:** Discharged\\n\\nMonroe Carell Jr. Children's Hospital\\n\\n## Discharge Summary\\n\\n**Kaine, Adam Jason. MD (Resident Physician) · Pediatric Neurology**\\n\\n**Cosigned by:** Gu, Hao H, MD at 5/17/2024 1:56 PM\\n\\nAttestation signed by Gu, Hao H, MD at 5/17/2024 1:56 PM (Updated)\\n\\nI saw the patient on: 5/17/2024 with Dr Kaine, I discussed the care with Dr Kaine, patient and his father at bedside and agree with the findings and plan as documented in the attached note.\\n\\nI personally spent more than 30 minutes on the patient's care unit in the preparation and execution of the hospital discharge.\\n\\n**S/p 4 days of high dose IVMP (1g/dose) today:**\\n\\n- Discharge home with oral decadron 180mg (equivalent to 1000mg IVMP) x 1 to round out 5 days of high dose steroid treatment for active demyelinating lesion (family wishes to be discharged today instead of Saturday)\\n- He will then start oral prednisone taper: Instructions provided +PPI\\n- First dose of Rituximab or biosimilar scheduled for May 22 at 9am; second dose of first course of Rituximab within 2 weeks after, we are working with local infusion facility in Knoxville to get this set up for her moving forward to minimize travel\\n- He will follow up with ophthalmologist in Knoxville\\n- School note for this week and next week\\n- PT/OT locally\\n- Continue vitamin D\\n- I will see her tentatively 3 months after completion of 1st course of Rituximab with same day\\n- MRI (she does not need sedation): looking at early or mid September. Will update family once we have that arranged\\n\\nHao Gu MD\\n\\n## Neurology Discharge Summary\\n\\n**Patient Name:** Shakh Abdulla\\n\\n**DOB:** 4/1/2001\\n\\n**Service:** Pediatric Neurology\\n\\n**Attending:** Harry, Tom, MD\\n\\n**Date of Admission:** 5/14/2024\"},\n",
              " {'page': 9,\n",
              "  'content': '05/22/2024 WED 11:34 FAX\\n\\n010/028\\n\\n5/22/24, 10:39 AM\\n\\n**Date of Discharge:** 5/17/2024\\n\\n**Diagnosis:**\\n\\n**Principal Problem:**\\n\\nAbnormal MRI\\n\\n**Resolved Problems:**\\n\\n*   No resolved hospital problems. *\\n\\n**Procedures:**\\n\\n**Bedside Procedures:**\\n\\nNo orders of the defined types were placed in this encounter.\\n\\n**OR Procedures:**\\n\\n*   Cannot find OR case *\\n\\n**Synopsis:**\\n\\nShakh Abdulla is a 23 year old male who established care with VCH neurology; with MRI brain and spine demonstrating multiple lesions consistent with atypical pediatric MS.\\n\\n**Hospital Course:**\\n\\nShakh Abdulla is a 23 year old male with history of optic neuritis and abnormal MRI brain concerning for MS who presented for admission following clinic visit and neuroimaging today. History from primary neurologist, clinic visit and patient and father at bedside. Patient referred to Dr. Gu by Dr. Fazal in East Bay. Confirms predominant symptoms since April of numbness in his right hand and urinary hesitancy/urgency. Additionally reporting right eye pain since time of clinic visit this morning. MRI brain and spine obtained following clinic visit and multiple lesions noted on brain and spine suggestive of pediatric MS. Presents for admission for IVMP.\\n\\n**Per clinic visit earlier today with Dr. Gu and confirmed with family at bedside:**\\n\\nShakh is a 23 years old male, previously healthy who has been referred to neuroimmunology clinic for diagnosis of optic neuritis and abnormal brain MRI concerning for MS. He is referred by Dr Fazal-pediatric neurology in East Bay.\\n\\nHe is here with dad; patient himself is an excellent historian and provided the following information- I do not have CSF results nor clinic note- I do have MRI report from Jan 21 2024 (no actual images)- with father and his permission, I reached out to Dr Shane- Dr Fazal\\'s colleague on service who can help assist with quick access to Shakh\\'s chart.\\n\\nToday, Shakh tells me that around early Oct 2023- he started to notice in right eye \"neon bright color\" fuzzy vision, and eye pain with movement and perhaps right side of his face in discomfort triggered by physical activities. Symptoms improved once he rested. By end of Oct 2023, he brought this up to parents and was brought to local eye doctor and recalled being told that \"right eye being inflamed\" and he recalled visual field deficits appreciated during exam.\\n\\nHe was referred to UT ophthalmology Dr Derrek in Jan this year, per report negative MOG and AQP4 [While waiting on this appt, he thought some improvement but not back to baseline entirely - \"not completely normal\"].\\n\\nWhen he saw UT ophthalmology clinic, recommended brain and orbit and noted WM changes and MS was mentioned. He was treated with 5 days of IVMP and referred to see Dr Kosentka ped neurology.\\n\\nMRI report from Jan 21 2024- \"Diffuse T2 hyperintensity and decreased volume throughout the right optic nerve is similar to prior examination however associated abnormal enhancement seen on prior study has resolved, presumably secondary to interveal treatment.\\n\\nLeft optic nerve is subtle but diffusely small in caliber without significant change from last exam. Several intracranial WM lesions, stable from last\"\\n\\nHe saw Dr Fazal in Feb 2024-who obtained LP and had markers of MS and referred to MS clinic today. Below are information provided by Dr Shane. Per note recommended referral to our MS center for\\n\\nPrinted by O\\'Rourke, Cydnie B. RN at 5/22/2024 10:39 AM\\n\\n2/9'},\n",
              " {'page': 10,\n",
              "  'content': '05/22/2024 WED 11:35 FAX\\n\\n6/22/24, 10:39 AM\\n\\nfurther evaluation and treatment.\\nCSF ?WBC, 837 rbc, IgG Index 0.87 (elevated), +OCB\\n\\nPrior to appt today May 14- he noted that in April of this year, started to have involvement of LEFT eye again similar with \"neon colors appearance\", some eye discomfort; it happened several times during the day for a few days and has since resolved\\n\\nSince April he has had intermittent numbness in his right hand (dominant hand)+ along with muscle twitch in his hands and shoulder like tics\\n\\nHe has noticed a change with urinary hesitancy- taking a long time to empty his bladder and in addition urinary urgency\\n\\nHe has not noticed weakness but noted intermittent drifting to right side, bumping in to things\\n\\nHe does note that at times when he laughs, bends his neck, does note electrical sensation\\n\\nAcademically doing very well, no difficulty\\n\\nSleeps well\\n\\nFamily history: parents and brothers are healthy\\n\\nFloor course (05/14 -\\n\\nPatient was admitted to the wards in a stable condition.\\n\\nPatient was initiated on high dose steroids for 5 days and tolerated well. MRI consistent with lesions in the brain and spinal cord consistent with atypical MS. ANA was positive as well as SSB so rheumatology was consulted but felt she did not have evidence of another systemic autoimmune disease. PT/OT evaluated his and he will follow outpatient. He was dc with Decadron and then steroid taper with Pepcid prophylaxis. He was arranged to have outpatient rituximab and Dr. Gu will follow his in clinic.\\n\\nPhysical Exam:\\n\\nTemp: [36.5 °C (97.7 °F)-36.7 °C (98.1 °F)] 36.7 °C (98 °F)\\n\\nPulse: [81-99] 84\\n\\nResp: [16-18] 16\\n\\nBP: (122-136)/(63-99) 126/63\\n\\nSpO2: [98 %] 98 %\\n\\nPhysical Exam:\\n\\nTemp: [36.5 °C (97.7 °F)-36.7 °C (98.1 °F)] 36.7 °C (98 °F)\\n\\nPulse: [81-99] 84\\n\\nResp: [16-18] 16\\n\\nBP: (122-136)/(63-99) 126/63\\n\\nSpO2: [98 %] 98 %\\n\\n-Well appearing; NAD\\n\\nCV:\\n\\n-RRR\\n\\nHIGHER INTEGRATIVE FUNCTIONS:\\n\\n-Attention & concentration: Normal\\n\\n-Orientation: Oriented to person, place & time\\n\\n-Memory: Recent and remote memory intact\\n\\n-Language: Normal\\n\\n-Fund of Knowledge: Normal\\n\\nCRANIAL NERVES:\\n\\n-CN 2: Visual fields full\\n\\n-CN 2.3: PERRL; rAPD\\n\\n-CN 3,4,6: EOMI\\n\\n-CN 5: Facial sensation intact\\n\\n-CN 7: Facial strength/movement intact bilaterally\\n\\nPrinted by O\\'Rourke, Cydnie B, RN at 5/22/2024 10:39 AM\\n\\n3/9'},\n",
              " {'page': 11,\n",
              "  'content': \"05/22/2024 WED 11:35 FAX\\n\\n5/22/24, 10:39 AM\\n\\n- CN 8: Hearing normal bilaterally\\n- CN 9,10: Palate elevates symmetrically\\n- CN 11: Normal shoulder shrug and head turn\\n- CN 12: Tongue protrudes midline\\n\\nMOTOR:\\n- Muscle tone normal in upper and lower extremities\\n- Muscle strength 5/5 in upper and lower extremities; RLE 4+ proximally\\n\\nSENSATION:\\n- Intact to light touch in upper and lower extremities bilaterally\\n\\nCOORDINATION:\\n- Finger/nose intact bilaterally\\n\\nGAIT:\\n- Normal gait\\n\\nImmunizations/Injections Administered for This Admission\\n\\nNo immunizations on file.\\n\\nAllergies:\\nNo Known Allergies\\n\\nDiagnostic Studies:\\nRecent Results (from the past 24 hour(s))\\nCBC w/ Differential\\nCollection Time: 05/14/24 10:47 AM\\nResult\\nValue\\nRef Range\\nWhite Blood Cells 7.7\\n3.4 - 10.2\\nx10(3)/mcL\\nRed Blood Cells 4.63\\n3.80 - 5.50\\nx10(6)/mcL\\nHemoglobin 13.0\\n12.0 - 16.0\\ngm/dL\\nHematocrit 40\\n35 - 49 %\\nMean Cell Volume 86\\n76 - 96 fL\\nMean Cell 28.1\\n25.0 - 35.0\\nHemoglobin pg\\nMean Cell 32.7\\n32.0 - 37.0\\nHemoglobin gm/dL\\nConcentration\\nRDW SD 38.4\\n37.4 - 52.4\\nfL\\nRDW CV 12.3\\n11.1 - 14.3\\n%\\nPlatelet 300\\n150 - 400\\nx10(3)/mcL\\n\\nPrinted by O'Rourke, Cydnie B. RN at 5/22/2024 10:39 AM\\n\\n4/9\"},\n",
              " {'page': 12,\n",
              "  'content': '05/22/2024 WED 11:35 FAX\\n\\n5/22/24, 10:39 AM\\n\\n|  |   |   |\\n| --- | --- | --- |\\n| Mean Platelet | 10.0 | 9.3 - 12.8 fL |\\n| Volume |  |  |\\n| Nucleated RBC | 0 | 0 - 0/100 |\\n|  |  | WBC |\\n| Nucleated RBC | 0.00 | 0.00 - 0.00 |\\n| Abs |  | x10(3)/mcL |\\n| Auto Neutrophil | 4.52 | 1.80 - 7.70 |\\n| Absolute |  | x10(3)/mcL |\\n| CMP |  |  |\\n| Collection Time: 05/14/24 10:47 AM |  |  |\\n| Result | Value | Ref Range |\\n| Sodium Level | 139 | 138 - 145 |\\n|  |  | mmol/L |\\n| Potassium Level | 3.8 | 3.3 - 4.8 |\\n|  |  | mmol/L |\\n| Chloride Level | 101 | 98 - 107 |\\n|  |  | mmol/L |\\n| Carbon Dioxide | 22 | 17 - 28 |\\n|  |  | mmol/L |\\n| Anion Gap | 16 | mmol/L |\\n| Glucose Level | 95 | 60 - 99 |\\n|  |  | mg/dL |\\n| Blood Urea | 13 | 7 - 18 |\\n| Nitrogen |  | mg/dL |\\n| Creatinine Level | 0.67 | 0.50 - 0.90 |\\n|  |  | mg/dL |\\n| Calcium Level | 9.9 | 8.4 - 10.2 |\\n| Total |  | mg/dL |\\n| Bilirubin Total | 0.4 | 0.0 - 0.7 |\\n|  |  | mg/dL |\\n| Albumin Level | 4.7 | 4.0 - 5.3 |\\n|  |  | gm/dL |\\n| Protein Total | 8.4 (H) | 6.3 - 7.8 |\\n|  |  | gm/dL |\\n| Alkaline | 55 | 50 - 117 |\\n| Phosphatase |  | unit/L |\\n| Aspartate | 25 | 21 - 34 |\\n| Aminotransferase |  | unit/L |\\n| Alanine | <6 | 0 - 17 unit/L |\\n| Aminotransferase |  |  |\\n| Hepatitis B Pnl |  |  |\\n| Collection Time: 05/14/24 10:47 AM |  |  |\\n| Result | Value | Ref Range |\\n| Hepatitis B Surface | Negative | Negative |\\n| Antigen |  |  |\\n| Hep B Core Ab | Negative | Negative |\\n| Total |  |  |\\n| Hepatitis B Surface | 44.7 (H) | <=10.0 |\\n| Ab Unit |  | mlU/mL |\\n| Hep Bs Ab Interp | Positive (A) | Negative |\\n| IgG |  |  |\\n| Collection Time: 05/14/24 10:47 AM |  |  |\\n| Result | Value | Ref Range |\\n| IgG Quantitative | 1,355 (H) | 600 - 1,310 |\\n|  |  | mg/dL |\\n\\n5/9'},\n",
              " {'page': 13,\n",
              "  'content': '05/22/2024 WED 11:35 FAX\\n\\n014/028\\n\\n5/22/24, 10:39 AM\\n\\nIgA\\n\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult | Value | Ref Range\\n--- | --- | ---\\nIgA Quantitative | 279 | 40 - 290 mg/dL\\n\\nAuto Diff\\n\\nCollection Time: 05/14/24 10:47 AM\\n\\nResult | Value | Ref Range\\n--- | --- | ---\\nNeutrophils | 58.3 | %\\nAbsolute | 4.52 | 1.80 - 7.70\\nNeutrophils | | x10(3)/mcL\\nLymphs | 33.6 | %\\nAbsolute | 2.60 | 1.70 - 4.50\\nLymphocytes | | x10(3)/mcL\\nMonocytes | 6.5 | %\\nAbsolute | 0.50 | 0.20 - 1.00\\nMonocytes | | x10(3)/mcL\\nEosinophils | 0.5 | %\\nAbsolute | 0.04 | 0.00 - 0.50\\nEosinophils | | x10(3)/mcL\\nBasophils | 0.8 | %\\nAbsolute Basophils | 0.06 | 0.01 - 0.08\\nImm Gran | 0.3 | x10(3)/mcL\\nAutomated | | %\\nAbsolute Imm | 0.02 | 0.00 - 0.03\\nGran Automated | | x10(3)/mcL\\n\\nConsultations Obtained:\\n\\nOrders Placed This Encounter\\n\\nProcedures\\n\\n- Inpatient Consult to Pediatric Ophthalmology\\n- Inpatient Consult to Pediatric Rheumatology\\n- Inpatient consult to Case Management\\n\\nCondition at Discharge:\\n\\nStable\\n\\nDisposition:\\n\\nHome or Self Care\\n\\nPatient Instructions:\\n\\nDischarge Medications\\n\\nNew Medications\\n\\ndexamethasone 4 mg/mL CONCENTRATED solution\\n\\nfamotidine 40 mg tablet\\n\\nCommonly known as: PEPCID\\n\\nSig\\n\\nTake 45 mL (180 mg total) by mouth daily for 1 dose. See comment\\n\\nTake 1 tablet (40 mg total) by mouth daily.\\n\\n6/9'},\n",
              " {'page': 14,\n",
              "  'content': \"05/22/2024 WED 11:35 FAX MIVLI/V29\\n5/22/24, 10:39 AM\\n\\nae : , cs « ‘a\\npredniSONE 20 mg tablet Taka 3 tablets (60 mg total) by mouth daily for 7\\n\\nCommonly known as: DELTASONE days, THEN 2 tablets (40 mg total) daily for 7\\n\\nStart taking on: May'16, 2024 days, THEN 1 tablet (20 mg total) dally for 7\\ndays, THEN 0,5 tablets (10 mg total) daily for 7\\ndays, Then stop.\\n\\nActivity instructions\\n\\nDischarge activity - Normal Activity\\n\\nSome medications such as for example pain medications and sleeping or anti-anxiety agents may affect your\\nabllity to operate heavy machinery including driving. Please always carefully read the labels on the medications\\nthat you take, If you have experienced confusion, seizures, lightheadedness or blackouts then it may not be safe\\nor even Jegal for you to operate heavy machinery (Including driving). Please act in the interest of your own safety\\nand that of others. Speak to a physician If you ara not sure whether it Ie safe or legal for you to drive,\\nCare Instructions: You should engages In exercise as tolerated to improve your health. You may go to the website\\nof the American Heart Association for additional information and tips an how to exercise right\\n\\n(WWW. americanheart.org).\\nScheduled Appointments\\nMay 22, 2024 10:30 AM 2211 Broad Way\\nPads Infusion (Leantaas) with PEDS INF UMBRELLA, Tower 4th FL, Suite 6102\\nPEDS 241+ MIN INFUSION Nashville TN 37232\\nChildran’s Hematology - Oncology (Peds DOT 6) 615-936-1762\\n\\n7/9\"}]"
            ]
          },
          "metadata": {},
          "execution_count": 24
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "pa_summary_prompt = \"\"\"\n",
        "You are a medical document specialist preparing a Prior Authorization (PA) summary.\n",
        "\n",
        "Your task is to review the full content of a referral packet—including faxes, therapy plans, and clinical notes—and generate a **concise PA summary report** that contains information typically required for prior authorization decisions.\n",
        "\n",
        "Organize the summary using the following sections (include only if information is found):\n",
        "\n",
        "1. **Patient Information** – name, DOB, contact info, address, MRN\n",
        "2. **Referring Provider** – name, practice name, phone, fax\n",
        "3. **Requesting Nurse/Coordinator** – name, phone, fax (if applicable)\n",
        "4. **Diagnosis and Clinical Details** – primary diagnosis (ICD-10 if found), clinical history, MS/cancer subtype, other relevant conditions\n",
        "5. **Treatment Plan** – medication, dosage, schedule, administration site, start date, maintenance plan\n",
        "6. **Pre-Medications & Infusion Orders** – include key pre-meds and infusion monitoring instructions\n",
        "7. **Labs & Monitoring** – labs to be collected, frequency\n",
        "8. **PRN Medications** – rescue medications ordered\n",
        "9. **Coverage Notes** – biosimilar use, contraindications, reasons for preferred drug, logistical constraints\n",
        "\n",
        "Summarize clearly and professionally. Use bullet points or short paragraphs. Do not hallucinate. Do not invent information. If something is mentioned but unclear, write “not specified” or “unclear.”\n",
        "\n",
        "Here is the full content of the document:\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "uDhai87rfz8g"
      },
      "execution_count": 51,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import asyncio\n",
        "import json\n",
        "from typing import List, Dict, Any\n",
        "from concurrent.futures import ThreadPoolExecutor\n",
        "\n",
        "MODEL = \"models/gemini-2.0-flash\"\n",
        "executor = ThreadPoolExecutor(max_workers=8)  # Adjust based on system resources\n",
        "\n",
        "async def generate_pa_summary(pages: List[Dict[str, Any]], client) -> str:\n",
        "    try:\n",
        "        full_text = \"\\n\\n---\\n\\n\".join(\n",
        "            f\"Page {page.get('page', idx)}:\\n{page['content']}\"\n",
        "            for idx, page in enumerate(pages)\n",
        "        )\n",
        "\n",
        "        prompt = pa_summary_prompt + full_text\n",
        "\n",
        "        loop = asyncio.get_event_loop()\n",
        "        response = await loop.run_in_executor(\n",
        "            executor,\n",
        "            lambda: client.models.generate_content(\n",
        "                model=MODEL,\n",
        "                contents=[prompt]\n",
        "            )\n",
        "        )\n",
        "\n",
        "        return response.candidates[0].content.parts[0].text\n",
        "\n",
        "    except Exception as e:\n",
        "        return f\"[Error during PA summary generation]: {str(e)}\"\n",
        "\n",
        "\n"
      ],
      "metadata": {
        "id": "gtlkAabTgyka"
      },
      "execution_count": 52,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import json"
      ],
      "metadata": {
        "id": "U6mDyI-YhhG2"
      },
      "execution_count": 53,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "summary_text = await generate_pa_summary(parsed_results, client)\n",
        "print(summary_text)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "1OJzCZD9hWgw",
        "outputId": "f21b8237-ec58-446e-eacc-059f2b03ff9f"
      },
      "execution_count": 54,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "**PA Summary Report**\n",
            "\n",
            "1.  **Patient Information**\n",
            "    *   Name: Shakh Abdulla\n",
            "    *   DOB: 04/01/2001\n",
            "    *   MRN: 041152153\n",
            "    *   Address: 425 Sherman Ave, Nashville TN 37995 (Preferred address)\n",
            "    *   Phone: 865-395-3958 (Home), 865-395-0481 (Mobile), 865-839-7458 (alternate)\n",
            "\n",
            "2.  **Referring Provider**\n",
            "    *   Name: Hao H Gu, MD\n",
            "    *   Practice: Better Life Multiple Sclerosis Center\n",
            "    *   Phone: 614-936-0065\n",
            "    *   Fax: Not specified\n",
            "\n",
            "3.  **Requesting Nurse/Coordinator**\n",
            "    *   Name: Erfan Rostami, BSN, RN\n",
            "    *   Phone: 615-343-1176\n",
            "    *   Fax: 615-343-1219\n",
            "\n",
            "4.  **Diagnosis and Clinical Details**\n",
            "    *   Primary Diagnosis: Multiple sclerosis in pediatric patient (CMS/HCC) \\[G35]\n",
            "    *   Clinical History:\n",
            "        *   Optic neuritis since October 2023.\n",
            "        *   Right eye pain with movement.\n",
            "        *   Visual field deficits.\n",
            "        *   Numbness in right hand, muscle twitch, urinary hesitancy/urgency since April 2024.\n",
            "        *   Positive ANA and SSB.\n",
            "    *   MRI brain and spine (5/14/2024) showed multiple lesions consistent with atypical pediatric MS.\n",
            "    *   CSF shows elevated IgG Index 0.87, +OCB.\n",
            "\n",
            "5.  **Treatment Plan**\n",
            "    *   Medication: Rituximab-abbs (Truxima)\n",
            "    *   Dosage: 694 mg IVPB (rounded from 693.75 mg = 375 mg/m2 x 1.85 m2 - BSA might be out of date)\n",
            "    *   Schedule:\n",
            "        *   Days 1, 15 Load Then Once Every 24 Weeks.\n",
            "        *   Initial Dose: Every 2 weeks, 2/2 remaining week of 5/19/2024 (starting 30 minutes after treatment start time).\n",
            "        *   Maintenance Dose: Every 24 weeks, starting Mon 11/4/2024.\n",
            "    *   Administration Site: IV\n",
            "    *   Start Date: First dose scheduled for May 22nd.\n",
            "\n",
            "6.  **Pre-Medications & Infusion Orders**\n",
            "    *   acetaminophen (TYLENOL) tablet 650 mg, oral, once.\n",
            "    *   diphenhydramine (BENADRYL) 50 mg in 50 mL NS, IV, once, administer 30 minutes before starting infusion.\n",
            "    *   methylprednisolone sod succinate (SOLU-Medrol) (20 mg/mL) 125 mg in NS 6.2 mL, IV, once, administer 30 minutes before starting infusion.\n",
            "    *   Infusion rate:\n",
            "        *   1st infusion - initiate at 50mg/hr and if no infusion toxicity reaction, may increase by 50mg/hr ever 30 minutes; Max Rate 400mg/hr\n",
            "        *   Subsequent infusions - initiate at 100mg/hr and if no infusion toxicity reaction, may increase by 100mg/hr every 30 min; Max Rate 400mg/hr\n",
            "    *   IV access.\n",
            "    *   Monitor pt for hypersensitivity reaction. If allergic reaction or infusion related reaction occurs, initiate adult hypersensitivity reaction protocol or pediatric guideline and CALL MD for additional orders.\n",
            "    *   Ensure that patient has not taken antihypertensive medications in the 12 hours prior to infusion.\n",
            "    *   For Hypotension, place patient in Trendelenberg position, support with NS, and call MD.\n",
            "\n",
            "7.  **Labs & Monitoring**\n",
            "    *   IgG every 24 weeks, clinic collect, blood.\n",
            "    *   CBC w/ Differential every visit, blood.\n",
            "    *   Flow Lymphocytes Subsets (TBNK) every visit, blood.\n",
            "    *   Vitals: Obtain VS prior to start therapy, Q30 minutes with each dose increase and at the end of treatment.\n",
            "\n",
            "8.  **PRN Medications**\n",
            "    *   diphenhydramine (BENADRYL) injection 25 mg, IV, as needed, chills, for 2 doses.\n",
            "    *   meperidine (DEMEROL) injection 25 mg, IV, as needed, rigors, for 2 doses.\n",
            "    *   ondansetron (ZOFRAN) injection 4 mg, IV, as needed, nausea, vomiting, for 2 doses.\n",
            "\n",
            "9.  **Coverage Notes**\n",
            "    *   Rituximab or biosimilar is being considered.\n",
            "    *   Patient has TC BLUE CARE NO COPAY insurance.\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#PA Extraction"
      ],
      "metadata": {
        "id": "2yz2Lmy04jeu"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "doc = fitz.open((\"PA.pdf\"))\n",
        "\n",
        "doc[1].get_text('blocks')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "iwSc82xdGGqK",
        "outputId": "4bbad6b5-c619-4f12-a40a-9d7b24624e49"
      },
      "execution_count": 55,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[(18.0,\n",
              "  768.580810546875,\n",
              "  87.8330078125,\n",
              "  779.4735107421875,\n",
              "  'GR-68535-3 (1-25) \\n',\n",
              "  0,\n",
              "  0),\n",
              " (161.99952697753906,\n",
              "  10.737120628356934,\n",
              "  427.83404541015625,\n",
              "  108.46498107910156,\n",
              "  'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 2 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n',\n",
              "  1,\n",
              "  0),\n",
              " (453.7799987792969,\n",
              "  13.48285961151123,\n",
              "  585.0285034179688,\n",
              "  44.80995559692383,\n",
              "  'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n',\n",
              "  2,\n",
              "  0),\n",
              " (454.55999755859375,\n",
              "  47.52688217163086,\n",
              "  589.5609130859375,\n",
              "  89.79430389404297,\n",
              "  'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n',\n",
              "  3,\n",
              "  0),\n",
              " (77.98930358886719,\n",
              "  110.7192153930664,\n",
              "  554.345703125,\n",
              "  135.1289825439453,\n",
              "  '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n',\n",
              "  4,\n",
              "  0),\n",
              " (76.3604965209961,\n",
              "  195.3408203125,\n",
              "  280.32928466796875,\n",
              "  206.2335205078125,\n",
              "  ' \\n  \\n  \\n \\n  \\n  \\n',\n",
              "  5,\n",
              "  0),\n",
              " (266.2629089355469,\n",
              "  223.600830078125,\n",
              "  415.6719970703125,\n",
              "  256.93353271484375,\n",
              "  '  \\n  \\n \\n   \\n',\n",
              "  6,\n",
              "  0),\n",
              " (450.2276916503906,\n",
              "  272.5979919433594,\n",
              "  452.7297058105469,\n",
              "  284.5049743652344,\n",
              "  ' \\n',\n",
              "  7,\n",
              "  0),\n",
              " (101.09100341796875,\n",
              "  363.3408203125,\n",
              "  103.30944061279297,\n",
              "  374.2335205078125,\n",
              "  ' \\n',\n",
              "  8,\n",
              "  0),\n",
              " (38.09709930419922,\n",
              "  405.1007995605469,\n",
              "  230.01846313476562,\n",
              "  458.83349609375,\n",
              "  '   \\n   \\n  \\n  \\n    \\n    \\n  \\n   \\n',\n",
              "  9,\n",
              "  0),\n",
              " (486.82611083984375,\n",
              "  375.580810546875,\n",
              "  497.9358825683594,\n",
              "  386.4735107421875,\n",
              "  '   \\n',\n",
              "  10,\n",
              "  0),\n",
              " (357.05230712890625,\n",
              "  387.76080322265625,\n",
              "  363.71881103515625,\n",
              "  398.65350341796875,\n",
              "  '  \\n',\n",
              "  11,\n",
              "  0),\n",
              " (353.99920654296875,\n",
              "  411.9407958984375,\n",
              "  517.1822509765625,\n",
              "  422.83349609375,\n",
              "  '  \\n  \\n  \\n',\n",
              "  12,\n",
              "  0),\n",
              " (363.3038024902344,\n",
              "  424.060791015625,\n",
              "  468.71160888671875,\n",
              "  434.9534912109375,\n",
              "  ' \\n \\n',\n",
              "  13,\n",
              "  0),\n",
              " (349.07550048828125,\n",
              "  436.1808166503906,\n",
              "  468.711669921875,\n",
              "  447.0735168457031,\n",
              "  '   \\n \\n',\n",
              "  14,\n",
              "  0),\n",
              " (349.07708740234375,\n",
              "  448.3608093261719,\n",
              "  360.1756896972656,\n",
              "  459.2535095214844,\n",
              "  '   \\n',\n",
              "  15,\n",
              "  0),\n",
              " (180.96009826660156,\n",
              "  475.8791809082031,\n",
              "  508.228759765625,\n",
              "  500.7235107421875,\n",
              "  ' \\n   \\n   \\n \\n  \\n  \\n',\n",
              "  16,\n",
              "  0),\n",
              " (325.87200927734375,\n",
              "  519.1392211914062,\n",
              "  328.2405700683594,\n",
              "  530.7689819335938,\n",
              "  ' \\n',\n",
              "  17,\n",
              "  0),\n",
              " (47.75510025024414,\n",
              "  585.5208129882812,\n",
              "  79.74994659423828,\n",
              "  596.4135131835938,\n",
              "  '  \\n  \\n',\n",
              "  18,\n",
              "  0),\n",
              " (75.89530181884766,\n",
              "  597.6408081054688,\n",
              "  78.11373901367188,\n",
              "  608.5335083007812,\n",
              "  ' \\n',\n",
              "  19,\n",
              "  0),\n",
              " (188.15899658203125,\n",
              "  608.0208129882812,\n",
              "  190.37744140625,\n",
              "  618.9135131835938,\n",
              "  ' \\n',\n",
              "  20,\n",
              "  0),\n",
              " (73.6769027709961,\n",
              "  643.4808349609375,\n",
              "  78.11377716064453,\n",
              "  654.37353515625,\n",
              "  '  \\n',\n",
              "  21,\n",
              "  0),\n",
              " (185.9405975341797,\n",
              "  653.86083984375,\n",
              "  190.3774871826172,\n",
              "  664.7535400390625,\n",
              "  '  \\n',\n",
              "  22,\n",
              "  0),\n",
              " (125.04219818115234,\n",
              "  709.7208251953125,\n",
              "  131.69752502441406,\n",
              "  720.613525390625,\n",
              "  '   \\n',\n",
              "  23,\n",
              "  0),\n",
              " (502.864990234375,\n",
              "  737.7963256835938,\n",
              "  596.2230224609375,\n",
              "  748.9204711914062,\n",
              "  'Continued on next page \\n',\n",
              "  24,\n",
              "  0),\n",
              " (18.0,\n",
              "  110.7192153930664,\n",
              "  495.24786376953125,\n",
              "  122.34901428222656,\n",
              "  'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n',\n",
              "  25,\n",
              "  0),\n",
              " (17.40106201171875,\n",
              "  123.36292266845703,\n",
              "  501.1325988769531,\n",
              "  135.56356811523438,\n",
              "  'Precertification Requested By: \\nPhone: \\nFax: \\n',\n",
              "  26,\n",
              "  0),\n",
              " (20.399999618530273,\n",
              "  137.673095703125,\n",
              "  125.64022064208984,\n",
              "  149.10044860839844,\n",
              "  'A. PATIENT INFORMATION\\n',\n",
              "  27,\n",
              "  0),\n",
              " (20.399999618530273,\n",
              "  150.7044677734375,\n",
              "  530.3218994140625,\n",
              "  161.59716796875,\n",
              "  'First Name:  \\nLast Name:  \\nDOB:  \\n',\n",
              "  28,\n",
              "  0),\n",
              " (20.39996337890625,\n",
              "  165.10467529296875,\n",
              "  525.4381713867188,\n",
              "  176.00103759765625,\n",
              "  'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "  29,\n",
              "  0),\n",
              " (20.399993896484375,\n",
              "  179.50079345703125,\n",
              "  450.2641906738281,\n",
              "  190.4012451171875,\n",
              "  'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n',\n",
              "  30,\n",
              "  0),\n",
              " (20.399993896484375,\n",
              "  195.3408203125,\n",
              "  370.4882507324219,\n",
              "  206.2337646484375,\n",
              "  'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n',\n",
              "  31,\n",
              "  0),\n",
              " (20.4000244140625,\n",
              "  210.031982421875,\n",
              "  139.0288848876953,\n",
              "  221.45933532714844,\n",
              "  'B. INSURANCE INFORMATION\\n',\n",
              "  32,\n",
              "  0),\n",
              " (20.390220642089844,\n",
              "  223.47027587890625,\n",
              "  74.55447387695312,\n",
              "  256.858642578125,\n",
              "  'Member ID #:  \\nGroup #:  \\nInsured:  \\n',\n",
              "  33,\n",
              "  0),\n",
              " (235.18788146972656,\n",
              "  223.5980224609375,\n",
              "  440.6332702636719,\n",
              "  256.933349609375,\n",
              "  'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n',\n",
              "  34,\n",
              "  0),\n",
              " (20.409637451171875,\n",
              "  260.189208984375,\n",
              "  143.95599365234375,\n",
              "  271.6165771484375,\n",
              "  'C. PRESCRIBER INFORMATION\\n',\n",
              "  35,\n",
              "  0),\n",
              " (20.409637451171875,\n",
              "  272.2200012207031,\n",
              "  593.2784423828125,\n",
              "  284.5049743652344,\n",
              "  'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n',\n",
              "  36,\n",
              "  0),\n",
              " (20.4022216796875,\n",
              "  287.620849609375,\n",
              "  525.446044921875,\n",
              "  298.5135498046875,\n",
              "  'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "  37,\n",
              "  0),\n",
              " (20.40228271484375,\n",
              "  302.02081298828125,\n",
              "  532.0935668945312,\n",
              "  312.9174499511719,\n",
              "  'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n',\n",
              "  38,\n",
              "  0),\n",
              " (20.39202880859375,\n",
              "  317.1429138183594,\n",
              "  450.62579345703125,\n",
              "  328.0356140136719,\n",
              "  'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n',\n",
              "  39,\n",
              "  0),\n",
              " (20.399993896484375,\n",
              "  330.810546875,\n",
              "  256.3798522949219,\n",
              "  342.2400207519531,\n",
              "  'D. DISPENSING PROVIDER/ADMINISTRATION INFORMATION\\n',\n",
              "  40,\n",
              "  0),\n",
              " (20.399999618530273,\n",
              "  342.8683166503906,\n",
              "  114.59831237792969,\n",
              "  354.2956848144531,\n",
              "  'Place of Administration: \\n',\n",
              "  41,\n",
              "  0),\n",
              " (22.570980072021484,\n",
              "  353.0747375488281,\n",
              "  249.09925842285156,\n",
              "  458.8310852050781,\n",
              "  ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "  42,\n",
              "  0),\n",
              " (329.1705627441406,\n",
              "  342.87371826171875,\n",
              "  454.4814758300781,\n",
              "  354.30108642578125,\n",
              "  'Dispensing Provider/Pharmacy:  \\n',\n",
              "  43,\n",
              "  0),\n",
              " (340.5101318359375,\n",
              "  353.14398193359375,\n",
              "  533.1074829101562,\n",
              "  386.4764404296875,\n",
              "  ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "  44,\n",
              "  0),\n",
              " (331.3331298828125,\n",
              "  387.76123046875,\n",
              "  357.06866455078125,\n",
              "  398.6539306640625,\n",
              "  'Name: \\n',\n",
              "  45,\n",
              "  0),\n",
              " (331.3331298828125,\n",
              "  399.8190002441406,\n",
              "  367.3149719238281,\n",
              "  410.7117004394531,\n",
              "  'Address:  \\n',\n",
              "  46,\n",
              "  0),\n",
              " (331.3251647949219,\n",
              "  411.93768310546875,\n",
              "  536.2573852539062,\n",
              "  422.83331298828125,\n",
              "  'City:  \\nState:  \\nZIP:  \\n',\n",
              "  47,\n",
              "  0),\n",
              " (331.322998046875,\n",
              "  424.0592956542969,\n",
              "  490.9054870605469,\n",
              "  434.9519958496094,\n",
              "  'Phone:  \\n Fax:  \\n',\n",
              "  48,\n",
              "  0),\n",
              " (331.322998046875,\n",
              "  436.05322265625,\n",
              "  490.9086608886719,\n",
              "  447.4805908203125,\n",
              "  'TIN: \\n PIN:  \\n',\n",
              "  49,\n",
              "  0),\n",
              " (331.322998046875,\n",
              "  448.3583984375,\n",
              "  349.0801086425781,\n",
              "  459.2510986328125,\n",
              "  'NPI: \\n',\n",
              "  50,\n",
              "  0),\n",
              " (20.406219482421875,\n",
              "  461.42962646484375,\n",
              "  130.56771850585938,\n",
              "  472.85699462890625,\n",
              "  'E. PRODUCT INFORMATION\\n',\n",
              "  51,\n",
              "  0),\n",
              " (20.399099349975586,\n",
              "  475.74285888671875,\n",
              "  522.478515625,\n",
              "  500.7235107421875,\n",
              "  'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n',\n",
              "  52,\n",
              "  0),\n",
              " (20.399999618530273,\n",
              "  504.75311279296875,\n",
              "  450.17755126953125,\n",
              "  516.1804809570312,\n",
              "  'F. DIAGNOSIS INFORMATION - Please indicate primary ICD code and specify any other any other where applicable (*).\\n',\n",
              "  53,\n",
              "  0),\n",
              " (20.399999618530273,\n",
              "  519.0028686523438,\n",
              "  370.3120422363281,\n",
              "  531.2034912109375,\n",
              "  'Primary ICD Code: \\n Other ICD Code: \\n',\n",
              "  54,\n",
              "  0),\n",
              " (20.399999618530273,\n",
              "  533.7930908203125,\n",
              "  423.8953857421875,\n",
              "  556.58349609375,\n",
              "  'G. CLINICAL INFORMATION - Required clinical information must be completed for ALL precertification requests.\\nFor Initiation Requests (clinical documentation required for all requests): \\n',\n",
              "  55,\n",
              "  0),\n",
              " (22.552032470703125,\n",
              "  556.713134765625,\n",
              "  570.1665649414062,\n",
              "  586.6221923828125,\n",
              "  'Note: Riabni and Rituxan are non-preferred. Ruxience and Truxima are the preferred biosimilars for most indications. \\nFor rheumatoid arthritis, all Rituxan and biosimilar products are non-preferred. Inflectra, Renflexis and Simponi Aria are preferred for MA plans. \\nEnbrel, Humira, Idacio, Rinvoq, Tyenne SC and Xeljanz/Xeljanz XR are preferred for MAPD plans. \\n',\n",
              "  56,\n",
              "  0),\n",
              " (31.737045288085938,\n",
              "  585.5209350585938,\n",
              "  384.74603271484375,\n",
              "  596.4136352539062,\n",
              "  'Has the patient had prior therapy with the requested product within the last 365 days? \\n Yes\\n No\\n',\n",
              "  57,\n",
              "  0),\n",
              " (78.10882568359375,\n",
              "  597.642578125,\n",
              "  471.17169189453125,\n",
              "  608.5352783203125,\n",
              "  ' Has the patient had a trial and failure of any of the following rituximab biosimilars? (If yes, select all that apply) \\n',\n",
              "  58,\n",
              "  0),\n",
              " (81.5941162109375,\n",
              "  608.0208129882812,\n",
              "  306.1827087402344,\n",
              "  630.0775146484375,\n",
              "  ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n',\n",
              "  59,\n",
              "  0),\n",
              " (81.5879135131836,\n",
              "  631.3623046875,\n",
              "  300.4075622558594,\n",
              "  642.2550048828125,\n",
              "  'Please describe the nature of the failure of the preferred drug \\n',\n",
              "  60,\n",
              "  0),\n",
              " (61.24689483642578,\n",
              "  597.6387939453125,\n",
              "  75.88221740722656,\n",
              "  608.531494140625,\n",
              "  ' No \\n',\n",
              "  61,\n",
              "  0),\n",
              " (78.10065460205078,\n",
              "  643.48388671875,\n",
              "  482.2637023925781,\n",
              "  654.3765869140625,\n",
              "  ' Has the patient had an adverse reaction to any of the following rituximab biosimilars? (If yes, select all that apply) \\n',\n",
              "  62,\n",
              "  0),\n",
              " (81.59410095214844,\n",
              "  653.85791015625,\n",
              "  317.46405029296875,\n",
              "  675.9175415039062,\n",
              "  ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n',\n",
              "  63,\n",
              "  0),\n",
              " (81.61186218261719,\n",
              "  677.1384887695312,\n",
              "  337.8099060058594,\n",
              "  688.0311889648438,\n",
              "  'Please describe the nature of the adverse reaction to the preferred drug \\n',\n",
              "  64,\n",
              "  0),\n",
              " (61.2548828125,\n",
              "  643.48681640625,\n",
              "  73.67176818847656,\n",
              "  654.3795166015625,\n",
              "  ' No\\n',\n",
              "  65,\n",
              "  0),\n",
              " (22.567840576171875,\n",
              "  689.2600708007812,\n",
              "  582.34375,\n",
              "  709.3943481445312,\n",
              "  'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when \\nindicated for the patient’s diagnosis? (select all that apply)   \\n',\n",
              "  66,\n",
              "  0),\n",
              " (31.744979858398438,\n",
              "  709.7208251953125,\n",
              "  234.30032348632812,\n",
              "  720.6141967773438,\n",
              "  ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n',\n",
              "  67,\n",
              "  0)]"
            ]
          },
          "metadata": {},
          "execution_count": 55
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def get_blocks(pdf_path):\n",
        "  doc = fitz.open((\"PA.pdf\"))\n",
        "  block_list = []\n",
        "  for i, p in enumerate(doc, start=1):\n",
        "    blocks = p.get_text('blocks')\n",
        "    for block in blocks:\n",
        "      obj = {\n",
        "          \"page\": i,\n",
        "          \"block\": block\n",
        "      }\n",
        "      print(obj)\n",
        "      block_list.append(obj)\n",
        "  return block_list\n",
        "\n",
        "blocks = get_blocks(\"PA.pdf\")\n",
        "print(blocks)\n",
        "#{'page': 2, 'name': 'T12', 'type': 7, 'rect': [62.843101501464844, 150.93402099609375, 230.375, 162.61297607421875], 'label': 'Patient First Name'}"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Sj30L2l0hjCL",
        "outputId": "1a519f74-1fe0-448c-9dc7-5ca7f85ac34a"
      },
      "execution_count": 56,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'page': 1, 'block': (18.0, 768.580810546875, 87.8329849243164, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}\n",
            "{'page': 1, 'block': (171.1199951171875, 88.86286163330078, 218.37191772460938, 101.06350708007812, 'Page 1 of 5 \\n', 1, 0)}\n",
            "{'page': 1, 'block': (171.11952209472656, 11.582880020141602, 436.9670715332031, 92.01454162597656, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\n', 2, 0)}\n",
            "{'page': 1, 'block': (445.3800048828125, 14.48285961151123, 576.630615234375, 45.81087112426758, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 3, 0)}\n",
            "{'page': 1, 'block': (445.3800048828125, 48.52688217163086, 580.3668823242188, 91.36349487304688, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 4, 0)}\n",
            "{'page': 1, 'block': (171.1199951171875, 98.67599487304688, 412.8420104980469, 111.56399536132812, '(All fields must be completed and legible for precertification review.) \\n', 5, 0)}\n",
            "{'page': 1, 'block': (31.68000030517578, 122.92514038085938, 579.0755615234375, 153.22991943359375, 'Would you like to use electronic prior authorization? Consider using Availity, our electronic prior authorization \\nportal. Learn more about Availity from the links in the table below. \\n', 6, 0)}\n",
            "{'page': 1, 'block': (31.680007934570312, 158.20384216308594, 578.8119506835938, 216.8699493408203, 'For phone or fax requests, refer to the table below for routing information. To determine which box to use, refer \\nto the patient’s Aetna ID card. State specific special needs and Medicare-Medicaid Plans may be designated on \\nthe front of the ID card or in the website URL on the back of the card. If you don’t see your specific plan listed, \\ncall the number on the back of the member’s ID card to confirm routing information. \\n', 7, 0)}\n",
            "{'page': 1, 'block': (51.05970764160156, 230.44125366210938, 520.5227661132812, 246.16461181640625, 'For Aetna Medicare Advantage and Allina Health Aetna Medicare members send request to: \\n', 8, 0)}\n",
            "{'page': 1, 'block': (51.048736572265625, 246.99911499023438, 514.5463256835938, 293.0931701660156, 'Phone: 1-866-503-0857 (TTY: 711)  \\nFax: \\n1-844-268-7263 \\nAvaility: https://www.aetna.com/health-care-professionals/resource-center/availity.html  \\n', 9, 0)}\n",
            "{'page': 1, 'block': (51.059722900390625, 303.524169921875, 502.14007568359375, 377.9365539550781, 'For Aetna Medicare Advantage Virginia Dual Eligible Special Needs Plans (HMO D-SNP) \\nsend request to: \\nPhone: 1-855-463-0933 \\nFax: \\n1-833-280-5224 \\nAvaility: https://www.aetnabetterhealth.com/virginia-hmosnp/providers/portal \\n', 10, 0)}\n",
            "{'page': 1, 'block': (51.059993743896484, 389.32281494140625, 552.38134765625, 463.736572265625, 'For Aetna Assure Premier Plus Medicare Advantage New Jersey Dual Eligible Special Needs Plans \\n(HMO D-SNP) send request to: \\nPhone: 1-844-362-0934\\nFax: \\n1-833-322-0034 \\nAvaility: https://www.aetnabetterhealth.com/new-jersey-hmosnp/providers/portal.html \\n', 11, 0)}\n",
            "{'page': 1, 'block': (51.060028076171875, 473.9809265136719, 508.9809265136719, 489.70428466796875, 'For Aetna Better Health of Illinois Premier Medicare Medicaid Plan (MMP) send request to: \\n', 12, 0)}\n",
            "{'page': 1, 'block': (51.04901885986328, 490.53875732421875, 409.17462158203125, 536.636962890625, 'Phone: 1-866-600-2139\\nFAX: \\n1-855-320-8445 \\nAvaility: https://www.aetnabetterhealth.com/illinois/providers/portal \\n', 13, 0)}\n",
            "{'page': 1, 'block': (51.060001373291016, 545.98095703125, 499.1976623535156, 561.7042846679688, 'For Aetna Better Health of Ohio Premier Medicare Medicaid Plan (MMP) send request to: \\n', 14, 0)}\n",
            "{'page': 1, 'block': (51.04901123046875, 562.538818359375, 397.58526611328125, 608.6370239257812, 'Phone: 1-855-364-0974\\nFax: \\n1-855-734-9389 \\nAvaility: https://www.aetnabetterhealth.com/ohio/providers/portal \\n', 15, 0)}\n",
            "{'page': 1, 'block': (51.060001373291016, 617.98095703125, 521.7615356445312, 633.704345703125, 'For Aetna Better Health of Michigan Premier Medicare Medicaid Plan (MMP) send request to: \\n', 16, 0)}\n",
            "{'page': 1, 'block': (51.049015045166016, 634.538818359375, 448.9452819824219, 680.6370239257812, 'Phone: 1-855-676-5772\\nFax: \\n1-844-241-2495 \\nAvaility: https://www.aetnabetterhealth.com/michigan/providers/portal.html \\n', 17, 0)}\n",
            "{'page': 2, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}\n",
            "{'page': 2, 'block': (161.99952697753906, 10.737120628356934, 427.83404541015625, 108.46498107910156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 2 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 1, 0)}\n",
            "{'page': 2, 'block': (453.7799987792969, 13.48285961151123, 585.0285034179688, 44.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 2, 0)}\n",
            "{'page': 2, 'block': (454.55999755859375, 47.52688217163086, 589.5609130859375, 89.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 3, 0)}\n",
            "{'page': 2, 'block': (77.98930358886719, 110.7192153930664, 554.345703125, 135.1289825439453, '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n', 4, 0)}\n",
            "{'page': 2, 'block': (76.3604965209961, 195.3408203125, 280.32928466796875, 206.2335205078125, ' \\n  \\n  \\n \\n  \\n  \\n', 5, 0)}\n",
            "{'page': 2, 'block': (266.2629089355469, 223.600830078125, 415.6719970703125, 256.93353271484375, '  \\n  \\n \\n   \\n', 6, 0)}\n",
            "{'page': 2, 'block': (450.2276916503906, 272.5979919433594, 452.7297058105469, 284.5049743652344, ' \\n', 7, 0)}\n",
            "{'page': 2, 'block': (101.09100341796875, 363.3408203125, 103.30944061279297, 374.2335205078125, ' \\n', 8, 0)}\n",
            "{'page': 2, 'block': (38.09709930419922, 405.1007995605469, 230.01846313476562, 458.83349609375, '   \\n   \\n  \\n  \\n    \\n    \\n  \\n   \\n', 9, 0)}\n",
            "{'page': 2, 'block': (486.82611083984375, 375.580810546875, 497.9358825683594, 386.4735107421875, '   \\n', 10, 0)}\n",
            "{'page': 2, 'block': (357.05230712890625, 387.76080322265625, 363.71881103515625, 398.65350341796875, '  \\n', 11, 0)}\n",
            "{'page': 2, 'block': (353.99920654296875, 411.9407958984375, 517.1822509765625, 422.83349609375, '  \\n  \\n  \\n', 12, 0)}\n",
            "{'page': 2, 'block': (363.3038024902344, 424.060791015625, 468.71160888671875, 434.9534912109375, ' \\n \\n', 13, 0)}\n",
            "{'page': 2, 'block': (349.07550048828125, 436.1808166503906, 468.711669921875, 447.0735168457031, '   \\n \\n', 14, 0)}\n",
            "{'page': 2, 'block': (349.07708740234375, 448.3608093261719, 360.1756896972656, 459.2535095214844, '   \\n', 15, 0)}\n",
            "{'page': 2, 'block': (180.96009826660156, 475.8791809082031, 508.228759765625, 500.7235107421875, ' \\n   \\n   \\n \\n  \\n  \\n', 16, 0)}\n",
            "{'page': 2, 'block': (325.87200927734375, 519.1392211914062, 328.2405700683594, 530.7689819335938, ' \\n', 17, 0)}\n",
            "{'page': 2, 'block': (47.75510025024414, 585.5208129882812, 79.74994659423828, 596.4135131835938, '  \\n  \\n', 18, 0)}\n",
            "{'page': 2, 'block': (75.89530181884766, 597.6408081054688, 78.11373901367188, 608.5335083007812, ' \\n', 19, 0)}\n",
            "{'page': 2, 'block': (188.15899658203125, 608.0208129882812, 190.37744140625, 618.9135131835938, ' \\n', 20, 0)}\n",
            "{'page': 2, 'block': (73.6769027709961, 643.4808349609375, 78.11377716064453, 654.37353515625, '  \\n', 21, 0)}\n",
            "{'page': 2, 'block': (185.9405975341797, 653.86083984375, 190.3774871826172, 664.7535400390625, '  \\n', 22, 0)}\n",
            "{'page': 2, 'block': (125.04219818115234, 709.7208251953125, 131.69752502441406, 720.613525390625, '   \\n', 23, 0)}\n",
            "{'page': 2, 'block': (502.864990234375, 737.7963256835938, 596.2230224609375, 748.9204711914062, 'Continued on next page \\n', 24, 0)}\n",
            "{'page': 2, 'block': (18.0, 110.7192153930664, 495.24786376953125, 122.34901428222656, 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n', 25, 0)}\n",
            "{'page': 2, 'block': (17.40106201171875, 123.36292266845703, 501.1325988769531, 135.56356811523438, 'Precertification Requested By: \\nPhone: \\nFax: \\n', 26, 0)}\n",
            "{'page': 2, 'block': (20.399999618530273, 137.673095703125, 125.64022064208984, 149.10044860839844, 'A. PATIENT INFORMATION\\n', 27, 0)}\n",
            "{'page': 2, 'block': (20.399999618530273, 150.7044677734375, 530.3218994140625, 161.59716796875, 'First Name:  \\nLast Name:  \\nDOB:  \\n', 28, 0)}\n",
            "{'page': 2, 'block': (20.39996337890625, 165.10467529296875, 525.4381713867188, 176.00103759765625, 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n', 29, 0)}\n",
            "{'page': 2, 'block': (20.399993896484375, 179.50079345703125, 450.2641906738281, 190.4012451171875, 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n', 30, 0)}\n",
            "{'page': 2, 'block': (20.399993896484375, 195.3408203125, 370.4882507324219, 206.2337646484375, 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n', 31, 0)}\n",
            "{'page': 2, 'block': (20.4000244140625, 210.031982421875, 139.0288848876953, 221.45933532714844, 'B. INSURANCE INFORMATION\\n', 32, 0)}\n",
            "{'page': 2, 'block': (20.390220642089844, 223.47027587890625, 74.55447387695312, 256.858642578125, 'Member ID #:  \\nGroup #:  \\nInsured:  \\n', 33, 0)}\n",
            "{'page': 2, 'block': (235.18788146972656, 223.5980224609375, 440.6332702636719, 256.933349609375, 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n', 34, 0)}\n",
            "{'page': 2, 'block': (20.409637451171875, 260.189208984375, 143.95599365234375, 271.6165771484375, 'C. PRESCRIBER INFORMATION\\n', 35, 0)}\n",
            "{'page': 2, 'block': (20.409637451171875, 272.2200012207031, 593.2784423828125, 284.5049743652344, 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n', 36, 0)}\n",
            "{'page': 2, 'block': (20.4022216796875, 287.620849609375, 525.446044921875, 298.5135498046875, 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n', 37, 0)}\n",
            "{'page': 2, 'block': (20.40228271484375, 302.02081298828125, 532.0935668945312, 312.9174499511719, 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n', 38, 0)}\n",
            "{'page': 2, 'block': (20.39202880859375, 317.1429138183594, 450.62579345703125, 328.0356140136719, 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n', 39, 0)}\n",
            "{'page': 2, 'block': (20.399993896484375, 330.810546875, 256.3798522949219, 342.2400207519531, 'D. DISPENSING PROVIDER/ADMINISTRATION INFORMATION\\n', 40, 0)}\n",
            "{'page': 2, 'block': (20.399999618530273, 342.8683166503906, 114.59831237792969, 354.2956848144531, 'Place of Administration: \\n', 41, 0)}\n",
            "{'page': 2, 'block': (22.570980072021484, 353.0747375488281, 249.09925842285156, 458.8310852050781, ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n', 42, 0)}\n",
            "{'page': 2, 'block': (329.1705627441406, 342.87371826171875, 454.4814758300781, 354.30108642578125, 'Dispensing Provider/Pharmacy:  \\n', 43, 0)}\n",
            "{'page': 2, 'block': (340.5101318359375, 353.14398193359375, 533.1074829101562, 386.4764404296875, ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n', 44, 0)}\n",
            "{'page': 2, 'block': (331.3331298828125, 387.76123046875, 357.06866455078125, 398.6539306640625, 'Name: \\n', 45, 0)}\n",
            "{'page': 2, 'block': (331.3331298828125, 399.8190002441406, 367.3149719238281, 410.7117004394531, 'Address:  \\n', 46, 0)}\n",
            "{'page': 2, 'block': (331.3251647949219, 411.93768310546875, 536.2573852539062, 422.83331298828125, 'City:  \\nState:  \\nZIP:  \\n', 47, 0)}\n",
            "{'page': 2, 'block': (331.322998046875, 424.0592956542969, 490.9054870605469, 434.9519958496094, 'Phone:  \\n Fax:  \\n', 48, 0)}\n",
            "{'page': 2, 'block': (331.322998046875, 436.05322265625, 490.9086608886719, 447.4805908203125, 'TIN: \\n PIN:  \\n', 49, 0)}\n",
            "{'page': 2, 'block': (331.322998046875, 448.3583984375, 349.0801086425781, 459.2510986328125, 'NPI: \\n', 50, 0)}\n",
            "{'page': 2, 'block': (20.406219482421875, 461.42962646484375, 130.56771850585938, 472.85699462890625, 'E. PRODUCT INFORMATION\\n', 51, 0)}\n",
            "{'page': 2, 'block': (20.399099349975586, 475.74285888671875, 522.478515625, 500.7235107421875, 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n', 52, 0)}\n",
            "{'page': 2, 'block': (20.399999618530273, 504.75311279296875, 450.17755126953125, 516.1804809570312, 'F. DIAGNOSIS INFORMATION - Please indicate primary ICD code and specify any other any other where applicable (*).\\n', 53, 0)}\n",
            "{'page': 2, 'block': (20.399999618530273, 519.0028686523438, 370.3120422363281, 531.2034912109375, 'Primary ICD Code: \\n Other ICD Code: \\n', 54, 0)}\n",
            "{'page': 2, 'block': (20.399999618530273, 533.7930908203125, 423.8953857421875, 556.58349609375, 'G. CLINICAL INFORMATION - Required clinical information must be completed for ALL precertification requests.\\nFor Initiation Requests (clinical documentation required for all requests): \\n', 55, 0)}\n",
            "{'page': 2, 'block': (22.552032470703125, 556.713134765625, 570.1665649414062, 586.6221923828125, 'Note: Riabni and Rituxan are non-preferred. Ruxience and Truxima are the preferred biosimilars for most indications. \\nFor rheumatoid arthritis, all Rituxan and biosimilar products are non-preferred. Inflectra, Renflexis and Simponi Aria are preferred for MA plans. \\nEnbrel, Humira, Idacio, Rinvoq, Tyenne SC and Xeljanz/Xeljanz XR are preferred for MAPD plans. \\n', 56, 0)}\n",
            "{'page': 2, 'block': (31.737045288085938, 585.5209350585938, 384.74603271484375, 596.4136352539062, 'Has the patient had prior therapy with the requested product within the last 365 days? \\n Yes\\n No\\n', 57, 0)}\n",
            "{'page': 2, 'block': (78.10882568359375, 597.642578125, 471.17169189453125, 608.5352783203125, ' Has the patient had a trial and failure of any of the following rituximab biosimilars? (If yes, select all that apply) \\n', 58, 0)}\n",
            "{'page': 2, 'block': (81.5941162109375, 608.0208129882812, 306.1827087402344, 630.0775146484375, ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n', 59, 0)}\n",
            "{'page': 2, 'block': (81.5879135131836, 631.3623046875, 300.4075622558594, 642.2550048828125, 'Please describe the nature of the failure of the preferred drug \\n', 60, 0)}\n",
            "{'page': 2, 'block': (61.24689483642578, 597.6387939453125, 75.88221740722656, 608.531494140625, ' No \\n', 61, 0)}\n",
            "{'page': 2, 'block': (78.10065460205078, 643.48388671875, 482.2637023925781, 654.3765869140625, ' Has the patient had an adverse reaction to any of the following rituximab biosimilars? (If yes, select all that apply) \\n', 62, 0)}\n",
            "{'page': 2, 'block': (81.59410095214844, 653.85791015625, 317.46405029296875, 675.9175415039062, ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n', 63, 0)}\n",
            "{'page': 2, 'block': (81.61186218261719, 677.1384887695312, 337.8099060058594, 688.0311889648438, 'Please describe the nature of the adverse reaction to the preferred drug \\n', 64, 0)}\n",
            "{'page': 2, 'block': (61.2548828125, 643.48681640625, 73.67176818847656, 654.3795166015625, ' No\\n', 65, 0)}\n",
            "{'page': 2, 'block': (22.567840576171875, 689.2600708007812, 582.34375, 709.3943481445312, 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when \\nindicated for the patient’s diagnosis? (select all that apply)   \\n', 66, 0)}\n",
            "{'page': 2, 'block': (31.744979858398438, 709.7208251953125, 234.30032348632812, 720.6141967773438, ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n', 67, 0)}\n",
            "{'page': 3, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}\n",
            "{'page': 3, 'block': (161.99301147460938, 12.357115745544434, 427.8236999511719, 109.48500061035156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 3 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 1, 0)}\n",
            "{'page': 3, 'block': (453.7799987792969, 14.48285961151123, 585.0285034179688, 45.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 2, 0)}\n",
            "{'page': 3, 'block': (454.55999755859375, 48.52688217163086, 589.5269775390625, 90.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 3, 0)}\n",
            "{'page': 3, 'block': (20.399999618530273, 141.54286193847656, 499.46856689453125, 153.74349975585938, 'G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed for ALL precertification requests.\\n', 4, 0)}\n",
            "{'page': 3, 'block': (73.6769027709961, 168.9407958984375, 80.33221435546875, 179.83349609375, '   \\n', 5, 0)}\n",
            "{'page': 3, 'block': (185.927001953125, 179.32080078125, 300.4560852050781, 190.2135009765625, ' \\n  \\n', 6, 0)}\n",
            "{'page': 3, 'block': (73.6769027709961, 214.7208251953125, 78.11377716064453, 225.613525390625, '  \\n', 7, 0)}\n",
            "{'page': 3, 'block': (181.49009704589844, 225.16082763671875, 300.4561462402344, 236.05352783203125, '   \\n   \\n', 8, 0)}\n",
            "{'page': 3, 'block': (342.2427062988281, 248.4407958984375, 348.8980407714844, 259.33349609375, '  \\n', 9, 0)}\n",
            "{'page': 3, 'block': (73.6769027709961, 260.560791015625, 80.33221435546875, 271.4534912109375, '   \\n', 10, 0)}\n",
            "{'page': 3, 'block': (163.6501007080078, 271.00079345703125, 594.7120361328125, 281.89349365234375, '  \\n   \\n   \\n   \\n   \\n', 11, 0)}\n",
            "{'page': 3, 'block': (73.6769027709961, 319.3008117675781, 78.11377716064453, 330.1935119628906, '  \\n', 12, 0)}\n",
            "{'page': 3, 'block': (161.43190002441406, 329.6808166503906, 464.660400390625, 340.5735168457031, '   \\n   \\n   \\n  \\n', 13, 0)}\n",
            "{'page': 3, 'block': (315.2414855957031, 353.74420166015625, 326.3337097167969, 364.63690185546875, '   \\n', 14, 0)}\n",
            "{'page': 3, 'block': (122.8102035522461, 398.4407958984375, 241.77613830566406, 409.33349609375, '   \\n   \\n', 15, 0)}\n",
            "{'page': 3, 'block': (102.3917007446289, 442.2408142089844, 401.125244140625, 453.1335144042969, '   \\n \\n   \\n \\n', 16, 0)}\n",
            "{'page': 3, 'block': (47.75510025024414, 491.14080810546875, 80.4521713256836, 502.03350830078125, '  \\n  \\n', 17, 0)}\n",
            "{'page': 3, 'block': (47.75510025024414, 513.580810546875, 80.45220947265625, 535.6934814453125, '  \\n   \\n \\n \\n', 18, 0)}\n",
            "{'page': 3, 'block': (47.75510025024414, 547.1807861328125, 80.4521713256836, 558.073486328125, '  \\n  \\n', 19, 0)}\n",
            "{'page': 3, 'block': (233.32504272460938, 569.6205444335938, 235.54348754882812, 580.5132446289062, ' \\n', 20, 0)}\n",
            "{'page': 3, 'block': (49.9734992980957, 580.2979736328125, 236.45864868164062, 602.7734985351562, ' \\n \\n  \\n', 21, 0)}\n",
            "{'page': 3, 'block': (47.75510025024414, 614.2608032226562, 78.23377227783203, 625.1535034179688, '  \\n  \\n', 22, 0)}\n",
            "{'page': 3, 'block': (314.5495910644531, 624.5208129882812, 500.9585266113281, 646.093505859375, '   \\n  \\n   \\n   \\n   \\n', 23, 0)}\n",
            "{'page': 3, 'block': (275.07470703125, 656.0208129882812, 500.9814453125, 688.2734985351562, '   \\n  \\n \\n   \\n   \\n  \\n  \\n', 24, 0)}\n",
            "{'page': 3, 'block': (304.9302978515625, 689.4407958984375, 309.3671875, 700.33349609375, '  \\n', 25, 0)}\n",
            "{'page': 3, 'block': (502.85980224609375, 704.6130981445312, 596.2178344726562, 716.0404663085938, 'Continued on next page \\n', 26, 0)}\n",
            "{'page': 3, 'block': (20.399999618530273, 117.61917877197266, 519.9957275390625, 129.2489776611328, 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n', 27, 0)}\n",
            "{'page': 3, 'block': (20.399999618530273, 154.3828887939453, 352.34820556640625, 166.58352661132812, 'For Initiation Requests continued (clinical documentation required for all requests): \\n', 28, 0)}\n",
            "{'page': 3, 'block': (80.33219909667969, 168.9407958984375, 396.53973388671875, 179.83349609375, 'Has the patient had a trial and failure of any of the following? (If yes, select all that apply) \\n', 29, 0)}\n",
            "{'page': 3, 'block': (81.59303283691406, 179.32275390625, 408.320556640625, 201.37945556640625, ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n', 30, 0)}\n",
            "{'page': 3, 'block': (81.59574890136719, 202.66229248046875, 300.4154052734375, 213.55499267578125, 'Please describe the nature of the failure of the preferred drug \\n', 31, 0)}\n",
            "{'page': 3, 'block': (61.26271057128906, 168.9388427734375, 73.67959594726562, 179.83154296875, ' No\\n', 32, 0)}\n",
            "{'page': 3, 'block': (78.10848999023438, 214.7200927734375, 407.6346740722656, 225.61279296875, ' Has the patient had an adverse reaction to any of the following? (If yes, select all that apply) \\n', 33, 0)}\n",
            "{'page': 3, 'block': (81.58778381347656, 225.157958984375, 408.3153076171875, 247.217529296875, ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n', 34, 0)}\n",
            "{'page': 3, 'block': (81.59574890136719, 248.4384765625, 337.7937927246094, 259.3311767578125, 'Please describe the nature of the adverse reaction to the preferred drug \\n', 35, 0)}\n",
            "{'page': 3, 'block': (61.254730224609375, 214.72296142578125, 73.67161560058594, 225.61566162109375, ' No\\n', 36, 0)}\n",
            "{'page': 3, 'block': (80.32693481445312, 260.56005859375, 396.53448486328125, 271.4527587890625, 'Has the patient had a trial and failure of any of the following? (If yes, select all that apply) \\n', 37, 0)}\n",
            "{'page': 3, 'block': (90.77273559570312, 270.9979248046875, 588.0537719726562, 292.9269714355469, ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n', 38, 0)}\n",
            "{'page': 3, 'block': (81.5957260131836, 295.0576171875, 306.1826171875, 305.9582824707031, 'When was the member’s trial and failure of the preferred drug? \\n', 39, 0)}\n",
            "{'page': 3, 'block': (81.5870361328125, 307.17779541015625, 300.4067077636719, 318.07049560546875, 'Please describe the nature of the failure of the preferred drug \\n', 40, 0)}\n",
            "{'page': 3, 'block': (61.24601745605469, 260.55865478515625, 73.66290283203125, 271.45135498046875, ' No\\n', 41, 0)}\n",
            "{'page': 3, 'block': (78.09977722167969, 319.2994384765625, 396.5257568359375, 330.192138671875, ' Has the patient had a trial and failure of any of the following? (If yes, select all that apply) \\n', 42, 0)}\n",
            "{'page': 3, 'block': (90.7640380859375, 329.6814270019531, 585.8162841796875, 351.6104736328125, ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n', 43, 0)}\n",
            "{'page': 3, 'block': (81.5870590209961, 353.7411193847656, 312.8380432128906, 364.6368408203125, 'When was the member’s adverse reaction to the preferred drug? \\n', 44, 0)}\n",
            "{'page': 3, 'block': (81.58714294433594, 365.921630859375, 337.7851867675781, 376.8143310546875, 'Please describe the nature of the adverse reaction to the preferred drug \\n', 45, 0)}\n",
            "{'page': 3, 'block': (61.246124267578125, 319.3024597167969, 73.66300964355469, 330.1951599121094, ' No\\n', 46, 0)}\n",
            "{'page': 3, 'block': (22.551105499267578, 378.0432434082031, 591.8544311523438, 398.1129455566406, 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for \\nthe patient’s diagnosis? (select all that apply) \\n', 47, 0)}\n",
            "{'page': 3, 'block': (31.73699188232422, 398.43768310546875, 347.5135498046875, 409.33038330078125, ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n', 48, 0)}\n",
            "{'page': 3, 'block': (22.552001953125, 421.8350524902344, 591.8512573242188, 441.9127197265625, 'Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for \\nthe patient’s diagnosis? (select all that apply)  \\n', 49, 0)}\n",
            "{'page': 3, 'block': (31.736968994140625, 442.2377014160156, 522.35546875, 464.29443359375, ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n', 50, 0)}\n",
            "{'page': 3, 'block': (20.397384643554688, 478.14288330078125, 288.7485656738281, 490.3435363769531, 'For All Requests (clinical documentation required for all requests): \\n', 51, 0)}\n",
            "{'page': 3, 'block': (31.73999786376953, 491.14080810546875, 548.70361328125, 502.03350830078125, 'Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)? \\n Yes\\n No \\n', 52, 0)}\n",
            "{'page': 3, 'block': (22.55501937866211, 503.19061279296875, 121.17971801757812, 514.6179809570312, 'Acute lymphoid leukemia \\n', 53, 0)}\n",
            "{'page': 3, 'block': (31.742279052734375, 513.58056640625, 502.07550048828125, 524.4732666015625, 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n', 54, 0)}\n",
            "{'page': 3, 'block': (31.742286682128906, 524.6729736328125, 326.8291015625, 536.100341796875, '  Is Rituxan (rituximab) being used as induction/consolidation therapy? \\n Yes \\n No\\n', 55, 0)}\n",
            "{'page': 3, 'block': (22.557308197021484, 536.8504638671875, 142.97547912597656, 548.2779541015625, 'Autoimmune hemolytic anemia \\n', 56, 0)}\n",
            "{'page': 3, 'block': (31.742252349853516, 547.1846923828125, 409.3965759277344, 558.077392578125, 'Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia? \\n Yes\\n No \\n', 57, 0)}\n",
            "{'page': 3, 'block': (22.549320220947266, 559.2305908203125, 482.70806884765625, 602.7694702148438, 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n', 58, 0)}\n",
            "{'page': 3, 'block': (22.565284729003906, 603.9265747070312, 245.70199584960938, 615.3619384765625, 'Autoimmune blistering diseases, corticosteroid-refractory \\n', 59, 0)}\n",
            "{'page': 3, 'block': (31.74222183227539, 614.2647094726562, 459.2891540527344, 625.1574096679688, ' Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease? \\n Yes\\n', 60, 0)}\n",
            "{'page': 3, 'block': (81.23418426513672, 624.5208129882812, 591.0953979492188, 646.0907592773438, 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n', 61, 0)}\n",
            "{'page': 3, 'block': (61.3829345703125, 614.2665405273438, 73.79981994628906, 625.1592407226562, ' No\\n', 62, 0)}\n",
            "{'page': 3, 'block': (22.560237884521484, 645.6279296875, 590.15869140625, 688.2680053710938, 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n', 63, 0)}\n",
            "{'page': 3, 'block': (184.91822814941406, 689.4330444335938, 347.44854736328125, 700.333740234375, ' Splenic marginal zone lymphoma\\n Other: \\n', 64, 0)}\n",
            "{'page': 4, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}\n",
            "{'page': 4, 'block': (161.99827575683594, 12.357115745544434, 448.1394958496094, 113.50502014160156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 4 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 1, 0)}\n",
            "{'page': 4, 'block': (453.7799987792969, 14.48285961151123, 585.0285034179688, 45.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 2, 0)}\n",
            "{'page': 4, 'block': (454.9800109863281, 48.52688217163086, 589.9522094726562, 90.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 3, 0)}\n",
            "{'page': 4, 'block': (20.399999618530273, 146.04286193847656, 499.4063720703125, 158.24349975585938, 'G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed for ALL precertification requests.\\n', 4, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 169.36077880859375, 80.4521713256836, 180.25347900390625, '  \\n  \\n', 5, 0)}\n",
            "{'page': 4, 'block': (170.9852752685547, 191.7366943359375, 449.31622314453125, 202.63348388671875, ' \\n   \\n   \\n', 6, 0)}\n",
            "{'page': 4, 'block': (170.98460388183594, 214.11669921875, 432.5870361328125, 225.01348876953125, ' \\n   \\n   \\n', 7, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 236.560791015625, 80.45220947265625, 258.67352294921875, '  \\n   \\n  \\n \\n', 8, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 270.16082763671875, 80.45220947265625, 281.05352783203125, ' \\n   \\n', 9, 0)}\n",
            "{'page': 4, 'block': (170.98532104492188, 292.5367431640625, 409.93548583984375, 303.4335021972656, ' \\n   \\n  \\n', 10, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 314.9208068847656, 78.23373413085938, 325.8135070800781, '  \\n \\n', 11, 0)}\n",
            "{'page': 4, 'block': (340.87139892578125, 335.32080078125, 345.30828857421875, 346.2135009765625, '  \\n', 12, 0)}\n",
            "{'page': 4, 'block': (289.3194885253906, 357.81640625, 486.1988220214844, 391.9934997558594, ' \\n   \\n   \\n  \\n   \\n   \\n', 13, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 403.90081787109375, 490.01776123046875, 424.9934997558594, '  \\n   \\n \\n   \\n', 14, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 436.5408020019531, 80.45220947265625, 447.4335021972656, '  \\n   \\n', 15, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 458.9208068847656, 80.45220947265625, 469.8135070800781, '  \\n   \\n', 16, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 491.50079345703125, 433.7326354980469, 513.6134643554688, '  \\n   \\n   \\n  \\n  \\n', 17, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 525.100830078125, 78.23377227783203, 535.9935302734375, '  \\n  \\n', 18, 0)}\n",
            "{'page': 4, 'block': (105.77510070800781, 537.2808227539062, 140.690673828125, 548.1735229492188, '  \\n    \\n', 19, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 559.7208251953125, 80.45220947265625, 581.83349609375, '  \\n   \\n  \\n  \\n', 20, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 593.32080078125, 80.4521713256836, 615.4334716796875, '  \\n  \\n \\n  \\n', 21, 0)}\n",
            "{'page': 4, 'block': (133.35910034179688, 625.9032592773438, 532.8065795898438, 648.0134887695312, '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n', 22, 0)}\n",
            "{'page': 4, 'block': (47.75510025024414, 660.5208129882812, 80.45220947265625, 671.4135131835938, '  \\n   \\n', 23, 0)}\n",
            "{'page': 4, 'block': (110.93509674072266, 672.7008056640625, 141.41378784179688, 683.593505859375, '  \\n  \\n', 24, 0)}\n",
            "{'page': 4, 'block': (502.8599853515625, 690.0331420898438, 596.218017578125, 701.4605102539062, 'Continued on next page \\n', 25, 0)}\n",
            "{'page': 4, 'block': (20.399999618530273, 122.11917877197266, 524.4943237304688, 133.7489776611328, 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n', 26, 0)}\n",
            "{'page': 4, 'block': (22.559999465942383, 159.03314208984375, 103.19789123535156, 170.4604949951172, \"Castleman's disease \\n\", 27, 0)}\n",
            "{'page': 4, 'block': (31.736995697021484, 169.3592529296875, 524.703857421875, 180.251953125, 'Does the patient have a documented diagnosis of multicentric Castleman’s disease (angiofollicular lymph node hyperplasia)? \\n Yes\\n No \\n', 28, 0)}\n",
            "{'page': 4, 'block': (22.552021026611328, 181.4090576171875, 527.0359497070312, 203.11611938476562, 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n', 29, 0)}\n",
            "{'page': 4, 'block': (22.556182861328125, 203.79058837890625, 510.2961730957031, 225.01739501953125, 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n', 30, 0)}\n",
            "{'page': 4, 'block': (22.55059814453125, 226.17059326171875, 92.33577728271484, 237.5979461669922, 'Cryoglobulinemia \\n', 31, 0)}\n",
            "{'page': 4, 'block': (31.743640899658203, 236.560546875, 324.9503479003906, 247.4532470703125, 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n', 32, 0)}\n",
            "{'page': 4, 'block': (31.743640899658203, 247.78045654296875, 520.0528564453125, 258.67315673828125, ' Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective? \\n Yes\\n No \\n', 33, 0)}\n",
            "{'page': 4, 'block': (22.558666229248047, 259.7744140625, 155.9342803955078, 271.2021484375, 'Graft versus host disease, chronic \\n', 34, 0)}\n",
            "{'page': 4, 'block': (31.7264404296875, 270.03704833984375, 547.3700561523438, 281.46441650390625, 'Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)? \\n Yes\\n No\\n', 35, 0)}\n",
            "{'page': 4, 'block': (22.541461944580078, 282.21063232421875, 487.6446228027344, 303.8443908691406, 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n', 36, 0)}\n",
            "{'page': 4, 'block': (22.565277099609375, 304.5906066894531, 147.89581298828125, 316.0218811035156, 'Heart and solid organ transplant \\n', 37, 0)}\n",
            "{'page': 4, 'block': (31.75030517578125, 314.9208068847656, 578.2815551757812, 336.0158386230469, ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n', 38, 0)}\n",
            "{'page': 4, 'block': (88.51203918457031, 335.31768798828125, 488.4099426269531, 346.21038818359375, 'Please select which applies to the patient: \\n heart transplant recipient \\n other solid organ transplant recipient \\n', 39, 0)}\n",
            "{'page': 4, 'block': (61.388031005859375, 314.9208068847656, 76.02335357666016, 325.8135070800781, ' No \\n', 40, 0)}\n",
            "{'page': 4, 'block': (22.564010620117188, 347.36749267578125, 584.3960571289062, 391.9921875, 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n', 41, 0)}\n",
            "{'page': 4, 'block': (22.55535888671875, 393.5722351074219, 210.11727905273438, 404.9996032714844, 'Immune or idiopathic thrombocytopenic purpura \\n', 42, 0)}\n",
            "{'page': 4, 'block': (31.732357025146484, 403.8983459472656, 487.533447265625, 414.7910461425781, 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n', 43, 0)}\n",
            "{'page': 4, 'block': (61.37005615234375, 403.8983459472656, 430.48516845703125, 424.9894714355469, ' refractory immune thrombocytopenic purpura\\n idiopathic thrombocytopenic purpura (ITP) \\n No\\n', 44, 0)}\n",
            "{'page': 4, 'block': (22.547359466552734, 426.1465759277344, 177.23976135253906, 437.5819091796875, 'Kidney transplant, rejection prophylaxis \\n', 45, 0)}\n",
            "{'page': 4, 'block': (31.742862701416016, 436.5405578613281, 542.0208129882812, 447.4332580566406, 'Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies? \\n Yes\\n No\\n', 46, 0)}\n",
            "{'page': 4, 'block': (22.56586456298828, 448.53448486328125, 205.81802368164062, 459.96209716796875, \"Lymphocyte-predominant Hodgkin's lymphoma \\n\", 47, 0)}\n",
            "{'page': 4, 'block': (31.758258819580078, 458.9246826171875, 429.13037109375, 469.8173828125, 'Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin’s lymphoma? \\n Yes\\n No\\n', 48, 0)}\n",
            "{'page': 4, 'block': (22.55730438232422, 470.9706115722656, 314.07391357421875, 492.1894226074219, 'Multiple Sclerosis \\nPlease indicate the type of multiple sclerosis the patient has been diagnosed with: \\n', 49, 0)}\n",
            "{'page': 4, 'block': (31.742284774780273, 491.50079345703125, 569.6559448242188, 513.6133422851562, ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n', 50, 0)}\n",
            "{'page': 4, 'block': (22.565528869628906, 514.7705078125, 138.60250854492188, 526.197998046875, 'Myasthenia gravis (MuSk-MG) \\n', 51, 0)}\n",
            "{'page': 4, 'block': (31.742340087890625, 525.104736328125, 486.8975830078125, 535.9974365234375, ' Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)? \\n Yes\\n', 52, 0)}\n",
            "{'page': 4, 'block': (89.75691986083984, 537.2782592773438, 401.1494140625, 548.1748657226562, 'Has the patient had an unsatisfactory response to initial immunotherapy? \\n Yes\\n No\\n', 53, 0)}\n",
            "{'page': 4, 'block': (61.38003921508789, 525.100830078125, 73.79692077636719, 535.9935302734375, ' No\\n', 54, 0)}\n",
            "{'page': 4, 'block': (22.557342529296875, 549.3280639648438, 170.58367919921875, 560.7579345703125, 'Neuromyelitis optica (Devic’s disease) \\n', 55, 0)}\n",
            "{'page': 4, 'block': (31.73965072631836, 559.7205810546875, 398.7877502441406, 570.61328125, 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n', 56, 0)}\n",
            "{'page': 4, 'block': (31.73965072631836, 570.9404296875, 308.09503173828125, 581.8331298828125, ' Was the treatment with at least one immunotherapy ineffective? \\n Yes\\n No\\n', 57, 0)}\n",
            "{'page': 4, 'block': (22.554676055908203, 582.9343872070312, 272.63458251953125, 594.3621215820312, 'Opsoclonus-myoclonus-ataxia (opsoclonus myoclonus syndrome) \\n', 58, 0)}\n",
            "{'page': 4, 'block': (31.742321014404297, 593.32470703125, 508.3160400390625, 604.2174072265625, 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n', 59, 0)}\n",
            "{'page': 4, 'block': (31.742321014404297, 604.5446166992188, 384.507080078125, 615.4373168945312, ' Is the patient refractory to steroids, chemotherapy and intravenous immunoglobulins? \\n Yes \\n', 60, 0)}\n",
            "{'page': 4, 'block': (90.2357177734375, 614.683349609375, 481.70257568359375, 648.015869140625, 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n', 61, 0)}\n",
            "{'page': 4, 'block': (61.387969970703125, 604.540771484375, 73.80485534667969, 615.4334716796875, ' No\\n', 62, 0)}\n",
            "{'page': 4, 'block': (22.57324981689453, 649.1729736328125, 194.16720581054688, 660.600341796875, 'Post-transplant lymphoproliferative disorder \\n', 63, 0)}\n",
            "{'page': 4, 'block': (31.73700714111328, 660.5205078125, 415.3221435546875, 671.4133911132812, 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n', 64, 0)}\n",
            "{'page': 4, 'block': (94.91436767578125, 672.6981811523438, 577.137939453125, 683.593505859375, ' Is Rituxan (rituximab) being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n', 65, 0)}\n",
            "{'page': 5, 'block': (161.99827575683594, 12.357115745544434, 448.1394958496094, 115.48500061035156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 5 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 0, 0)}\n",
            "{'page': 5, 'block': (453.7799987792969, 14.48285961151123, 585.0285034179688, 45.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 1, 0)}\n",
            "{'page': 5, 'block': (454.9800109863281, 48.52688217163086, 589.9669189453125, 90.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 2, 0)}\n",
            "{'page': 5, 'block': (20.399999618530273, 146.04286193847656, 499.4063720703125, 158.24349975585938, 'G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed for ALL precertification requests.\\n', 3, 0)}\n",
            "{'page': 5, 'block': (47.75510025024414, 168.3408203125, 333.8779296875, 200.65350341796875, '  \\n   \\n \\n   \\n  \\n \\n', 4, 0)}\n",
            "{'page': 5, 'block': (111.83509826660156, 199.9608154296875, 308.304931640625, 221.05352783203125, '  \\n   \\n \\n   \\n   \\n', 5, 0)}\n",
            "{'page': 5, 'block': (111.83509826660156, 222.3408203125, 455.9510192871094, 243.43353271484375, '  \\n   \\n \\n   \\n  \\n   \\n  \\n', 6, 0)}\n",
            "{'page': 5, 'block': (47.75510025024414, 254.9207763671875, 80.45220947265625, 277.03350830078125, '  \\n   \\n  \\n \\n', 7, 0)}\n",
            "{'page': 5, 'block': (133.35910034179688, 286.5376892089844, 532.8065185546875, 308.65350341796875, '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n', 8, 0)}\n",
            "{'page': 5, 'block': (47.75510025024414, 320.6808166503906, 80.45220947265625, 331.5735168457031, '  \\n   \\n', 9, 0)}\n",
            "{'page': 5, 'block': (47.75510025024414, 343.060791015625, 80.45220947265625, 353.9534912109375, '  \\n   \\n', 10, 0)}\n",
            "{'page': 5, 'block': (47.75510025024414, 366.4608154296875, 80.4521713256836, 377.353515625, '  \\n  \\n', 11, 0)}\n",
            "{'page': 5, 'block': (47.75510025024414, 399.0392150878906, 437.8565368652344, 431.353515625, ' \\n \\n   \\n  \\n \\n  \\n \\n', 12, 0)}\n",
            "{'page': 5, 'block': (47.75510025024414, 442.8408203125, 80.45223999023438, 464.9534912109375, '  \\n   \\n \\n \\n', 13, 0)}\n",
            "{'page': 5, 'block': (204.83689880371094, 485.8992004394531, 564.42333984375, 497.5290222167969, ' \\n/ \\n/ \\n', 14, 0)}\n",
            "{'page': 5, 'block': (20.399999618530273, 122.11917877197266, 524.4943237304688, 133.7489776611328, 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n', 15, 0)}\n",
            "{'page': 5, 'block': (22.55999755859375, 159.03314208984375, 372.96185302734375, 189.428955078125, 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n', 16, 0)}\n",
            "{'page': 5, 'block': (31.737014770507812, 189.75616455078125, 319.1925964355469, 200.64886474609375, '  Will Rituxan (rituximab) be used in combination with methotrexate? \\n Yes\\n No\\n', 17, 0)}\n",
            "{'page': 5, 'block': (95.81642150878906, 199.95458984375, 421.4748229980469, 210.8472900390625, 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n', 18, 0)}\n",
            "{'page': 5, 'block': (125.45199584960938, 199.95281982421875, 376.3017883300781, 221.0537109375, 'Please select:\\n ineffective\\n not tolerated\\n contraindicated \\n No\\n', 19, 0)}\n",
            "{'page': 5, 'block': (95.81428527832031, 222.33673095703125, 365.9931640625, 233.22943115234375, 'Was treatment with another conventional DMARD ineffective? \\n Yes\\n', 20, 0)}\n",
            "{'page': 5, 'block': (125.4678955078125, 222.33282470703125, 517.3258056640625, 243.43585205078125, 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n', 21, 0)}\n",
            "{'page': 5, 'block': (22.56578826904297, 244.58905029296875, 95.04107666015625, 256.01800537109375, 'Sjögren syndrome \\n', 22, 0)}\n",
            "{'page': 5, 'block': (31.743724822998047, 254.92474365234375, 335.62933349609375, 265.81744384765625, 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n', 23, 0)}\n",
            "{'page': 5, 'block': (31.743728637695312, 266.1446533203125, 383.2788391113281, 277.037353515625, '  Was treatment with corticosteroids and other immunosuppressive agents ineffective? \\n Yes\\n', 24, 0)}\n",
            "{'page': 5, 'block': (90.24359893798828, 276.3392333984375, 479.50006103515625, 308.65350341796875, 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n', 25, 0)}\n",
            "{'page': 5, 'block': (61.380001068115234, 266.14080810546875, 73.79688262939453, 277.03350830078125, ' No\\n', 26, 0)}\n",
            "{'page': 5, 'block': (22.56528091430664, 309.807373046875, 173.22767639160156, 321.2347412109375, 'Thrombotic thrombocytopenic purpura \\n', 27, 0)}\n",
            "{'page': 5, 'block': (31.74227523803711, 320.6761474609375, 456.2386474609375, 331.56884765625, 'Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)? \\n Yes\\n No\\n', 28, 0)}\n",
            "{'page': 5, 'block': (22.557300567626953, 332.7259521484375, 157.73851013183594, 344.1612854003906, 'Waldenstrom’s macroglobulinemia \\n', 29, 0)}\n",
            "{'page': 5, 'block': (31.742290496826172, 343.0647277832031, 381.45062255859375, 353.9574279785156, 'Does the patient have a documented diagnosis of Waldenström macroglobulinemia? \\n Yes\\n No\\n', 30, 0)}\n",
            "{'page': 5, 'block': (20.4027099609375, 355.1744384765625, 127.92521667480469, 366.6057434082031, 'For Continuation Requests: \\n', 31, 0)}\n",
            "{'page': 5, 'block': (22.56528091430664, 366.4581604003906, 403.6510009765625, 387.55194091796875, 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n', 32, 0)}\n",
            "{'page': 5, 'block': (22.557296752929688, 388.7170104980469, 476.9332275390625, 420.13037109375, 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n', 33, 0)}\n",
            "{'page': 5, 'block': (31.729000091552734, 420.4575500488281, 312.47174072265625, 431.3502502441406, ' Is there clinical documentation supporting disease improvement? \\n Yes\\n No \\n', 34, 0)}\n",
            "{'page': 5, 'block': (22.544025421142578, 432.5073547363281, 118.07713317871094, 443.93798828125, 'For all other indications: \\n', 35, 0)}\n",
            "{'page': 5, 'block': (31.742321014404297, 442.8447265625, 292.9938659667969, 453.7374267578125, 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n', 36, 0)}\n",
            "{'page': 5, 'block': (31.742321014404297, 454.0646057128906, 312.4850769042969, 464.9573059082031, 'Is there clinical documentation supporting disease improvement? \\n Yes \\n No  \\n', 37, 0)}\n",
            "{'page': 5, 'block': (20.402740478515625, 467.9737548828125, 119.84233093261719, 479.401123046875, 'H. ACKNOWLEDGEMENT\\n', 38, 0)}\n",
            "{'page': 5, 'block': (22.559999465942383, 485.76287841796875, 510.09149169921875, 497.9635314941406, 'Request Completed By (Signature Required):\\n  Date: \\n', 39, 0)}\n",
            "{'page': 5, 'block': (22.55999755859375, 502.1553649902344, 590.3668212890625, 533.3508911132812, 'Any person who knowingly files a request for authorization of coverage of a medical procedure or service with the intent to injure, defraud or deceive \\nany insurance company by providing materially false information or conceals material information for the purpose of misleading, commits a fraudulent \\ninsurance act, which is a crime and subjects such person to criminal and civil penalties. \\n', 40, 0)}\n",
            "{'page': 5, 'block': (18.001800537109375, 538.2158813476562, 363.9308776855469, 549.8456420898438, 'The plan may request additional information or clarification, if needed, to evaluate requests. \\n', 41, 0)}\n",
            "{'page': 5, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 42, 0)}\n",
            "[{'page': 1, 'block': (18.0, 768.580810546875, 87.8329849243164, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}, {'page': 1, 'block': (171.1199951171875, 88.86286163330078, 218.37191772460938, 101.06350708007812, 'Page 1 of 5 \\n', 1, 0)}, {'page': 1, 'block': (171.11952209472656, 11.582880020141602, 436.9670715332031, 92.01454162597656, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\n', 2, 0)}, {'page': 1, 'block': (445.3800048828125, 14.48285961151123, 576.630615234375, 45.81087112426758, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 3, 0)}, {'page': 1, 'block': (445.3800048828125, 48.52688217163086, 580.3668823242188, 91.36349487304688, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 4, 0)}, {'page': 1, 'block': (171.1199951171875, 98.67599487304688, 412.8420104980469, 111.56399536132812, '(All fields must be completed and legible for precertification review.) \\n', 5, 0)}, {'page': 1, 'block': (31.68000030517578, 122.92514038085938, 579.0755615234375, 153.22991943359375, 'Would you like to use electronic prior authorization? Consider using Availity, our electronic prior authorization \\nportal. Learn more about Availity from the links in the table below. \\n', 6, 0)}, {'page': 1, 'block': (31.680007934570312, 158.20384216308594, 578.8119506835938, 216.8699493408203, 'For phone or fax requests, refer to the table below for routing information. To determine which box to use, refer \\nto the patient’s Aetna ID card. State specific special needs and Medicare-Medicaid Plans may be designated on \\nthe front of the ID card or in the website URL on the back of the card. If you don’t see your specific plan listed, \\ncall the number on the back of the member’s ID card to confirm routing information. \\n', 7, 0)}, {'page': 1, 'block': (51.05970764160156, 230.44125366210938, 520.5227661132812, 246.16461181640625, 'For Aetna Medicare Advantage and Allina Health Aetna Medicare members send request to: \\n', 8, 0)}, {'page': 1, 'block': (51.048736572265625, 246.99911499023438, 514.5463256835938, 293.0931701660156, 'Phone: 1-866-503-0857 (TTY: 711)  \\nFax: \\n1-844-268-7263 \\nAvaility: https://www.aetna.com/health-care-professionals/resource-center/availity.html  \\n', 9, 0)}, {'page': 1, 'block': (51.059722900390625, 303.524169921875, 502.14007568359375, 377.9365539550781, 'For Aetna Medicare Advantage Virginia Dual Eligible Special Needs Plans (HMO D-SNP) \\nsend request to: \\nPhone: 1-855-463-0933 \\nFax: \\n1-833-280-5224 \\nAvaility: https://www.aetnabetterhealth.com/virginia-hmosnp/providers/portal \\n', 10, 0)}, {'page': 1, 'block': (51.059993743896484, 389.32281494140625, 552.38134765625, 463.736572265625, 'For Aetna Assure Premier Plus Medicare Advantage New Jersey Dual Eligible Special Needs Plans \\n(HMO D-SNP) send request to: \\nPhone: 1-844-362-0934\\nFax: \\n1-833-322-0034 \\nAvaility: https://www.aetnabetterhealth.com/new-jersey-hmosnp/providers/portal.html \\n', 11, 0)}, {'page': 1, 'block': (51.060028076171875, 473.9809265136719, 508.9809265136719, 489.70428466796875, 'For Aetna Better Health of Illinois Premier Medicare Medicaid Plan (MMP) send request to: \\n', 12, 0)}, {'page': 1, 'block': (51.04901885986328, 490.53875732421875, 409.17462158203125, 536.636962890625, 'Phone: 1-866-600-2139\\nFAX: \\n1-855-320-8445 \\nAvaility: https://www.aetnabetterhealth.com/illinois/providers/portal \\n', 13, 0)}, {'page': 1, 'block': (51.060001373291016, 545.98095703125, 499.1976623535156, 561.7042846679688, 'For Aetna Better Health of Ohio Premier Medicare Medicaid Plan (MMP) send request to: \\n', 14, 0)}, {'page': 1, 'block': (51.04901123046875, 562.538818359375, 397.58526611328125, 608.6370239257812, 'Phone: 1-855-364-0974\\nFax: \\n1-855-734-9389 \\nAvaility: https://www.aetnabetterhealth.com/ohio/providers/portal \\n', 15, 0)}, {'page': 1, 'block': (51.060001373291016, 617.98095703125, 521.7615356445312, 633.704345703125, 'For Aetna Better Health of Michigan Premier Medicare Medicaid Plan (MMP) send request to: \\n', 16, 0)}, {'page': 1, 'block': (51.049015045166016, 634.538818359375, 448.9452819824219, 680.6370239257812, 'Phone: 1-855-676-5772\\nFax: \\n1-844-241-2495 \\nAvaility: https://www.aetnabetterhealth.com/michigan/providers/portal.html \\n', 17, 0)}, {'page': 2, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}, {'page': 2, 'block': (161.99952697753906, 10.737120628356934, 427.83404541015625, 108.46498107910156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 2 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 1, 0)}, {'page': 2, 'block': (453.7799987792969, 13.48285961151123, 585.0285034179688, 44.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 2, 0)}, {'page': 2, 'block': (454.55999755859375, 47.52688217163086, 589.5609130859375, 89.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 3, 0)}, {'page': 2, 'block': (77.98930358886719, 110.7192153930664, 554.345703125, 135.1289825439453, '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n', 4, 0)}, {'page': 2, 'block': (76.3604965209961, 195.3408203125, 280.32928466796875, 206.2335205078125, ' \\n  \\n  \\n \\n  \\n  \\n', 5, 0)}, {'page': 2, 'block': (266.2629089355469, 223.600830078125, 415.6719970703125, 256.93353271484375, '  \\n  \\n \\n   \\n', 6, 0)}, {'page': 2, 'block': (450.2276916503906, 272.5979919433594, 452.7297058105469, 284.5049743652344, ' \\n', 7, 0)}, {'page': 2, 'block': (101.09100341796875, 363.3408203125, 103.30944061279297, 374.2335205078125, ' \\n', 8, 0)}, {'page': 2, 'block': (38.09709930419922, 405.1007995605469, 230.01846313476562, 458.83349609375, '   \\n   \\n  \\n  \\n    \\n    \\n  \\n   \\n', 9, 0)}, {'page': 2, 'block': (486.82611083984375, 375.580810546875, 497.9358825683594, 386.4735107421875, '   \\n', 10, 0)}, {'page': 2, 'block': (357.05230712890625, 387.76080322265625, 363.71881103515625, 398.65350341796875, '  \\n', 11, 0)}, {'page': 2, 'block': (353.99920654296875, 411.9407958984375, 517.1822509765625, 422.83349609375, '  \\n  \\n  \\n', 12, 0)}, {'page': 2, 'block': (363.3038024902344, 424.060791015625, 468.71160888671875, 434.9534912109375, ' \\n \\n', 13, 0)}, {'page': 2, 'block': (349.07550048828125, 436.1808166503906, 468.711669921875, 447.0735168457031, '   \\n \\n', 14, 0)}, {'page': 2, 'block': (349.07708740234375, 448.3608093261719, 360.1756896972656, 459.2535095214844, '   \\n', 15, 0)}, {'page': 2, 'block': (180.96009826660156, 475.8791809082031, 508.228759765625, 500.7235107421875, ' \\n   \\n   \\n \\n  \\n  \\n', 16, 0)}, {'page': 2, 'block': (325.87200927734375, 519.1392211914062, 328.2405700683594, 530.7689819335938, ' \\n', 17, 0)}, {'page': 2, 'block': (47.75510025024414, 585.5208129882812, 79.74994659423828, 596.4135131835938, '  \\n  \\n', 18, 0)}, {'page': 2, 'block': (75.89530181884766, 597.6408081054688, 78.11373901367188, 608.5335083007812, ' \\n', 19, 0)}, {'page': 2, 'block': (188.15899658203125, 608.0208129882812, 190.37744140625, 618.9135131835938, ' \\n', 20, 0)}, {'page': 2, 'block': (73.6769027709961, 643.4808349609375, 78.11377716064453, 654.37353515625, '  \\n', 21, 0)}, {'page': 2, 'block': (185.9405975341797, 653.86083984375, 190.3774871826172, 664.7535400390625, '  \\n', 22, 0)}, {'page': 2, 'block': (125.04219818115234, 709.7208251953125, 131.69752502441406, 720.613525390625, '   \\n', 23, 0)}, {'page': 2, 'block': (502.864990234375, 737.7963256835938, 596.2230224609375, 748.9204711914062, 'Continued on next page \\n', 24, 0)}, {'page': 2, 'block': (18.0, 110.7192153930664, 495.24786376953125, 122.34901428222656, 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n', 25, 0)}, {'page': 2, 'block': (17.40106201171875, 123.36292266845703, 501.1325988769531, 135.56356811523438, 'Precertification Requested By: \\nPhone: \\nFax: \\n', 26, 0)}, {'page': 2, 'block': (20.399999618530273, 137.673095703125, 125.64022064208984, 149.10044860839844, 'A. PATIENT INFORMATION\\n', 27, 0)}, {'page': 2, 'block': (20.399999618530273, 150.7044677734375, 530.3218994140625, 161.59716796875, 'First Name:  \\nLast Name:  \\nDOB:  \\n', 28, 0)}, {'page': 2, 'block': (20.39996337890625, 165.10467529296875, 525.4381713867188, 176.00103759765625, 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n', 29, 0)}, {'page': 2, 'block': (20.399993896484375, 179.50079345703125, 450.2641906738281, 190.4012451171875, 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n', 30, 0)}, {'page': 2, 'block': (20.399993896484375, 195.3408203125, 370.4882507324219, 206.2337646484375, 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n', 31, 0)}, {'page': 2, 'block': (20.4000244140625, 210.031982421875, 139.0288848876953, 221.45933532714844, 'B. INSURANCE INFORMATION\\n', 32, 0)}, {'page': 2, 'block': (20.390220642089844, 223.47027587890625, 74.55447387695312, 256.858642578125, 'Member ID #:  \\nGroup #:  \\nInsured:  \\n', 33, 0)}, {'page': 2, 'block': (235.18788146972656, 223.5980224609375, 440.6332702636719, 256.933349609375, 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n', 34, 0)}, {'page': 2, 'block': (20.409637451171875, 260.189208984375, 143.95599365234375, 271.6165771484375, 'C. PRESCRIBER INFORMATION\\n', 35, 0)}, {'page': 2, 'block': (20.409637451171875, 272.2200012207031, 593.2784423828125, 284.5049743652344, 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n', 36, 0)}, {'page': 2, 'block': (20.4022216796875, 287.620849609375, 525.446044921875, 298.5135498046875, 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n', 37, 0)}, {'page': 2, 'block': (20.40228271484375, 302.02081298828125, 532.0935668945312, 312.9174499511719, 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n', 38, 0)}, {'page': 2, 'block': (20.39202880859375, 317.1429138183594, 450.62579345703125, 328.0356140136719, 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n', 39, 0)}, {'page': 2, 'block': (20.399993896484375, 330.810546875, 256.3798522949219, 342.2400207519531, 'D. DISPENSING PROVIDER/ADMINISTRATION INFORMATION\\n', 40, 0)}, {'page': 2, 'block': (20.399999618530273, 342.8683166503906, 114.59831237792969, 354.2956848144531, 'Place of Administration: \\n', 41, 0)}, {'page': 2, 'block': (22.570980072021484, 353.0747375488281, 249.09925842285156, 458.8310852050781, ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n', 42, 0)}, {'page': 2, 'block': (329.1705627441406, 342.87371826171875, 454.4814758300781, 354.30108642578125, 'Dispensing Provider/Pharmacy:  \\n', 43, 0)}, {'page': 2, 'block': (340.5101318359375, 353.14398193359375, 533.1074829101562, 386.4764404296875, ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n', 44, 0)}, {'page': 2, 'block': (331.3331298828125, 387.76123046875, 357.06866455078125, 398.6539306640625, 'Name: \\n', 45, 0)}, {'page': 2, 'block': (331.3331298828125, 399.8190002441406, 367.3149719238281, 410.7117004394531, 'Address:  \\n', 46, 0)}, {'page': 2, 'block': (331.3251647949219, 411.93768310546875, 536.2573852539062, 422.83331298828125, 'City:  \\nState:  \\nZIP:  \\n', 47, 0)}, {'page': 2, 'block': (331.322998046875, 424.0592956542969, 490.9054870605469, 434.9519958496094, 'Phone:  \\n Fax:  \\n', 48, 0)}, {'page': 2, 'block': (331.322998046875, 436.05322265625, 490.9086608886719, 447.4805908203125, 'TIN: \\n PIN:  \\n', 49, 0)}, {'page': 2, 'block': (331.322998046875, 448.3583984375, 349.0801086425781, 459.2510986328125, 'NPI: \\n', 50, 0)}, {'page': 2, 'block': (20.406219482421875, 461.42962646484375, 130.56771850585938, 472.85699462890625, 'E. PRODUCT INFORMATION\\n', 51, 0)}, {'page': 2, 'block': (20.399099349975586, 475.74285888671875, 522.478515625, 500.7235107421875, 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n', 52, 0)}, {'page': 2, 'block': (20.399999618530273, 504.75311279296875, 450.17755126953125, 516.1804809570312, 'F. DIAGNOSIS INFORMATION - Please indicate primary ICD code and specify any other any other where applicable (*).\\n', 53, 0)}, {'page': 2, 'block': (20.399999618530273, 519.0028686523438, 370.3120422363281, 531.2034912109375, 'Primary ICD Code: \\n Other ICD Code: \\n', 54, 0)}, {'page': 2, 'block': (20.399999618530273, 533.7930908203125, 423.8953857421875, 556.58349609375, 'G. CLINICAL INFORMATION - Required clinical information must be completed for ALL precertification requests.\\nFor Initiation Requests (clinical documentation required for all requests): \\n', 55, 0)}, {'page': 2, 'block': (22.552032470703125, 556.713134765625, 570.1665649414062, 586.6221923828125, 'Note: Riabni and Rituxan are non-preferred. Ruxience and Truxima are the preferred biosimilars for most indications. \\nFor rheumatoid arthritis, all Rituxan and biosimilar products are non-preferred. Inflectra, Renflexis and Simponi Aria are preferred for MA plans. \\nEnbrel, Humira, Idacio, Rinvoq, Tyenne SC and Xeljanz/Xeljanz XR are preferred for MAPD plans. \\n', 56, 0)}, {'page': 2, 'block': (31.737045288085938, 585.5209350585938, 384.74603271484375, 596.4136352539062, 'Has the patient had prior therapy with the requested product within the last 365 days? \\n Yes\\n No\\n', 57, 0)}, {'page': 2, 'block': (78.10882568359375, 597.642578125, 471.17169189453125, 608.5352783203125, ' Has the patient had a trial and failure of any of the following rituximab biosimilars? (If yes, select all that apply) \\n', 58, 0)}, {'page': 2, 'block': (81.5941162109375, 608.0208129882812, 306.1827087402344, 630.0775146484375, ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n', 59, 0)}, {'page': 2, 'block': (81.5879135131836, 631.3623046875, 300.4075622558594, 642.2550048828125, 'Please describe the nature of the failure of the preferred drug \\n', 60, 0)}, {'page': 2, 'block': (61.24689483642578, 597.6387939453125, 75.88221740722656, 608.531494140625, ' No \\n', 61, 0)}, {'page': 2, 'block': (78.10065460205078, 643.48388671875, 482.2637023925781, 654.3765869140625, ' Has the patient had an adverse reaction to any of the following rituximab biosimilars? (If yes, select all that apply) \\n', 62, 0)}, {'page': 2, 'block': (81.59410095214844, 653.85791015625, 317.46405029296875, 675.9175415039062, ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n', 63, 0)}, {'page': 2, 'block': (81.61186218261719, 677.1384887695312, 337.8099060058594, 688.0311889648438, 'Please describe the nature of the adverse reaction to the preferred drug \\n', 64, 0)}, {'page': 2, 'block': (61.2548828125, 643.48681640625, 73.67176818847656, 654.3795166015625, ' No\\n', 65, 0)}, {'page': 2, 'block': (22.567840576171875, 689.2600708007812, 582.34375, 709.3943481445312, 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when \\nindicated for the patient’s diagnosis? (select all that apply)   \\n', 66, 0)}, {'page': 2, 'block': (31.744979858398438, 709.7208251953125, 234.30032348632812, 720.6141967773438, ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n', 67, 0)}, {'page': 3, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}, {'page': 3, 'block': (161.99301147460938, 12.357115745544434, 427.8236999511719, 109.48500061035156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 3 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 1, 0)}, {'page': 3, 'block': (453.7799987792969, 14.48285961151123, 585.0285034179688, 45.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 2, 0)}, {'page': 3, 'block': (454.55999755859375, 48.52688217163086, 589.5269775390625, 90.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 3, 0)}, {'page': 3, 'block': (20.399999618530273, 141.54286193847656, 499.46856689453125, 153.74349975585938, 'G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed for ALL precertification requests.\\n', 4, 0)}, {'page': 3, 'block': (73.6769027709961, 168.9407958984375, 80.33221435546875, 179.83349609375, '   \\n', 5, 0)}, {'page': 3, 'block': (185.927001953125, 179.32080078125, 300.4560852050781, 190.2135009765625, ' \\n  \\n', 6, 0)}, {'page': 3, 'block': (73.6769027709961, 214.7208251953125, 78.11377716064453, 225.613525390625, '  \\n', 7, 0)}, {'page': 3, 'block': (181.49009704589844, 225.16082763671875, 300.4561462402344, 236.05352783203125, '   \\n   \\n', 8, 0)}, {'page': 3, 'block': (342.2427062988281, 248.4407958984375, 348.8980407714844, 259.33349609375, '  \\n', 9, 0)}, {'page': 3, 'block': (73.6769027709961, 260.560791015625, 80.33221435546875, 271.4534912109375, '   \\n', 10, 0)}, {'page': 3, 'block': (163.6501007080078, 271.00079345703125, 594.7120361328125, 281.89349365234375, '  \\n   \\n   \\n   \\n   \\n', 11, 0)}, {'page': 3, 'block': (73.6769027709961, 319.3008117675781, 78.11377716064453, 330.1935119628906, '  \\n', 12, 0)}, {'page': 3, 'block': (161.43190002441406, 329.6808166503906, 464.660400390625, 340.5735168457031, '   \\n   \\n   \\n  \\n', 13, 0)}, {'page': 3, 'block': (315.2414855957031, 353.74420166015625, 326.3337097167969, 364.63690185546875, '   \\n', 14, 0)}, {'page': 3, 'block': (122.8102035522461, 398.4407958984375, 241.77613830566406, 409.33349609375, '   \\n   \\n', 15, 0)}, {'page': 3, 'block': (102.3917007446289, 442.2408142089844, 401.125244140625, 453.1335144042969, '   \\n \\n   \\n \\n', 16, 0)}, {'page': 3, 'block': (47.75510025024414, 491.14080810546875, 80.4521713256836, 502.03350830078125, '  \\n  \\n', 17, 0)}, {'page': 3, 'block': (47.75510025024414, 513.580810546875, 80.45220947265625, 535.6934814453125, '  \\n   \\n \\n \\n', 18, 0)}, {'page': 3, 'block': (47.75510025024414, 547.1807861328125, 80.4521713256836, 558.073486328125, '  \\n  \\n', 19, 0)}, {'page': 3, 'block': (233.32504272460938, 569.6205444335938, 235.54348754882812, 580.5132446289062, ' \\n', 20, 0)}, {'page': 3, 'block': (49.9734992980957, 580.2979736328125, 236.45864868164062, 602.7734985351562, ' \\n \\n  \\n', 21, 0)}, {'page': 3, 'block': (47.75510025024414, 614.2608032226562, 78.23377227783203, 625.1535034179688, '  \\n  \\n', 22, 0)}, {'page': 3, 'block': (314.5495910644531, 624.5208129882812, 500.9585266113281, 646.093505859375, '   \\n  \\n   \\n   \\n   \\n', 23, 0)}, {'page': 3, 'block': (275.07470703125, 656.0208129882812, 500.9814453125, 688.2734985351562, '   \\n  \\n \\n   \\n   \\n  \\n  \\n', 24, 0)}, {'page': 3, 'block': (304.9302978515625, 689.4407958984375, 309.3671875, 700.33349609375, '  \\n', 25, 0)}, {'page': 3, 'block': (502.85980224609375, 704.6130981445312, 596.2178344726562, 716.0404663085938, 'Continued on next page \\n', 26, 0)}, {'page': 3, 'block': (20.399999618530273, 117.61917877197266, 519.9957275390625, 129.2489776611328, 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n', 27, 0)}, {'page': 3, 'block': (20.399999618530273, 154.3828887939453, 352.34820556640625, 166.58352661132812, 'For Initiation Requests continued (clinical documentation required for all requests): \\n', 28, 0)}, {'page': 3, 'block': (80.33219909667969, 168.9407958984375, 396.53973388671875, 179.83349609375, 'Has the patient had a trial and failure of any of the following? (If yes, select all that apply) \\n', 29, 0)}, {'page': 3, 'block': (81.59303283691406, 179.32275390625, 408.320556640625, 201.37945556640625, ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n', 30, 0)}, {'page': 3, 'block': (81.59574890136719, 202.66229248046875, 300.4154052734375, 213.55499267578125, 'Please describe the nature of the failure of the preferred drug \\n', 31, 0)}, {'page': 3, 'block': (61.26271057128906, 168.9388427734375, 73.67959594726562, 179.83154296875, ' No\\n', 32, 0)}, {'page': 3, 'block': (78.10848999023438, 214.7200927734375, 407.6346740722656, 225.61279296875, ' Has the patient had an adverse reaction to any of the following? (If yes, select all that apply) \\n', 33, 0)}, {'page': 3, 'block': (81.58778381347656, 225.157958984375, 408.3153076171875, 247.217529296875, ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n', 34, 0)}, {'page': 3, 'block': (81.59574890136719, 248.4384765625, 337.7937927246094, 259.3311767578125, 'Please describe the nature of the adverse reaction to the preferred drug \\n', 35, 0)}, {'page': 3, 'block': (61.254730224609375, 214.72296142578125, 73.67161560058594, 225.61566162109375, ' No\\n', 36, 0)}, {'page': 3, 'block': (80.32693481445312, 260.56005859375, 396.53448486328125, 271.4527587890625, 'Has the patient had a trial and failure of any of the following? (If yes, select all that apply) \\n', 37, 0)}, {'page': 3, 'block': (90.77273559570312, 270.9979248046875, 588.0537719726562, 292.9269714355469, ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n', 38, 0)}, {'page': 3, 'block': (81.5957260131836, 295.0576171875, 306.1826171875, 305.9582824707031, 'When was the member’s trial and failure of the preferred drug? \\n', 39, 0)}, {'page': 3, 'block': (81.5870361328125, 307.17779541015625, 300.4067077636719, 318.07049560546875, 'Please describe the nature of the failure of the preferred drug \\n', 40, 0)}, {'page': 3, 'block': (61.24601745605469, 260.55865478515625, 73.66290283203125, 271.45135498046875, ' No\\n', 41, 0)}, {'page': 3, 'block': (78.09977722167969, 319.2994384765625, 396.5257568359375, 330.192138671875, ' Has the patient had a trial and failure of any of the following? (If yes, select all that apply) \\n', 42, 0)}, {'page': 3, 'block': (90.7640380859375, 329.6814270019531, 585.8162841796875, 351.6104736328125, ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n', 43, 0)}, {'page': 3, 'block': (81.5870590209961, 353.7411193847656, 312.8380432128906, 364.6368408203125, 'When was the member’s adverse reaction to the preferred drug? \\n', 44, 0)}, {'page': 3, 'block': (81.58714294433594, 365.921630859375, 337.7851867675781, 376.8143310546875, 'Please describe the nature of the adverse reaction to the preferred drug \\n', 45, 0)}, {'page': 3, 'block': (61.246124267578125, 319.3024597167969, 73.66300964355469, 330.1951599121094, ' No\\n', 46, 0)}, {'page': 3, 'block': (22.551105499267578, 378.0432434082031, 591.8544311523438, 398.1129455566406, 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for \\nthe patient’s diagnosis? (select all that apply) \\n', 47, 0)}, {'page': 3, 'block': (31.73699188232422, 398.43768310546875, 347.5135498046875, 409.33038330078125, ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n', 48, 0)}, {'page': 3, 'block': (22.552001953125, 421.8350524902344, 591.8512573242188, 441.9127197265625, 'Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for \\nthe patient’s diagnosis? (select all that apply)  \\n', 49, 0)}, {'page': 3, 'block': (31.736968994140625, 442.2377014160156, 522.35546875, 464.29443359375, ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n', 50, 0)}, {'page': 3, 'block': (20.397384643554688, 478.14288330078125, 288.7485656738281, 490.3435363769531, 'For All Requests (clinical documentation required for all requests): \\n', 51, 0)}, {'page': 3, 'block': (31.73999786376953, 491.14080810546875, 548.70361328125, 502.03350830078125, 'Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)? \\n Yes\\n No \\n', 52, 0)}, {'page': 3, 'block': (22.55501937866211, 503.19061279296875, 121.17971801757812, 514.6179809570312, 'Acute lymphoid leukemia \\n', 53, 0)}, {'page': 3, 'block': (31.742279052734375, 513.58056640625, 502.07550048828125, 524.4732666015625, 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n', 54, 0)}, {'page': 3, 'block': (31.742286682128906, 524.6729736328125, 326.8291015625, 536.100341796875, '  Is Rituxan (rituximab) being used as induction/consolidation therapy? \\n Yes \\n No\\n', 55, 0)}, {'page': 3, 'block': (22.557308197021484, 536.8504638671875, 142.97547912597656, 548.2779541015625, 'Autoimmune hemolytic anemia \\n', 56, 0)}, {'page': 3, 'block': (31.742252349853516, 547.1846923828125, 409.3965759277344, 558.077392578125, 'Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia? \\n Yes\\n No \\n', 57, 0)}, {'page': 3, 'block': (22.549320220947266, 559.2305908203125, 482.70806884765625, 602.7694702148438, 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n', 58, 0)}, {'page': 3, 'block': (22.565284729003906, 603.9265747070312, 245.70199584960938, 615.3619384765625, 'Autoimmune blistering diseases, corticosteroid-refractory \\n', 59, 0)}, {'page': 3, 'block': (31.74222183227539, 614.2647094726562, 459.2891540527344, 625.1574096679688, ' Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease? \\n Yes\\n', 60, 0)}, {'page': 3, 'block': (81.23418426513672, 624.5208129882812, 591.0953979492188, 646.0907592773438, 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n', 61, 0)}, {'page': 3, 'block': (61.3829345703125, 614.2665405273438, 73.79981994628906, 625.1592407226562, ' No\\n', 62, 0)}, {'page': 3, 'block': (22.560237884521484, 645.6279296875, 590.15869140625, 688.2680053710938, 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n', 63, 0)}, {'page': 3, 'block': (184.91822814941406, 689.4330444335938, 347.44854736328125, 700.333740234375, ' Splenic marginal zone lymphoma\\n Other: \\n', 64, 0)}, {'page': 4, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}, {'page': 4, 'block': (161.99827575683594, 12.357115745544434, 448.1394958496094, 113.50502014160156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 4 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 1, 0)}, {'page': 4, 'block': (453.7799987792969, 14.48285961151123, 585.0285034179688, 45.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 2, 0)}, {'page': 4, 'block': (454.9800109863281, 48.52688217163086, 589.9522094726562, 90.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 3, 0)}, {'page': 4, 'block': (20.399999618530273, 146.04286193847656, 499.4063720703125, 158.24349975585938, 'G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed for ALL precertification requests.\\n', 4, 0)}, {'page': 4, 'block': (47.75510025024414, 169.36077880859375, 80.4521713256836, 180.25347900390625, '  \\n  \\n', 5, 0)}, {'page': 4, 'block': (170.9852752685547, 191.7366943359375, 449.31622314453125, 202.63348388671875, ' \\n   \\n   \\n', 6, 0)}, {'page': 4, 'block': (170.98460388183594, 214.11669921875, 432.5870361328125, 225.01348876953125, ' \\n   \\n   \\n', 7, 0)}, {'page': 4, 'block': (47.75510025024414, 236.560791015625, 80.45220947265625, 258.67352294921875, '  \\n   \\n  \\n \\n', 8, 0)}, {'page': 4, 'block': (47.75510025024414, 270.16082763671875, 80.45220947265625, 281.05352783203125, ' \\n   \\n', 9, 0)}, {'page': 4, 'block': (170.98532104492188, 292.5367431640625, 409.93548583984375, 303.4335021972656, ' \\n   \\n  \\n', 10, 0)}, {'page': 4, 'block': (47.75510025024414, 314.9208068847656, 78.23373413085938, 325.8135070800781, '  \\n \\n', 11, 0)}, {'page': 4, 'block': (340.87139892578125, 335.32080078125, 345.30828857421875, 346.2135009765625, '  \\n', 12, 0)}, {'page': 4, 'block': (289.3194885253906, 357.81640625, 486.1988220214844, 391.9934997558594, ' \\n   \\n   \\n  \\n   \\n   \\n', 13, 0)}, {'page': 4, 'block': (47.75510025024414, 403.90081787109375, 490.01776123046875, 424.9934997558594, '  \\n   \\n \\n   \\n', 14, 0)}, {'page': 4, 'block': (47.75510025024414, 436.5408020019531, 80.45220947265625, 447.4335021972656, '  \\n   \\n', 15, 0)}, {'page': 4, 'block': (47.75510025024414, 458.9208068847656, 80.45220947265625, 469.8135070800781, '  \\n   \\n', 16, 0)}, {'page': 4, 'block': (47.75510025024414, 491.50079345703125, 433.7326354980469, 513.6134643554688, '  \\n   \\n   \\n  \\n  \\n', 17, 0)}, {'page': 4, 'block': (47.75510025024414, 525.100830078125, 78.23377227783203, 535.9935302734375, '  \\n  \\n', 18, 0)}, {'page': 4, 'block': (105.77510070800781, 537.2808227539062, 140.690673828125, 548.1735229492188, '  \\n    \\n', 19, 0)}, {'page': 4, 'block': (47.75510025024414, 559.7208251953125, 80.45220947265625, 581.83349609375, '  \\n   \\n  \\n  \\n', 20, 0)}, {'page': 4, 'block': (47.75510025024414, 593.32080078125, 80.4521713256836, 615.4334716796875, '  \\n  \\n \\n  \\n', 21, 0)}, {'page': 4, 'block': (133.35910034179688, 625.9032592773438, 532.8065795898438, 648.0134887695312, '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n', 22, 0)}, {'page': 4, 'block': (47.75510025024414, 660.5208129882812, 80.45220947265625, 671.4135131835938, '  \\n   \\n', 23, 0)}, {'page': 4, 'block': (110.93509674072266, 672.7008056640625, 141.41378784179688, 683.593505859375, '  \\n  \\n', 24, 0)}, {'page': 4, 'block': (502.8599853515625, 690.0331420898438, 596.218017578125, 701.4605102539062, 'Continued on next page \\n', 25, 0)}, {'page': 4, 'block': (20.399999618530273, 122.11917877197266, 524.4943237304688, 133.7489776611328, 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n', 26, 0)}, {'page': 4, 'block': (22.559999465942383, 159.03314208984375, 103.19789123535156, 170.4604949951172, \"Castleman's disease \\n\", 27, 0)}, {'page': 4, 'block': (31.736995697021484, 169.3592529296875, 524.703857421875, 180.251953125, 'Does the patient have a documented diagnosis of multicentric Castleman’s disease (angiofollicular lymph node hyperplasia)? \\n Yes\\n No \\n', 28, 0)}, {'page': 4, 'block': (22.552021026611328, 181.4090576171875, 527.0359497070312, 203.11611938476562, 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n', 29, 0)}, {'page': 4, 'block': (22.556182861328125, 203.79058837890625, 510.2961730957031, 225.01739501953125, 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n', 30, 0)}, {'page': 4, 'block': (22.55059814453125, 226.17059326171875, 92.33577728271484, 237.5979461669922, 'Cryoglobulinemia \\n', 31, 0)}, {'page': 4, 'block': (31.743640899658203, 236.560546875, 324.9503479003906, 247.4532470703125, 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n', 32, 0)}, {'page': 4, 'block': (31.743640899658203, 247.78045654296875, 520.0528564453125, 258.67315673828125, ' Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective? \\n Yes\\n No \\n', 33, 0)}, {'page': 4, 'block': (22.558666229248047, 259.7744140625, 155.9342803955078, 271.2021484375, 'Graft versus host disease, chronic \\n', 34, 0)}, {'page': 4, 'block': (31.7264404296875, 270.03704833984375, 547.3700561523438, 281.46441650390625, 'Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)? \\n Yes\\n No\\n', 35, 0)}, {'page': 4, 'block': (22.541461944580078, 282.21063232421875, 487.6446228027344, 303.8443908691406, 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n', 36, 0)}, {'page': 4, 'block': (22.565277099609375, 304.5906066894531, 147.89581298828125, 316.0218811035156, 'Heart and solid organ transplant \\n', 37, 0)}, {'page': 4, 'block': (31.75030517578125, 314.9208068847656, 578.2815551757812, 336.0158386230469, ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n', 38, 0)}, {'page': 4, 'block': (88.51203918457031, 335.31768798828125, 488.4099426269531, 346.21038818359375, 'Please select which applies to the patient: \\n heart transplant recipient \\n other solid organ transplant recipient \\n', 39, 0)}, {'page': 4, 'block': (61.388031005859375, 314.9208068847656, 76.02335357666016, 325.8135070800781, ' No \\n', 40, 0)}, {'page': 4, 'block': (22.564010620117188, 347.36749267578125, 584.3960571289062, 391.9921875, 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n', 41, 0)}, {'page': 4, 'block': (22.55535888671875, 393.5722351074219, 210.11727905273438, 404.9996032714844, 'Immune or idiopathic thrombocytopenic purpura \\n', 42, 0)}, {'page': 4, 'block': (31.732357025146484, 403.8983459472656, 487.533447265625, 414.7910461425781, 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n', 43, 0)}, {'page': 4, 'block': (61.37005615234375, 403.8983459472656, 430.48516845703125, 424.9894714355469, ' refractory immune thrombocytopenic purpura\\n idiopathic thrombocytopenic purpura (ITP) \\n No\\n', 44, 0)}, {'page': 4, 'block': (22.547359466552734, 426.1465759277344, 177.23976135253906, 437.5819091796875, 'Kidney transplant, rejection prophylaxis \\n', 45, 0)}, {'page': 4, 'block': (31.742862701416016, 436.5405578613281, 542.0208129882812, 447.4332580566406, 'Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies? \\n Yes\\n No\\n', 46, 0)}, {'page': 4, 'block': (22.56586456298828, 448.53448486328125, 205.81802368164062, 459.96209716796875, \"Lymphocyte-predominant Hodgkin's lymphoma \\n\", 47, 0)}, {'page': 4, 'block': (31.758258819580078, 458.9246826171875, 429.13037109375, 469.8173828125, 'Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin’s lymphoma? \\n Yes\\n No\\n', 48, 0)}, {'page': 4, 'block': (22.55730438232422, 470.9706115722656, 314.07391357421875, 492.1894226074219, 'Multiple Sclerosis \\nPlease indicate the type of multiple sclerosis the patient has been diagnosed with: \\n', 49, 0)}, {'page': 4, 'block': (31.742284774780273, 491.50079345703125, 569.6559448242188, 513.6133422851562, ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n', 50, 0)}, {'page': 4, 'block': (22.565528869628906, 514.7705078125, 138.60250854492188, 526.197998046875, 'Myasthenia gravis (MuSk-MG) \\n', 51, 0)}, {'page': 4, 'block': (31.742340087890625, 525.104736328125, 486.8975830078125, 535.9974365234375, ' Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)? \\n Yes\\n', 52, 0)}, {'page': 4, 'block': (89.75691986083984, 537.2782592773438, 401.1494140625, 548.1748657226562, 'Has the patient had an unsatisfactory response to initial immunotherapy? \\n Yes\\n No\\n', 53, 0)}, {'page': 4, 'block': (61.38003921508789, 525.100830078125, 73.79692077636719, 535.9935302734375, ' No\\n', 54, 0)}, {'page': 4, 'block': (22.557342529296875, 549.3280639648438, 170.58367919921875, 560.7579345703125, 'Neuromyelitis optica (Devic’s disease) \\n', 55, 0)}, {'page': 4, 'block': (31.73965072631836, 559.7205810546875, 398.7877502441406, 570.61328125, 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n', 56, 0)}, {'page': 4, 'block': (31.73965072631836, 570.9404296875, 308.09503173828125, 581.8331298828125, ' Was the treatment with at least one immunotherapy ineffective? \\n Yes\\n No\\n', 57, 0)}, {'page': 4, 'block': (22.554676055908203, 582.9343872070312, 272.63458251953125, 594.3621215820312, 'Opsoclonus-myoclonus-ataxia (opsoclonus myoclonus syndrome) \\n', 58, 0)}, {'page': 4, 'block': (31.742321014404297, 593.32470703125, 508.3160400390625, 604.2174072265625, 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n', 59, 0)}, {'page': 4, 'block': (31.742321014404297, 604.5446166992188, 384.507080078125, 615.4373168945312, ' Is the patient refractory to steroids, chemotherapy and intravenous immunoglobulins? \\n Yes \\n', 60, 0)}, {'page': 4, 'block': (90.2357177734375, 614.683349609375, 481.70257568359375, 648.015869140625, 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n', 61, 0)}, {'page': 4, 'block': (61.387969970703125, 604.540771484375, 73.80485534667969, 615.4334716796875, ' No\\n', 62, 0)}, {'page': 4, 'block': (22.57324981689453, 649.1729736328125, 194.16720581054688, 660.600341796875, 'Post-transplant lymphoproliferative disorder \\n', 63, 0)}, {'page': 4, 'block': (31.73700714111328, 660.5205078125, 415.3221435546875, 671.4133911132812, 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n', 64, 0)}, {'page': 4, 'block': (94.91436767578125, 672.6981811523438, 577.137939453125, 683.593505859375, ' Is Rituxan (rituximab) being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n', 65, 0)}, {'page': 5, 'block': (161.99827575683594, 12.357115745544434, 448.1394958496094, 115.48500061035156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 5 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 0, 0)}, {'page': 5, 'block': (453.7799987792969, 14.48285961151123, 585.0285034179688, 45.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 1, 0)}, {'page': 5, 'block': (454.9800109863281, 48.52688217163086, 589.9669189453125, 90.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 2, 0)}, {'page': 5, 'block': (20.399999618530273, 146.04286193847656, 499.4063720703125, 158.24349975585938, 'G. CLINICAL INFORMATION (Continued) - Required clinical information must be completed for ALL precertification requests.\\n', 3, 0)}, {'page': 5, 'block': (47.75510025024414, 168.3408203125, 333.8779296875, 200.65350341796875, '  \\n   \\n \\n   \\n  \\n \\n', 4, 0)}, {'page': 5, 'block': (111.83509826660156, 199.9608154296875, 308.304931640625, 221.05352783203125, '  \\n   \\n \\n   \\n   \\n', 5, 0)}, {'page': 5, 'block': (111.83509826660156, 222.3408203125, 455.9510192871094, 243.43353271484375, '  \\n   \\n \\n   \\n  \\n   \\n  \\n', 6, 0)}, {'page': 5, 'block': (47.75510025024414, 254.9207763671875, 80.45220947265625, 277.03350830078125, '  \\n   \\n  \\n \\n', 7, 0)}, {'page': 5, 'block': (133.35910034179688, 286.5376892089844, 532.8065185546875, 308.65350341796875, '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n', 8, 0)}, {'page': 5, 'block': (47.75510025024414, 320.6808166503906, 80.45220947265625, 331.5735168457031, '  \\n   \\n', 9, 0)}, {'page': 5, 'block': (47.75510025024414, 343.060791015625, 80.45220947265625, 353.9534912109375, '  \\n   \\n', 10, 0)}, {'page': 5, 'block': (47.75510025024414, 366.4608154296875, 80.4521713256836, 377.353515625, '  \\n  \\n', 11, 0)}, {'page': 5, 'block': (47.75510025024414, 399.0392150878906, 437.8565368652344, 431.353515625, ' \\n \\n   \\n  \\n \\n  \\n \\n', 12, 0)}, {'page': 5, 'block': (47.75510025024414, 442.8408203125, 80.45223999023438, 464.9534912109375, '  \\n   \\n \\n \\n', 13, 0)}, {'page': 5, 'block': (204.83689880371094, 485.8992004394531, 564.42333984375, 497.5290222167969, ' \\n/ \\n/ \\n', 14, 0)}, {'page': 5, 'block': (20.399999618530273, 122.11917877197266, 524.4943237304688, 133.7489776611328, 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n', 15, 0)}, {'page': 5, 'block': (22.55999755859375, 159.03314208984375, 372.96185302734375, 189.428955078125, 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n', 16, 0)}, {'page': 5, 'block': (31.737014770507812, 189.75616455078125, 319.1925964355469, 200.64886474609375, '  Will Rituxan (rituximab) be used in combination with methotrexate? \\n Yes\\n No\\n', 17, 0)}, {'page': 5, 'block': (95.81642150878906, 199.95458984375, 421.4748229980469, 210.8472900390625, 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n', 18, 0)}, {'page': 5, 'block': (125.45199584960938, 199.95281982421875, 376.3017883300781, 221.0537109375, 'Please select:\\n ineffective\\n not tolerated\\n contraindicated \\n No\\n', 19, 0)}, {'page': 5, 'block': (95.81428527832031, 222.33673095703125, 365.9931640625, 233.22943115234375, 'Was treatment with another conventional DMARD ineffective? \\n Yes\\n', 20, 0)}, {'page': 5, 'block': (125.4678955078125, 222.33282470703125, 517.3258056640625, 243.43585205078125, 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n', 21, 0)}, {'page': 5, 'block': (22.56578826904297, 244.58905029296875, 95.04107666015625, 256.01800537109375, 'Sjögren syndrome \\n', 22, 0)}, {'page': 5, 'block': (31.743724822998047, 254.92474365234375, 335.62933349609375, 265.81744384765625, 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n', 23, 0)}, {'page': 5, 'block': (31.743728637695312, 266.1446533203125, 383.2788391113281, 277.037353515625, '  Was treatment with corticosteroids and other immunosuppressive agents ineffective? \\n Yes\\n', 24, 0)}, {'page': 5, 'block': (90.24359893798828, 276.3392333984375, 479.50006103515625, 308.65350341796875, 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n', 25, 0)}, {'page': 5, 'block': (61.380001068115234, 266.14080810546875, 73.79688262939453, 277.03350830078125, ' No\\n', 26, 0)}, {'page': 5, 'block': (22.56528091430664, 309.807373046875, 173.22767639160156, 321.2347412109375, 'Thrombotic thrombocytopenic purpura \\n', 27, 0)}, {'page': 5, 'block': (31.74227523803711, 320.6761474609375, 456.2386474609375, 331.56884765625, 'Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)? \\n Yes\\n No\\n', 28, 0)}, {'page': 5, 'block': (22.557300567626953, 332.7259521484375, 157.73851013183594, 344.1612854003906, 'Waldenstrom’s macroglobulinemia \\n', 29, 0)}, {'page': 5, 'block': (31.742290496826172, 343.0647277832031, 381.45062255859375, 353.9574279785156, 'Does the patient have a documented diagnosis of Waldenström macroglobulinemia? \\n Yes\\n No\\n', 30, 0)}, {'page': 5, 'block': (20.4027099609375, 355.1744384765625, 127.92521667480469, 366.6057434082031, 'For Continuation Requests: \\n', 31, 0)}, {'page': 5, 'block': (22.56528091430664, 366.4581604003906, 403.6510009765625, 387.55194091796875, 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n', 32, 0)}, {'page': 5, 'block': (22.557296752929688, 388.7170104980469, 476.9332275390625, 420.13037109375, 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n', 33, 0)}, {'page': 5, 'block': (31.729000091552734, 420.4575500488281, 312.47174072265625, 431.3502502441406, ' Is there clinical documentation supporting disease improvement? \\n Yes\\n No \\n', 34, 0)}, {'page': 5, 'block': (22.544025421142578, 432.5073547363281, 118.07713317871094, 443.93798828125, 'For all other indications: \\n', 35, 0)}, {'page': 5, 'block': (31.742321014404297, 442.8447265625, 292.9938659667969, 453.7374267578125, 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n', 36, 0)}, {'page': 5, 'block': (31.742321014404297, 454.0646057128906, 312.4850769042969, 464.9573059082031, 'Is there clinical documentation supporting disease improvement? \\n Yes \\n No  \\n', 37, 0)}, {'page': 5, 'block': (20.402740478515625, 467.9737548828125, 119.84233093261719, 479.401123046875, 'H. ACKNOWLEDGEMENT\\n', 38, 0)}, {'page': 5, 'block': (22.559999465942383, 485.76287841796875, 510.09149169921875, 497.9635314941406, 'Request Completed By (Signature Required):\\n  Date: \\n', 39, 0)}, {'page': 5, 'block': (22.55999755859375, 502.1553649902344, 590.3668212890625, 533.3508911132812, 'Any person who knowingly files a request for authorization of coverage of a medical procedure or service with the intent to injure, defraud or deceive \\nany insurance company by providing materially false information or conceals material information for the purpose of misleading, commits a fraudulent \\ninsurance act, which is a crime and subjects such person to criminal and civil penalties. \\n', 40, 0)}, {'page': 5, 'block': (18.001800537109375, 538.2158813476562, 363.9308776855469, 549.8456420898438, 'The plan may request additional information or clarification, if needed, to evaluate requests. \\n', 41, 0)}, {'page': 5, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 42, 0)}]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def extract_pdf_fields(pdf_path):\n",
        "    doc = fitz.open(pdf_path)\n",
        "    fields = []\n",
        "\n",
        "    for i, page in enumerate(doc, start=1):\n",
        "        block = page.get_text('blocks')\n",
        "        for w in page.widgets():\n",
        "            field = {\n",
        "                \"page\": i,\n",
        "                \"name\": w.field_name,\n",
        "                \"type\": w.field_type,\n",
        "                \"rect\": list(w.rect),  # Convert to list for JSON compatibility\n",
        "                \"label\": w.field_label\n",
        "            }\n",
        "            fields.append(field)\n",
        "    for f in fields:\n",
        "      print(f)\n",
        "\n",
        "    return fields\n",
        "\n",
        "fields = extract_pdf_fields(\"PA.pdf\")\n",
        "print(fields)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "eqU3tTVA82sX",
        "outputId": "1065495c-dfac-48f7-f4c3-4f4d022d5683"
      },
      "execution_count": 58,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'page': 2, 'name': 'CB1', 'type': 2, 'rect': [82.92900085449219, 110.4580078125, 93.23079681396484, 121.0150146484375], 'label': 'Start of treatment'}\n",
            "{'page': 2, 'name': 'T2', 'type': 7, 'rect': [210.19700622558594, 109.281982421875, 231.8699951171875, 120.96099853515625], 'label': 'Start date: (MM)'}\n",
            "{'page': 2, 'name': 'T3', 'type': 7, 'rect': [236.83399963378906, 109.281982421875, 258.5069885253906, 120.96099853515625], 'label': 'Start date: (DD)'}\n",
            "{'page': 2, 'name': 'T4', 'type': 7, 'rect': [262.1719970703125, 109.281982421875, 285.8070068359375, 120.96099853515625], 'label': 'Start date: (YYYY)'}\n",
            "{'page': 2, 'name': 'CB5', 'type': 2, 'rect': [306.0480041503906, 110.03802490234375, 316.3500061035156, 120.594970703125], 'label': 'Continuation of therapy'}\n",
            "{'page': 2, 'name': 'T6', 'type': 7, 'rect': [502.3739929199219, 109.2760009765625, 524.0469970703125, 120.95501708984375], 'label': 'Date of last treatment: (MM)'}\n",
            "{'page': 2, 'name': 'T7', 'type': 7, 'rect': [529.010986328125, 109.2760009765625, 550.6840209960938, 120.95501708984375], 'label': 'Date of last treatment: (DD)'}\n",
            "{'page': 2, 'name': 'T8', 'type': 7, 'rect': [554.9990234375, 109.2760009765625, 578.135986328125, 120.95501708984375], 'label': 'Date of last treatment: (YYYY)'}\n",
            "{'page': 2, 'name': 'T9', 'type': 7, 'rect': [143.625, 122.6729736328125, 350.625, 134.35198974609375], 'label': 'Precertification Requested By:'}\n",
            "{'page': 2, 'name': 'T10', 'type': 7, 'rect': [386.3070068359375, 123.7030029296875, 480.1470031738281, 135.38201904296875], 'label': 'Phone:'}\n",
            "{'page': 2, 'name': 'T11', 'type': 7, 'rect': [501.19500732421875, 123.69598388671875, 593.594970703125, 135.375], 'label': 'Fax:'}\n",
            "{'page': 2, 'name': 'T12', 'type': 7, 'rect': [62.843101501464844, 150.93402099609375, 230.375, 162.61297607421875], 'label': 'Patient First Name'}\n",
            "{'page': 2, 'name': 'T13', 'type': 7, 'rect': [277.2619934082031, 150.93402099609375, 501.9209899902344, 162.61297607421875], 'label': 'Patient Last Name'}\n",
            "{'page': 2, 'name': 'T14', 'type': 7, 'rect': [526.2670288085938, 150.93402099609375, 592.1160278320312, 162.61297607421875], 'label': 'Patient DOB (MM/DD/YYYY)'}\n",
            "{'page': 2, 'name': 'T15', 'type': 7, 'rect': [52.88520050048828, 164.8270263671875, 327.07598876953125, 176.5059814453125], 'label': 'Address:'}\n",
            "{'page': 2, 'name': 'T16', 'type': 7, 'rect': [347.5299987792969, 164.8270263671875, 443.9800109863281, 176.5059814453125], 'label': 'City:'}\n",
            "{'page': 2, 'name': 'T17', 'type': 7, 'rect': [469.6700134277344, 164.8270263671875, 501.9209899902344, 176.5059814453125], 'label': 'State:'}\n",
            "{'page': 2, 'name': 'T18', 'type': 7, 'rect': [521.6199951171875, 164.8270263671875, 592.1160278320312, 176.5059814453125], 'label': 'ZIP:'}\n",
            "{'page': 2, 'name': 'T19', 'type': 7, 'rect': [69.14689636230469, 179.32098388671875, 151.4929962158203, 191.0], 'label': 'Patient Phone'}\n",
            "{'page': 2, 'name': 'T20', 'type': 7, 'rect': [201.93499755859375, 179.32098388671875, 286.2969970703125, 191.0], 'label': 'Work Phone:'}\n",
            "{'page': 2, 'name': 'T21', 'type': 7, 'rect': [332.29400634765625, 179.44097900390625, 421.7250061035156, 191.1199951171875], 'label': 'Cell Phone:'}\n",
            "{'page': 2, 'name': 'T22', 'type': 7, 'rect': [450.6510009765625, 179.44097900390625, 592.1160278320312, 191.1199951171875], 'label': 'E-mail:'}\n",
            "{'page': 2, 'name': 'T24', 'type': 7, 'rect': [78.66909790039062, 194.8740234375, 100.60900115966797, 206.552978515625], 'label': 'lbs'}\n",
            "{'page': 2, 'name': 'T25', 'type': 7, 'rect': [128.6300048828125, 194.989990234375, 151.65899658203125, 206.66900634765625], 'label': 'kgs'}\n",
            "{'page': 2, 'name': 'T26', 'type': 7, 'rect': [216.36099243164062, 194.93597412109375, 239.2469940185547, 206.614990234375], 'label': 'inches'}\n",
            "{'page': 2, 'name': 'T27', 'type': 7, 'rect': [280.114990234375, 194.85400390625, 303.5719909667969, 206.53302001953125], 'label': 'cms'}\n",
            "{'page': 2, 'name': 'T23', 'type': 7, 'rect': [363.9159851074219, 195.40802001953125, 592.1160278320312, 207.08697509765625], 'label': 'Allergies:'}\n",
            "{'page': 2, 'name': 'T28', 'type': 7, 'rect': [72.4458999633789, 222.19500732421875, 229.36099243164062, 232.90301513671875], 'label': 'Member ID #:'}\n",
            "{'page': 2, 'name': 'T29', 'type': 7, 'rect': [55.536800384521484, 233.70098876953125, 229.41600036621094, 244.40899658203125], 'label': 'Group #:'}\n",
            "{'page': 2, 'name': 'T30', 'type': 7, 'rect': [53.76750183105469, 244.69598388671875, 229.44700622558594, 254.6669921875], 'label': 'Insured:'}\n",
            "{'page': 2, 'name': 'CB31', 'type': 2, 'rect': [386.09100341796875, 222.927978515625, 396.39300537109375, 233.4840087890625], 'label': 'Yes'}\n",
            "{'page': 2, 'name': 'CB32', 'type': 2, 'rect': [415.6910095214844, 222.906982421875, 425.99200439453125, 233.4630126953125], 'label': 'No'}\n",
            "{'page': 2, 'name': 'T33', 'type': 7, 'rect': [304.1390075683594, 233.13201904296875, 386.218994140625, 244.40899658203125], 'label': 'If yes, provide ID#:'}\n",
            "{'page': 2, 'name': 'T34', 'type': 7, 'rect': [440.7279968261719, 233.13201904296875, 588.68798828125, 244.40899658203125], 'label': 'Carrier Name:'}\n",
            "{'page': 2, 'name': 'T35', 'type': 7, 'rect': [266.8479919433594, 245.7550048828125, 588.68798828125, 256.031982421875], 'label': 'Insured:'}\n",
            "{'page': 2, 'name': 'T42', 'type': 7, 'rect': [61.66939926147461, 272.82098388671875, 231.23199462890625, 283.5010070800781], 'label': 'First Name:'}\n",
            "{'page': 2, 'name': 'T43', 'type': 7, 'rect': [277.4209899902344, 272.81097412109375, 395.2850036621094, 283.4909973144531], 'label': 'Last Name:'}\n",
            "{'page': 2, 'name': 'CB44', 'type': 2, 'rect': [453.2449951171875, 271.9940185546875, 463.5469970703125, 282.5509948730469], 'label': 'M.D.'}\n",
            "{'page': 2, 'name': 'CB45', 'type': 2, 'rect': [490.072998046875, 271.98297119140625, 500.375, 282.5400085449219], 'label': 'D.O.'}\n",
            "{'page': 2, 'name': 'CB46', 'type': 2, 'rect': [526.3419799804688, 272.0040283203125, 536.6439819335938, 282.5610046386719], 'label': 'N.P.'}\n",
            "{'page': 2, 'name': 'CB47', 'type': 2, 'rect': [561.6890258789062, 271.98297119140625, 571.9910278320312, 282.5400085449219], 'label': 'P.A.'}\n",
            "{'page': 2, 'name': 'T48', 'type': 7, 'rect': [52.40890121459961, 287.9179992675781, 326.39801025390625, 298.5979919433594], 'label': 'Address:'}\n",
            "{'page': 2, 'name': 'T49', 'type': 7, 'rect': [347.1679992675781, 287.9179992675781, 443.7019958496094, 298.5979919433594], 'label': 'City:'}\n",
            "{'page': 2, 'name': 'T50', 'type': 7, 'rect': [470.031005859375, 287.8869934082031, 502.8450012207031, 298.5669860839844], 'label': 'State:'}\n",
            "{'page': 2, 'name': 'T51', 'type': 7, 'rect': [521.7979736328125, 287.8869934082031, 592.8610229492188, 298.5669860839844], 'label': 'ZIP:'}\n",
            "{'page': 2, 'name': 'T52', 'type': 7, 'rect': [45.78519821166992, 302.1709899902344, 113.06099700927734, 312.85101318359375], 'label': 'Phone:'}\n",
            "{'page': 2, 'name': 'T53', 'type': 7, 'rect': [132.92300415039062, 302.1709899902344, 209.58200073242188, 312.85101318359375], 'label': 'Fax:'}\n",
            "{'page': 2, 'name': 'T54', 'type': 7, 'rect': [243.28700256347656, 302.1709899902344, 326.14599609375, 312.85101318359375], 'label': 'St Lic #:'}\n",
            "{'page': 2, 'name': 'T55', 'type': 7, 'rect': [353.95098876953125, 302.1709899902344, 417.0400085449219, 312.85101318359375], 'label': 'NPI #:'}\n",
            "{'page': 2, 'name': 'T56', 'type': 7, 'rect': [446.7349853515625, 302.1709899902344, 502.8450012207031, 312.85101318359375], 'label': 'DEA #:'}\n",
            "{'page': 2, 'name': 'T57', 'type': 7, 'rect': [527.7540283203125, 302.1499938964844, 592.8610229492188, 312.8299865722656], 'label': 'UPIN:'}\n",
            "{'page': 2, 'name': 'T58.0', 'type': 7, 'rect': [74.67269897460938, 317.27301025390625, 209.50900268554688, 327.9530029296875], 'label': 'Provider Email:'}\n",
            "{'page': 2, 'name': 'T58.1', 'type': 7, 'rect': [290.1669921875, 317.27301025390625, 417.0400085449219, 327.9530029296875], 'label': 'Office Contact Name:'}\n",
            "{'page': 2, 'name': 'T59', 'type': 7, 'rect': [446.9049987792969, 317.27301025390625, 592.8610229492188, 327.9530029296875], 'label': 'Phone:'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.1', 'type': 2, 'rect': [22.34000015258789, 352.0459899902344, 32.375999450683594, 362.5190124511719], 'label': 'Self-administered'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.2', 'type': 2, 'rect': [107.87300109863281, 352.0790100097656, 117.90899658203125, 362.552001953125], 'label': 'Physician’s Office'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.3', 'type': 2, 'rect': [194.05499267578125, 352.0790100097656, 204.09100341796875, 362.552001953125], 'label': 'Home'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.4', 'type': 2, 'rect': [22.34000015258789, 362.49700927734375, 32.375999450683594, 372.9700012207031], 'label': 'Outpatient Infusion Center'}\n",
            "{'page': 2, 'name': 'Provider Admin T.5', 'type': 7, 'rect': [157.18699645996094, 362.43499755859375, 320.2829895019531, 373.0169982910156], 'label': 'Name:'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.7', 'type': 2, 'rect': [22.34000015258789, 372.5169982910156, 32.375999450683594, 382.989990234375], 'label': 'Home Infusion Center'}\n",
            "{'page': 2, 'name': 'Provider Admin T.6', 'type': 7, 'rect': [165.0959930419922, 373.2980041503906, 320.2829895019531, 383.8800048828125], 'label': 'Phone:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.8', 'type': 7, 'rect': [111.47799682617188, 383.5799865722656, 320.2829895019531, 394.1619873046875], 'label': 'Agency Name:'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.10', 'type': 2, 'rect': [22.34000015258789, 393.0249938964844, 32.375999450683594, 403.49798583984375], 'label': 'Administration code(s)'}\n",
            "{'page': 2, 'name': 'Provider Admin T.9', 'type': 7, 'rect': [143.82699584960938, 393.6579895019531, 320.2829895019531, 404.239990234375], 'label': 'CPT:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.11A', 'type': 7, 'rect': [56.31019973754883, 403.95599365234375, 320.2829895019531, 414.5379943847656], 'label': 'Address:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.13', 'type': 7, 'rect': [40.63639831542969, 415.3280029296875, 167.3459930419922, 425.9100036621094], 'label': 'City:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.14', 'type': 7, 'rect': [193.09100341796875, 415.3280029296875, 229.23599243164062, 425.9100036621094], 'label': 'State:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.15', 'type': 7, 'rect': [246.7010040283203, 415.7640075683594, 320.2829895019531, 426.34600830078125], 'label': 'ZIP:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.16', 'type': 7, 'rect': [49.74549865722656, 425.79998779296875, 167.3459930419922, 436.3819885253906], 'label': 'Phone:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.17A', 'type': 7, 'rect': [189.15499877929688, 425.79998779296875, 320.2829895019531, 436.3819885253906], 'label': 'Fax:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.18', 'type': 7, 'rect': [39.92729949951172, 437.27301025390625, 167.3459930419922, 447.8550109863281], 'label': 'TIN:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.19', 'type': 7, 'rect': [189.15499877929688, 437.27301025390625, 320.2829895019531, 447.8550109863281], 'label': 'PIN:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.20', 'type': 7, 'rect': [39.86439895629883, 448.2250061035156, 320.2829895019531, 458.8070068359375], 'label': 'NPI:'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.21', 'type': 2, 'rect': [331.30499267578125, 352.072998046875, 341.34100341796875, 362.5459899902344], 'label': 'Outpatient Dialysis Center'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.22', 'type': 2, 'rect': [448.74798583984375, 352.0220031738281, 458.78399658203125, 362.4949951171875], 'label': 'Physician’s Office'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.23.0.0', 'type': 2, 'rect': [331.2909851074219, 363.12799072265625, 341.3269958496094, 373.60101318359375], 'label': 'Retail Pharmacy'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.24.0.0', 'type': 2, 'rect': [448.6730041503906, 363.12799072265625, 458.7090148925781, 373.60101318359375], 'label': 'Specialty Pharmacy'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.25', 'type': 2, 'rect': [331.2909851074219, 374.8550109863281, 341.3269958496094, 385.3280029296875], 'label': 'Mail Order'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.26', 'type': 2, 'rect': [448.6730041503906, 374.8550109863281, 458.7090148925781, 385.3280029296875], 'label': 'Other:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.27', 'type': 7, 'rect': [484.71099853515625, 374.8219909667969, 591.8259887695312, 385.8489990234375], 'label': 'Other:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.28', 'type': 7, 'rect': [356.0669860839844, 386.92401123046875, 591.8259887695312, 398.0429992675781], 'label': 'Name:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.29a', 'type': 7, 'rect': [363.8489990234375, 399.135009765625, 591.8259887695312, 410.2539978027344], 'label': 'Address:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.30a', 'type': 7, 'rect': [349.0429992675781, 411.1409912109375, 448.72601318359375, 422.1679992675781], 'label': 'City:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.31', 'type': 7, 'rect': [476.072998046875, 411.2590026855469, 513.3820190429688, 422.1679992675781], 'label': 'State:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.32', 'type': 7, 'rect': [533.135009765625, 411.2590026855469, 591.8259887695312, 422.1679992675781], 'label': 'ZIP:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.33', 'type': 7, 'rect': [359.12799072265625, 423.7099914550781, 466.9100036621094, 434.6189880371094], 'label': 'Phone:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.34', 'type': 7, 'rect': [488.0799865722656, 423.7099914550781, 591.8259887695312, 434.6189880371094], 'label': 'Fax:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.35', 'type': 7, 'rect': [349.09100341796875, 436.05499267578125, 466.9100036621094, 446.9639892578125], 'label': 'TIN:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.36', 'type': 7, 'rect': [488.08099365234375, 436.05499267578125, 591.8259887695312, 446.9639892578125], 'label': 'PIN:'}\n",
            "{'page': 2, 'name': 'Provider Admin T.37', 'type': 7, 'rect': [349.0989990234375, 447.89801025390625, 591.8259887695312, 458.8070068359375], 'label': 'NPI:'}\n",
            "{'page': 2, 'name': 'CB60', 'type': 2, 'rect': [82.12529754638672, 475.0929870605469, 92.31230163574219, 485.68701171875], 'label': 'Riabni (rituximab-arrx)'}\n",
            "{'page': 2, 'name': 'CB61', 'type': 2, 'rect': [188.06199645996094, 475.0929870605469, 198.24899291992188, 485.68701171875], 'label': 'Rituxan (rituximab)'}\n",
            "{'page': 2, 'name': 'CB62', 'type': 2, 'rect': [281.27899169921875, 475.177001953125, 291.46600341796875, 485.77099609375], 'label': 'Ruxience (rituximab-pvvr)'}\n",
            "{'page': 2, 'name': 'CB63', 'type': 2, 'rect': [398.927001953125, 475.177001953125, 409.114013671875, 485.77099609375], 'label': 'Truxima (rituximab-abbs)'}\n",
            "{'page': 2, 'name': 'T64', 'type': 7, 'rect': [45.61000061035156, 487.57000732421875, 225.343994140625, 498.47900390625], 'label': 'Dose:'}\n",
            "{'page': 2, 'name': 'T65', 'type': 7, 'rect': [308.4649963378906, 487.57000732421875, 459.3169860839844, 498.47900390625], 'label': 'Directions for Use:'}\n",
            "{'page': 2, 'name': 'T66', 'type': 7, 'rect': [524.906005859375, 487.57000732421875, 589.9249877929688, 498.47900390625], 'label': 'HCPCS Code:'}\n",
            "{'page': 2, 'name': 'T67', 'type': 7, 'rect': [97.97879791259766, 518.5599975585938, 270.3380126953125, 529.259033203125], 'label': 'Primary ICD Code:'}\n",
            "{'page': 2, 'name': 'CB68', 'type': 2, 'rect': [292.47198486328125, 518.5599975585938, 302.77398681640625, 529.259033203125], 'label': 'Other ICD Code:'}\n",
            "{'page': 2, 'name': 'T69', 'type': 7, 'rect': [370.33099365234375, 518.5599975585938, 589.5579833984375, 529.259033203125], 'label': 'Other ICD Code:'}\n",
            "{'page': 2, 'name': 'CB70', 'type': 2, 'rect': [22.825700759887695, 584.4249877929688, 33.12770080566406, 594.9819946289062], 'label': 'Yes'}\n",
            "{'page': 2, 'name': 'CB71', 'type': 2, 'rect': [52.699501037597656, 584.6510009765625, 62.623199462890625, 594.9819946289062], 'label': 'No'}\n",
            "{'page': 2, 'name': 'CB72', 'type': 2, 'rect': [52.699501037597656, 596.738037109375, 62.623199462890625, 607.0689697265625], 'label': 'No'}\n",
            "{'page': 2, 'name': 'CB73', 'type': 2, 'rect': [81.47090148925781, 606.9550170898438, 91.65750122070312, 617.5490112304688], 'label': 'Ruxience (rituximab-pvvr)'}\n",
            "{'page': 2, 'name': 'CB74', 'type': 2, 'rect': [190.92300415039062, 606.9550170898438, 201.11000061035156, 617.5490112304688], 'label': 'Truxima (rituximab-abbs)'}\n",
            "{'page': 2, 'name': 'T75', 'type': 7, 'rect': [315.31298828125, 617.7750244140625, 585.489013671875, 628.6840209960938], 'label': 'When was the member’s trial and failure of the preferred drug?'}\n",
            "{'page': 2, 'name': 'T76', 'type': 7, 'rect': [315.31298828125, 630.634033203125, 585.489013671875, 641.54296875], 'label': 'Please describe the nature of the failure of the preferred drug'}\n",
            "{'page': 2, 'name': 'CB77', 'type': 2, 'rect': [52.699501037597656, 642.22998046875, 63.001399993896484, 652.7869873046875], 'label': 'No'}\n",
            "{'page': 2, 'name': 'CB78', 'type': 2, 'rect': [81.47090148925781, 653.0399780273438, 91.65750122070312, 663.634033203125], 'label': 'Ruxience (rituximab-pvvr)'}\n",
            "{'page': 2, 'name': 'CB79', 'type': 2, 'rect': [190.92300415039062, 653.0399780273438, 201.11000061035156, 663.634033203125], 'label': 'Truxima (rituximab-abbs)'}\n",
            "{'page': 2, 'name': 'T80', 'type': 7, 'rect': [315.31298828125, 664.2340087890625, 585.489013671875, 675.1430053710938], 'label': 'When was the member’s adverse reaction to the preferred drug?'}\n",
            "{'page': 2, 'name': 'T81', 'type': 7, 'rect': [342.1499938964844, 676.0919799804688, 585.489013671875, 687.0009765625], 'label': 'Please describe the nature of the adverse reaction to the preferred drug'}\n",
            "{'page': 2, 'name': 'T84', 'type': 7, 'rect': [22.731800079345703, 720.555908203125, 585.489013671875, 731.4649047851562], 'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?'}\n",
            "{'page': 2, 'name': 'CB82', 'type': 2, 'rect': [22.825700759887695, 708.5637817382812, 33.12770080566406, 719.1207885742188], 'label': 'Ruxience (rituximab-pvvr)'}\n",
            "{'page': 2, 'name': 'CB83', 'type': 2, 'rect': [131.9810028076172, 708.4747924804688, 141.90499877929688, 718.8057861328125], 'label': 'Truxima (rituximab-abbs)'}\n",
            "{'page': 3, 'name': 'T12', 'type': 7, 'rect': [19.95840072631836, 128.02301025390625, 164.60400390625, 140.68499755859375], 'label': 'Patient First Name'}\n",
            "{'page': 3, 'name': 'T13', 'type': 7, 'rect': [168.7469940185547, 128.02301025390625, 348.12200927734375, 140.68499755859375], 'label': 'Patient Last Name'}\n",
            "{'page': 3, 'name': 'T19', 'type': 7, 'rect': [353.4530029296875, 128.02301025390625, 465.8210144042969, 140.68499755859375], 'label': 'Patient Phone'}\n",
            "{'page': 3, 'name': 'T14', 'type': 7, 'rect': [470.8710021972656, 128.02301025390625, 591.301025390625, 140.68499755859375], 'label': 'Patient DOB (MM/DD/YYYY)'}\n",
            "{'page': 3, 'name': 'CB86', 'type': 2, 'rect': [81.38929748535156, 178.2750244140625, 91.69129943847656, 188.83197021484375], 'label': 'Inflectra (infliximab-dyyb)'}\n",
            "{'page': 3, 'name': 'CB87', 'type': 2, 'rect': [188.22500610351562, 178.3590087890625, 198.26100158691406, 188.83197021484375], 'label': 'Renflexis (infliximab-abda)'}\n",
            "{'page': 3, 'name': 'CB88', 'type': 2, 'rect': [300.7449951171875, 178.3590087890625, 310.781005859375, 188.83197021484375], 'label': 'Simponi Aria (golimumab)'}\n",
            "{'page': 3, 'name': 'T89', 'type': 7, 'rect': [314.85101318359375, 189.10797119140625, 582.4080200195312, 199.8070068359375], 'label': 'When was the member’s trial and failure of the preferred drug?'}\n",
            "{'page': 3, 'name': 'T90', 'type': 7, 'rect': [314.85101318359375, 201.96600341796875, 582.4080200195312, 212.66497802734375], 'label': 'Please describe the nature of the failure of the preferred drug'}\n",
            "{'page': 3, 'name': 'CB85', 'type': 2, 'rect': [52.34349822998047, 168.1290283203125, 62.64540100097656, 178.68597412109375], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB92', 'type': 2, 'rect': [81.38929748535156, 223.86602783203125, 91.69129943847656, 234.4229736328125], 'label': 'Inflectra (infliximab-dyyb)'}\n",
            "{'page': 3, 'name': 'CB93', 'type': 2, 'rect': [188.552001953125, 223.95001220703125, 198.58799743652344, 234.4229736328125], 'label': 'Renflexis (infliximab-abda)'}\n",
            "{'page': 3, 'name': 'CB94', 'type': 2, 'rect': [301.4179992675781, 223.95001220703125, 311.4540100097656, 234.4229736328125], 'label': 'Simponi Aria (golimumab)'}\n",
            "{'page': 3, 'name': 'T95', 'type': 7, 'rect': [314.85101318359375, 235.56597900390625, 582.4080200195312, 246.2650146484375], 'label': 'When was the member’s adverse reaction to the preferred drug?'}\n",
            "{'page': 3, 'name': 'T96a', 'type': 7, 'rect': [342.0140075683594, 247.42401123046875, 582.4080200195312, 258.12298583984375], 'label': 'Please describe the nature of the adverse reaction to the preferred drug'}\n",
            "{'page': 3, 'name': 'CB91', 'type': 2, 'rect': [52.34349822998047, 214.0479736328125, 62.64540100097656, 224.60498046875], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB98a', 'type': 2, 'rect': [81.38929748535156, 269.666015625, 91.69129943847656, 280.2229919433594], 'label': 'Enbrel (etanercept)'}\n",
            "{'page': 3, 'name': 'CB99a', 'type': 2, 'rect': [168.93499755859375, 269.75, 178.9709930419922, 280.2229919433594], 'label': 'Humira (adalimumab)'}\n",
            "{'page': 3, 'name': 'CB100a', 'type': 2, 'rect': [263.5639953613281, 269.75, 273.6000061035156, 280.2229919433594], 'label': 'Idacio (adalimumab-aacf)'}\n",
            "{'page': 3, 'name': 'CB101a', 'type': 2, 'rect': [371.9209899902344, 269.75, 381.9570007324219, 280.2229919433594], 'label': 'Rinvoq (upadacitinib)'}\n",
            "{'page': 3, 'name': 'CB102a', 'type': 2, 'rect': [465.09600830078125, 269.75, 475.1319885253906, 280.2229919433594], 'label': 'Tyenne SC (tocilizumab-aazg)'}\n",
            "{'page': 3, 'name': 'CB103a', 'type': 2, 'rect': [81.38929748535156, 280.92999267578125, 91.69129943847656, 291.48699951171875], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)'}\n",
            "{'page': 3, 'name': 'T104', 'type': 7, 'rect': [314.85101318359375, 294.3110046386719, 582.4080200195312, 305.010009765625], 'label': 'When was the member’s trial and failure of the preferred drug?'}\n",
            "{'page': 3, 'name': 'T105', 'type': 7, 'rect': [314.85101318359375, 306.16900634765625, 582.4080200195312, 316.8680114746094], 'label': 'Please describe the nature of the failure of the preferred drug'}\n",
            "{'page': 3, 'name': 'CB97', 'type': 2, 'rect': [52.34349822998047, 260.1939697265625, 62.64540100097656, 270.7509765625], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB107z', 'type': 2, 'rect': [81.38929748535156, 328.5570068359375, 91.69129943847656, 339.114013671875], 'label': 'Enbrel (etanercept)'}\n",
            "{'page': 3, 'name': 'CB108z', 'type': 2, 'rect': [168.93499755859375, 328.6409912109375, 178.9709930419922, 339.114013671875], 'label': 'Humira (adalimumab)'}\n",
            "{'page': 3, 'name': 'CB109z', 'type': 2, 'rect': [263.5639953613281, 328.6409912109375, 273.6000061035156, 339.114013671875], 'label': 'Idacio (adalimumab-aacf)'}\n",
            "{'page': 3, 'name': 'CB110z', 'type': 2, 'rect': [371.9209899902344, 328.6409912109375, 381.9570007324219, 339.114013671875], 'label': 'Rinvoq (upadacitinib)'}\n",
            "{'page': 3, 'name': 'CB111z', 'type': 2, 'rect': [465.0780029296875, 328.6409912109375, 475.114013671875, 339.114013671875], 'label': 'Tyenne SC (tocilizumab-aazg)'}\n",
            "{'page': 3, 'name': 'CB112z', 'type': 2, 'rect': [81.38929748535156, 339.8210144042969, 91.69129943847656, 350.37799072265625], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)'}\n",
            "{'page': 3, 'name': 'T113', 'type': 7, 'rect': [314.85101318359375, 352.33599853515625, 582.4080200195312, 363.0360107421875], 'label': 'When was the member’s adverse reaction to the preferred drug?'}\n",
            "{'page': 3, 'name': 'T114', 'type': 7, 'rect': [342.34100341796875, 364.19500732421875, 582.4080200195312, 374.8940124511719], 'label': 'Please describe the nature of the adverse reaction to the preferred drug'}\n",
            "{'page': 3, 'name': 'CB106z', 'type': 2, 'rect': [52.34349822998047, 318.0840148925781, 62.64540100097656, 328.6419982910156], 'label': 'No'}\n",
            "{'page': 3, 'name': 'T118', 'type': 7, 'rect': [22.0226993560791, 409.406005859375, 582.4080200195312, 420.85198974609375], 'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?'}\n",
            "{'page': 3, 'name': 'CB115z', 'type': 2, 'rect': [22.401899337768555, 397.3210144042969, 32.70389938354492, 407.87799072265625], 'label': 'Inflectra (infliximab-dyyb)'}\n",
            "{'page': 3, 'name': 'CB116z', 'type': 2, 'rect': [129.55799865722656, 397.4049987792969, 139.593994140625, 407.87799072265625], 'label': 'Renflexis (infliximab-abda)'}\n",
            "{'page': 3, 'name': 'CB117z', 'type': 2, 'rect': [241.75100708007812, 397.4049987792969, 251.78700256347656, 407.87799072265625], 'label': 'Simponi Aria (golimumab)'}\n",
            "{'page': 3, 'name': 'T125', 'type': 7, 'rect': [22.0226993560791, 464.6180114746094, 582.4080200195312, 476.0639953613281], 'label': 'Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?'}\n",
            "{'page': 3, 'name': 'CB119z', 'type': 2, 'rect': [22.401899337768555, 441.5849914550781, 32.70389938354492, 452.1409912109375], 'label': 'Enbrel (etanercept)'}\n",
            "{'page': 3, 'name': 'CB120z', 'type': 2, 'rect': [109.67500305175781, 441.5469970703125, 119.86100006103516, 452.1409912109375], 'label': 'Humira (adalimumab)'}\n",
            "{'page': 3, 'name': 'CB121z', 'type': 2, 'rect': [201.76400756835938, 441.5469970703125, 211.9499969482422, 452.1409912109375], 'label': 'Idacio (adalimumab-aacf)'}\n",
            "{'page': 3, 'name': 'CB122z', 'type': 2, 'rect': [310.4049987792969, 441.5379943847656, 320.5840148925781, 452.1409912109375], 'label': 'Rinvoq (upadacitinib)'}\n",
            "{'page': 3, 'name': 'CB123z', 'type': 2, 'rect': [401.4320068359375, 441.5379943847656, 411.6109924316406, 452.1409912109375], 'label': 'Tyenne SC (tocilizumab-aazg)'}\n",
            "{'page': 3, 'name': 'CB124z', 'type': 2, 'rect': [22.401899337768555, 452.5150146484375, 32.58890151977539, 463.1090087890625], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)'}\n",
            "{'page': 3, 'name': 'CB96.4.0', 'type': 2, 'rect': [22.401899337768555, 489.9960021972656, 32.58890151977539, 500.5899963378906], 'label': 'Yes'}\n",
            "{'page': 3, 'name': 'CB98', 'type': 2, 'rect': [52.02109909057617, 490.0329895019531, 62.323001861572266, 500.5899963378906], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB99.0', 'type': 2, 'rect': [22.401899337768555, 512.27001953125, 32.70389938354492, 522.8270263671875], 'label': 'Yes'}\n",
            "{'page': 3, 'name': 'CB100.0', 'type': 2, 'rect': [52.02109909057617, 512.6729736328125, 61.89899826049805, 522.8060302734375], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB101.0', 'type': 2, 'rect': [22.401899337768555, 523.8699951171875, 32.70389938354492, 534.427001953125], 'label': 'Yes'}\n",
            "{'page': 3, 'name': 'CB102.0', 'type': 2, 'rect': [52.02109909057617, 523.8699951171875, 62.323001861572266, 534.427001953125], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB103', 'type': 2, 'rect': [22.401899337768555, 546.2080078125, 32.703800201416016, 556.7650146484375], 'label': 'Yes'}\n",
            "{'page': 3, 'name': 'CB104', 'type': 2, 'rect': [52.02109909057617, 546.218017578125, 62.323001861572266, 556.7750244140625], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB104a', 'type': 2, 'rect': [238.76499938964844, 568.7449951171875, 249.0659942626953, 579.301025390625], 'label': 'Wegener granulomatosis'}\n",
            "{'page': 3, 'name': 'CB104b', 'type': 2, 'rect': [351.2770080566406, 568.7249755859375, 361.5780029296875, 579.281005859375], 'label': 'Churg-Strauss syndrome'}\n",
            "{'page': 3, 'name': 'CB104c', 'type': 2, 'rect': [238.77499389648438, 579.343017578125, 249.0760040283203, 589.8989868164062], 'label': 'microscopic polyangiitis'}\n",
            "{'page': 3, 'name': 'CB104d', 'type': 2, 'rect': [351.2860107421875, 579.3330078125, 361.5880126953125, 589.8890380859375], 'label': 'pauci-immune glomerulonephritis'}\n",
            "{'page': 3, 'name': 'CB105', 'type': 2, 'rect': [22.401899337768555, 591.3099975585938, 32.703800201416016, 601.865966796875], 'label': 'Yes'}\n",
            "{'page': 3, 'name': 'CB106', 'type': 2, 'rect': [52.02109909057617, 591.3410034179688, 62.323001861572266, 601.89697265625], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB106a', 'type': 2, 'rect': [22.401899337768555, 613.6580200195312, 32.703800201416016, 624.2139892578125], 'label': 'Yes'}\n",
            "{'page': 3, 'name': 'CB107', 'type': 2, 'rect': [234.27999877929688, 623.35400390625, 244.58099365234375, 633.9100341796875], 'label': 'pemphigus vulgaris'}\n",
            "{'page': 3, 'name': 'CB108', 'type': 2, 'rect': [321.2820129394531, 623.343017578125, 331.5830078125, 633.9000244140625], 'label': 'pemphigus folliaceus'}\n",
            "{'page': 3, 'name': 'CB109', 'type': 2, 'rect': [414.0069885253906, 623.3370361328125, 424.3080139160156, 633.8930053710938], 'label': 'bullous pemphigoid'}\n",
            "{'page': 3, 'name': 'CB110', 'type': 2, 'rect': [501.04901123046875, 623.322998046875, 511.3500061035156, 633.8800048828125], 'label': 'cicatricial pemphigoid'}\n",
            "{'page': 3, 'name': 'CB111', 'type': 2, 'rect': [234.29100036621094, 633.9869995117188, 244.5919952392578, 644.5440063476562], 'label': 'epidermolysis bullosa acquisita'}\n",
            "{'page': 3, 'name': 'CB112', 'type': 2, 'rect': [362.60101318359375, 633.9970092773438, 372.9020080566406, 644.5540161132812], 'label': 'paraneoplastic pemphigus'}\n",
            "{'page': 3, 'name': 'CB113', 'type': 2, 'rect': [473.9859924316406, 633.9830322265625, 484.2869873046875, 644.5390014648438], 'label': 'None of the above'}\n",
            "{'page': 3, 'name': 'CB106b', 'type': 2, 'rect': [52.02109909057617, 613.66796875, 62.323001861572266, 624.2249755859375], 'label': 'No'}\n",
            "{'page': 3, 'name': 'CB114', 'type': 2, 'rect': [175.54200744628906, 655.4459838867188, 185.843994140625, 666.0029907226562], 'label': 'AIDS-related B-cell lymphoma'}\n",
            "{'page': 3, 'name': 'CB115', 'type': 2, 'rect': [301.32501220703125, 655.4459838867188, 311.62701416015625, 666.0029907226562], 'label': 'Burkitt lymphoma'}\n",
            "{'page': 3, 'name': 'CB116', 'type': 2, 'rect': [380.8210144042969, 655.4459838867188, 391.12298583984375, 666.0029907226562], 'label': 'Diffuse large B-cell lymphoma'}\n",
            "{'page': 3, 'name': 'CB117', 'type': 2, 'rect': [505.20098876953125, 655.4459838867188, 515.5029907226562, 666.0029907226562], 'label': 'Follicular lymphoma'}\n",
            "{'page': 3, 'name': 'CB118', 'type': 2, 'rect': [175.54200744628906, 665.8720092773438, 185.843994140625, 676.4290161132812], 'label': 'Gastric MALT lymphoma'}\n",
            "{'page': 3, 'name': 'CB119', 'type': 2, 'rect': [281.6090087890625, 665.8720092773438, 291.9110107421875, 676.4290161132812], 'label': 'High-grade B-Cell lymphoma'}\n",
            "{'page': 3, 'name': 'CB120', 'type': 2, 'rect': [403.06201171875, 665.8720092773438, 413.364013671875, 676.4290161132812], 'label': 'Mantle cell lymphoma'}\n",
            "{'page': 3, 'name': 'CB121', 'type': 2, 'rect': [175.54200744628906, 676.5670166015625, 185.843994140625, 687.1240234375], 'label': 'Nodal marginal zone lymphoma'}\n",
            "{'page': 3, 'name': 'CB122', 'type': 2, 'rect': [306.08599853515625, 676.5670166015625, 316.38800048828125, 687.1240234375], 'label': 'Nongastric MALT lymphoma'}\n",
            "{'page': 3, 'name': 'CB123', 'type': 2, 'rect': [425.44000244140625, 676.5670166015625, 435.74200439453125, 687.1240234375], 'label': 'Primary cutaneous B-cell lymphomas'}\n",
            "{'page': 3, 'name': 'CB124', 'type': 2, 'rect': [175.54200744628906, 687.93701171875, 185.843994140625, 698.4945068359375], 'label': 'Splenic marginal zone lymphoma'}\n",
            "{'page': 3, 'name': 'CB125', 'type': 2, 'rect': [311.91900634765625, 688.2860107421875, 322.22100830078125, 698.8427124023438], 'label': 'Other:'}\n",
            "{'page': 3, 'name': 'T126', 'type': 7, 'rect': [347.5450134277344, 688.0380249023438, 585.0689697265625, 698.70947265625], 'label': 'Other:'}\n",
            "{'page': 4, 'name': 'T12', 'type': 7, 'rect': [20.796199798583984, 131.79498291015625, 164.06300354003906, 144.45697021484375], 'label': 'Patient First Name'}\n",
            "{'page': 4, 'name': 'T13', 'type': 7, 'rect': [168.93800354003906, 131.79498291015625, 348.9230041503906, 144.45697021484375], 'label': 'Patient Last Name'}\n",
            "{'page': 4, 'name': 'T19', 'type': 7, 'rect': [354.30499267578125, 131.79498291015625, 469.82598876953125, 144.45697021484375], 'label': 'Patient Phone'}\n",
            "{'page': 4, 'name': 'T14', 'type': 7, 'rect': [475.18701171875, 131.79498291015625, 592.4639892578125, 144.45697021484375], 'label': 'Patient DOB (MM/DD/YYYY)'}\n",
            "{'page': 4, 'name': 'CB127', 'type': 2, 'rect': [22.673200607299805, 167.864013671875, 32.975101470947266, 178.4210205078125], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB128', 'type': 2, 'rect': [52.01240158081055, 167.87298583984375, 62.31420135498047, 178.42999267578125], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB129', 'type': 2, 'rect': [173.50999450683594, 190.15802001953125, 183.81199645996094, 200.71502685546875], 'label': 'leptomeningeal metastases from lymphoma'}\n",
            "{'page': 4, 'name': 'CB130', 'type': 2, 'rect': [346.9599914550781, 190.15802001953125, 357.2619934082031, 200.71502685546875], 'label': 'primary CNS lymphoma'}\n",
            "{'page': 4, 'name': 'CB131', 'type': 2, 'rect': [449.24700927734375, 190.15802001953125, 459.54901123046875, 200.71502685546875], 'label': 'none of the above'}\n",
            "{'page': 4, 'name': 'CB132', 'type': 2, 'rect': [173.1649932861328, 212.5050048828125, 183.4669952392578, 223.06201171875], 'label': 'chronic lymphocytic leukemia (CLL)'}\n",
            "{'page': 4, 'name': 'CB133', 'type': 2, 'rect': [317.5360107421875, 212.5050048828125, 327.8380126953125, 223.06201171875], 'label': 'small lymphocytic leukemia'}\n",
            "{'page': 4, 'name': 'CB134', 'type': 2, 'rect': [432.5050048828125, 212.5050048828125, 442.8070068359375, 223.06201171875], 'label': 'none of the above'}\n",
            "{'page': 4, 'name': 'CB135', 'type': 2, 'rect': [22.673099517822266, 235.28399658203125, 32.975101470947266, 245.84100341796875], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB136', 'type': 2, 'rect': [52.012298583984375, 235.27197265625, 62.31420135498047, 245.8289794921875], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB139', 'type': 2, 'rect': [22.673099517822266, 246.739990234375, 32.975101470947266, 257.2969970703125], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB140', 'type': 2, 'rect': [52.012298583984375, 246.739990234375, 62.31420135498047, 257.2969970703125], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB144', 'type': 2, 'rect': [22.673099517822266, 268.89697265625, 32.975101470947266, 279.4539794921875], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB145', 'type': 2, 'rect': [52.012298583984375, 269.38201904296875, 62.31420135498047, 279.93902587890625], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB141', 'type': 2, 'rect': [173.4029998779297, 291.9289855957031, 183.7050018310547, 302.4859924316406], 'label': 'relapsed hairy cell leukemia'}\n",
            "{'page': 4, 'name': 'CB142', 'type': 2, 'rect': [290.2030029296875, 291.91900634765625, 300.5050048828125, 302.47601318359375], 'label': 'refractory hairy cell leukemia'}\n",
            "{'page': 4, 'name': 'CB143', 'type': 2, 'rect': [410.20599365234375, 291.90899658203125, 420.50799560546875, 302.46600341796875], 'label': 'none of the above'}\n",
            "{'page': 4, 'name': 'CB137', 'type': 2, 'rect': [22.673099517822266, 313.6650085449219, 32.975101470947266, 324.22198486328125], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB146', 'type': 2, 'rect': [239.57899475097656, 334.8080139160156, 249.88099670410156, 345.364990234375], 'label': 'heart transplant recipient'}\n",
            "{'page': 4, 'name': 'CB147', 'type': 2, 'rect': [345.38299560546875, 334.7669982910156, 355.68499755859375, 345.3240051269531], 'label': 'other solid organ transplant recipient'}\n",
            "{'page': 4, 'name': 'CB138', 'type': 2, 'rect': [52.012298583984375, 313.67401123046875, 62.31420135498047, 324.2309875488281], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB148', 'type': 2, 'rect': [293.14898681640625, 357.11199951171875, 303.45098876953125, 367.66900634765625], 'label': 'Bavencio (avelumab)'}\n",
            "{'page': 4, 'name': 'CB149', 'type': 2, 'rect': [386.4150085449219, 357.11199951171875, 396.7170104980469, 367.66900634765625], 'label': 'Imfinzi (durvalumab)'}\n",
            "{'page': 4, 'name': 'CB150', 'type': 2, 'rect': [476.68499755859375, 357.11199951171875, 486.98699951171875, 367.66900634765625], 'label': 'Keytruda (pembrolizumab)'}\n",
            "{'page': 4, 'name': 'CB151', 'type': 2, 'rect': [293.14898681640625, 368.8280029296875, 303.45098876953125, 379.385009765625], 'label': 'Opdivo (nivolumab)'}\n",
            "{'page': 4, 'name': 'CB152', 'type': 2, 'rect': [380.1409912109375, 368.8280029296875, 390.4429931640625, 379.385009765625], 'label': 'Tecentriq (atezolizumab)'}\n",
            "{'page': 4, 'name': 'CB153', 'type': 2, 'rect': [486.5639953613281, 368.8280029296875, 496.8659973144531, 379.385009765625], 'label': 'Yervoy (ipilimumab)'}\n",
            "{'page': 4, 'name': 'CB154', 'type': 2, 'rect': [293.14898681640625, 380.08099365234375, 303.45098876953125, 390.63800048828125], 'label': 'Other:'}\n",
            "{'page': 4, 'name': 'T155', 'type': 7, 'rect': [327.6289978027344, 380.3970031738281, 584.3980102539062, 391.5920104980469], 'label': 'Other:'}\n",
            "{'page': 4, 'name': 'CB156', 'type': 2, 'rect': [22.673099517822266, 402.6449890136719, 32.975101470947266, 413.2019958496094], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB158', 'type': 2, 'rect': [90.4845962524414, 413.0060119628906, 100.78600311279297, 423.56201171875], 'label': 'refractory immune thrombocytopenic purpura'}\n",
            "{'page': 4, 'name': 'CB159', 'type': 2, 'rect': [268.21099853515625, 413.0060119628906, 278.51300048828125, 423.56201171875], 'label': 'idiopathic thrombocytopenic purpura (ITP)'}\n",
            "{'page': 4, 'name': 'CB157', 'type': 2, 'rect': [51.7942008972168, 403.08099365234375, 62.96879959106445, 413.2019958496094], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB160', 'type': 2, 'rect': [22.673099517822266, 435.7309875488281, 32.975101470947266, 446.2879943847656], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB161', 'type': 2, 'rect': [52.66699981689453, 435.70098876953125, 62.96879959106445, 446.25799560546875], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB162', 'type': 2, 'rect': [22.673099517822266, 458.125, 32.975101470947266, 468.6820068359375], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB163', 'type': 2, 'rect': [52.666900634765625, 458.1050109863281, 62.96879959106445, 468.6619873046875], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB164', 'type': 2, 'rect': [22.673099517822266, 490.4849853515625, 32.975101470947266, 501.0419921875], 'label': 'Relapsing-remitting MS (RRMS)'}\n",
            "{'page': 4, 'name': 'CB165', 'type': 2, 'rect': [155.08900451660156, 490.4849853515625, 165.39100646972656, 501.0419921875], 'label': 'Secondary-progressive MS (SPMS)'}\n",
            "{'page': 4, 'name': 'CB166', 'type': 2, 'rect': [299.5010070800781, 490.65899658203125, 309.8030090332031, 501.21600341796875], 'label': 'Primary-progressive MS (PPMS)'}\n",
            "{'page': 4, 'name': 'CB167', 'type': 2, 'rect': [433.9739990234375, 490.7030029296875, 444.2760009765625, 501.260009765625], 'label': 'Progressive-relapsing MS (PRMS)'}\n",
            "{'page': 4, 'name': 'CB168', 'type': 2, 'rect': [22.673099517822266, 501.45001220703125, 32.975101470947266, 512.0069580078125], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB169', 'type': 2, 'rect': [52.666900634765625, 501.47100830078125, 62.96879959106445, 512.0280151367188], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB170', 'type': 2, 'rect': [22.673099517822266, 523.8510131835938, 32.975101470947266, 534.407958984375], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB172', 'type': 2, 'rect': [80.48059844970703, 536.14697265625, 90.78199768066406, 546.7039794921875], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB173', 'type': 2, 'rect': [110.12899780273438, 536.136962890625, 120.43099975585938, 546.6939697265625], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB171', 'type': 2, 'rect': [52.666900634765625, 523.8510131835938, 62.96879959106445, 534.407958984375], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB174', 'type': 2, 'rect': [22.673099517822266, 558.5859985351562, 32.975101470947266, 569.1430053710938], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB175', 'type': 2, 'rect': [52.666900634765625, 558.5250244140625, 62.96879959106445, 569.08203125], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB176', 'type': 2, 'rect': [22.673099517822266, 569.6649780273438, 32.975101470947266, 580.2219848632812], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB177', 'type': 2, 'rect': [52.666900634765625, 569.614990234375, 62.96879959106445, 580.1719970703125], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB178', 'type': 2, 'rect': [22.673099517822266, 591.4509887695312, 32.975101470947266, 602.0079956054688], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB179', 'type': 2, 'rect': [52.666900634765625, 591.4199829101562, 62.96879959106445, 601.9769897460938], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB180', 'type': 2, 'rect': [22.673099517822266, 603.18701171875, 32.975101470947266, 613.7440185546875], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'T189', 'type': 7, 'rect': [135.4010009765625, 624.9459838867188, 373.4419860839844, 635.29296875], 'label': 'Medication:'}\n",
            "{'page': 4, 'name': 'T190', 'type': 7, 'rect': [403.30499267578125, 625.0750122070312, 423.9419860839844, 635.29296875], 'label': 'Date: (MM)'}\n",
            "{'page': 4, 'name': 'T191', 'type': 7, 'rect': [428.614013671875, 625.0750122070312, 449.25, 635.29296875], 'label': 'Date: (DD)'}\n",
            "{'page': 4, 'name': 'T192', 'type': 7, 'rect': [452.177001953125, 625.0750122070312, 474.48699951171875, 635.29296875], 'label': 'Date: (YYYY)'}\n",
            "{'page': 4, 'name': 'T193', 'type': 7, 'rect': [481.57000732421875, 625.0750122070312, 502.2070007324219, 635.29296875], 'label': 'Date: (MM)'}\n",
            "{'page': 4, 'name': 'T194', 'type': 7, 'rect': [507.2860107421875, 625.0750122070312, 527.9219970703125, 635.29296875], 'label': 'Date: (DD)'}\n",
            "{'page': 4, 'name': 'T195', 'type': 7, 'rect': [530.97802734375, 625.0750122070312, 554.6589965820312, 635.29296875], 'label': 'Date: (YYYY)'}\n",
            "{'page': 4, 'name': 'T196', 'type': 7, 'rect': [135.4010009765625, 636.1209716796875, 373.4419860839844, 646.4660034179688], 'label': 'Medication:'}\n",
            "{'page': 4, 'name': 'T197', 'type': 7, 'rect': [403.28399658203125, 636.2470092773438, 423.9219970703125, 646.4660034179688], 'label': 'Date: (MM)'}\n",
            "{'page': 4, 'name': 'T198', 'type': 7, 'rect': [428.593994140625, 636.2470092773438, 449.2309875488281, 646.4660034179688], 'label': 'Date: (DD)'}\n",
            "{'page': 4, 'name': 'T199', 'type': 7, 'rect': [452.1579895019531, 636.2479858398438, 474.46600341796875, 646.4660034179688], 'label': 'Date: (YYYY)'}\n",
            "{'page': 4, 'name': 'T200', 'type': 7, 'rect': [481.5509948730469, 636.2470092773438, 502.1860046386719, 646.4660034179688], 'label': 'Date: (MM)'}\n",
            "{'page': 4, 'name': 'T201', 'type': 7, 'rect': [507.2669982910156, 636.2470092773438, 527.9030151367188, 646.4660034179688], 'label': 'Date: (DD)'}\n",
            "{'page': 4, 'name': 'T202', 'type': 7, 'rect': [530.9580078125, 636.2470092773438, 554.6389770507812, 646.4660034179688], 'label': 'Date: (YYYY)'}\n",
            "{'page': 4, 'name': 'CB181', 'type': 2, 'rect': [52.666900634765625, 603.18701171875, 62.96879959106445, 613.7440185546875], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB203', 'type': 2, 'rect': [22.673099517822266, 659.490966796875, 32.975101470947266, 670.0479736328125], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB204', 'type': 2, 'rect': [52.012298583984375, 659.4710083007812, 62.31420135498047, 670.0269775390625], 'label': 'No'}\n",
            "{'page': 4, 'name': 'CB205', 'type': 2, 'rect': [85.74980163574219, 671.2470092773438, 96.05130004882812, 681.8040161132812], 'label': 'Yes'}\n",
            "{'page': 4, 'name': 'CB206', 'type': 2, 'rect': [115.375, 671.2260131835938, 125.677001953125, 681.7830200195312], 'label': 'No'}\n",
            "{'page': 5, 'name': 'T12', 'type': 7, 'rect': [20.796199798583984, 131.79498291015625, 164.39100646972656, 144.45697021484375], 'label': 'Patient First Name'}\n",
            "{'page': 5, 'name': 'T13', 'type': 7, 'rect': [169.26499938964844, 131.79498291015625, 348.5950012207031, 144.45697021484375], 'label': 'Patient Last Name'}\n",
            "{'page': 5, 'name': 'T19', 'type': 7, 'rect': [354.30499267578125, 131.79498291015625, 469.82598876953125, 144.45697021484375], 'label': 'Patient Phone'}\n",
            "{'page': 5, 'name': 'T14', 'type': 7, 'rect': [475.18701171875, 131.7960205078125, 592.4639892578125, 144.45697021484375], 'label': 'Patient DOB (MM/DD/YYYY)'}\n",
            "{'page': 5, 'name': 'CB207', 'type': 2, 'rect': [249.6199951171875, 167.4429931640625, 259.9209899902344, 178.0], 'label': 'Mild'}\n",
            "{'page': 5, 'name': 'CB208', 'type': 2, 'rect': [282.375, 167.4429931640625, 292.6759948730469, 178.0], 'label': 'Moderate'}\n",
            "{'page': 5, 'name': 'CB209', 'type': 2, 'rect': [334.2569885253906, 167.4429931640625, 344.5580139160156, 178.0], 'label': 'Severe'}\n",
            "{'page': 5, 'name': 'CB210', 'type': 2, 'rect': [22.707700729370117, 177.44500732421875, 33.00960159301758, 188.00201416015625], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB211', 'type': 2, 'rect': [52.012298583984375, 177.4429931640625, 62.3140983581543, 188.0], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB212', 'type': 2, 'rect': [22.707700729370117, 188.08599853515625, 33.00960159301758, 198.64300537109375], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB213', 'type': 2, 'rect': [52.012298583984375, 188.05401611328125, 62.3140983581543, 198.61102294921875], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB214', 'type': 2, 'rect': [86.60260009765625, 198.60699462890625, 96.90440368652344, 209.16400146484375], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB216', 'type': 2, 'rect': [191.60000610351562, 209.0369873046875, 201.90199279785156, 219.593994140625], 'label': 'ineffective'}\n",
            "{'page': 5, 'name': 'CB217', 'type': 2, 'rect': [246.1739959716797, 209.0369873046875, 256.4750061035156, 219.593994140625], 'label': 'not tolerated'}\n",
            "{'page': 5, 'name': 'CB218', 'type': 2, 'rect': [308.3710021972656, 209.0369873046875, 318.6719970703125, 219.593994140625], 'label': 'contraindicated'}\n",
            "{'page': 5, 'name': 'CB215', 'type': 2, 'rect': [116.39199829101562, 198.60699462890625, 126.69400024414062, 209.16400146484375], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB223', 'type': 2, 'rect': [86.60260009765625, 221.36798095703125, 96.90440368652344, 231.92498779296875], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB225', 'type': 2, 'rect': [191.07400512695312, 231.44598388671875, 201.37600708007812, 242.00299072265625], 'label': 'azathioprine'}\n",
            "{'page': 5, 'name': 'CB226', 'type': 2, 'rect': [251.9080047607422, 231.44598388671875, 262.2090148925781, 242.00299072265625], 'label': 'cyclosporine'}\n",
            "{'page': 5, 'name': 'CB227', 'type': 2, 'rect': [313.947998046875, 231.44598388671875, 324.2489929199219, 242.00299072265625], 'label': 'hydroxychloroquine'}\n",
            "{'page': 5, 'name': 'CB228', 'type': 2, 'rect': [399.94500732421875, 231.44598388671875, 410.2460021972656, 242.00299072265625], 'label': 'leflunomide'}\n",
            "{'page': 5, 'name': 'CB229', 'type': 2, 'rect': [458.1929931640625, 231.44598388671875, 468.4939880371094, 242.00299072265625], 'label': 'sulfasalazine'}\n",
            "{'page': 5, 'name': 'CB224', 'type': 2, 'rect': [116.39199829101562, 221.36798095703125, 126.69400024414062, 231.92498779296875], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB281', 'type': 2, 'rect': [22.707700729370117, 253.572021484375, 33.009498596191406, 264.1290283203125], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB282', 'type': 2, 'rect': [52.012298583984375, 253.58099365234375, 62.3140983581543, 264.13800048828125], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB283', 'type': 2, 'rect': [22.707700729370117, 265.31402587890625, 33.009498596191406, 275.8709716796875], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'T285', 'type': 7, 'rect': [136.13800048828125, 285.8590087890625, 374.1789855957031, 296.2049865722656], 'label': 'Medication:'}\n",
            "{'page': 5, 'name': 'T286', 'type': 7, 'rect': [404.0140075683594, 285.9859924316406, 424.6510009765625, 296.3320007324219], 'label': 'Date: (MM)'}\n",
            "{'page': 5, 'name': 'T287', 'type': 7, 'rect': [428.8139953613281, 285.9859924316406, 449.45098876953125, 296.3320007324219], 'label': 'Date: (DD)'}\n",
            "{'page': 5, 'name': 'T288', 'type': 7, 'rect': [453.23199462890625, 285.9859924316406, 476.1180114746094, 296.3320007324219], 'label': 'Date: (YYYY)'}\n",
            "{'page': 5, 'name': 'T289', 'type': 7, 'rect': [482.5660095214844, 285.9859924316406, 504.2019958496094, 296.3320007324219], 'label': 'Date: (MM)'}\n",
            "{'page': 5, 'name': 'T290', 'type': 7, 'rect': [506.7909851074219, 285.9859924316406, 528.427001953125, 296.3320007324219], 'label': 'Date: (DD)'}\n",
            "{'page': 5, 'name': 'T291', 'type': 7, 'rect': [531.7750244140625, 285.9859924316406, 553.8289794921875, 296.3320007324219], 'label': 'Date: (YYYY)'}\n",
            "{'page': 5, 'name': 'T292', 'type': 7, 'rect': [136.08299255371094, 296.54400634765625, 374.1239929199219, 306.8900146484375], 'label': 'Medication:'}\n",
            "{'page': 5, 'name': 'T293', 'type': 7, 'rect': [404.32000732421875, 296.7300109863281, 424.99200439453125, 307.07598876953125], 'label': 'Date: (MM)'}\n",
            "{'page': 5, 'name': 'T294', 'type': 7, 'rect': [428.8139953613281, 296.7300109863281, 449.4849853515625, 307.07598876953125], 'label': 'Date: (DD)'}\n",
            "{'page': 5, 'name': 'T295', 'type': 7, 'rect': [453.0889892578125, 296.6719970703125, 475.9750061035156, 307.01800537109375], 'label': 'Date: (YYYY)'}\n",
            "{'page': 5, 'name': 'T296', 'type': 7, 'rect': [482.197998046875, 296.6719970703125, 503.8340148925781, 307.01800537109375], 'label': 'Date: (MM)'}\n",
            "{'page': 5, 'name': 'T297', 'type': 7, 'rect': [506.75, 296.6719970703125, 528.385986328125, 307.01800537109375], 'label': 'Date: (DD)'}\n",
            "{'page': 5, 'name': 'T298', 'type': 7, 'rect': [531.7750244140625, 296.6719970703125, 553.8289794921875, 307.01800537109375], 'label': 'Date: (YYYY)'}\n",
            "{'page': 5, 'name': 'CB284', 'type': 2, 'rect': [52.012298583984375, 265.322021484375, 62.3140983581543, 275.8790283203125], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB299', 'type': 2, 'rect': [22.707700729370117, 320.2669982910156, 33.009498596191406, 330.8240051269531], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB300', 'type': 2, 'rect': [52.012298583984375, 320.2760009765625, 62.31420135498047, 330.8330078125], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB301', 'type': 2, 'rect': [22.707700729370117, 342.3320007324219, 33.0093994140625, 352.8890075683594], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB302', 'type': 2, 'rect': [52.012298583984375, 342.3489990234375, 62.31420135498047, 352.906005859375], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB303', 'type': 2, 'rect': [22.707700729370117, 365.67498779296875, 33.00960159301758, 376.23199462890625], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB304', 'type': 2, 'rect': [52.012298583984375, 365.6730041503906, 62.31399917602539, 376.2300109863281], 'label': 'No'}\n",
            "{'page': 5, 'name': 'T305', 'type': 7, 'rect': [225.25999450683594, 374.875, 512.3599853515625, 386.5299987792969], 'label': 'Please indicate the length of time on Rituxan (rituximab):'}\n",
            "{'page': 5, 'name': 'CB310', 'type': 2, 'rect': [353.3630065917969, 398.0530090332031, 363.66400146484375, 408.6099853515625], 'label': 'Mild'}\n",
            "{'page': 5, 'name': 'CB311', 'type': 2, 'rect': [386.1109924316406, 398.02301025390625, 396.4119873046875, 408.5799865722656], 'label': 'Moderate'}\n",
            "{'page': 5, 'name': 'CB312', 'type': 2, 'rect': [437.9490051269531, 398.02301025390625, 448.25, 408.5799865722656], 'label': 'Severe'}\n",
            "{'page': 5, 'name': 'CB306', 'type': 2, 'rect': [22.707700729370117, 408.30999755859375, 33.00960159301758, 418.86700439453125], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB307', 'type': 2, 'rect': [52.012298583984375, 408.2569885253906, 62.31420135498047, 418.8139953613281], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB308', 'type': 2, 'rect': [22.707700729370117, 419.2879943847656, 33.0093994140625, 429.8450012207031], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB309', 'type': 2, 'rect': [52.012298583984375, 419.2860107421875, 62.31399917602539, 429.8429870605469], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB313', 'type': 2, 'rect': [22.707700729370117, 441.96099853515625, 33.0093994140625, 452.51800537109375], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB314', 'type': 2, 'rect': [52.012298583984375, 441.9620056152344, 62.31420135498047, 452.5190124511719], 'label': 'No'}\n",
            "{'page': 5, 'name': 'CB315', 'type': 2, 'rect': [22.707700729370117, 453.41900634765625, 33.00960159301758, 463.97601318359375], 'label': 'Yes'}\n",
            "{'page': 5, 'name': 'CB316', 'type': 2, 'rect': [52.012298583984375, 453.43798828125, 62.31399917602539, 463.9949951171875], 'label': 'No'}\n",
            "{'page': 5, 'name': 'T317', 'type': 7, 'rect': [508.2340087890625, 484.19500732421875, 531.7239990234375, 496.53900146484375], 'label': 'Date: (MM)'}\n",
            "{'page': 5, 'name': 'T318', 'type': 7, 'rect': [536.8720092773438, 484.19500732421875, 556.3619995117188, 496.53900146484375], 'label': 'Date: (DD)'}\n",
            "{'page': 5, 'name': 'T319', 'type': 7, 'rect': [561.8579711914062, 484.19500732421875, 584.239013671875, 496.53900146484375], 'label': 'Date: (YYYY)'}\n",
            "[{'page': 2, 'name': 'CB1', 'type': 2, 'rect': [82.92900085449219, 110.4580078125, 93.23079681396484, 121.0150146484375], 'label': 'Start of treatment'}, {'page': 2, 'name': 'T2', 'type': 7, 'rect': [210.19700622558594, 109.281982421875, 231.8699951171875, 120.96099853515625], 'label': 'Start date: (MM)'}, {'page': 2, 'name': 'T3', 'type': 7, 'rect': [236.83399963378906, 109.281982421875, 258.5069885253906, 120.96099853515625], 'label': 'Start date: (DD)'}, {'page': 2, 'name': 'T4', 'type': 7, 'rect': [262.1719970703125, 109.281982421875, 285.8070068359375, 120.96099853515625], 'label': 'Start date: (YYYY)'}, {'page': 2, 'name': 'CB5', 'type': 2, 'rect': [306.0480041503906, 110.03802490234375, 316.3500061035156, 120.594970703125], 'label': 'Continuation of therapy'}, {'page': 2, 'name': 'T6', 'type': 7, 'rect': [502.3739929199219, 109.2760009765625, 524.0469970703125, 120.95501708984375], 'label': 'Date of last treatment: (MM)'}, {'page': 2, 'name': 'T7', 'type': 7, 'rect': [529.010986328125, 109.2760009765625, 550.6840209960938, 120.95501708984375], 'label': 'Date of last treatment: (DD)'}, {'page': 2, 'name': 'T8', 'type': 7, 'rect': [554.9990234375, 109.2760009765625, 578.135986328125, 120.95501708984375], 'label': 'Date of last treatment: (YYYY)'}, {'page': 2, 'name': 'T9', 'type': 7, 'rect': [143.625, 122.6729736328125, 350.625, 134.35198974609375], 'label': 'Precertification Requested By:'}, {'page': 2, 'name': 'T10', 'type': 7, 'rect': [386.3070068359375, 123.7030029296875, 480.1470031738281, 135.38201904296875], 'label': 'Phone:'}, {'page': 2, 'name': 'T11', 'type': 7, 'rect': [501.19500732421875, 123.69598388671875, 593.594970703125, 135.375], 'label': 'Fax:'}, {'page': 2, 'name': 'T12', 'type': 7, 'rect': [62.843101501464844, 150.93402099609375, 230.375, 162.61297607421875], 'label': 'Patient First Name'}, {'page': 2, 'name': 'T13', 'type': 7, 'rect': [277.2619934082031, 150.93402099609375, 501.9209899902344, 162.61297607421875], 'label': 'Patient Last Name'}, {'page': 2, 'name': 'T14', 'type': 7, 'rect': [526.2670288085938, 150.93402099609375, 592.1160278320312, 162.61297607421875], 'label': 'Patient DOB (MM/DD/YYYY)'}, {'page': 2, 'name': 'T15', 'type': 7, 'rect': [52.88520050048828, 164.8270263671875, 327.07598876953125, 176.5059814453125], 'label': 'Address:'}, {'page': 2, 'name': 'T16', 'type': 7, 'rect': [347.5299987792969, 164.8270263671875, 443.9800109863281, 176.5059814453125], 'label': 'City:'}, {'page': 2, 'name': 'T17', 'type': 7, 'rect': [469.6700134277344, 164.8270263671875, 501.9209899902344, 176.5059814453125], 'label': 'State:'}, {'page': 2, 'name': 'T18', 'type': 7, 'rect': [521.6199951171875, 164.8270263671875, 592.1160278320312, 176.5059814453125], 'label': 'ZIP:'}, {'page': 2, 'name': 'T19', 'type': 7, 'rect': [69.14689636230469, 179.32098388671875, 151.4929962158203, 191.0], 'label': 'Patient Phone'}, {'page': 2, 'name': 'T20', 'type': 7, 'rect': [201.93499755859375, 179.32098388671875, 286.2969970703125, 191.0], 'label': 'Work Phone:'}, {'page': 2, 'name': 'T21', 'type': 7, 'rect': [332.29400634765625, 179.44097900390625, 421.7250061035156, 191.1199951171875], 'label': 'Cell Phone:'}, {'page': 2, 'name': 'T22', 'type': 7, 'rect': [450.6510009765625, 179.44097900390625, 592.1160278320312, 191.1199951171875], 'label': 'E-mail:'}, {'page': 2, 'name': 'T24', 'type': 7, 'rect': [78.66909790039062, 194.8740234375, 100.60900115966797, 206.552978515625], 'label': 'lbs'}, {'page': 2, 'name': 'T25', 'type': 7, 'rect': [128.6300048828125, 194.989990234375, 151.65899658203125, 206.66900634765625], 'label': 'kgs'}, {'page': 2, 'name': 'T26', 'type': 7, 'rect': [216.36099243164062, 194.93597412109375, 239.2469940185547, 206.614990234375], 'label': 'inches'}, {'page': 2, 'name': 'T27', 'type': 7, 'rect': [280.114990234375, 194.85400390625, 303.5719909667969, 206.53302001953125], 'label': 'cms'}, {'page': 2, 'name': 'T23', 'type': 7, 'rect': [363.9159851074219, 195.40802001953125, 592.1160278320312, 207.08697509765625], 'label': 'Allergies:'}, {'page': 2, 'name': 'T28', 'type': 7, 'rect': [72.4458999633789, 222.19500732421875, 229.36099243164062, 232.90301513671875], 'label': 'Member ID #:'}, {'page': 2, 'name': 'T29', 'type': 7, 'rect': [55.536800384521484, 233.70098876953125, 229.41600036621094, 244.40899658203125], 'label': 'Group #:'}, {'page': 2, 'name': 'T30', 'type': 7, 'rect': [53.76750183105469, 244.69598388671875, 229.44700622558594, 254.6669921875], 'label': 'Insured:'}, {'page': 2, 'name': 'CB31', 'type': 2, 'rect': [386.09100341796875, 222.927978515625, 396.39300537109375, 233.4840087890625], 'label': 'Yes'}, {'page': 2, 'name': 'CB32', 'type': 2, 'rect': [415.6910095214844, 222.906982421875, 425.99200439453125, 233.4630126953125], 'label': 'No'}, {'page': 2, 'name': 'T33', 'type': 7, 'rect': [304.1390075683594, 233.13201904296875, 386.218994140625, 244.40899658203125], 'label': 'If yes, provide ID#:'}, {'page': 2, 'name': 'T34', 'type': 7, 'rect': [440.7279968261719, 233.13201904296875, 588.68798828125, 244.40899658203125], 'label': 'Carrier Name:'}, {'page': 2, 'name': 'T35', 'type': 7, 'rect': [266.8479919433594, 245.7550048828125, 588.68798828125, 256.031982421875], 'label': 'Insured:'}, {'page': 2, 'name': 'T42', 'type': 7, 'rect': [61.66939926147461, 272.82098388671875, 231.23199462890625, 283.5010070800781], 'label': 'First Name:'}, {'page': 2, 'name': 'T43', 'type': 7, 'rect': [277.4209899902344, 272.81097412109375, 395.2850036621094, 283.4909973144531], 'label': 'Last Name:'}, {'page': 2, 'name': 'CB44', 'type': 2, 'rect': [453.2449951171875, 271.9940185546875, 463.5469970703125, 282.5509948730469], 'label': 'M.D.'}, {'page': 2, 'name': 'CB45', 'type': 2, 'rect': [490.072998046875, 271.98297119140625, 500.375, 282.5400085449219], 'label': 'D.O.'}, {'page': 2, 'name': 'CB46', 'type': 2, 'rect': [526.3419799804688, 272.0040283203125, 536.6439819335938, 282.5610046386719], 'label': 'N.P.'}, {'page': 2, 'name': 'CB47', 'type': 2, 'rect': [561.6890258789062, 271.98297119140625, 571.9910278320312, 282.5400085449219], 'label': 'P.A.'}, {'page': 2, 'name': 'T48', 'type': 7, 'rect': [52.40890121459961, 287.9179992675781, 326.39801025390625, 298.5979919433594], 'label': 'Address:'}, {'page': 2, 'name': 'T49', 'type': 7, 'rect': [347.1679992675781, 287.9179992675781, 443.7019958496094, 298.5979919433594], 'label': 'City:'}, {'page': 2, 'name': 'T50', 'type': 7, 'rect': [470.031005859375, 287.8869934082031, 502.8450012207031, 298.5669860839844], 'label': 'State:'}, {'page': 2, 'name': 'T51', 'type': 7, 'rect': [521.7979736328125, 287.8869934082031, 592.8610229492188, 298.5669860839844], 'label': 'ZIP:'}, {'page': 2, 'name': 'T52', 'type': 7, 'rect': [45.78519821166992, 302.1709899902344, 113.06099700927734, 312.85101318359375], 'label': 'Phone:'}, {'page': 2, 'name': 'T53', 'type': 7, 'rect': [132.92300415039062, 302.1709899902344, 209.58200073242188, 312.85101318359375], 'label': 'Fax:'}, {'page': 2, 'name': 'T54', 'type': 7, 'rect': [243.28700256347656, 302.1709899902344, 326.14599609375, 312.85101318359375], 'label': 'St Lic #:'}, {'page': 2, 'name': 'T55', 'type': 7, 'rect': [353.95098876953125, 302.1709899902344, 417.0400085449219, 312.85101318359375], 'label': 'NPI #:'}, {'page': 2, 'name': 'T56', 'type': 7, 'rect': [446.7349853515625, 302.1709899902344, 502.8450012207031, 312.85101318359375], 'label': 'DEA #:'}, {'page': 2, 'name': 'T57', 'type': 7, 'rect': [527.7540283203125, 302.1499938964844, 592.8610229492188, 312.8299865722656], 'label': 'UPIN:'}, {'page': 2, 'name': 'T58.0', 'type': 7, 'rect': [74.67269897460938, 317.27301025390625, 209.50900268554688, 327.9530029296875], 'label': 'Provider Email:'}, {'page': 2, 'name': 'T58.1', 'type': 7, 'rect': [290.1669921875, 317.27301025390625, 417.0400085449219, 327.9530029296875], 'label': 'Office Contact Name:'}, {'page': 2, 'name': 'T59', 'type': 7, 'rect': [446.9049987792969, 317.27301025390625, 592.8610229492188, 327.9530029296875], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin CB.1', 'type': 2, 'rect': [22.34000015258789, 352.0459899902344, 32.375999450683594, 362.5190124511719], 'label': 'Self-administered'}, {'page': 2, 'name': 'Provider Admin CB.2', 'type': 2, 'rect': [107.87300109863281, 352.0790100097656, 117.90899658203125, 362.552001953125], 'label': 'Physician’s Office'}, {'page': 2, 'name': 'Provider Admin CB.3', 'type': 2, 'rect': [194.05499267578125, 352.0790100097656, 204.09100341796875, 362.552001953125], 'label': 'Home'}, {'page': 2, 'name': 'Provider Admin CB.4', 'type': 2, 'rect': [22.34000015258789, 362.49700927734375, 32.375999450683594, 372.9700012207031], 'label': 'Outpatient Infusion Center'}, {'page': 2, 'name': 'Provider Admin T.5', 'type': 7, 'rect': [157.18699645996094, 362.43499755859375, 320.2829895019531, 373.0169982910156], 'label': 'Name:'}, {'page': 2, 'name': 'Provider Admin CB.7', 'type': 2, 'rect': [22.34000015258789, 372.5169982910156, 32.375999450683594, 382.989990234375], 'label': 'Home Infusion Center'}, {'page': 2, 'name': 'Provider Admin T.6', 'type': 7, 'rect': [165.0959930419922, 373.2980041503906, 320.2829895019531, 383.8800048828125], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin T.8', 'type': 7, 'rect': [111.47799682617188, 383.5799865722656, 320.2829895019531, 394.1619873046875], 'label': 'Agency Name:'}, {'page': 2, 'name': 'Provider Admin CB.10', 'type': 2, 'rect': [22.34000015258789, 393.0249938964844, 32.375999450683594, 403.49798583984375], 'label': 'Administration code(s)'}, {'page': 2, 'name': 'Provider Admin T.9', 'type': 7, 'rect': [143.82699584960938, 393.6579895019531, 320.2829895019531, 404.239990234375], 'label': 'CPT:'}, {'page': 2, 'name': 'Provider Admin T.11A', 'type': 7, 'rect': [56.31019973754883, 403.95599365234375, 320.2829895019531, 414.5379943847656], 'label': 'Address:'}, {'page': 2, 'name': 'Provider Admin T.13', 'type': 7, 'rect': [40.63639831542969, 415.3280029296875, 167.3459930419922, 425.9100036621094], 'label': 'City:'}, {'page': 2, 'name': 'Provider Admin T.14', 'type': 7, 'rect': [193.09100341796875, 415.3280029296875, 229.23599243164062, 425.9100036621094], 'label': 'State:'}, {'page': 2, 'name': 'Provider Admin T.15', 'type': 7, 'rect': [246.7010040283203, 415.7640075683594, 320.2829895019531, 426.34600830078125], 'label': 'ZIP:'}, {'page': 2, 'name': 'Provider Admin T.16', 'type': 7, 'rect': [49.74549865722656, 425.79998779296875, 167.3459930419922, 436.3819885253906], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin T.17A', 'type': 7, 'rect': [189.15499877929688, 425.79998779296875, 320.2829895019531, 436.3819885253906], 'label': 'Fax:'}, {'page': 2, 'name': 'Provider Admin T.18', 'type': 7, 'rect': [39.92729949951172, 437.27301025390625, 167.3459930419922, 447.8550109863281], 'label': 'TIN:'}, {'page': 2, 'name': 'Provider Admin T.19', 'type': 7, 'rect': [189.15499877929688, 437.27301025390625, 320.2829895019531, 447.8550109863281], 'label': 'PIN:'}, {'page': 2, 'name': 'Provider Admin T.20', 'type': 7, 'rect': [39.86439895629883, 448.2250061035156, 320.2829895019531, 458.8070068359375], 'label': 'NPI:'}, {'page': 2, 'name': 'Provider Admin CB.21', 'type': 2, 'rect': [331.30499267578125, 352.072998046875, 341.34100341796875, 362.5459899902344], 'label': 'Outpatient Dialysis Center'}, {'page': 2, 'name': 'Provider Admin CB.22', 'type': 2, 'rect': [448.74798583984375, 352.0220031738281, 458.78399658203125, 362.4949951171875], 'label': 'Physician’s Office'}, {'page': 2, 'name': 'Provider Admin CB.23.0.0', 'type': 2, 'rect': [331.2909851074219, 363.12799072265625, 341.3269958496094, 373.60101318359375], 'label': 'Retail Pharmacy'}, {'page': 2, 'name': 'Provider Admin CB.24.0.0', 'type': 2, 'rect': [448.6730041503906, 363.12799072265625, 458.7090148925781, 373.60101318359375], 'label': 'Specialty Pharmacy'}, {'page': 2, 'name': 'Provider Admin CB.25', 'type': 2, 'rect': [331.2909851074219, 374.8550109863281, 341.3269958496094, 385.3280029296875], 'label': 'Mail Order'}, {'page': 2, 'name': 'Provider Admin CB.26', 'type': 2, 'rect': [448.6730041503906, 374.8550109863281, 458.7090148925781, 385.3280029296875], 'label': 'Other:'}, {'page': 2, 'name': 'Provider Admin T.27', 'type': 7, 'rect': [484.71099853515625, 374.8219909667969, 591.8259887695312, 385.8489990234375], 'label': 'Other:'}, {'page': 2, 'name': 'Provider Admin T.28', 'type': 7, 'rect': [356.0669860839844, 386.92401123046875, 591.8259887695312, 398.0429992675781], 'label': 'Name:'}, {'page': 2, 'name': 'Provider Admin T.29a', 'type': 7, 'rect': [363.8489990234375, 399.135009765625, 591.8259887695312, 410.2539978027344], 'label': 'Address:'}, {'page': 2, 'name': 'Provider Admin T.30a', 'type': 7, 'rect': [349.0429992675781, 411.1409912109375, 448.72601318359375, 422.1679992675781], 'label': 'City:'}, {'page': 2, 'name': 'Provider Admin T.31', 'type': 7, 'rect': [476.072998046875, 411.2590026855469, 513.3820190429688, 422.1679992675781], 'label': 'State:'}, {'page': 2, 'name': 'Provider Admin T.32', 'type': 7, 'rect': [533.135009765625, 411.2590026855469, 591.8259887695312, 422.1679992675781], 'label': 'ZIP:'}, {'page': 2, 'name': 'Provider Admin T.33', 'type': 7, 'rect': [359.12799072265625, 423.7099914550781, 466.9100036621094, 434.6189880371094], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin T.34', 'type': 7, 'rect': [488.0799865722656, 423.7099914550781, 591.8259887695312, 434.6189880371094], 'label': 'Fax:'}, {'page': 2, 'name': 'Provider Admin T.35', 'type': 7, 'rect': [349.09100341796875, 436.05499267578125, 466.9100036621094, 446.9639892578125], 'label': 'TIN:'}, {'page': 2, 'name': 'Provider Admin T.36', 'type': 7, 'rect': [488.08099365234375, 436.05499267578125, 591.8259887695312, 446.9639892578125], 'label': 'PIN:'}, {'page': 2, 'name': 'Provider Admin T.37', 'type': 7, 'rect': [349.0989990234375, 447.89801025390625, 591.8259887695312, 458.8070068359375], 'label': 'NPI:'}, {'page': 2, 'name': 'CB60', 'type': 2, 'rect': [82.12529754638672, 475.0929870605469, 92.31230163574219, 485.68701171875], 'label': 'Riabni (rituximab-arrx)'}, {'page': 2, 'name': 'CB61', 'type': 2, 'rect': [188.06199645996094, 475.0929870605469, 198.24899291992188, 485.68701171875], 'label': 'Rituxan (rituximab)'}, {'page': 2, 'name': 'CB62', 'type': 2, 'rect': [281.27899169921875, 475.177001953125, 291.46600341796875, 485.77099609375], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB63', 'type': 2, 'rect': [398.927001953125, 475.177001953125, 409.114013671875, 485.77099609375], 'label': 'Truxima (rituximab-abbs)'}, {'page': 2, 'name': 'T64', 'type': 7, 'rect': [45.61000061035156, 487.57000732421875, 225.343994140625, 498.47900390625], 'label': 'Dose:'}, {'page': 2, 'name': 'T65', 'type': 7, 'rect': [308.4649963378906, 487.57000732421875, 459.3169860839844, 498.47900390625], 'label': 'Directions for Use:'}, {'page': 2, 'name': 'T66', 'type': 7, 'rect': [524.906005859375, 487.57000732421875, 589.9249877929688, 498.47900390625], 'label': 'HCPCS Code:'}, {'page': 2, 'name': 'T67', 'type': 7, 'rect': [97.97879791259766, 518.5599975585938, 270.3380126953125, 529.259033203125], 'label': 'Primary ICD Code:'}, {'page': 2, 'name': 'CB68', 'type': 2, 'rect': [292.47198486328125, 518.5599975585938, 302.77398681640625, 529.259033203125], 'label': 'Other ICD Code:'}, {'page': 2, 'name': 'T69', 'type': 7, 'rect': [370.33099365234375, 518.5599975585938, 589.5579833984375, 529.259033203125], 'label': 'Other ICD Code:'}, {'page': 2, 'name': 'CB70', 'type': 2, 'rect': [22.825700759887695, 584.4249877929688, 33.12770080566406, 594.9819946289062], 'label': 'Yes'}, {'page': 2, 'name': 'CB71', 'type': 2, 'rect': [52.699501037597656, 584.6510009765625, 62.623199462890625, 594.9819946289062], 'label': 'No'}, {'page': 2, 'name': 'CB72', 'type': 2, 'rect': [52.699501037597656, 596.738037109375, 62.623199462890625, 607.0689697265625], 'label': 'No'}, {'page': 2, 'name': 'CB73', 'type': 2, 'rect': [81.47090148925781, 606.9550170898438, 91.65750122070312, 617.5490112304688], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB74', 'type': 2, 'rect': [190.92300415039062, 606.9550170898438, 201.11000061035156, 617.5490112304688], 'label': 'Truxima (rituximab-abbs)'}, {'page': 2, 'name': 'T75', 'type': 7, 'rect': [315.31298828125, 617.7750244140625, 585.489013671875, 628.6840209960938], 'label': 'When was the member’s trial and failure of the preferred drug?'}, {'page': 2, 'name': 'T76', 'type': 7, 'rect': [315.31298828125, 630.634033203125, 585.489013671875, 641.54296875], 'label': 'Please describe the nature of the failure of the preferred drug'}, {'page': 2, 'name': 'CB77', 'type': 2, 'rect': [52.699501037597656, 642.22998046875, 63.001399993896484, 652.7869873046875], 'label': 'No'}, {'page': 2, 'name': 'CB78', 'type': 2, 'rect': [81.47090148925781, 653.0399780273438, 91.65750122070312, 663.634033203125], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB79', 'type': 2, 'rect': [190.92300415039062, 653.0399780273438, 201.11000061035156, 663.634033203125], 'label': 'Truxima (rituximab-abbs)'}, {'page': 2, 'name': 'T80', 'type': 7, 'rect': [315.31298828125, 664.2340087890625, 585.489013671875, 675.1430053710938], 'label': 'When was the member’s adverse reaction to the preferred drug?'}, {'page': 2, 'name': 'T81', 'type': 7, 'rect': [342.1499938964844, 676.0919799804688, 585.489013671875, 687.0009765625], 'label': 'Please describe the nature of the adverse reaction to the preferred drug'}, {'page': 2, 'name': 'T84', 'type': 7, 'rect': [22.731800079345703, 720.555908203125, 585.489013671875, 731.4649047851562], 'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?'}, {'page': 2, 'name': 'CB82', 'type': 2, 'rect': [22.825700759887695, 708.5637817382812, 33.12770080566406, 719.1207885742188], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB83', 'type': 2, 'rect': [131.9810028076172, 708.4747924804688, 141.90499877929688, 718.8057861328125], 'label': 'Truxima (rituximab-abbs)'}, {'page': 3, 'name': 'T12', 'type': 7, 'rect': [19.95840072631836, 128.02301025390625, 164.60400390625, 140.68499755859375], 'label': 'Patient First Name'}, {'page': 3, 'name': 'T13', 'type': 7, 'rect': [168.7469940185547, 128.02301025390625, 348.12200927734375, 140.68499755859375], 'label': 'Patient Last Name'}, {'page': 3, 'name': 'T19', 'type': 7, 'rect': [353.4530029296875, 128.02301025390625, 465.8210144042969, 140.68499755859375], 'label': 'Patient Phone'}, {'page': 3, 'name': 'T14', 'type': 7, 'rect': [470.8710021972656, 128.02301025390625, 591.301025390625, 140.68499755859375], 'label': 'Patient DOB (MM/DD/YYYY)'}, {'page': 3, 'name': 'CB86', 'type': 2, 'rect': [81.38929748535156, 178.2750244140625, 91.69129943847656, 188.83197021484375], 'label': 'Inflectra (infliximab-dyyb)'}, {'page': 3, 'name': 'CB87', 'type': 2, 'rect': [188.22500610351562, 178.3590087890625, 198.26100158691406, 188.83197021484375], 'label': 'Renflexis (infliximab-abda)'}, {'page': 3, 'name': 'CB88', 'type': 2, 'rect': [300.7449951171875, 178.3590087890625, 310.781005859375, 188.83197021484375], 'label': 'Simponi Aria (golimumab)'}, {'page': 3, 'name': 'T89', 'type': 7, 'rect': [314.85101318359375, 189.10797119140625, 582.4080200195312, 199.8070068359375], 'label': 'When was the member’s trial and failure of the preferred drug?'}, {'page': 3, 'name': 'T90', 'type': 7, 'rect': [314.85101318359375, 201.96600341796875, 582.4080200195312, 212.66497802734375], 'label': 'Please describe the nature of the failure of the preferred drug'}, {'page': 3, 'name': 'CB85', 'type': 2, 'rect': [52.34349822998047, 168.1290283203125, 62.64540100097656, 178.68597412109375], 'label': 'No'}, {'page': 3, 'name': 'CB92', 'type': 2, 'rect': [81.38929748535156, 223.86602783203125, 91.69129943847656, 234.4229736328125], 'label': 'Inflectra (infliximab-dyyb)'}, {'page': 3, 'name': 'CB93', 'type': 2, 'rect': [188.552001953125, 223.95001220703125, 198.58799743652344, 234.4229736328125], 'label': 'Renflexis (infliximab-abda)'}, {'page': 3, 'name': 'CB94', 'type': 2, 'rect': [301.4179992675781, 223.95001220703125, 311.4540100097656, 234.4229736328125], 'label': 'Simponi Aria (golimumab)'}, {'page': 3, 'name': 'T95', 'type': 7, 'rect': [314.85101318359375, 235.56597900390625, 582.4080200195312, 246.2650146484375], 'label': 'When was the member’s adverse reaction to the preferred drug?'}, {'page': 3, 'name': 'T96a', 'type': 7, 'rect': [342.0140075683594, 247.42401123046875, 582.4080200195312, 258.12298583984375], 'label': 'Please describe the nature of the adverse reaction to the preferred drug'}, {'page': 3, 'name': 'CB91', 'type': 2, 'rect': [52.34349822998047, 214.0479736328125, 62.64540100097656, 224.60498046875], 'label': 'No'}, {'page': 3, 'name': 'CB98a', 'type': 2, 'rect': [81.38929748535156, 269.666015625, 91.69129943847656, 280.2229919433594], 'label': 'Enbrel (etanercept)'}, {'page': 3, 'name': 'CB99a', 'type': 2, 'rect': [168.93499755859375, 269.75, 178.9709930419922, 280.2229919433594], 'label': 'Humira (adalimumab)'}, {'page': 3, 'name': 'CB100a', 'type': 2, 'rect': [263.5639953613281, 269.75, 273.6000061035156, 280.2229919433594], 'label': 'Idacio (adalimumab-aacf)'}, {'page': 3, 'name': 'CB101a', 'type': 2, 'rect': [371.9209899902344, 269.75, 381.9570007324219, 280.2229919433594], 'label': 'Rinvoq (upadacitinib)'}, {'page': 3, 'name': 'CB102a', 'type': 2, 'rect': [465.09600830078125, 269.75, 475.1319885253906, 280.2229919433594], 'label': 'Tyenne SC (tocilizumab-aazg)'}, {'page': 3, 'name': 'CB103a', 'type': 2, 'rect': [81.38929748535156, 280.92999267578125, 91.69129943847656, 291.48699951171875], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)'}, {'page': 3, 'name': 'T104', 'type': 7, 'rect': [314.85101318359375, 294.3110046386719, 582.4080200195312, 305.010009765625], 'label': 'When was the member’s trial and failure of the preferred drug?'}, {'page': 3, 'name': 'T105', 'type': 7, 'rect': [314.85101318359375, 306.16900634765625, 582.4080200195312, 316.8680114746094], 'label': 'Please describe the nature of the failure of the preferred drug'}, {'page': 3, 'name': 'CB97', 'type': 2, 'rect': [52.34349822998047, 260.1939697265625, 62.64540100097656, 270.7509765625], 'label': 'No'}, {'page': 3, 'name': 'CB107z', 'type': 2, 'rect': [81.38929748535156, 328.5570068359375, 91.69129943847656, 339.114013671875], 'label': 'Enbrel (etanercept)'}, {'page': 3, 'name': 'CB108z', 'type': 2, 'rect': [168.93499755859375, 328.6409912109375, 178.9709930419922, 339.114013671875], 'label': 'Humira (adalimumab)'}, {'page': 3, 'name': 'CB109z', 'type': 2, 'rect': [263.5639953613281, 328.6409912109375, 273.6000061035156, 339.114013671875], 'label': 'Idacio (adalimumab-aacf)'}, {'page': 3, 'name': 'CB110z', 'type': 2, 'rect': [371.9209899902344, 328.6409912109375, 381.9570007324219, 339.114013671875], 'label': 'Rinvoq (upadacitinib)'}, {'page': 3, 'name': 'CB111z', 'type': 2, 'rect': [465.0780029296875, 328.6409912109375, 475.114013671875, 339.114013671875], 'label': 'Tyenne SC (tocilizumab-aazg)'}, {'page': 3, 'name': 'CB112z', 'type': 2, 'rect': [81.38929748535156, 339.8210144042969, 91.69129943847656, 350.37799072265625], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)'}, {'page': 3, 'name': 'T113', 'type': 7, 'rect': [314.85101318359375, 352.33599853515625, 582.4080200195312, 363.0360107421875], 'label': 'When was the member’s adverse reaction to the preferred drug?'}, {'page': 3, 'name': 'T114', 'type': 7, 'rect': [342.34100341796875, 364.19500732421875, 582.4080200195312, 374.8940124511719], 'label': 'Please describe the nature of the adverse reaction to the preferred drug'}, {'page': 3, 'name': 'CB106z', 'type': 2, 'rect': [52.34349822998047, 318.0840148925781, 62.64540100097656, 328.6419982910156], 'label': 'No'}, {'page': 3, 'name': 'T118', 'type': 7, 'rect': [22.0226993560791, 409.406005859375, 582.4080200195312, 420.85198974609375], 'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?'}, {'page': 3, 'name': 'CB115z', 'type': 2, 'rect': [22.401899337768555, 397.3210144042969, 32.70389938354492, 407.87799072265625], 'label': 'Inflectra (infliximab-dyyb)'}, {'page': 3, 'name': 'CB116z', 'type': 2, 'rect': [129.55799865722656, 397.4049987792969, 139.593994140625, 407.87799072265625], 'label': 'Renflexis (infliximab-abda)'}, {'page': 3, 'name': 'CB117z', 'type': 2, 'rect': [241.75100708007812, 397.4049987792969, 251.78700256347656, 407.87799072265625], 'label': 'Simponi Aria (golimumab)'}, {'page': 3, 'name': 'T125', 'type': 7, 'rect': [22.0226993560791, 464.6180114746094, 582.4080200195312, 476.0639953613281], 'label': 'Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?'}, {'page': 3, 'name': 'CB119z', 'type': 2, 'rect': [22.401899337768555, 441.5849914550781, 32.70389938354492, 452.1409912109375], 'label': 'Enbrel (etanercept)'}, {'page': 3, 'name': 'CB120z', 'type': 2, 'rect': [109.67500305175781, 441.5469970703125, 119.86100006103516, 452.1409912109375], 'label': 'Humira (adalimumab)'}, {'page': 3, 'name': 'CB121z', 'type': 2, 'rect': [201.76400756835938, 441.5469970703125, 211.9499969482422, 452.1409912109375], 'label': 'Idacio (adalimumab-aacf)'}, {'page': 3, 'name': 'CB122z', 'type': 2, 'rect': [310.4049987792969, 441.5379943847656, 320.5840148925781, 452.1409912109375], 'label': 'Rinvoq (upadacitinib)'}, {'page': 3, 'name': 'CB123z', 'type': 2, 'rect': [401.4320068359375, 441.5379943847656, 411.6109924316406, 452.1409912109375], 'label': 'Tyenne SC (tocilizumab-aazg)'}, {'page': 3, 'name': 'CB124z', 'type': 2, 'rect': [22.401899337768555, 452.5150146484375, 32.58890151977539, 463.1090087890625], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)'}, {'page': 3, 'name': 'CB96.4.0', 'type': 2, 'rect': [22.401899337768555, 489.9960021972656, 32.58890151977539, 500.5899963378906], 'label': 'Yes'}, {'page': 3, 'name': 'CB98', 'type': 2, 'rect': [52.02109909057617, 490.0329895019531, 62.323001861572266, 500.5899963378906], 'label': 'No'}, {'page': 3, 'name': 'CB99.0', 'type': 2, 'rect': [22.401899337768555, 512.27001953125, 32.70389938354492, 522.8270263671875], 'label': 'Yes'}, {'page': 3, 'name': 'CB100.0', 'type': 2, 'rect': [52.02109909057617, 512.6729736328125, 61.89899826049805, 522.8060302734375], 'label': 'No'}, {'page': 3, 'name': 'CB101.0', 'type': 2, 'rect': [22.401899337768555, 523.8699951171875, 32.70389938354492, 534.427001953125], 'label': 'Yes'}, {'page': 3, 'name': 'CB102.0', 'type': 2, 'rect': [52.02109909057617, 523.8699951171875, 62.323001861572266, 534.427001953125], 'label': 'No'}, {'page': 3, 'name': 'CB103', 'type': 2, 'rect': [22.401899337768555, 546.2080078125, 32.703800201416016, 556.7650146484375], 'label': 'Yes'}, {'page': 3, 'name': 'CB104', 'type': 2, 'rect': [52.02109909057617, 546.218017578125, 62.323001861572266, 556.7750244140625], 'label': 'No'}, {'page': 3, 'name': 'CB104a', 'type': 2, 'rect': [238.76499938964844, 568.7449951171875, 249.0659942626953, 579.301025390625], 'label': 'Wegener granulomatosis'}, {'page': 3, 'name': 'CB104b', 'type': 2, 'rect': [351.2770080566406, 568.7249755859375, 361.5780029296875, 579.281005859375], 'label': 'Churg-Strauss syndrome'}, {'page': 3, 'name': 'CB104c', 'type': 2, 'rect': [238.77499389648438, 579.343017578125, 249.0760040283203, 589.8989868164062], 'label': 'microscopic polyangiitis'}, {'page': 3, 'name': 'CB104d', 'type': 2, 'rect': [351.2860107421875, 579.3330078125, 361.5880126953125, 589.8890380859375], 'label': 'pauci-immune glomerulonephritis'}, {'page': 3, 'name': 'CB105', 'type': 2, 'rect': [22.401899337768555, 591.3099975585938, 32.703800201416016, 601.865966796875], 'label': 'Yes'}, {'page': 3, 'name': 'CB106', 'type': 2, 'rect': [52.02109909057617, 591.3410034179688, 62.323001861572266, 601.89697265625], 'label': 'No'}, {'page': 3, 'name': 'CB106a', 'type': 2, 'rect': [22.401899337768555, 613.6580200195312, 32.703800201416016, 624.2139892578125], 'label': 'Yes'}, {'page': 3, 'name': 'CB107', 'type': 2, 'rect': [234.27999877929688, 623.35400390625, 244.58099365234375, 633.9100341796875], 'label': 'pemphigus vulgaris'}, {'page': 3, 'name': 'CB108', 'type': 2, 'rect': [321.2820129394531, 623.343017578125, 331.5830078125, 633.9000244140625], 'label': 'pemphigus folliaceus'}, {'page': 3, 'name': 'CB109', 'type': 2, 'rect': [414.0069885253906, 623.3370361328125, 424.3080139160156, 633.8930053710938], 'label': 'bullous pemphigoid'}, {'page': 3, 'name': 'CB110', 'type': 2, 'rect': [501.04901123046875, 623.322998046875, 511.3500061035156, 633.8800048828125], 'label': 'cicatricial pemphigoid'}, {'page': 3, 'name': 'CB111', 'type': 2, 'rect': [234.29100036621094, 633.9869995117188, 244.5919952392578, 644.5440063476562], 'label': 'epidermolysis bullosa acquisita'}, {'page': 3, 'name': 'CB112', 'type': 2, 'rect': [362.60101318359375, 633.9970092773438, 372.9020080566406, 644.5540161132812], 'label': 'paraneoplastic pemphigus'}, {'page': 3, 'name': 'CB113', 'type': 2, 'rect': [473.9859924316406, 633.9830322265625, 484.2869873046875, 644.5390014648438], 'label': 'None of the above'}, {'page': 3, 'name': 'CB106b', 'type': 2, 'rect': [52.02109909057617, 613.66796875, 62.323001861572266, 624.2249755859375], 'label': 'No'}, {'page': 3, 'name': 'CB114', 'type': 2, 'rect': [175.54200744628906, 655.4459838867188, 185.843994140625, 666.0029907226562], 'label': 'AIDS-related B-cell lymphoma'}, {'page': 3, 'name': 'CB115', 'type': 2, 'rect': [301.32501220703125, 655.4459838867188, 311.62701416015625, 666.0029907226562], 'label': 'Burkitt lymphoma'}, {'page': 3, 'name': 'CB116', 'type': 2, 'rect': [380.8210144042969, 655.4459838867188, 391.12298583984375, 666.0029907226562], 'label': 'Diffuse large B-cell lymphoma'}, {'page': 3, 'name': 'CB117', 'type': 2, 'rect': [505.20098876953125, 655.4459838867188, 515.5029907226562, 666.0029907226562], 'label': 'Follicular lymphoma'}, {'page': 3, 'name': 'CB118', 'type': 2, 'rect': [175.54200744628906, 665.8720092773438, 185.843994140625, 676.4290161132812], 'label': 'Gastric MALT lymphoma'}, {'page': 3, 'name': 'CB119', 'type': 2, 'rect': [281.6090087890625, 665.8720092773438, 291.9110107421875, 676.4290161132812], 'label': 'High-grade B-Cell lymphoma'}, {'page': 3, 'name': 'CB120', 'type': 2, 'rect': [403.06201171875, 665.8720092773438, 413.364013671875, 676.4290161132812], 'label': 'Mantle cell lymphoma'}, {'page': 3, 'name': 'CB121', 'type': 2, 'rect': [175.54200744628906, 676.5670166015625, 185.843994140625, 687.1240234375], 'label': 'Nodal marginal zone lymphoma'}, {'page': 3, 'name': 'CB122', 'type': 2, 'rect': [306.08599853515625, 676.5670166015625, 316.38800048828125, 687.1240234375], 'label': 'Nongastric MALT lymphoma'}, {'page': 3, 'name': 'CB123', 'type': 2, 'rect': [425.44000244140625, 676.5670166015625, 435.74200439453125, 687.1240234375], 'label': 'Primary cutaneous B-cell lymphomas'}, {'page': 3, 'name': 'CB124', 'type': 2, 'rect': [175.54200744628906, 687.93701171875, 185.843994140625, 698.4945068359375], 'label': 'Splenic marginal zone lymphoma'}, {'page': 3, 'name': 'CB125', 'type': 2, 'rect': [311.91900634765625, 688.2860107421875, 322.22100830078125, 698.8427124023438], 'label': 'Other:'}, {'page': 3, 'name': 'T126', 'type': 7, 'rect': [347.5450134277344, 688.0380249023438, 585.0689697265625, 698.70947265625], 'label': 'Other:'}, {'page': 4, 'name': 'T12', 'type': 7, 'rect': [20.796199798583984, 131.79498291015625, 164.06300354003906, 144.45697021484375], 'label': 'Patient First Name'}, {'page': 4, 'name': 'T13', 'type': 7, 'rect': [168.93800354003906, 131.79498291015625, 348.9230041503906, 144.45697021484375], 'label': 'Patient Last Name'}, {'page': 4, 'name': 'T19', 'type': 7, 'rect': [354.30499267578125, 131.79498291015625, 469.82598876953125, 144.45697021484375], 'label': 'Patient Phone'}, {'page': 4, 'name': 'T14', 'type': 7, 'rect': [475.18701171875, 131.79498291015625, 592.4639892578125, 144.45697021484375], 'label': 'Patient DOB (MM/DD/YYYY)'}, {'page': 4, 'name': 'CB127', 'type': 2, 'rect': [22.673200607299805, 167.864013671875, 32.975101470947266, 178.4210205078125], 'label': 'Yes'}, {'page': 4, 'name': 'CB128', 'type': 2, 'rect': [52.01240158081055, 167.87298583984375, 62.31420135498047, 178.42999267578125], 'label': 'No'}, {'page': 4, 'name': 'CB129', 'type': 2, 'rect': [173.50999450683594, 190.15802001953125, 183.81199645996094, 200.71502685546875], 'label': 'leptomeningeal metastases from lymphoma'}, {'page': 4, 'name': 'CB130', 'type': 2, 'rect': [346.9599914550781, 190.15802001953125, 357.2619934082031, 200.71502685546875], 'label': 'primary CNS lymphoma'}, {'page': 4, 'name': 'CB131', 'type': 2, 'rect': [449.24700927734375, 190.15802001953125, 459.54901123046875, 200.71502685546875], 'label': 'none of the above'}, {'page': 4, 'name': 'CB132', 'type': 2, 'rect': [173.1649932861328, 212.5050048828125, 183.4669952392578, 223.06201171875], 'label': 'chronic lymphocytic leukemia (CLL)'}, {'page': 4, 'name': 'CB133', 'type': 2, 'rect': [317.5360107421875, 212.5050048828125, 327.8380126953125, 223.06201171875], 'label': 'small lymphocytic leukemia'}, {'page': 4, 'name': 'CB134', 'type': 2, 'rect': [432.5050048828125, 212.5050048828125, 442.8070068359375, 223.06201171875], 'label': 'none of the above'}, {'page': 4, 'name': 'CB135', 'type': 2, 'rect': [22.673099517822266, 235.28399658203125, 32.975101470947266, 245.84100341796875], 'label': 'Yes'}, {'page': 4, 'name': 'CB136', 'type': 2, 'rect': [52.012298583984375, 235.27197265625, 62.31420135498047, 245.8289794921875], 'label': 'No'}, {'page': 4, 'name': 'CB139', 'type': 2, 'rect': [22.673099517822266, 246.739990234375, 32.975101470947266, 257.2969970703125], 'label': 'Yes'}, {'page': 4, 'name': 'CB140', 'type': 2, 'rect': [52.012298583984375, 246.739990234375, 62.31420135498047, 257.2969970703125], 'label': 'No'}, {'page': 4, 'name': 'CB144', 'type': 2, 'rect': [22.673099517822266, 268.89697265625, 32.975101470947266, 279.4539794921875], 'label': 'Yes'}, {'page': 4, 'name': 'CB145', 'type': 2, 'rect': [52.012298583984375, 269.38201904296875, 62.31420135498047, 279.93902587890625], 'label': 'No'}, {'page': 4, 'name': 'CB141', 'type': 2, 'rect': [173.4029998779297, 291.9289855957031, 183.7050018310547, 302.4859924316406], 'label': 'relapsed hairy cell leukemia'}, {'page': 4, 'name': 'CB142', 'type': 2, 'rect': [290.2030029296875, 291.91900634765625, 300.5050048828125, 302.47601318359375], 'label': 'refractory hairy cell leukemia'}, {'page': 4, 'name': 'CB143', 'type': 2, 'rect': [410.20599365234375, 291.90899658203125, 420.50799560546875, 302.46600341796875], 'label': 'none of the above'}, {'page': 4, 'name': 'CB137', 'type': 2, 'rect': [22.673099517822266, 313.6650085449219, 32.975101470947266, 324.22198486328125], 'label': 'Yes'}, {'page': 4, 'name': 'CB146', 'type': 2, 'rect': [239.57899475097656, 334.8080139160156, 249.88099670410156, 345.364990234375], 'label': 'heart transplant recipient'}, {'page': 4, 'name': 'CB147', 'type': 2, 'rect': [345.38299560546875, 334.7669982910156, 355.68499755859375, 345.3240051269531], 'label': 'other solid organ transplant recipient'}, {'page': 4, 'name': 'CB138', 'type': 2, 'rect': [52.012298583984375, 313.67401123046875, 62.31420135498047, 324.2309875488281], 'label': 'No'}, {'page': 4, 'name': 'CB148', 'type': 2, 'rect': [293.14898681640625, 357.11199951171875, 303.45098876953125, 367.66900634765625], 'label': 'Bavencio (avelumab)'}, {'page': 4, 'name': 'CB149', 'type': 2, 'rect': [386.4150085449219, 357.11199951171875, 396.7170104980469, 367.66900634765625], 'label': 'Imfinzi (durvalumab)'}, {'page': 4, 'name': 'CB150', 'type': 2, 'rect': [476.68499755859375, 357.11199951171875, 486.98699951171875, 367.66900634765625], 'label': 'Keytruda (pembrolizumab)'}, {'page': 4, 'name': 'CB151', 'type': 2, 'rect': [293.14898681640625, 368.8280029296875, 303.45098876953125, 379.385009765625], 'label': 'Opdivo (nivolumab)'}, {'page': 4, 'name': 'CB152', 'type': 2, 'rect': [380.1409912109375, 368.8280029296875, 390.4429931640625, 379.385009765625], 'label': 'Tecentriq (atezolizumab)'}, {'page': 4, 'name': 'CB153', 'type': 2, 'rect': [486.5639953613281, 368.8280029296875, 496.8659973144531, 379.385009765625], 'label': 'Yervoy (ipilimumab)'}, {'page': 4, 'name': 'CB154', 'type': 2, 'rect': [293.14898681640625, 380.08099365234375, 303.45098876953125, 390.63800048828125], 'label': 'Other:'}, {'page': 4, 'name': 'T155', 'type': 7, 'rect': [327.6289978027344, 380.3970031738281, 584.3980102539062, 391.5920104980469], 'label': 'Other:'}, {'page': 4, 'name': 'CB156', 'type': 2, 'rect': [22.673099517822266, 402.6449890136719, 32.975101470947266, 413.2019958496094], 'label': 'Yes'}, {'page': 4, 'name': 'CB158', 'type': 2, 'rect': [90.4845962524414, 413.0060119628906, 100.78600311279297, 423.56201171875], 'label': 'refractory immune thrombocytopenic purpura'}, {'page': 4, 'name': 'CB159', 'type': 2, 'rect': [268.21099853515625, 413.0060119628906, 278.51300048828125, 423.56201171875], 'label': 'idiopathic thrombocytopenic purpura (ITP)'}, {'page': 4, 'name': 'CB157', 'type': 2, 'rect': [51.7942008972168, 403.08099365234375, 62.96879959106445, 413.2019958496094], 'label': 'No'}, {'page': 4, 'name': 'CB160', 'type': 2, 'rect': [22.673099517822266, 435.7309875488281, 32.975101470947266, 446.2879943847656], 'label': 'Yes'}, {'page': 4, 'name': 'CB161', 'type': 2, 'rect': [52.66699981689453, 435.70098876953125, 62.96879959106445, 446.25799560546875], 'label': 'No'}, {'page': 4, 'name': 'CB162', 'type': 2, 'rect': [22.673099517822266, 458.125, 32.975101470947266, 468.6820068359375], 'label': 'Yes'}, {'page': 4, 'name': 'CB163', 'type': 2, 'rect': [52.666900634765625, 458.1050109863281, 62.96879959106445, 468.6619873046875], 'label': 'No'}, {'page': 4, 'name': 'CB164', 'type': 2, 'rect': [22.673099517822266, 490.4849853515625, 32.975101470947266, 501.0419921875], 'label': 'Relapsing-remitting MS (RRMS)'}, {'page': 4, 'name': 'CB165', 'type': 2, 'rect': [155.08900451660156, 490.4849853515625, 165.39100646972656, 501.0419921875], 'label': 'Secondary-progressive MS (SPMS)'}, {'page': 4, 'name': 'CB166', 'type': 2, 'rect': [299.5010070800781, 490.65899658203125, 309.8030090332031, 501.21600341796875], 'label': 'Primary-progressive MS (PPMS)'}, {'page': 4, 'name': 'CB167', 'type': 2, 'rect': [433.9739990234375, 490.7030029296875, 444.2760009765625, 501.260009765625], 'label': 'Progressive-relapsing MS (PRMS)'}, {'page': 4, 'name': 'CB168', 'type': 2, 'rect': [22.673099517822266, 501.45001220703125, 32.975101470947266, 512.0069580078125], 'label': 'Yes'}, {'page': 4, 'name': 'CB169', 'type': 2, 'rect': [52.666900634765625, 501.47100830078125, 62.96879959106445, 512.0280151367188], 'label': 'No'}, {'page': 4, 'name': 'CB170', 'type': 2, 'rect': [22.673099517822266, 523.8510131835938, 32.975101470947266, 534.407958984375], 'label': 'Yes'}, {'page': 4, 'name': 'CB172', 'type': 2, 'rect': [80.48059844970703, 536.14697265625, 90.78199768066406, 546.7039794921875], 'label': 'Yes'}, {'page': 4, 'name': 'CB173', 'type': 2, 'rect': [110.12899780273438, 536.136962890625, 120.43099975585938, 546.6939697265625], 'label': 'No'}, {'page': 4, 'name': 'CB171', 'type': 2, 'rect': [52.666900634765625, 523.8510131835938, 62.96879959106445, 534.407958984375], 'label': 'No'}, {'page': 4, 'name': 'CB174', 'type': 2, 'rect': [22.673099517822266, 558.5859985351562, 32.975101470947266, 569.1430053710938], 'label': 'Yes'}, {'page': 4, 'name': 'CB175', 'type': 2, 'rect': [52.666900634765625, 558.5250244140625, 62.96879959106445, 569.08203125], 'label': 'No'}, {'page': 4, 'name': 'CB176', 'type': 2, 'rect': [22.673099517822266, 569.6649780273438, 32.975101470947266, 580.2219848632812], 'label': 'Yes'}, {'page': 4, 'name': 'CB177', 'type': 2, 'rect': [52.666900634765625, 569.614990234375, 62.96879959106445, 580.1719970703125], 'label': 'No'}, {'page': 4, 'name': 'CB178', 'type': 2, 'rect': [22.673099517822266, 591.4509887695312, 32.975101470947266, 602.0079956054688], 'label': 'Yes'}, {'page': 4, 'name': 'CB179', 'type': 2, 'rect': [52.666900634765625, 591.4199829101562, 62.96879959106445, 601.9769897460938], 'label': 'No'}, {'page': 4, 'name': 'CB180', 'type': 2, 'rect': [22.673099517822266, 603.18701171875, 32.975101470947266, 613.7440185546875], 'label': 'Yes'}, {'page': 4, 'name': 'T189', 'type': 7, 'rect': [135.4010009765625, 624.9459838867188, 373.4419860839844, 635.29296875], 'label': 'Medication:'}, {'page': 4, 'name': 'T190', 'type': 7, 'rect': [403.30499267578125, 625.0750122070312, 423.9419860839844, 635.29296875], 'label': 'Date: (MM)'}, {'page': 4, 'name': 'T191', 'type': 7, 'rect': [428.614013671875, 625.0750122070312, 449.25, 635.29296875], 'label': 'Date: (DD)'}, {'page': 4, 'name': 'T192', 'type': 7, 'rect': [452.177001953125, 625.0750122070312, 474.48699951171875, 635.29296875], 'label': 'Date: (YYYY)'}, {'page': 4, 'name': 'T193', 'type': 7, 'rect': [481.57000732421875, 625.0750122070312, 502.2070007324219, 635.29296875], 'label': 'Date: (MM)'}, {'page': 4, 'name': 'T194', 'type': 7, 'rect': [507.2860107421875, 625.0750122070312, 527.9219970703125, 635.29296875], 'label': 'Date: (DD)'}, {'page': 4, 'name': 'T195', 'type': 7, 'rect': [530.97802734375, 625.0750122070312, 554.6589965820312, 635.29296875], 'label': 'Date: (YYYY)'}, {'page': 4, 'name': 'T196', 'type': 7, 'rect': [135.4010009765625, 636.1209716796875, 373.4419860839844, 646.4660034179688], 'label': 'Medication:'}, {'page': 4, 'name': 'T197', 'type': 7, 'rect': [403.28399658203125, 636.2470092773438, 423.9219970703125, 646.4660034179688], 'label': 'Date: (MM)'}, {'page': 4, 'name': 'T198', 'type': 7, 'rect': [428.593994140625, 636.2470092773438, 449.2309875488281, 646.4660034179688], 'label': 'Date: (DD)'}, {'page': 4, 'name': 'T199', 'type': 7, 'rect': [452.1579895019531, 636.2479858398438, 474.46600341796875, 646.4660034179688], 'label': 'Date: (YYYY)'}, {'page': 4, 'name': 'T200', 'type': 7, 'rect': [481.5509948730469, 636.2470092773438, 502.1860046386719, 646.4660034179688], 'label': 'Date: (MM)'}, {'page': 4, 'name': 'T201', 'type': 7, 'rect': [507.2669982910156, 636.2470092773438, 527.9030151367188, 646.4660034179688], 'label': 'Date: (DD)'}, {'page': 4, 'name': 'T202', 'type': 7, 'rect': [530.9580078125, 636.2470092773438, 554.6389770507812, 646.4660034179688], 'label': 'Date: (YYYY)'}, {'page': 4, 'name': 'CB181', 'type': 2, 'rect': [52.666900634765625, 603.18701171875, 62.96879959106445, 613.7440185546875], 'label': 'No'}, {'page': 4, 'name': 'CB203', 'type': 2, 'rect': [22.673099517822266, 659.490966796875, 32.975101470947266, 670.0479736328125], 'label': 'Yes'}, {'page': 4, 'name': 'CB204', 'type': 2, 'rect': [52.012298583984375, 659.4710083007812, 62.31420135498047, 670.0269775390625], 'label': 'No'}, {'page': 4, 'name': 'CB205', 'type': 2, 'rect': [85.74980163574219, 671.2470092773438, 96.05130004882812, 681.8040161132812], 'label': 'Yes'}, {'page': 4, 'name': 'CB206', 'type': 2, 'rect': [115.375, 671.2260131835938, 125.677001953125, 681.7830200195312], 'label': 'No'}, {'page': 5, 'name': 'T12', 'type': 7, 'rect': [20.796199798583984, 131.79498291015625, 164.39100646972656, 144.45697021484375], 'label': 'Patient First Name'}, {'page': 5, 'name': 'T13', 'type': 7, 'rect': [169.26499938964844, 131.79498291015625, 348.5950012207031, 144.45697021484375], 'label': 'Patient Last Name'}, {'page': 5, 'name': 'T19', 'type': 7, 'rect': [354.30499267578125, 131.79498291015625, 469.82598876953125, 144.45697021484375], 'label': 'Patient Phone'}, {'page': 5, 'name': 'T14', 'type': 7, 'rect': [475.18701171875, 131.7960205078125, 592.4639892578125, 144.45697021484375], 'label': 'Patient DOB (MM/DD/YYYY)'}, {'page': 5, 'name': 'CB207', 'type': 2, 'rect': [249.6199951171875, 167.4429931640625, 259.9209899902344, 178.0], 'label': 'Mild'}, {'page': 5, 'name': 'CB208', 'type': 2, 'rect': [282.375, 167.4429931640625, 292.6759948730469, 178.0], 'label': 'Moderate'}, {'page': 5, 'name': 'CB209', 'type': 2, 'rect': [334.2569885253906, 167.4429931640625, 344.5580139160156, 178.0], 'label': 'Severe'}, {'page': 5, 'name': 'CB210', 'type': 2, 'rect': [22.707700729370117, 177.44500732421875, 33.00960159301758, 188.00201416015625], 'label': 'Yes'}, {'page': 5, 'name': 'CB211', 'type': 2, 'rect': [52.012298583984375, 177.4429931640625, 62.3140983581543, 188.0], 'label': 'No'}, {'page': 5, 'name': 'CB212', 'type': 2, 'rect': [22.707700729370117, 188.08599853515625, 33.00960159301758, 198.64300537109375], 'label': 'Yes'}, {'page': 5, 'name': 'CB213', 'type': 2, 'rect': [52.012298583984375, 188.05401611328125, 62.3140983581543, 198.61102294921875], 'label': 'No'}, {'page': 5, 'name': 'CB214', 'type': 2, 'rect': [86.60260009765625, 198.60699462890625, 96.90440368652344, 209.16400146484375], 'label': 'Yes'}, {'page': 5, 'name': 'CB216', 'type': 2, 'rect': [191.60000610351562, 209.0369873046875, 201.90199279785156, 219.593994140625], 'label': 'ineffective'}, {'page': 5, 'name': 'CB217', 'type': 2, 'rect': [246.1739959716797, 209.0369873046875, 256.4750061035156, 219.593994140625], 'label': 'not tolerated'}, {'page': 5, 'name': 'CB218', 'type': 2, 'rect': [308.3710021972656, 209.0369873046875, 318.6719970703125, 219.593994140625], 'label': 'contraindicated'}, {'page': 5, 'name': 'CB215', 'type': 2, 'rect': [116.39199829101562, 198.60699462890625, 126.69400024414062, 209.16400146484375], 'label': 'No'}, {'page': 5, 'name': 'CB223', 'type': 2, 'rect': [86.60260009765625, 221.36798095703125, 96.90440368652344, 231.92498779296875], 'label': 'Yes'}, {'page': 5, 'name': 'CB225', 'type': 2, 'rect': [191.07400512695312, 231.44598388671875, 201.37600708007812, 242.00299072265625], 'label': 'azathioprine'}, {'page': 5, 'name': 'CB226', 'type': 2, 'rect': [251.9080047607422, 231.44598388671875, 262.2090148925781, 242.00299072265625], 'label': 'cyclosporine'}, {'page': 5, 'name': 'CB227', 'type': 2, 'rect': [313.947998046875, 231.44598388671875, 324.2489929199219, 242.00299072265625], 'label': 'hydroxychloroquine'}, {'page': 5, 'name': 'CB228', 'type': 2, 'rect': [399.94500732421875, 231.44598388671875, 410.2460021972656, 242.00299072265625], 'label': 'leflunomide'}, {'page': 5, 'name': 'CB229', 'type': 2, 'rect': [458.1929931640625, 231.44598388671875, 468.4939880371094, 242.00299072265625], 'label': 'sulfasalazine'}, {'page': 5, 'name': 'CB224', 'type': 2, 'rect': [116.39199829101562, 221.36798095703125, 126.69400024414062, 231.92498779296875], 'label': 'No'}, {'page': 5, 'name': 'CB281', 'type': 2, 'rect': [22.707700729370117, 253.572021484375, 33.009498596191406, 264.1290283203125], 'label': 'Yes'}, {'page': 5, 'name': 'CB282', 'type': 2, 'rect': [52.012298583984375, 253.58099365234375, 62.3140983581543, 264.13800048828125], 'label': 'No'}, {'page': 5, 'name': 'CB283', 'type': 2, 'rect': [22.707700729370117, 265.31402587890625, 33.009498596191406, 275.8709716796875], 'label': 'Yes'}, {'page': 5, 'name': 'T285', 'type': 7, 'rect': [136.13800048828125, 285.8590087890625, 374.1789855957031, 296.2049865722656], 'label': 'Medication:'}, {'page': 5, 'name': 'T286', 'type': 7, 'rect': [404.0140075683594, 285.9859924316406, 424.6510009765625, 296.3320007324219], 'label': 'Date: (MM)'}, {'page': 5, 'name': 'T287', 'type': 7, 'rect': [428.8139953613281, 285.9859924316406, 449.45098876953125, 296.3320007324219], 'label': 'Date: (DD)'}, {'page': 5, 'name': 'T288', 'type': 7, 'rect': [453.23199462890625, 285.9859924316406, 476.1180114746094, 296.3320007324219], 'label': 'Date: (YYYY)'}, {'page': 5, 'name': 'T289', 'type': 7, 'rect': [482.5660095214844, 285.9859924316406, 504.2019958496094, 296.3320007324219], 'label': 'Date: (MM)'}, {'page': 5, 'name': 'T290', 'type': 7, 'rect': [506.7909851074219, 285.9859924316406, 528.427001953125, 296.3320007324219], 'label': 'Date: (DD)'}, {'page': 5, 'name': 'T291', 'type': 7, 'rect': [531.7750244140625, 285.9859924316406, 553.8289794921875, 296.3320007324219], 'label': 'Date: (YYYY)'}, {'page': 5, 'name': 'T292', 'type': 7, 'rect': [136.08299255371094, 296.54400634765625, 374.1239929199219, 306.8900146484375], 'label': 'Medication:'}, {'page': 5, 'name': 'T293', 'type': 7, 'rect': [404.32000732421875, 296.7300109863281, 424.99200439453125, 307.07598876953125], 'label': 'Date: (MM)'}, {'page': 5, 'name': 'T294', 'type': 7, 'rect': [428.8139953613281, 296.7300109863281, 449.4849853515625, 307.07598876953125], 'label': 'Date: (DD)'}, {'page': 5, 'name': 'T295', 'type': 7, 'rect': [453.0889892578125, 296.6719970703125, 475.9750061035156, 307.01800537109375], 'label': 'Date: (YYYY)'}, {'page': 5, 'name': 'T296', 'type': 7, 'rect': [482.197998046875, 296.6719970703125, 503.8340148925781, 307.01800537109375], 'label': 'Date: (MM)'}, {'page': 5, 'name': 'T297', 'type': 7, 'rect': [506.75, 296.6719970703125, 528.385986328125, 307.01800537109375], 'label': 'Date: (DD)'}, {'page': 5, 'name': 'T298', 'type': 7, 'rect': [531.7750244140625, 296.6719970703125, 553.8289794921875, 307.01800537109375], 'label': 'Date: (YYYY)'}, {'page': 5, 'name': 'CB284', 'type': 2, 'rect': [52.012298583984375, 265.322021484375, 62.3140983581543, 275.8790283203125], 'label': 'No'}, {'page': 5, 'name': 'CB299', 'type': 2, 'rect': [22.707700729370117, 320.2669982910156, 33.009498596191406, 330.8240051269531], 'label': 'Yes'}, {'page': 5, 'name': 'CB300', 'type': 2, 'rect': [52.012298583984375, 320.2760009765625, 62.31420135498047, 330.8330078125], 'label': 'No'}, {'page': 5, 'name': 'CB301', 'type': 2, 'rect': [22.707700729370117, 342.3320007324219, 33.0093994140625, 352.8890075683594], 'label': 'Yes'}, {'page': 5, 'name': 'CB302', 'type': 2, 'rect': [52.012298583984375, 342.3489990234375, 62.31420135498047, 352.906005859375], 'label': 'No'}, {'page': 5, 'name': 'CB303', 'type': 2, 'rect': [22.707700729370117, 365.67498779296875, 33.00960159301758, 376.23199462890625], 'label': 'Yes'}, {'page': 5, 'name': 'CB304', 'type': 2, 'rect': [52.012298583984375, 365.6730041503906, 62.31399917602539, 376.2300109863281], 'label': 'No'}, {'page': 5, 'name': 'T305', 'type': 7, 'rect': [225.25999450683594, 374.875, 512.3599853515625, 386.5299987792969], 'label': 'Please indicate the length of time on Rituxan (rituximab):'}, {'page': 5, 'name': 'CB310', 'type': 2, 'rect': [353.3630065917969, 398.0530090332031, 363.66400146484375, 408.6099853515625], 'label': 'Mild'}, {'page': 5, 'name': 'CB311', 'type': 2, 'rect': [386.1109924316406, 398.02301025390625, 396.4119873046875, 408.5799865722656], 'label': 'Moderate'}, {'page': 5, 'name': 'CB312', 'type': 2, 'rect': [437.9490051269531, 398.02301025390625, 448.25, 408.5799865722656], 'label': 'Severe'}, {'page': 5, 'name': 'CB306', 'type': 2, 'rect': [22.707700729370117, 408.30999755859375, 33.00960159301758, 418.86700439453125], 'label': 'Yes'}, {'page': 5, 'name': 'CB307', 'type': 2, 'rect': [52.012298583984375, 408.2569885253906, 62.31420135498047, 418.8139953613281], 'label': 'No'}, {'page': 5, 'name': 'CB308', 'type': 2, 'rect': [22.707700729370117, 419.2879943847656, 33.0093994140625, 429.8450012207031], 'label': 'Yes'}, {'page': 5, 'name': 'CB309', 'type': 2, 'rect': [52.012298583984375, 419.2860107421875, 62.31399917602539, 429.8429870605469], 'label': 'No'}, {'page': 5, 'name': 'CB313', 'type': 2, 'rect': [22.707700729370117, 441.96099853515625, 33.0093994140625, 452.51800537109375], 'label': 'Yes'}, {'page': 5, 'name': 'CB314', 'type': 2, 'rect': [52.012298583984375, 441.9620056152344, 62.31420135498047, 452.5190124511719], 'label': 'No'}, {'page': 5, 'name': 'CB315', 'type': 2, 'rect': [22.707700729370117, 453.41900634765625, 33.00960159301758, 463.97601318359375], 'label': 'Yes'}, {'page': 5, 'name': 'CB316', 'type': 2, 'rect': [52.012298583984375, 453.43798828125, 62.31399917602539, 463.9949951171875], 'label': 'No'}, {'page': 5, 'name': 'T317', 'type': 7, 'rect': [508.2340087890625, 484.19500732421875, 531.7239990234375, 496.53900146484375], 'label': 'Date: (MM)'}, {'page': 5, 'name': 'T318', 'type': 7, 'rect': [536.8720092773438, 484.19500732421875, 556.3619995117188, 496.53900146484375], 'label': 'Date: (DD)'}, {'page': 5, 'name': 'T319', 'type': 7, 'rect': [561.8579711914062, 484.19500732421875, 584.239013671875, 496.53900146484375], 'label': 'Date: (YYYY)'}]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "client = genai.Client(api_key=userdata.get(\"GOOGLE_API_KEY\"))"
      ],
      "metadata": {
        "id": "8acnX3MIKxsO"
      },
      "execution_count": 59,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def get_element_by_value(key, value, array):\n",
        "  filter = [e for e in array if e[key] == 2]\n",
        "  return filter"
      ],
      "metadata": {
        "id": "C9i8cbNe4h9r"
      },
      "execution_count": 60,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(get_element_by_value(\"page\", 2, fields))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "i4pK4gKCBQfw",
        "outputId": "ede899f5-852a-47ef-db0b-5360f71e55c7"
      },
      "execution_count": 61,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[{'page': 2, 'name': 'CB1', 'type': 2, 'rect': [82.92900085449219, 110.4580078125, 93.23079681396484, 121.0150146484375], 'label': 'Start of treatment'}, {'page': 2, 'name': 'T2', 'type': 7, 'rect': [210.19700622558594, 109.281982421875, 231.8699951171875, 120.96099853515625], 'label': 'Start date: (MM)'}, {'page': 2, 'name': 'T3', 'type': 7, 'rect': [236.83399963378906, 109.281982421875, 258.5069885253906, 120.96099853515625], 'label': 'Start date: (DD)'}, {'page': 2, 'name': 'T4', 'type': 7, 'rect': [262.1719970703125, 109.281982421875, 285.8070068359375, 120.96099853515625], 'label': 'Start date: (YYYY)'}, {'page': 2, 'name': 'CB5', 'type': 2, 'rect': [306.0480041503906, 110.03802490234375, 316.3500061035156, 120.594970703125], 'label': 'Continuation of therapy'}, {'page': 2, 'name': 'T6', 'type': 7, 'rect': [502.3739929199219, 109.2760009765625, 524.0469970703125, 120.95501708984375], 'label': 'Date of last treatment: (MM)'}, {'page': 2, 'name': 'T7', 'type': 7, 'rect': [529.010986328125, 109.2760009765625, 550.6840209960938, 120.95501708984375], 'label': 'Date of last treatment: (DD)'}, {'page': 2, 'name': 'T8', 'type': 7, 'rect': [554.9990234375, 109.2760009765625, 578.135986328125, 120.95501708984375], 'label': 'Date of last treatment: (YYYY)'}, {'page': 2, 'name': 'T9', 'type': 7, 'rect': [143.625, 122.6729736328125, 350.625, 134.35198974609375], 'label': 'Precertification Requested By:'}, {'page': 2, 'name': 'T10', 'type': 7, 'rect': [386.3070068359375, 123.7030029296875, 480.1470031738281, 135.38201904296875], 'label': 'Phone:'}, {'page': 2, 'name': 'T11', 'type': 7, 'rect': [501.19500732421875, 123.69598388671875, 593.594970703125, 135.375], 'label': 'Fax:'}, {'page': 2, 'name': 'T12', 'type': 7, 'rect': [62.843101501464844, 150.93402099609375, 230.375, 162.61297607421875], 'label': 'Patient First Name'}, {'page': 2, 'name': 'T13', 'type': 7, 'rect': [277.2619934082031, 150.93402099609375, 501.9209899902344, 162.61297607421875], 'label': 'Patient Last Name'}, {'page': 2, 'name': 'T14', 'type': 7, 'rect': [526.2670288085938, 150.93402099609375, 592.1160278320312, 162.61297607421875], 'label': 'Patient DOB (MM/DD/YYYY)'}, {'page': 2, 'name': 'T15', 'type': 7, 'rect': [52.88520050048828, 164.8270263671875, 327.07598876953125, 176.5059814453125], 'label': 'Address:'}, {'page': 2, 'name': 'T16', 'type': 7, 'rect': [347.5299987792969, 164.8270263671875, 443.9800109863281, 176.5059814453125], 'label': 'City:'}, {'page': 2, 'name': 'T17', 'type': 7, 'rect': [469.6700134277344, 164.8270263671875, 501.9209899902344, 176.5059814453125], 'label': 'State:'}, {'page': 2, 'name': 'T18', 'type': 7, 'rect': [521.6199951171875, 164.8270263671875, 592.1160278320312, 176.5059814453125], 'label': 'ZIP:'}, {'page': 2, 'name': 'T19', 'type': 7, 'rect': [69.14689636230469, 179.32098388671875, 151.4929962158203, 191.0], 'label': 'Patient Phone'}, {'page': 2, 'name': 'T20', 'type': 7, 'rect': [201.93499755859375, 179.32098388671875, 286.2969970703125, 191.0], 'label': 'Work Phone:'}, {'page': 2, 'name': 'T21', 'type': 7, 'rect': [332.29400634765625, 179.44097900390625, 421.7250061035156, 191.1199951171875], 'label': 'Cell Phone:'}, {'page': 2, 'name': 'T22', 'type': 7, 'rect': [450.6510009765625, 179.44097900390625, 592.1160278320312, 191.1199951171875], 'label': 'E-mail:'}, {'page': 2, 'name': 'T24', 'type': 7, 'rect': [78.66909790039062, 194.8740234375, 100.60900115966797, 206.552978515625], 'label': 'lbs'}, {'page': 2, 'name': 'T25', 'type': 7, 'rect': [128.6300048828125, 194.989990234375, 151.65899658203125, 206.66900634765625], 'label': 'kgs'}, {'page': 2, 'name': 'T26', 'type': 7, 'rect': [216.36099243164062, 194.93597412109375, 239.2469940185547, 206.614990234375], 'label': 'inches'}, {'page': 2, 'name': 'T27', 'type': 7, 'rect': [280.114990234375, 194.85400390625, 303.5719909667969, 206.53302001953125], 'label': 'cms'}, {'page': 2, 'name': 'T23', 'type': 7, 'rect': [363.9159851074219, 195.40802001953125, 592.1160278320312, 207.08697509765625], 'label': 'Allergies:'}, {'page': 2, 'name': 'T28', 'type': 7, 'rect': [72.4458999633789, 222.19500732421875, 229.36099243164062, 232.90301513671875], 'label': 'Member ID #:'}, {'page': 2, 'name': 'T29', 'type': 7, 'rect': [55.536800384521484, 233.70098876953125, 229.41600036621094, 244.40899658203125], 'label': 'Group #:'}, {'page': 2, 'name': 'T30', 'type': 7, 'rect': [53.76750183105469, 244.69598388671875, 229.44700622558594, 254.6669921875], 'label': 'Insured:'}, {'page': 2, 'name': 'CB31', 'type': 2, 'rect': [386.09100341796875, 222.927978515625, 396.39300537109375, 233.4840087890625], 'label': 'Yes'}, {'page': 2, 'name': 'CB32', 'type': 2, 'rect': [415.6910095214844, 222.906982421875, 425.99200439453125, 233.4630126953125], 'label': 'No'}, {'page': 2, 'name': 'T33', 'type': 7, 'rect': [304.1390075683594, 233.13201904296875, 386.218994140625, 244.40899658203125], 'label': 'If yes, provide ID#:'}, {'page': 2, 'name': 'T34', 'type': 7, 'rect': [440.7279968261719, 233.13201904296875, 588.68798828125, 244.40899658203125], 'label': 'Carrier Name:'}, {'page': 2, 'name': 'T35', 'type': 7, 'rect': [266.8479919433594, 245.7550048828125, 588.68798828125, 256.031982421875], 'label': 'Insured:'}, {'page': 2, 'name': 'T42', 'type': 7, 'rect': [61.66939926147461, 272.82098388671875, 231.23199462890625, 283.5010070800781], 'label': 'First Name:'}, {'page': 2, 'name': 'T43', 'type': 7, 'rect': [277.4209899902344, 272.81097412109375, 395.2850036621094, 283.4909973144531], 'label': 'Last Name:'}, {'page': 2, 'name': 'CB44', 'type': 2, 'rect': [453.2449951171875, 271.9940185546875, 463.5469970703125, 282.5509948730469], 'label': 'M.D.'}, {'page': 2, 'name': 'CB45', 'type': 2, 'rect': [490.072998046875, 271.98297119140625, 500.375, 282.5400085449219], 'label': 'D.O.'}, {'page': 2, 'name': 'CB46', 'type': 2, 'rect': [526.3419799804688, 272.0040283203125, 536.6439819335938, 282.5610046386719], 'label': 'N.P.'}, {'page': 2, 'name': 'CB47', 'type': 2, 'rect': [561.6890258789062, 271.98297119140625, 571.9910278320312, 282.5400085449219], 'label': 'P.A.'}, {'page': 2, 'name': 'T48', 'type': 7, 'rect': [52.40890121459961, 287.9179992675781, 326.39801025390625, 298.5979919433594], 'label': 'Address:'}, {'page': 2, 'name': 'T49', 'type': 7, 'rect': [347.1679992675781, 287.9179992675781, 443.7019958496094, 298.5979919433594], 'label': 'City:'}, {'page': 2, 'name': 'T50', 'type': 7, 'rect': [470.031005859375, 287.8869934082031, 502.8450012207031, 298.5669860839844], 'label': 'State:'}, {'page': 2, 'name': 'T51', 'type': 7, 'rect': [521.7979736328125, 287.8869934082031, 592.8610229492188, 298.5669860839844], 'label': 'ZIP:'}, {'page': 2, 'name': 'T52', 'type': 7, 'rect': [45.78519821166992, 302.1709899902344, 113.06099700927734, 312.85101318359375], 'label': 'Phone:'}, {'page': 2, 'name': 'T53', 'type': 7, 'rect': [132.92300415039062, 302.1709899902344, 209.58200073242188, 312.85101318359375], 'label': 'Fax:'}, {'page': 2, 'name': 'T54', 'type': 7, 'rect': [243.28700256347656, 302.1709899902344, 326.14599609375, 312.85101318359375], 'label': 'St Lic #:'}, {'page': 2, 'name': 'T55', 'type': 7, 'rect': [353.95098876953125, 302.1709899902344, 417.0400085449219, 312.85101318359375], 'label': 'NPI #:'}, {'page': 2, 'name': 'T56', 'type': 7, 'rect': [446.7349853515625, 302.1709899902344, 502.8450012207031, 312.85101318359375], 'label': 'DEA #:'}, {'page': 2, 'name': 'T57', 'type': 7, 'rect': [527.7540283203125, 302.1499938964844, 592.8610229492188, 312.8299865722656], 'label': 'UPIN:'}, {'page': 2, 'name': 'T58.0', 'type': 7, 'rect': [74.67269897460938, 317.27301025390625, 209.50900268554688, 327.9530029296875], 'label': 'Provider Email:'}, {'page': 2, 'name': 'T58.1', 'type': 7, 'rect': [290.1669921875, 317.27301025390625, 417.0400085449219, 327.9530029296875], 'label': 'Office Contact Name:'}, {'page': 2, 'name': 'T59', 'type': 7, 'rect': [446.9049987792969, 317.27301025390625, 592.8610229492188, 327.9530029296875], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin CB.1', 'type': 2, 'rect': [22.34000015258789, 352.0459899902344, 32.375999450683594, 362.5190124511719], 'label': 'Self-administered'}, {'page': 2, 'name': 'Provider Admin CB.2', 'type': 2, 'rect': [107.87300109863281, 352.0790100097656, 117.90899658203125, 362.552001953125], 'label': 'Physician’s Office'}, {'page': 2, 'name': 'Provider Admin CB.3', 'type': 2, 'rect': [194.05499267578125, 352.0790100097656, 204.09100341796875, 362.552001953125], 'label': 'Home'}, {'page': 2, 'name': 'Provider Admin CB.4', 'type': 2, 'rect': [22.34000015258789, 362.49700927734375, 32.375999450683594, 372.9700012207031], 'label': 'Outpatient Infusion Center'}, {'page': 2, 'name': 'Provider Admin T.5', 'type': 7, 'rect': [157.18699645996094, 362.43499755859375, 320.2829895019531, 373.0169982910156], 'label': 'Name:'}, {'page': 2, 'name': 'Provider Admin CB.7', 'type': 2, 'rect': [22.34000015258789, 372.5169982910156, 32.375999450683594, 382.989990234375], 'label': 'Home Infusion Center'}, {'page': 2, 'name': 'Provider Admin T.6', 'type': 7, 'rect': [165.0959930419922, 373.2980041503906, 320.2829895019531, 383.8800048828125], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin T.8', 'type': 7, 'rect': [111.47799682617188, 383.5799865722656, 320.2829895019531, 394.1619873046875], 'label': 'Agency Name:'}, {'page': 2, 'name': 'Provider Admin CB.10', 'type': 2, 'rect': [22.34000015258789, 393.0249938964844, 32.375999450683594, 403.49798583984375], 'label': 'Administration code(s)'}, {'page': 2, 'name': 'Provider Admin T.9', 'type': 7, 'rect': [143.82699584960938, 393.6579895019531, 320.2829895019531, 404.239990234375], 'label': 'CPT:'}, {'page': 2, 'name': 'Provider Admin T.11A', 'type': 7, 'rect': [56.31019973754883, 403.95599365234375, 320.2829895019531, 414.5379943847656], 'label': 'Address:'}, {'page': 2, 'name': 'Provider Admin T.13', 'type': 7, 'rect': [40.63639831542969, 415.3280029296875, 167.3459930419922, 425.9100036621094], 'label': 'City:'}, {'page': 2, 'name': 'Provider Admin T.14', 'type': 7, 'rect': [193.09100341796875, 415.3280029296875, 229.23599243164062, 425.9100036621094], 'label': 'State:'}, {'page': 2, 'name': 'Provider Admin T.15', 'type': 7, 'rect': [246.7010040283203, 415.7640075683594, 320.2829895019531, 426.34600830078125], 'label': 'ZIP:'}, {'page': 2, 'name': 'Provider Admin T.16', 'type': 7, 'rect': [49.74549865722656, 425.79998779296875, 167.3459930419922, 436.3819885253906], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin T.17A', 'type': 7, 'rect': [189.15499877929688, 425.79998779296875, 320.2829895019531, 436.3819885253906], 'label': 'Fax:'}, {'page': 2, 'name': 'Provider Admin T.18', 'type': 7, 'rect': [39.92729949951172, 437.27301025390625, 167.3459930419922, 447.8550109863281], 'label': 'TIN:'}, {'page': 2, 'name': 'Provider Admin T.19', 'type': 7, 'rect': [189.15499877929688, 437.27301025390625, 320.2829895019531, 447.8550109863281], 'label': 'PIN:'}, {'page': 2, 'name': 'Provider Admin T.20', 'type': 7, 'rect': [39.86439895629883, 448.2250061035156, 320.2829895019531, 458.8070068359375], 'label': 'NPI:'}, {'page': 2, 'name': 'Provider Admin CB.21', 'type': 2, 'rect': [331.30499267578125, 352.072998046875, 341.34100341796875, 362.5459899902344], 'label': 'Outpatient Dialysis Center'}, {'page': 2, 'name': 'Provider Admin CB.22', 'type': 2, 'rect': [448.74798583984375, 352.0220031738281, 458.78399658203125, 362.4949951171875], 'label': 'Physician’s Office'}, {'page': 2, 'name': 'Provider Admin CB.23.0.0', 'type': 2, 'rect': [331.2909851074219, 363.12799072265625, 341.3269958496094, 373.60101318359375], 'label': 'Retail Pharmacy'}, {'page': 2, 'name': 'Provider Admin CB.24.0.0', 'type': 2, 'rect': [448.6730041503906, 363.12799072265625, 458.7090148925781, 373.60101318359375], 'label': 'Specialty Pharmacy'}, {'page': 2, 'name': 'Provider Admin CB.25', 'type': 2, 'rect': [331.2909851074219, 374.8550109863281, 341.3269958496094, 385.3280029296875], 'label': 'Mail Order'}, {'page': 2, 'name': 'Provider Admin CB.26', 'type': 2, 'rect': [448.6730041503906, 374.8550109863281, 458.7090148925781, 385.3280029296875], 'label': 'Other:'}, {'page': 2, 'name': 'Provider Admin T.27', 'type': 7, 'rect': [484.71099853515625, 374.8219909667969, 591.8259887695312, 385.8489990234375], 'label': 'Other:'}, {'page': 2, 'name': 'Provider Admin T.28', 'type': 7, 'rect': [356.0669860839844, 386.92401123046875, 591.8259887695312, 398.0429992675781], 'label': 'Name:'}, {'page': 2, 'name': 'Provider Admin T.29a', 'type': 7, 'rect': [363.8489990234375, 399.135009765625, 591.8259887695312, 410.2539978027344], 'label': 'Address:'}, {'page': 2, 'name': 'Provider Admin T.30a', 'type': 7, 'rect': [349.0429992675781, 411.1409912109375, 448.72601318359375, 422.1679992675781], 'label': 'City:'}, {'page': 2, 'name': 'Provider Admin T.31', 'type': 7, 'rect': [476.072998046875, 411.2590026855469, 513.3820190429688, 422.1679992675781], 'label': 'State:'}, {'page': 2, 'name': 'Provider Admin T.32', 'type': 7, 'rect': [533.135009765625, 411.2590026855469, 591.8259887695312, 422.1679992675781], 'label': 'ZIP:'}, {'page': 2, 'name': 'Provider Admin T.33', 'type': 7, 'rect': [359.12799072265625, 423.7099914550781, 466.9100036621094, 434.6189880371094], 'label': 'Phone:'}, {'page': 2, 'name': 'Provider Admin T.34', 'type': 7, 'rect': [488.0799865722656, 423.7099914550781, 591.8259887695312, 434.6189880371094], 'label': 'Fax:'}, {'page': 2, 'name': 'Provider Admin T.35', 'type': 7, 'rect': [349.09100341796875, 436.05499267578125, 466.9100036621094, 446.9639892578125], 'label': 'TIN:'}, {'page': 2, 'name': 'Provider Admin T.36', 'type': 7, 'rect': [488.08099365234375, 436.05499267578125, 591.8259887695312, 446.9639892578125], 'label': 'PIN:'}, {'page': 2, 'name': 'Provider Admin T.37', 'type': 7, 'rect': [349.0989990234375, 447.89801025390625, 591.8259887695312, 458.8070068359375], 'label': 'NPI:'}, {'page': 2, 'name': 'CB60', 'type': 2, 'rect': [82.12529754638672, 475.0929870605469, 92.31230163574219, 485.68701171875], 'label': 'Riabni (rituximab-arrx)'}, {'page': 2, 'name': 'CB61', 'type': 2, 'rect': [188.06199645996094, 475.0929870605469, 198.24899291992188, 485.68701171875], 'label': 'Rituxan (rituximab)'}, {'page': 2, 'name': 'CB62', 'type': 2, 'rect': [281.27899169921875, 475.177001953125, 291.46600341796875, 485.77099609375], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB63', 'type': 2, 'rect': [398.927001953125, 475.177001953125, 409.114013671875, 485.77099609375], 'label': 'Truxima (rituximab-abbs)'}, {'page': 2, 'name': 'T64', 'type': 7, 'rect': [45.61000061035156, 487.57000732421875, 225.343994140625, 498.47900390625], 'label': 'Dose:'}, {'page': 2, 'name': 'T65', 'type': 7, 'rect': [308.4649963378906, 487.57000732421875, 459.3169860839844, 498.47900390625], 'label': 'Directions for Use:'}, {'page': 2, 'name': 'T66', 'type': 7, 'rect': [524.906005859375, 487.57000732421875, 589.9249877929688, 498.47900390625], 'label': 'HCPCS Code:'}, {'page': 2, 'name': 'T67', 'type': 7, 'rect': [97.97879791259766, 518.5599975585938, 270.3380126953125, 529.259033203125], 'label': 'Primary ICD Code:'}, {'page': 2, 'name': 'CB68', 'type': 2, 'rect': [292.47198486328125, 518.5599975585938, 302.77398681640625, 529.259033203125], 'label': 'Other ICD Code:'}, {'page': 2, 'name': 'T69', 'type': 7, 'rect': [370.33099365234375, 518.5599975585938, 589.5579833984375, 529.259033203125], 'label': 'Other ICD Code:'}, {'page': 2, 'name': 'CB70', 'type': 2, 'rect': [22.825700759887695, 584.4249877929688, 33.12770080566406, 594.9819946289062], 'label': 'Yes'}, {'page': 2, 'name': 'CB71', 'type': 2, 'rect': [52.699501037597656, 584.6510009765625, 62.623199462890625, 594.9819946289062], 'label': 'No'}, {'page': 2, 'name': 'CB72', 'type': 2, 'rect': [52.699501037597656, 596.738037109375, 62.623199462890625, 607.0689697265625], 'label': 'No'}, {'page': 2, 'name': 'CB73', 'type': 2, 'rect': [81.47090148925781, 606.9550170898438, 91.65750122070312, 617.5490112304688], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB74', 'type': 2, 'rect': [190.92300415039062, 606.9550170898438, 201.11000061035156, 617.5490112304688], 'label': 'Truxima (rituximab-abbs)'}, {'page': 2, 'name': 'T75', 'type': 7, 'rect': [315.31298828125, 617.7750244140625, 585.489013671875, 628.6840209960938], 'label': 'When was the member’s trial and failure of the preferred drug?'}, {'page': 2, 'name': 'T76', 'type': 7, 'rect': [315.31298828125, 630.634033203125, 585.489013671875, 641.54296875], 'label': 'Please describe the nature of the failure of the preferred drug'}, {'page': 2, 'name': 'CB77', 'type': 2, 'rect': [52.699501037597656, 642.22998046875, 63.001399993896484, 652.7869873046875], 'label': 'No'}, {'page': 2, 'name': 'CB78', 'type': 2, 'rect': [81.47090148925781, 653.0399780273438, 91.65750122070312, 663.634033203125], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB79', 'type': 2, 'rect': [190.92300415039062, 653.0399780273438, 201.11000061035156, 663.634033203125], 'label': 'Truxima (rituximab-abbs)'}, {'page': 2, 'name': 'T80', 'type': 7, 'rect': [315.31298828125, 664.2340087890625, 585.489013671875, 675.1430053710938], 'label': 'When was the member’s adverse reaction to the preferred drug?'}, {'page': 2, 'name': 'T81', 'type': 7, 'rect': [342.1499938964844, 676.0919799804688, 585.489013671875, 687.0009765625], 'label': 'Please describe the nature of the adverse reaction to the preferred drug'}, {'page': 2, 'name': 'T84', 'type': 7, 'rect': [22.731800079345703, 720.555908203125, 585.489013671875, 731.4649047851562], 'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?'}, {'page': 2, 'name': 'CB82', 'type': 2, 'rect': [22.825700759887695, 708.5637817382812, 33.12770080566406, 719.1207885742188], 'label': 'Ruxience (rituximab-pvvr)'}, {'page': 2, 'name': 'CB83', 'type': 2, 'rect': [131.9810028076172, 708.4747924804688, 141.90499877929688, 718.8057861328125], 'label': 'Truxima (rituximab-abbs)'}]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(get_element_by_value(\"page\", 2, blocks))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "wzmC3UXcBsdw",
        "outputId": "f13744e3-b987-4d4b-c889-95d585233145"
      },
      "execution_count": 62,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[{'page': 2, 'block': (18.0, 768.580810546875, 87.8330078125, 779.4735107421875, 'GR-68535-3 (1-25) \\n', 0, 0)}, {'page': 2, 'block': (161.99952697753906, 10.737120628356934, 427.83404541015625, 108.46498107910156, 'MEDICARE FORM \\nRiabni\\n® (rituximab-arrx),  \\nRituxan\\n® (rituximab), Ruxience  \\n(rituximab-pvvr), Truxima (rituximab-abbs) \\nMedication Precertification Request \\nPage 2 of 5 \\n(All fields must be completed and return both pages for precertification review.) \\n', 1, 0)}, {'page': 2, 'block': (453.7799987792969, 13.48285961151123, 585.0285034179688, 44.80995559692383, 'For Medicare Advantage Part B: \\nFor other lines of business:  \\nPlease use commercial form. \\n', 2, 0)}, {'page': 2, 'block': (454.55999755859375, 47.52688217163086, 589.5609130859375, 89.79430389404297, 'Note: Riabni and Rituxan are non-\\npreferred. The preferred biosimilar \\nproducts are Ruxience and Truxima.  \\nFor rheumatoid arthritis, all Rituxan and \\nbiosimilar products are non-preferred. \\n', 3, 0)}, {'page': 2, 'block': (77.98930358886719, 110.7192153930664, 554.345703125, 135.1289825439453, '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n', 4, 0)}, {'page': 2, 'block': (76.3604965209961, 195.3408203125, 280.32928466796875, 206.2335205078125, ' \\n  \\n  \\n \\n  \\n  \\n', 5, 0)}, {'page': 2, 'block': (266.2629089355469, 223.600830078125, 415.6719970703125, 256.93353271484375, '  \\n  \\n \\n   \\n', 6, 0)}, {'page': 2, 'block': (450.2276916503906, 272.5979919433594, 452.7297058105469, 284.5049743652344, ' \\n', 7, 0)}, {'page': 2, 'block': (101.09100341796875, 363.3408203125, 103.30944061279297, 374.2335205078125, ' \\n', 8, 0)}, {'page': 2, 'block': (38.09709930419922, 405.1007995605469, 230.01846313476562, 458.83349609375, '   \\n   \\n  \\n  \\n    \\n    \\n  \\n   \\n', 9, 0)}, {'page': 2, 'block': (486.82611083984375, 375.580810546875, 497.9358825683594, 386.4735107421875, '   \\n', 10, 0)}, {'page': 2, 'block': (357.05230712890625, 387.76080322265625, 363.71881103515625, 398.65350341796875, '  \\n', 11, 0)}, {'page': 2, 'block': (353.99920654296875, 411.9407958984375, 517.1822509765625, 422.83349609375, '  \\n  \\n  \\n', 12, 0)}, {'page': 2, 'block': (363.3038024902344, 424.060791015625, 468.71160888671875, 434.9534912109375, ' \\n \\n', 13, 0)}, {'page': 2, 'block': (349.07550048828125, 436.1808166503906, 468.711669921875, 447.0735168457031, '   \\n \\n', 14, 0)}, {'page': 2, 'block': (349.07708740234375, 448.3608093261719, 360.1756896972656, 459.2535095214844, '   \\n', 15, 0)}, {'page': 2, 'block': (180.96009826660156, 475.8791809082031, 508.228759765625, 500.7235107421875, ' \\n   \\n   \\n \\n  \\n  \\n', 16, 0)}, {'page': 2, 'block': (325.87200927734375, 519.1392211914062, 328.2405700683594, 530.7689819335938, ' \\n', 17, 0)}, {'page': 2, 'block': (47.75510025024414, 585.5208129882812, 79.74994659423828, 596.4135131835938, '  \\n  \\n', 18, 0)}, {'page': 2, 'block': (75.89530181884766, 597.6408081054688, 78.11373901367188, 608.5335083007812, ' \\n', 19, 0)}, {'page': 2, 'block': (188.15899658203125, 608.0208129882812, 190.37744140625, 618.9135131835938, ' \\n', 20, 0)}, {'page': 2, 'block': (73.6769027709961, 643.4808349609375, 78.11377716064453, 654.37353515625, '  \\n', 21, 0)}, {'page': 2, 'block': (185.9405975341797, 653.86083984375, 190.3774871826172, 664.7535400390625, '  \\n', 22, 0)}, {'page': 2, 'block': (125.04219818115234, 709.7208251953125, 131.69752502441406, 720.613525390625, '   \\n', 23, 0)}, {'page': 2, 'block': (502.864990234375, 737.7963256835938, 596.2230224609375, 748.9204711914062, 'Continued on next page \\n', 24, 0)}, {'page': 2, 'block': (18.0, 110.7192153930664, 495.24786376953125, 122.34901428222656, 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n', 25, 0)}, {'page': 2, 'block': (17.40106201171875, 123.36292266845703, 501.1325988769531, 135.56356811523438, 'Precertification Requested By: \\nPhone: \\nFax: \\n', 26, 0)}, {'page': 2, 'block': (20.399999618530273, 137.673095703125, 125.64022064208984, 149.10044860839844, 'A. PATIENT INFORMATION\\n', 27, 0)}, {'page': 2, 'block': (20.399999618530273, 150.7044677734375, 530.3218994140625, 161.59716796875, 'First Name:  \\nLast Name:  \\nDOB:  \\n', 28, 0)}, {'page': 2, 'block': (20.39996337890625, 165.10467529296875, 525.4381713867188, 176.00103759765625, 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n', 29, 0)}, {'page': 2, 'block': (20.399993896484375, 179.50079345703125, 450.2641906738281, 190.4012451171875, 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n', 30, 0)}, {'page': 2, 'block': (20.399993896484375, 195.3408203125, 370.4882507324219, 206.2337646484375, 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n', 31, 0)}, {'page': 2, 'block': (20.4000244140625, 210.031982421875, 139.0288848876953, 221.45933532714844, 'B. INSURANCE INFORMATION\\n', 32, 0)}, {'page': 2, 'block': (20.390220642089844, 223.47027587890625, 74.55447387695312, 256.858642578125, 'Member ID #:  \\nGroup #:  \\nInsured:  \\n', 33, 0)}, {'page': 2, 'block': (235.18788146972656, 223.5980224609375, 440.6332702636719, 256.933349609375, 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n', 34, 0)}, {'page': 2, 'block': (20.409637451171875, 260.189208984375, 143.95599365234375, 271.6165771484375, 'C. PRESCRIBER INFORMATION\\n', 35, 0)}, {'page': 2, 'block': (20.409637451171875, 272.2200012207031, 593.2784423828125, 284.5049743652344, 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n', 36, 0)}, {'page': 2, 'block': (20.4022216796875, 287.620849609375, 525.446044921875, 298.5135498046875, 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n', 37, 0)}, {'page': 2, 'block': (20.40228271484375, 302.02081298828125, 532.0935668945312, 312.9174499511719, 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n', 38, 0)}, {'page': 2, 'block': (20.39202880859375, 317.1429138183594, 450.62579345703125, 328.0356140136719, 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n', 39, 0)}, {'page': 2, 'block': (20.399993896484375, 330.810546875, 256.3798522949219, 342.2400207519531, 'D. DISPENSING PROVIDER/ADMINISTRATION INFORMATION\\n', 40, 0)}, {'page': 2, 'block': (20.399999618530273, 342.8683166503906, 114.59831237792969, 354.2956848144531, 'Place of Administration: \\n', 41, 0)}, {'page': 2, 'block': (22.570980072021484, 353.0747375488281, 249.09925842285156, 458.8310852050781, ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n', 42, 0)}, {'page': 2, 'block': (329.1705627441406, 342.87371826171875, 454.4814758300781, 354.30108642578125, 'Dispensing Provider/Pharmacy:  \\n', 43, 0)}, {'page': 2, 'block': (340.5101318359375, 353.14398193359375, 533.1074829101562, 386.4764404296875, ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n', 44, 0)}, {'page': 2, 'block': (331.3331298828125, 387.76123046875, 357.06866455078125, 398.6539306640625, 'Name: \\n', 45, 0)}, {'page': 2, 'block': (331.3331298828125, 399.8190002441406, 367.3149719238281, 410.7117004394531, 'Address:  \\n', 46, 0)}, {'page': 2, 'block': (331.3251647949219, 411.93768310546875, 536.2573852539062, 422.83331298828125, 'City:  \\nState:  \\nZIP:  \\n', 47, 0)}, {'page': 2, 'block': (331.322998046875, 424.0592956542969, 490.9054870605469, 434.9519958496094, 'Phone:  \\n Fax:  \\n', 48, 0)}, {'page': 2, 'block': (331.322998046875, 436.05322265625, 490.9086608886719, 447.4805908203125, 'TIN: \\n PIN:  \\n', 49, 0)}, {'page': 2, 'block': (331.322998046875, 448.3583984375, 349.0801086425781, 459.2510986328125, 'NPI: \\n', 50, 0)}, {'page': 2, 'block': (20.406219482421875, 461.42962646484375, 130.56771850585938, 472.85699462890625, 'E. PRODUCT INFORMATION\\n', 51, 0)}, {'page': 2, 'block': (20.399099349975586, 475.74285888671875, 522.478515625, 500.7235107421875, 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n', 52, 0)}, {'page': 2, 'block': (20.399999618530273, 504.75311279296875, 450.17755126953125, 516.1804809570312, 'F. DIAGNOSIS INFORMATION - Please indicate primary ICD code and specify any other any other where applicable (*).\\n', 53, 0)}, {'page': 2, 'block': (20.399999618530273, 519.0028686523438, 370.3120422363281, 531.2034912109375, 'Primary ICD Code: \\n Other ICD Code: \\n', 54, 0)}, {'page': 2, 'block': (20.399999618530273, 533.7930908203125, 423.8953857421875, 556.58349609375, 'G. CLINICAL INFORMATION - Required clinical information must be completed for ALL precertification requests.\\nFor Initiation Requests (clinical documentation required for all requests): \\n', 55, 0)}, {'page': 2, 'block': (22.552032470703125, 556.713134765625, 570.1665649414062, 586.6221923828125, 'Note: Riabni and Rituxan are non-preferred. Ruxience and Truxima are the preferred biosimilars for most indications. \\nFor rheumatoid arthritis, all Rituxan and biosimilar products are non-preferred. Inflectra, Renflexis and Simponi Aria are preferred for MA plans. \\nEnbrel, Humira, Idacio, Rinvoq, Tyenne SC and Xeljanz/Xeljanz XR are preferred for MAPD plans. \\n', 56, 0)}, {'page': 2, 'block': (31.737045288085938, 585.5209350585938, 384.74603271484375, 596.4136352539062, 'Has the patient had prior therapy with the requested product within the last 365 days? \\n Yes\\n No\\n', 57, 0)}, {'page': 2, 'block': (78.10882568359375, 597.642578125, 471.17169189453125, 608.5352783203125, ' Has the patient had a trial and failure of any of the following rituximab biosimilars? (If yes, select all that apply) \\n', 58, 0)}, {'page': 2, 'block': (81.5941162109375, 608.0208129882812, 306.1827087402344, 630.0775146484375, ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n', 59, 0)}, {'page': 2, 'block': (81.5879135131836, 631.3623046875, 300.4075622558594, 642.2550048828125, 'Please describe the nature of the failure of the preferred drug \\n', 60, 0)}, {'page': 2, 'block': (61.24689483642578, 597.6387939453125, 75.88221740722656, 608.531494140625, ' No \\n', 61, 0)}, {'page': 2, 'block': (78.10065460205078, 643.48388671875, 482.2637023925781, 654.3765869140625, ' Has the patient had an adverse reaction to any of the following rituximab biosimilars? (If yes, select all that apply) \\n', 62, 0)}, {'page': 2, 'block': (81.59410095214844, 653.85791015625, 317.46405029296875, 675.9175415039062, ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n', 63, 0)}, {'page': 2, 'block': (81.61186218261719, 677.1384887695312, 337.8099060058594, 688.0311889648438, 'Please describe the nature of the adverse reaction to the preferred drug \\n', 64, 0)}, {'page': 2, 'block': (61.2548828125, 643.48681640625, 73.67176818847656, 654.3795166015625, ' No\\n', 65, 0)}, {'page': 2, 'block': (22.567840576171875, 689.2600708007812, 582.34375, 709.3943481445312, 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when \\nindicated for the patient’s diagnosis? (select all that apply)   \\n', 66, 0)}, {'page': 2, 'block': (31.744979858398438, 709.7208251953125, 234.30032348632812, 720.6141967773438, ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n', 67, 0)}]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def rects_intersect(rect1, rect2):\n",
        "    x0, y0, x1, y1 = rect1\n",
        "    a0, b0, a1, b1 = rect2\n",
        "    dx = max(0, min(x1, a1) - max(x0, a0))\n",
        "    dy = max(0, min(y1, b1) - max(y0, b0))\n",
        "    return dx * dy > 0\n",
        "\n",
        "def rects_intersect_debug(rect1, rect2):\n",
        "    x0, y0, x1, y1 = rect1\n",
        "    a0, b0, a1, b1 = rect2\n",
        "    dx = min(x1, a1) - max(x0, a0)\n",
        "    dy = min(y1, b1) - max(y0, b0)\n",
        "    intersection = max(0, dx) * max(0, dy)\n",
        "    #print(f\"[DEBUG] Checking overlap between {rect1} and {rect2}: dx={dx:.3f}, dy={dy:.3f}, intersection={intersection:.3f}\")\n",
        "    return intersection > 0\n",
        "\n",
        "def text_similarity(a: str, b: str) -> float:\n",
        "    return difflib.SequenceMatcher(None, a.lower(), b.lower()).ratio()\n",
        "\n",
        "def map_fields_to_blocks(fields, blocks):\n",
        "    labeled_fields = []\n",
        "\n",
        "    for field in fields:\n",
        "        field_rect = field[\"rect\"]\n",
        "        field_page = field[\"page\"]\n",
        "        field_label = field[\"label\"]\n",
        "        field_label_lower = field_label.lower()\n",
        "\n",
        "        #print(f\"\\n[INFO] Processing field '{field_label}' on page {field_page} with rect {field_rect}\")\n",
        "\n",
        "        overlapping_blocks = []\n",
        "\n",
        "        for block in blocks:\n",
        "            if block[\"page\"] != field_page:\n",
        "                continue\n",
        "\n",
        "            block_rect = block[\"block\"][:4]\n",
        "\n",
        "            if rects_intersect_debug(field_rect, block_rect):\n",
        "                overlapping_blocks.append(block)\n",
        "\n",
        "        best_block_context = \"\"\n",
        "\n",
        "        if not overlapping_blocks:\n",
        "            print(\"[INFO] No overlapping blocks found for this field.\")\n",
        "        else:\n",
        "            # First fallback: substring match for short labels like \"yes\", \"no\", etc.\n",
        "            for block in overlapping_blocks:\n",
        "                block_text = block[\"block\"][4].lower()\n",
        "                if field_label_lower in block_text:\n",
        "                    best_block_context = block[\"block\"][4]\n",
        "                    #print(f\"[INFO] Substring fallback matched '{field_label}' in block text.\")\n",
        "                    break\n",
        "\n",
        "            # If no substring match found, use text similarity\n",
        "            if not best_block_context:\n",
        "                best_score = 0\n",
        "                for block in overlapping_blocks:\n",
        "                    block_text = block[\"block\"][4]\n",
        "                    score = text_similarity(field_label, block_text)\n",
        "                    #print(f\"  [DEBUG] Similarity between field label '{field_label}' and block text start '{block_text[:30]}...': {score:.3f}\")\n",
        "\n",
        "                    if score > best_score:\n",
        "                        best_score = score\n",
        "                        best_block_context = block_text\n",
        "\n",
        "                #print(f\"[INFO] Best matching block context selected with similarity score {best_score:.3f}\")\n",
        "\n",
        "        labeled_fields.append({\n",
        "            \"page\": field_page,\n",
        "            \"name\": field[\"name\"],\n",
        "            \"type\": field[\"type\"],\n",
        "            \"rect\": list(field_rect),\n",
        "            \"label\": field_label,\n",
        "            \"block_context\": best_block_context\n",
        "        })\n",
        "\n",
        "        print({\n",
        "            \"page\": field_page,\n",
        "            \"name\": field[\"name\"],\n",
        "            \"type\": field[\"type\"],\n",
        "            \"rect\": list(field_rect),\n",
        "            \"label\": field_label,\n",
        "            \"block_context\": best_block_context\n",
        "        })\n",
        "\n",
        "    return labeled_fields\n",
        "\n",
        "\n",
        "# Example usage:\n",
        "# labeled_blocks = map_fields_to_blocks(fields, blocks)\n",
        "# print(labeled_blocks)\n",
        "\n",
        "\n",
        "labeled_blocks = map_fields_to_blocks(fields, blocks)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "HXiaXnAPDdNs",
        "outputId": "a0b1b2da-4e1a-4e2d-9b0a-1d46934cd158"
      },
      "execution_count": 64,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'page': 2, 'name': 'CB1', 'type': 2, 'rect': [82.92900085449219, 110.4580078125, 93.23079681396484, 121.0150146484375], 'label': 'Start of treatment', 'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n'}\n",
            "{'page': 2, 'name': 'T2', 'type': 7, 'rect': [210.19700622558594, 109.281982421875, 231.8699951171875, 120.96099853515625], 'label': 'Start date: (MM)', 'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n'}\n",
            "{'page': 2, 'name': 'T3', 'type': 7, 'rect': [236.83399963378906, 109.281982421875, 258.5069885253906, 120.96099853515625], 'label': 'Start date: (DD)', 'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n'}\n",
            "{'page': 2, 'name': 'T4', 'type': 7, 'rect': [262.1719970703125, 109.281982421875, 285.8070068359375, 120.96099853515625], 'label': 'Start date: (YYYY)', 'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n'}\n",
            "{'page': 2, 'name': 'CB5', 'type': 2, 'rect': [306.0480041503906, 110.03802490234375, 316.3500061035156, 120.594970703125], 'label': 'Continuation of therapy', 'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n'}\n",
            "{'page': 2, 'name': 'T6', 'type': 7, 'rect': [502.3739929199219, 109.2760009765625, 524.0469970703125, 120.95501708984375], 'label': 'Date of last treatment: (MM)', 'block_context': '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n'}\n",
            "{'page': 2, 'name': 'T7', 'type': 7, 'rect': [529.010986328125, 109.2760009765625, 550.6840209960938, 120.95501708984375], 'label': 'Date of last treatment: (DD)', 'block_context': '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T8', 'type': 7, 'rect': [554.9990234375, 109.2760009765625, 578.135986328125, 120.95501708984375], 'label': 'Date of last treatment: (YYYY)', 'block_context': ''}\n",
            "{'page': 2, 'name': 'T9', 'type': 7, 'rect': [143.625, 122.6729736328125, 350.625, 134.35198974609375], 'label': 'Precertification Requested By:', 'block_context': 'Precertification Requested By: \\nPhone: \\nFax: \\n'}\n",
            "{'page': 2, 'name': 'T10', 'type': 7, 'rect': [386.3070068359375, 123.7030029296875, 480.1470031738281, 135.38201904296875], 'label': 'Phone:', 'block_context': 'Precertification Requested By: \\nPhone: \\nFax: \\n'}\n",
            "{'page': 2, 'name': 'T11', 'type': 7, 'rect': [501.19500732421875, 123.69598388671875, 593.594970703125, 135.375], 'label': 'Fax:', 'block_context': ''}\n",
            "{'page': 2, 'name': 'T12', 'type': 7, 'rect': [62.843101501464844, 150.93402099609375, 230.375, 162.61297607421875], 'label': 'Patient First Name', 'block_context': 'First Name:  \\nLast Name:  \\nDOB:  \\n'}\n",
            "{'page': 2, 'name': 'T13', 'type': 7, 'rect': [277.2619934082031, 150.93402099609375, 501.9209899902344, 162.61297607421875], 'label': 'Patient Last Name', 'block_context': 'First Name:  \\nLast Name:  \\nDOB:  \\n'}\n",
            "{'page': 2, 'name': 'T14', 'type': 7, 'rect': [526.2670288085938, 150.93402099609375, 592.1160278320312, 162.61297607421875], 'label': 'Patient DOB (MM/DD/YYYY)', 'block_context': 'First Name:  \\nLast Name:  \\nDOB:  \\n'}\n",
            "{'page': 2, 'name': 'T15', 'type': 7, 'rect': [52.88520050048828, 164.8270263671875, 327.07598876953125, 176.5059814453125], 'label': 'Address:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T16', 'type': 7, 'rect': [347.5299987792969, 164.8270263671875, 443.9800109863281, 176.5059814453125], 'label': 'City:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T17', 'type': 7, 'rect': [469.6700134277344, 164.8270263671875, 501.9209899902344, 176.5059814453125], 'label': 'State:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T18', 'type': 7, 'rect': [521.6199951171875, 164.8270263671875, 592.1160278320312, 176.5059814453125], 'label': 'ZIP:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T19', 'type': 7, 'rect': [69.14689636230469, 179.32098388671875, 151.4929962158203, 191.0], 'label': 'Patient Phone', 'block_context': 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n'}\n",
            "{'page': 2, 'name': 'T20', 'type': 7, 'rect': [201.93499755859375, 179.32098388671875, 286.2969970703125, 191.0], 'label': 'Work Phone:', 'block_context': 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n'}\n",
            "{'page': 2, 'name': 'T21', 'type': 7, 'rect': [332.29400634765625, 179.44097900390625, 421.7250061035156, 191.1199951171875], 'label': 'Cell Phone:', 'block_context': 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T22', 'type': 7, 'rect': [450.6510009765625, 179.44097900390625, 592.1160278320312, 191.1199951171875], 'label': 'E-mail:', 'block_context': ''}\n",
            "{'page': 2, 'name': 'T24', 'type': 7, 'rect': [78.66909790039062, 194.8740234375, 100.60900115966797, 206.552978515625], 'label': 'lbs', 'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n'}\n",
            "{'page': 2, 'name': 'T25', 'type': 7, 'rect': [128.6300048828125, 194.989990234375, 151.65899658203125, 206.66900634765625], 'label': 'kgs', 'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n'}\n",
            "{'page': 2, 'name': 'T26', 'type': 7, 'rect': [216.36099243164062, 194.93597412109375, 239.2469940185547, 206.614990234375], 'label': 'inches', 'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n'}\n",
            "{'page': 2, 'name': 'T27', 'type': 7, 'rect': [280.114990234375, 194.85400390625, 303.5719909667969, 206.53302001953125], 'label': 'cms', 'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n'}\n",
            "{'page': 2, 'name': 'T23', 'type': 7, 'rect': [363.9159851074219, 195.40802001953125, 592.1160278320312, 207.08697509765625], 'label': 'Allergies:', 'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n'}\n",
            "{'page': 2, 'name': 'T28', 'type': 7, 'rect': [72.4458999633789, 222.19500732421875, 229.36099243164062, 232.90301513671875], 'label': 'Member ID #:', 'block_context': 'Member ID #:  \\nGroup #:  \\nInsured:  \\n'}\n",
            "{'page': 2, 'name': 'T29', 'type': 7, 'rect': [55.536800384521484, 233.70098876953125, 229.41600036621094, 244.40899658203125], 'label': 'Group #:', 'block_context': 'Member ID #:  \\nGroup #:  \\nInsured:  \\n'}\n",
            "{'page': 2, 'name': 'T30', 'type': 7, 'rect': [53.76750183105469, 244.69598388671875, 229.44700622558594, 254.6669921875], 'label': 'Insured:', 'block_context': 'Member ID #:  \\nGroup #:  \\nInsured:  \\n'}\n",
            "{'page': 2, 'name': 'CB31', 'type': 2, 'rect': [386.09100341796875, 222.927978515625, 396.39300537109375, 233.4840087890625], 'label': 'Yes', 'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n'}\n",
            "{'page': 2, 'name': 'CB32', 'type': 2, 'rect': [415.6910095214844, 222.906982421875, 425.99200439453125, 233.4630126953125], 'label': 'No', 'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n'}\n",
            "{'page': 2, 'name': 'T33', 'type': 7, 'rect': [304.1390075683594, 233.13201904296875, 386.218994140625, 244.40899658203125], 'label': 'If yes, provide ID#:', 'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T34', 'type': 7, 'rect': [440.7279968261719, 233.13201904296875, 588.68798828125, 244.40899658203125], 'label': 'Carrier Name:', 'block_context': ''}\n",
            "{'page': 2, 'name': 'T35', 'type': 7, 'rect': [266.8479919433594, 245.7550048828125, 588.68798828125, 256.031982421875], 'label': 'Insured:', 'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n'}\n",
            "{'page': 2, 'name': 'T42', 'type': 7, 'rect': [61.66939926147461, 272.82098388671875, 231.23199462890625, 283.5010070800781], 'label': 'First Name:', 'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n'}\n",
            "{'page': 2, 'name': 'T43', 'type': 7, 'rect': [277.4209899902344, 272.81097412109375, 395.2850036621094, 283.4909973144531], 'label': 'Last Name:', 'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n'}\n",
            "{'page': 2, 'name': 'CB44', 'type': 2, 'rect': [453.2449951171875, 271.9940185546875, 463.5469970703125, 282.5509948730469], 'label': 'M.D.', 'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n'}\n",
            "{'page': 2, 'name': 'CB45', 'type': 2, 'rect': [490.072998046875, 271.98297119140625, 500.375, 282.5400085449219], 'label': 'D.O.', 'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n'}\n",
            "{'page': 2, 'name': 'CB46', 'type': 2, 'rect': [526.3419799804688, 272.0040283203125, 536.6439819335938, 282.5610046386719], 'label': 'N.P.', 'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n'}\n",
            "{'page': 2, 'name': 'CB47', 'type': 2, 'rect': [561.6890258789062, 271.98297119140625, 571.9910278320312, 282.5400085449219], 'label': 'P.A.', 'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n'}\n",
            "{'page': 2, 'name': 'T48', 'type': 7, 'rect': [52.40890121459961, 287.9179992675781, 326.39801025390625, 298.5979919433594], 'label': 'Address:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T49', 'type': 7, 'rect': [347.1679992675781, 287.9179992675781, 443.7019958496094, 298.5979919433594], 'label': 'City:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T50', 'type': 7, 'rect': [470.031005859375, 287.8869934082031, 502.8450012207031, 298.5669860839844], 'label': 'State:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T51', 'type': 7, 'rect': [521.7979736328125, 287.8869934082031, 592.8610229492188, 298.5669860839844], 'label': 'ZIP:', 'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'T52', 'type': 7, 'rect': [45.78519821166992, 302.1709899902344, 113.06099700927734, 312.85101318359375], 'label': 'Phone:', 'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n'}\n",
            "{'page': 2, 'name': 'T53', 'type': 7, 'rect': [132.92300415039062, 302.1709899902344, 209.58200073242188, 312.85101318359375], 'label': 'Fax:', 'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n'}\n",
            "{'page': 2, 'name': 'T54', 'type': 7, 'rect': [243.28700256347656, 302.1709899902344, 326.14599609375, 312.85101318359375], 'label': 'St Lic #:', 'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n'}\n",
            "{'page': 2, 'name': 'T55', 'type': 7, 'rect': [353.95098876953125, 302.1709899902344, 417.0400085449219, 312.85101318359375], 'label': 'NPI #:', 'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n'}\n",
            "{'page': 2, 'name': 'T56', 'type': 7, 'rect': [446.7349853515625, 302.1709899902344, 502.8450012207031, 312.85101318359375], 'label': 'DEA #:', 'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n'}\n",
            "{'page': 2, 'name': 'T57', 'type': 7, 'rect': [527.7540283203125, 302.1499938964844, 592.8610229492188, 312.8299865722656], 'label': 'UPIN:', 'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n'}\n",
            "{'page': 2, 'name': 'T58.0', 'type': 7, 'rect': [74.67269897460938, 317.27301025390625, 209.50900268554688, 327.9530029296875], 'label': 'Provider Email:', 'block_context': 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n'}\n",
            "{'page': 2, 'name': 'T58.1', 'type': 7, 'rect': [290.1669921875, 317.27301025390625, 417.0400085449219, 327.9530029296875], 'label': 'Office Contact Name:', 'block_context': 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n'}\n",
            "{'page': 2, 'name': 'T59', 'type': 7, 'rect': [446.9049987792969, 317.27301025390625, 592.8610229492188, 327.9530029296875], 'label': 'Phone:', 'block_context': 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.1', 'type': 2, 'rect': [22.34000015258789, 352.0459899902344, 32.375999450683594, 362.5190124511719], 'label': 'Self-administered', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.2', 'type': 2, 'rect': [107.87300109863281, 352.0790100097656, 117.90899658203125, 362.552001953125], 'label': 'Physician’s Office', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.3', 'type': 2, 'rect': [194.05499267578125, 352.0790100097656, 204.09100341796875, 362.552001953125], 'label': 'Home', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.4', 'type': 2, 'rect': [22.34000015258789, 362.49700927734375, 32.375999450683594, 372.9700012207031], 'label': 'Outpatient Infusion Center', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.5', 'type': 7, 'rect': [157.18699645996094, 362.43499755859375, 320.2829895019531, 373.0169982910156], 'label': 'Name:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.7', 'type': 2, 'rect': [22.34000015258789, 372.5169982910156, 32.375999450683594, 382.989990234375], 'label': 'Home Infusion Center', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.6', 'type': 7, 'rect': [165.0959930419922, 373.2980041503906, 320.2829895019531, 383.8800048828125], 'label': 'Phone:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.8', 'type': 7, 'rect': [111.47799682617188, 383.5799865722656, 320.2829895019531, 394.1619873046875], 'label': 'Agency Name:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.10', 'type': 2, 'rect': [22.34000015258789, 393.0249938964844, 32.375999450683594, 403.49798583984375], 'label': 'Administration code(s)', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.9', 'type': 7, 'rect': [143.82699584960938, 393.6579895019531, 320.2829895019531, 404.239990234375], 'label': 'CPT:', 'block_context': ''}\n",
            "{'page': 2, 'name': 'Provider Admin T.11A', 'type': 7, 'rect': [56.31019973754883, 403.95599365234375, 320.2829895019531, 414.5379943847656], 'label': 'Address:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.13', 'type': 7, 'rect': [40.63639831542969, 415.3280029296875, 167.3459930419922, 425.9100036621094], 'label': 'City:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.14', 'type': 7, 'rect': [193.09100341796875, 415.3280029296875, 229.23599243164062, 425.9100036621094], 'label': 'State:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.15', 'type': 7, 'rect': [246.7010040283203, 415.7640075683594, 320.2829895019531, 426.34600830078125], 'label': 'ZIP:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.16', 'type': 7, 'rect': [49.74549865722656, 425.79998779296875, 167.3459930419922, 436.3819885253906], 'label': 'Phone:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.17A', 'type': 7, 'rect': [189.15499877929688, 425.79998779296875, 320.2829895019531, 436.3819885253906], 'label': 'Fax:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.18', 'type': 7, 'rect': [39.92729949951172, 437.27301025390625, 167.3459930419922, 447.8550109863281], 'label': 'TIN:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.19', 'type': 7, 'rect': [189.15499877929688, 437.27301025390625, 320.2829895019531, 447.8550109863281], 'label': 'PIN:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.20', 'type': 7, 'rect': [39.86439895629883, 448.2250061035156, 320.2829895019531, 458.8070068359375], 'label': 'NPI:', 'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.21', 'type': 2, 'rect': [331.30499267578125, 352.072998046875, 341.34100341796875, 362.5459899902344], 'label': 'Outpatient Dialysis Center', 'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.22', 'type': 2, 'rect': [448.74798583984375, 352.0220031738281, 458.78399658203125, 362.4949951171875], 'label': 'Physician’s Office', 'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.23.0.0', 'type': 2, 'rect': [331.2909851074219, 363.12799072265625, 341.3269958496094, 373.60101318359375], 'label': 'Retail Pharmacy', 'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.24.0.0', 'type': 2, 'rect': [448.6730041503906, 363.12799072265625, 458.7090148925781, 373.60101318359375], 'label': 'Specialty Pharmacy', 'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.25', 'type': 2, 'rect': [331.2909851074219, 374.8550109863281, 341.3269958496094, 385.3280029296875], 'label': 'Mail Order', 'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin CB.26', 'type': 2, 'rect': [448.6730041503906, 374.8550109863281, 458.7090148925781, 385.3280029296875], 'label': 'Other:', 'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.27', 'type': 7, 'rect': [484.71099853515625, 374.8219909667969, 591.8259887695312, 385.8489990234375], 'label': 'Other:', 'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.28', 'type': 7, 'rect': [356.0669860839844, 386.92401123046875, 591.8259887695312, 398.0429992675781], 'label': 'Name:', 'block_context': 'Name: \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.29a', 'type': 7, 'rect': [363.8489990234375, 399.135009765625, 591.8259887695312, 410.2539978027344], 'label': 'Address:', 'block_context': 'Address:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.30a', 'type': 7, 'rect': [349.0429992675781, 411.1409912109375, 448.72601318359375, 422.1679992675781], 'label': 'City:', 'block_context': 'City:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.31', 'type': 7, 'rect': [476.072998046875, 411.2590026855469, 513.3820190429688, 422.1679992675781], 'label': 'State:', 'block_context': 'City:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.32', 'type': 7, 'rect': [533.135009765625, 411.2590026855469, 591.8259887695312, 422.1679992675781], 'label': 'ZIP:', 'block_context': 'City:  \\nState:  \\nZIP:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.33', 'type': 7, 'rect': [359.12799072265625, 423.7099914550781, 466.9100036621094, 434.6189880371094], 'label': 'Phone:', 'block_context': 'Phone:  \\n Fax:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.34', 'type': 7, 'rect': [488.0799865722656, 423.7099914550781, 591.8259887695312, 434.6189880371094], 'label': 'Fax:', 'block_context': 'Phone:  \\n Fax:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.35', 'type': 7, 'rect': [349.09100341796875, 436.05499267578125, 466.9100036621094, 446.9639892578125], 'label': 'TIN:', 'block_context': 'TIN: \\n PIN:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.36', 'type': 7, 'rect': [488.08099365234375, 436.05499267578125, 591.8259887695312, 446.9639892578125], 'label': 'PIN:', 'block_context': 'TIN: \\n PIN:  \\n'}\n",
            "{'page': 2, 'name': 'Provider Admin T.37', 'type': 7, 'rect': [349.0989990234375, 447.89801025390625, 591.8259887695312, 458.8070068359375], 'label': 'NPI:', 'block_context': ''}\n",
            "{'page': 2, 'name': 'CB60', 'type': 2, 'rect': [82.12529754638672, 475.0929870605469, 92.31230163574219, 485.68701171875], 'label': 'Riabni (rituximab-arrx)', 'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n'}\n",
            "{'page': 2, 'name': 'CB61', 'type': 2, 'rect': [188.06199645996094, 475.0929870605469, 198.24899291992188, 485.68701171875], 'label': 'Rituxan (rituximab)', 'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n'}\n",
            "{'page': 2, 'name': 'CB62', 'type': 2, 'rect': [281.27899169921875, 475.177001953125, 291.46600341796875, 485.77099609375], 'label': 'Ruxience (rituximab-pvvr)', 'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n'}\n",
            "{'page': 2, 'name': 'CB63', 'type': 2, 'rect': [398.927001953125, 475.177001953125, 409.114013671875, 485.77099609375], 'label': 'Truxima (rituximab-abbs)', 'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n'}\n",
            "{'page': 2, 'name': 'T64', 'type': 7, 'rect': [45.61000061035156, 487.57000732421875, 225.343994140625, 498.47900390625], 'label': 'Dose:', 'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n'}\n",
            "{'page': 2, 'name': 'T65', 'type': 7, 'rect': [308.4649963378906, 487.57000732421875, 459.3169860839844, 498.47900390625], 'label': 'Directions for Use:', 'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T66', 'type': 7, 'rect': [524.906005859375, 487.57000732421875, 589.9249877929688, 498.47900390625], 'label': 'HCPCS Code:', 'block_context': ''}\n",
            "{'page': 2, 'name': 'T67', 'type': 7, 'rect': [97.97879791259766, 518.5599975585938, 270.3380126953125, 529.259033203125], 'label': 'Primary ICD Code:', 'block_context': 'Primary ICD Code: \\n Other ICD Code: \\n'}\n",
            "{'page': 2, 'name': 'CB68', 'type': 2, 'rect': [292.47198486328125, 518.5599975585938, 302.77398681640625, 529.259033203125], 'label': 'Other ICD Code:', 'block_context': 'Primary ICD Code: \\n Other ICD Code: \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T69', 'type': 7, 'rect': [370.33099365234375, 518.5599975585938, 589.5579833984375, 529.259033203125], 'label': 'Other ICD Code:', 'block_context': ''}\n",
            "{'page': 2, 'name': 'CB70', 'type': 2, 'rect': [22.825700759887695, 584.4249877929688, 33.12770080566406, 594.9819946289062], 'label': 'Yes', 'block_context': 'Has the patient had prior therapy with the requested product within the last 365 days? \\n Yes\\n No\\n'}\n",
            "{'page': 2, 'name': 'CB71', 'type': 2, 'rect': [52.699501037597656, 584.6510009765625, 62.623199462890625, 594.9819946289062], 'label': 'No', 'block_context': 'Note: Riabni and Rituxan are non-preferred. Ruxience and Truxima are the preferred biosimilars for most indications. \\nFor rheumatoid arthritis, all Rituxan and biosimilar products are non-preferred. Inflectra, Renflexis and Simponi Aria are preferred for MA plans. \\nEnbrel, Humira, Idacio, Rinvoq, Tyenne SC and Xeljanz/Xeljanz XR are preferred for MAPD plans. \\n'}\n",
            "{'page': 2, 'name': 'CB72', 'type': 2, 'rect': [52.699501037597656, 596.738037109375, 62.623199462890625, 607.0689697265625], 'label': 'No', 'block_context': ' No \\n'}\n",
            "{'page': 2, 'name': 'CB73', 'type': 2, 'rect': [81.47090148925781, 606.9550170898438, 91.65750122070312, 617.5490112304688], 'label': 'Ruxience (rituximab-pvvr)', 'block_context': ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n'}\n",
            "{'page': 2, 'name': 'CB74', 'type': 2, 'rect': [190.92300415039062, 606.9550170898438, 201.11000061035156, 617.5490112304688], 'label': 'Truxima (rituximab-abbs)', 'block_context': ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T75', 'type': 7, 'rect': [315.31298828125, 617.7750244140625, 585.489013671875, 628.6840209960938], 'label': 'When was the member’s trial and failure of the preferred drug?', 'block_context': ''}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T76', 'type': 7, 'rect': [315.31298828125, 630.634033203125, 585.489013671875, 641.54296875], 'label': 'Please describe the nature of the failure of the preferred drug', 'block_context': ''}\n",
            "{'page': 2, 'name': 'CB77', 'type': 2, 'rect': [52.699501037597656, 642.22998046875, 63.001399993896484, 652.7869873046875], 'label': 'No', 'block_context': ' No\\n'}\n",
            "{'page': 2, 'name': 'CB78', 'type': 2, 'rect': [81.47090148925781, 653.0399780273438, 91.65750122070312, 663.634033203125], 'label': 'Ruxience (rituximab-pvvr)', 'block_context': ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n'}\n",
            "{'page': 2, 'name': 'CB79', 'type': 2, 'rect': [190.92300415039062, 653.0399780273438, 201.11000061035156, 663.634033203125], 'label': 'Truxima (rituximab-abbs)', 'block_context': ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n'}\n",
            "{'page': 2, 'name': 'T80', 'type': 7, 'rect': [315.31298828125, 664.2340087890625, 585.489013671875, 675.1430053710938], 'label': 'When was the member’s adverse reaction to the preferred drug?', 'block_context': ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 2, 'name': 'T81', 'type': 7, 'rect': [342.1499938964844, 676.0919799804688, 585.489013671875, 687.0009765625], 'label': 'Please describe the nature of the adverse reaction to the preferred drug', 'block_context': ''}\n",
            "{'page': 2, 'name': 'T84', 'type': 7, 'rect': [22.731800079345703, 720.555908203125, 585.489013671875, 731.4649047851562], 'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?', 'block_context': ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n'}\n",
            "{'page': 2, 'name': 'CB82', 'type': 2, 'rect': [22.825700759887695, 708.5637817382812, 33.12770080566406, 719.1207885742188], 'label': 'Ruxience (rituximab-pvvr)', 'block_context': ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n'}\n",
            "{'page': 2, 'name': 'CB83', 'type': 2, 'rect': [131.9810028076172, 708.4747924804688, 141.90499877929688, 718.8057861328125], 'label': 'Truxima (rituximab-abbs)', 'block_context': ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n'}\n",
            "{'page': 3, 'name': 'T12', 'type': 7, 'rect': [19.95840072631836, 128.02301025390625, 164.60400390625, 140.68499755859375], 'label': 'Patient First Name', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 3, 'name': 'T13', 'type': 7, 'rect': [168.7469940185547, 128.02301025390625, 348.12200927734375, 140.68499755859375], 'label': 'Patient Last Name', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 3, 'name': 'T19', 'type': 7, 'rect': [353.4530029296875, 128.02301025390625, 465.8210144042969, 140.68499755859375], 'label': 'Patient Phone', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 3, 'name': 'T14', 'type': 7, 'rect': [470.8710021972656, 128.02301025390625, 591.301025390625, 140.68499755859375], 'label': 'Patient DOB (MM/DD/YYYY)', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 3, 'name': 'CB86', 'type': 2, 'rect': [81.38929748535156, 178.2750244140625, 91.69129943847656, 188.83197021484375], 'label': 'Inflectra (infliximab-dyyb)', 'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n'}\n",
            "{'page': 3, 'name': 'CB87', 'type': 2, 'rect': [188.22500610351562, 178.3590087890625, 198.26100158691406, 188.83197021484375], 'label': 'Renflexis (infliximab-abda)', 'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n'}\n",
            "{'page': 3, 'name': 'CB88', 'type': 2, 'rect': [300.7449951171875, 178.3590087890625, 310.781005859375, 188.83197021484375], 'label': 'Simponi Aria (golimumab)', 'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n'}\n",
            "{'page': 3, 'name': 'T89', 'type': 7, 'rect': [314.85101318359375, 189.10797119140625, 582.4080200195312, 199.8070068359375], 'label': 'When was the member’s trial and failure of the preferred drug?', 'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 3, 'name': 'T90', 'type': 7, 'rect': [314.85101318359375, 201.96600341796875, 582.4080200195312, 212.66497802734375], 'label': 'Please describe the nature of the failure of the preferred drug', 'block_context': ''}\n",
            "{'page': 3, 'name': 'CB85', 'type': 2, 'rect': [52.34349822998047, 168.1290283203125, 62.64540100097656, 178.68597412109375], 'label': 'No', 'block_context': ' No\\n'}\n",
            "{'page': 3, 'name': 'CB92', 'type': 2, 'rect': [81.38929748535156, 223.86602783203125, 91.69129943847656, 234.4229736328125], 'label': 'Inflectra (infliximab-dyyb)', 'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n'}\n",
            "{'page': 3, 'name': 'CB93', 'type': 2, 'rect': [188.552001953125, 223.95001220703125, 198.58799743652344, 234.4229736328125], 'label': 'Renflexis (infliximab-abda)', 'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n'}\n",
            "{'page': 3, 'name': 'CB94', 'type': 2, 'rect': [301.4179992675781, 223.95001220703125, 311.4540100097656, 234.4229736328125], 'label': 'Simponi Aria (golimumab)', 'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n'}\n",
            "{'page': 3, 'name': 'T95', 'type': 7, 'rect': [314.85101318359375, 235.56597900390625, 582.4080200195312, 246.2650146484375], 'label': 'When was the member’s adverse reaction to the preferred drug?', 'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n'}\n",
            "{'page': 3, 'name': 'T96a', 'type': 7, 'rect': [342.0140075683594, 247.42401123046875, 582.4080200195312, 258.12298583984375], 'label': 'Please describe the nature of the adverse reaction to the preferred drug', 'block_context': '  \\n'}\n",
            "{'page': 3, 'name': 'CB91', 'type': 2, 'rect': [52.34349822998047, 214.0479736328125, 62.64540100097656, 224.60498046875], 'label': 'No', 'block_context': ' No\\n'}\n",
            "{'page': 3, 'name': 'CB98a', 'type': 2, 'rect': [81.38929748535156, 269.666015625, 91.69129943847656, 280.2229919433594], 'label': 'Enbrel (etanercept)', 'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB99a', 'type': 2, 'rect': [168.93499755859375, 269.75, 178.9709930419922, 280.2229919433594], 'label': 'Humira (adalimumab)', 'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB100a', 'type': 2, 'rect': [263.5639953613281, 269.75, 273.6000061035156, 280.2229919433594], 'label': 'Idacio (adalimumab-aacf)', 'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB101a', 'type': 2, 'rect': [371.9209899902344, 269.75, 381.9570007324219, 280.2229919433594], 'label': 'Rinvoq (upadacitinib)', 'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB102a', 'type': 2, 'rect': [465.09600830078125, 269.75, 475.1319885253906, 280.2229919433594], 'label': 'Tyenne SC (tocilizumab-aazg)', 'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB103a', 'type': 2, 'rect': [81.38929748535156, 280.92999267578125, 91.69129943847656, 291.48699951171875], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)', 'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 3, 'name': 'T104', 'type': 7, 'rect': [314.85101318359375, 294.3110046386719, 582.4080200195312, 305.010009765625], 'label': 'When was the member’s trial and failure of the preferred drug?', 'block_context': ''}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 3, 'name': 'T105', 'type': 7, 'rect': [314.85101318359375, 306.16900634765625, 582.4080200195312, 316.8680114746094], 'label': 'Please describe the nature of the failure of the preferred drug', 'block_context': ''}\n",
            "{'page': 3, 'name': 'CB97', 'type': 2, 'rect': [52.34349822998047, 260.1939697265625, 62.64540100097656, 270.7509765625], 'label': 'No', 'block_context': ' No\\n'}\n",
            "{'page': 3, 'name': 'CB107z', 'type': 2, 'rect': [81.38929748535156, 328.5570068359375, 91.69129943847656, 339.114013671875], 'label': 'Enbrel (etanercept)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB108z', 'type': 2, 'rect': [168.93499755859375, 328.6409912109375, 178.9709930419922, 339.114013671875], 'label': 'Humira (adalimumab)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB109z', 'type': 2, 'rect': [263.5639953613281, 328.6409912109375, 273.6000061035156, 339.114013671875], 'label': 'Idacio (adalimumab-aacf)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB110z', 'type': 2, 'rect': [371.9209899902344, 328.6409912109375, 381.9570007324219, 339.114013671875], 'label': 'Rinvoq (upadacitinib)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB111z', 'type': 2, 'rect': [465.0780029296875, 328.6409912109375, 475.114013671875, 339.114013671875], 'label': 'Tyenne SC (tocilizumab-aazg)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB112z', 'type': 2, 'rect': [81.38929748535156, 339.8210144042969, 91.69129943847656, 350.37799072265625], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'T113', 'type': 7, 'rect': [314.85101318359375, 352.33599853515625, 582.4080200195312, 363.0360107421875], 'label': 'When was the member’s adverse reaction to the preferred drug?', 'block_context': '   \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 3, 'name': 'T114', 'type': 7, 'rect': [342.34100341796875, 364.19500732421875, 582.4080200195312, 374.8940124511719], 'label': 'Please describe the nature of the adverse reaction to the preferred drug', 'block_context': ''}\n",
            "{'page': 3, 'name': 'CB106z', 'type': 2, 'rect': [52.34349822998047, 318.0840148925781, 62.64540100097656, 328.6419982910156], 'label': 'No', 'block_context': ' No\\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 3, 'name': 'T118', 'type': 7, 'rect': [22.0226993560791, 409.406005859375, 582.4080200195312, 420.85198974609375], 'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?', 'block_context': ''}\n",
            "{'page': 3, 'name': 'CB115z', 'type': 2, 'rect': [22.401899337768555, 397.3210144042969, 32.70389938354492, 407.87799072265625], 'label': 'Inflectra (infliximab-dyyb)', 'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n'}\n",
            "{'page': 3, 'name': 'CB116z', 'type': 2, 'rect': [129.55799865722656, 397.4049987792969, 139.593994140625, 407.87799072265625], 'label': 'Renflexis (infliximab-abda)', 'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n'}\n",
            "{'page': 3, 'name': 'CB117z', 'type': 2, 'rect': [241.75100708007812, 397.4049987792969, 251.78700256347656, 407.87799072265625], 'label': 'Simponi Aria (golimumab)', 'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n'}\n",
            "[INFO] No overlapping blocks found for this field.\n",
            "{'page': 3, 'name': 'T125', 'type': 7, 'rect': [22.0226993560791, 464.6180114746094, 582.4080200195312, 476.0639953613281], 'label': 'Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?', 'block_context': ''}\n",
            "{'page': 3, 'name': 'CB119z', 'type': 2, 'rect': [22.401899337768555, 441.5849914550781, 32.70389938354492, 452.1409912109375], 'label': 'Enbrel (etanercept)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB120z', 'type': 2, 'rect': [109.67500305175781, 441.5469970703125, 119.86100006103516, 452.1409912109375], 'label': 'Humira (adalimumab)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB121z', 'type': 2, 'rect': [201.76400756835938, 441.5469970703125, 211.9499969482422, 452.1409912109375], 'label': 'Idacio (adalimumab-aacf)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB122z', 'type': 2, 'rect': [310.4049987792969, 441.5379943847656, 320.5840148925781, 452.1409912109375], 'label': 'Rinvoq (upadacitinib)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB123z', 'type': 2, 'rect': [401.4320068359375, 441.5379943847656, 411.6109924316406, 452.1409912109375], 'label': 'Tyenne SC (tocilizumab-aazg)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB124z', 'type': 2, 'rect': [22.401899337768555, 452.5150146484375, 32.58890151977539, 463.1090087890625], 'label': 'Xeljanz/Xeljanz XR (tofacitinib)', 'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n'}\n",
            "{'page': 3, 'name': 'CB96.4.0', 'type': 2, 'rect': [22.401899337768555, 489.9960021972656, 32.58890151977539, 500.5899963378906], 'label': 'Yes', 'block_context': 'Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)? \\n Yes\\n No \\n'}\n",
            "{'page': 3, 'name': 'CB98', 'type': 2, 'rect': [52.02109909057617, 490.0329895019531, 62.323001861572266, 500.5899963378906], 'label': 'No', 'block_context': 'Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)? \\n Yes\\n No \\n'}\n",
            "{'page': 3, 'name': 'CB99.0', 'type': 2, 'rect': [22.401899337768555, 512.27001953125, 32.70389938354492, 522.8270263671875], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n'}\n",
            "{'page': 3, 'name': 'CB100.0', 'type': 2, 'rect': [52.02109909057617, 512.6729736328125, 61.89899826049805, 522.8060302734375], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n'}\n",
            "{'page': 3, 'name': 'CB101.0', 'type': 2, 'rect': [22.401899337768555, 523.8699951171875, 32.70389938354492, 534.427001953125], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n'}\n",
            "{'page': 3, 'name': 'CB102.0', 'type': 2, 'rect': [52.02109909057617, 523.8699951171875, 62.323001861572266, 534.427001953125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n'}\n",
            "{'page': 3, 'name': 'CB103', 'type': 2, 'rect': [22.401899337768555, 546.2080078125, 32.703800201416016, 556.7650146484375], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia? \\n Yes\\n No \\n'}\n",
            "{'page': 3, 'name': 'CB104', 'type': 2, 'rect': [52.02109909057617, 546.218017578125, 62.323001861572266, 556.7750244140625], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia? \\n Yes\\n No \\n'}\n",
            "{'page': 3, 'name': 'CB104a', 'type': 2, 'rect': [238.76499938964844, 568.7449951171875, 249.0659942626953, 579.301025390625], 'label': 'Wegener granulomatosis', 'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n'}\n",
            "{'page': 3, 'name': 'CB104b', 'type': 2, 'rect': [351.2770080566406, 568.7249755859375, 361.5780029296875, 579.281005859375], 'label': 'Churg-Strauss syndrome', 'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n'}\n",
            "{'page': 3, 'name': 'CB104c', 'type': 2, 'rect': [238.77499389648438, 579.343017578125, 249.0760040283203, 589.8989868164062], 'label': 'microscopic polyangiitis', 'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n'}\n",
            "{'page': 3, 'name': 'CB104d', 'type': 2, 'rect': [351.2860107421875, 579.3330078125, 361.5880126953125, 589.8890380859375], 'label': 'pauci-immune glomerulonephritis', 'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n'}\n",
            "{'page': 3, 'name': 'CB105', 'type': 2, 'rect': [22.401899337768555, 591.3099975585938, 32.703800201416016, 601.865966796875], 'label': 'Yes', 'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n'}\n",
            "{'page': 3, 'name': 'CB106', 'type': 2, 'rect': [52.02109909057617, 591.3410034179688, 62.323001861572266, 601.89697265625], 'label': 'No', 'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n'}\n",
            "{'page': 3, 'name': 'CB106a', 'type': 2, 'rect': [22.401899337768555, 613.6580200195312, 32.703800201416016, 624.2139892578125], 'label': 'Yes', 'block_context': ' Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease? \\n Yes\\n'}\n",
            "{'page': 3, 'name': 'CB107', 'type': 2, 'rect': [234.27999877929688, 623.35400390625, 244.58099365234375, 633.9100341796875], 'label': 'pemphigus vulgaris', 'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n'}\n",
            "{'page': 3, 'name': 'CB108', 'type': 2, 'rect': [321.2820129394531, 623.343017578125, 331.5830078125, 633.9000244140625], 'label': 'pemphigus folliaceus', 'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n'}\n",
            "{'page': 3, 'name': 'CB109', 'type': 2, 'rect': [414.0069885253906, 623.3370361328125, 424.3080139160156, 633.8930053710938], 'label': 'bullous pemphigoid', 'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n'}\n",
            "{'page': 3, 'name': 'CB110', 'type': 2, 'rect': [501.04901123046875, 623.322998046875, 511.3500061035156, 633.8800048828125], 'label': 'cicatricial pemphigoid', 'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n'}\n",
            "{'page': 3, 'name': 'CB111', 'type': 2, 'rect': [234.29100036621094, 633.9869995117188, 244.5919952392578, 644.5440063476562], 'label': 'epidermolysis bullosa acquisita', 'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n'}\n",
            "{'page': 3, 'name': 'CB112', 'type': 2, 'rect': [362.60101318359375, 633.9970092773438, 372.9020080566406, 644.5540161132812], 'label': 'paraneoplastic pemphigus', 'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n'}\n",
            "{'page': 3, 'name': 'CB113', 'type': 2, 'rect': [473.9859924316406, 633.9830322265625, 484.2869873046875, 644.5390014648438], 'label': 'None of the above', 'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n'}\n",
            "{'page': 3, 'name': 'CB106b', 'type': 2, 'rect': [52.02109909057617, 613.66796875, 62.323001861572266, 624.2249755859375], 'label': 'No', 'block_context': ' Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease? \\n Yes\\n'}\n",
            "{'page': 3, 'name': 'CB114', 'type': 2, 'rect': [175.54200744628906, 655.4459838867188, 185.843994140625, 666.0029907226562], 'label': 'AIDS-related B-cell lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB115', 'type': 2, 'rect': [301.32501220703125, 655.4459838867188, 311.62701416015625, 666.0029907226562], 'label': 'Burkitt lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB116', 'type': 2, 'rect': [380.8210144042969, 655.4459838867188, 391.12298583984375, 666.0029907226562], 'label': 'Diffuse large B-cell lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB117', 'type': 2, 'rect': [505.20098876953125, 655.4459838867188, 515.5029907226562, 666.0029907226562], 'label': 'Follicular lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB118', 'type': 2, 'rect': [175.54200744628906, 665.8720092773438, 185.843994140625, 676.4290161132812], 'label': 'Gastric MALT lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB119', 'type': 2, 'rect': [281.6090087890625, 665.8720092773438, 291.9110107421875, 676.4290161132812], 'label': 'High-grade B-Cell lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB120', 'type': 2, 'rect': [403.06201171875, 665.8720092773438, 413.364013671875, 676.4290161132812], 'label': 'Mantle cell lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB121', 'type': 2, 'rect': [175.54200744628906, 676.5670166015625, 185.843994140625, 687.1240234375], 'label': 'Nodal marginal zone lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB122', 'type': 2, 'rect': [306.08599853515625, 676.5670166015625, 316.38800048828125, 687.1240234375], 'label': 'Nongastric MALT lymphoma', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB123', 'type': 2, 'rect': [425.44000244140625, 676.5670166015625, 435.74200439453125, 687.1240234375], 'label': 'Primary cutaneous B-cell lymphomas', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 3, 'name': 'CB124', 'type': 2, 'rect': [175.54200744628906, 687.93701171875, 185.843994140625, 698.4945068359375], 'label': 'Splenic marginal zone lymphoma', 'block_context': ' Splenic marginal zone lymphoma\\n Other: \\n'}\n",
            "{'page': 3, 'name': 'CB125', 'type': 2, 'rect': [311.91900634765625, 688.2860107421875, 322.22100830078125, 698.8427124023438], 'label': 'Other:', 'block_context': ' Splenic marginal zone lymphoma\\n Other: \\n'}\n",
            "{'page': 3, 'name': 'T126', 'type': 7, 'rect': [347.5450134277344, 688.0380249023438, 585.0689697265625, 698.70947265625], 'label': 'Other:', 'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n'}\n",
            "{'page': 4, 'name': 'T12', 'type': 7, 'rect': [20.796199798583984, 131.79498291015625, 164.06300354003906, 144.45697021484375], 'label': 'Patient First Name', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 4, 'name': 'T13', 'type': 7, 'rect': [168.93800354003906, 131.79498291015625, 348.9230041503906, 144.45697021484375], 'label': 'Patient Last Name', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 4, 'name': 'T19', 'type': 7, 'rect': [354.30499267578125, 131.79498291015625, 469.82598876953125, 144.45697021484375], 'label': 'Patient Phone', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 4, 'name': 'T14', 'type': 7, 'rect': [475.18701171875, 131.79498291015625, 592.4639892578125, 144.45697021484375], 'label': 'Patient DOB (MM/DD/YYYY)', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 4, 'name': 'CB127', 'type': 2, 'rect': [22.673200607299805, 167.864013671875, 32.975101470947266, 178.4210205078125], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of multicentric Castleman’s disease (angiofollicular lymph node hyperplasia)? \\n Yes\\n No \\n'}\n",
            "{'page': 4, 'name': 'CB128', 'type': 2, 'rect': [52.01240158081055, 167.87298583984375, 62.31420135498047, 178.42999267578125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of multicentric Castleman’s disease (angiofollicular lymph node hyperplasia)? \\n Yes\\n No \\n'}\n",
            "{'page': 4, 'name': 'CB129', 'type': 2, 'rect': [173.50999450683594, 190.15802001953125, 183.81199645996094, 200.71502685546875], 'label': 'leptomeningeal metastases from lymphoma', 'block_context': 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB130', 'type': 2, 'rect': [346.9599914550781, 190.15802001953125, 357.2619934082031, 200.71502685546875], 'label': 'primary CNS lymphoma', 'block_context': 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB131', 'type': 2, 'rect': [449.24700927734375, 190.15802001953125, 459.54901123046875, 200.71502685546875], 'label': 'none of the above', 'block_context': 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB132', 'type': 2, 'rect': [173.1649932861328, 212.5050048828125, 183.4669952392578, 223.06201171875], 'label': 'chronic lymphocytic leukemia (CLL)', 'block_context': 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB133', 'type': 2, 'rect': [317.5360107421875, 212.5050048828125, 327.8380126953125, 223.06201171875], 'label': 'small lymphocytic leukemia', 'block_context': 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB134', 'type': 2, 'rect': [432.5050048828125, 212.5050048828125, 442.8070068359375, 223.06201171875], 'label': 'none of the above', 'block_context': 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB135', 'type': 2, 'rect': [22.673099517822266, 235.28399658203125, 32.975101470947266, 245.84100341796875], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB136', 'type': 2, 'rect': [52.012298583984375, 235.27197265625, 62.31420135498047, 245.8289794921875], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB139', 'type': 2, 'rect': [22.673099517822266, 246.739990234375, 32.975101470947266, 257.2969970703125], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB140', 'type': 2, 'rect': [52.012298583984375, 246.739990234375, 62.31420135498047, 257.2969970703125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB144', 'type': 2, 'rect': [22.673099517822266, 268.89697265625, 32.975101470947266, 279.4539794921875], 'label': 'Yes', 'block_context': 'Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB145', 'type': 2, 'rect': [52.012298583984375, 269.38201904296875, 62.31420135498047, 279.93902587890625], 'label': 'No', 'block_context': 'Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB141', 'type': 2, 'rect': [173.4029998779297, 291.9289855957031, 183.7050018310547, 302.4859924316406], 'label': 'relapsed hairy cell leukemia', 'block_context': 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB142', 'type': 2, 'rect': [290.2030029296875, 291.91900634765625, 300.5050048828125, 302.47601318359375], 'label': 'refractory hairy cell leukemia', 'block_context': 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB143', 'type': 2, 'rect': [410.20599365234375, 291.90899658203125, 420.50799560546875, 302.46600341796875], 'label': 'none of the above', 'block_context': 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n'}\n",
            "{'page': 4, 'name': 'CB137', 'type': 2, 'rect': [22.673099517822266, 313.6650085449219, 32.975101470947266, 324.22198486328125], 'label': 'Yes', 'block_context': ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB146', 'type': 2, 'rect': [239.57899475097656, 334.8080139160156, 249.88099670410156, 345.364990234375], 'label': 'heart transplant recipient', 'block_context': ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB147', 'type': 2, 'rect': [345.38299560546875, 334.7669982910156, 355.68499755859375, 345.3240051269531], 'label': 'other solid organ transplant recipient', 'block_context': ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB138', 'type': 2, 'rect': [52.012298583984375, 313.67401123046875, 62.31420135498047, 324.2309875488281], 'label': 'No', 'block_context': ' No \\n'}\n",
            "{'page': 4, 'name': 'CB148', 'type': 2, 'rect': [293.14898681640625, 357.11199951171875, 303.45098876953125, 367.66900634765625], 'label': 'Bavencio (avelumab)', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'CB149', 'type': 2, 'rect': [386.4150085449219, 357.11199951171875, 396.7170104980469, 367.66900634765625], 'label': 'Imfinzi (durvalumab)', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'CB150', 'type': 2, 'rect': [476.68499755859375, 357.11199951171875, 486.98699951171875, 367.66900634765625], 'label': 'Keytruda (pembrolizumab)', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'CB151', 'type': 2, 'rect': [293.14898681640625, 368.8280029296875, 303.45098876953125, 379.385009765625], 'label': 'Opdivo (nivolumab)', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'CB152', 'type': 2, 'rect': [380.1409912109375, 368.8280029296875, 390.4429931640625, 379.385009765625], 'label': 'Tecentriq (atezolizumab)', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'CB153', 'type': 2, 'rect': [486.5639953613281, 368.8280029296875, 496.8659973144531, 379.385009765625], 'label': 'Yervoy (ipilimumab)', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'CB154', 'type': 2, 'rect': [293.14898681640625, 380.08099365234375, 303.45098876953125, 390.63800048828125], 'label': 'Other:', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'T155', 'type': 7, 'rect': [327.6289978027344, 380.3970031738281, 584.3980102539062, 391.5920104980469], 'label': 'Other:', 'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n'}\n",
            "{'page': 4, 'name': 'CB156', 'type': 2, 'rect': [22.673099517822266, 402.6449890136719, 32.975101470947266, 413.2019958496094], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB158', 'type': 2, 'rect': [90.4845962524414, 413.0060119628906, 100.78600311279297, 423.56201171875], 'label': 'refractory immune thrombocytopenic purpura', 'block_context': ' refractory immune thrombocytopenic purpura\\n idiopathic thrombocytopenic purpura (ITP) \\n No\\n'}\n",
            "{'page': 4, 'name': 'CB159', 'type': 2, 'rect': [268.21099853515625, 413.0060119628906, 278.51300048828125, 423.56201171875], 'label': 'idiopathic thrombocytopenic purpura (ITP)', 'block_context': 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB157', 'type': 2, 'rect': [51.7942008972168, 403.08099365234375, 62.96879959106445, 413.2019958496094], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB160', 'type': 2, 'rect': [22.673099517822266, 435.7309875488281, 32.975101470947266, 446.2879943847656], 'label': 'Yes', 'block_context': 'Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB161', 'type': 2, 'rect': [52.66699981689453, 435.70098876953125, 62.96879959106445, 446.25799560546875], 'label': 'No', 'block_context': 'Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB162', 'type': 2, 'rect': [22.673099517822266, 458.125, 32.975101470947266, 468.6820068359375], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin’s lymphoma? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB163', 'type': 2, 'rect': [52.666900634765625, 458.1050109863281, 62.96879959106445, 468.6619873046875], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin’s lymphoma? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB164', 'type': 2, 'rect': [22.673099517822266, 490.4849853515625, 32.975101470947266, 501.0419921875], 'label': 'Relapsing-remitting MS (RRMS)', 'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB165', 'type': 2, 'rect': [155.08900451660156, 490.4849853515625, 165.39100646972656, 501.0419921875], 'label': 'Secondary-progressive MS (SPMS)', 'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB166', 'type': 2, 'rect': [299.5010070800781, 490.65899658203125, 309.8030090332031, 501.21600341796875], 'label': 'Primary-progressive MS (PPMS)', 'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB167', 'type': 2, 'rect': [433.9739990234375, 490.7030029296875, 444.2760009765625, 501.260009765625], 'label': 'Progressive-relapsing MS (PRMS)', 'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB168', 'type': 2, 'rect': [22.673099517822266, 501.45001220703125, 32.975101470947266, 512.0069580078125], 'label': 'Yes', 'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB169', 'type': 2, 'rect': [52.666900634765625, 501.47100830078125, 62.96879959106445, 512.0280151367188], 'label': 'No', 'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB170', 'type': 2, 'rect': [22.673099517822266, 523.8510131835938, 32.975101470947266, 534.407958984375], 'label': 'Yes', 'block_context': ' Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)? \\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB172', 'type': 2, 'rect': [80.48059844970703, 536.14697265625, 90.78199768066406, 546.7039794921875], 'label': 'Yes', 'block_context': 'Has the patient had an unsatisfactory response to initial immunotherapy? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB173', 'type': 2, 'rect': [110.12899780273438, 536.136962890625, 120.43099975585938, 546.6939697265625], 'label': 'No', 'block_context': 'Has the patient had an unsatisfactory response to initial immunotherapy? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB171', 'type': 2, 'rect': [52.666900634765625, 523.8510131835938, 62.96879959106445, 534.407958984375], 'label': 'No', 'block_context': ' Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)? \\n Yes\\n'}\n",
            "{'page': 4, 'name': 'CB174', 'type': 2, 'rect': [22.673099517822266, 558.5859985351562, 32.975101470947266, 569.1430053710938], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB175', 'type': 2, 'rect': [52.666900634765625, 558.5250244140625, 62.96879959106445, 569.08203125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB176', 'type': 2, 'rect': [22.673099517822266, 569.6649780273438, 32.975101470947266, 580.2219848632812], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB177', 'type': 2, 'rect': [52.666900634765625, 569.614990234375, 62.96879959106445, 580.1719970703125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB178', 'type': 2, 'rect': [22.673099517822266, 591.4509887695312, 32.975101470947266, 602.0079956054688], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n'}\n",
            "{'page': 4, 'name': 'CB179', 'type': 2, 'rect': [52.666900634765625, 591.4199829101562, 62.96879959106445, 601.9769897460938], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n'}\n",
            "{'page': 4, 'name': 'CB180', 'type': 2, 'rect': [22.673099517822266, 603.18701171875, 32.975101470947266, 613.7440185546875], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n'}\n",
            "{'page': 4, 'name': 'T189', 'type': 7, 'rect': [135.4010009765625, 624.9459838867188, 373.4419860839844, 635.29296875], 'label': 'Medication:', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T190', 'type': 7, 'rect': [403.30499267578125, 625.0750122070312, 423.9419860839844, 635.29296875], 'label': 'Date: (MM)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T191', 'type': 7, 'rect': [428.614013671875, 625.0750122070312, 449.25, 635.29296875], 'label': 'Date: (DD)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T192', 'type': 7, 'rect': [452.177001953125, 625.0750122070312, 474.48699951171875, 635.29296875], 'label': 'Date: (YYYY)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T193', 'type': 7, 'rect': [481.57000732421875, 625.0750122070312, 502.2070007324219, 635.29296875], 'label': 'Date: (MM)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T194', 'type': 7, 'rect': [507.2860107421875, 625.0750122070312, 527.9219970703125, 635.29296875], 'label': 'Date: (DD)', 'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n'}\n",
            "{'page': 4, 'name': 'T195', 'type': 7, 'rect': [530.97802734375, 625.0750122070312, 554.6589965820312, 635.29296875], 'label': 'Date: (YYYY)', 'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n'}\n",
            "{'page': 4, 'name': 'T196', 'type': 7, 'rect': [135.4010009765625, 636.1209716796875, 373.4419860839844, 646.4660034179688], 'label': 'Medication:', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T197', 'type': 7, 'rect': [403.28399658203125, 636.2470092773438, 423.9219970703125, 646.4660034179688], 'label': 'Date: (MM)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T198', 'type': 7, 'rect': [428.593994140625, 636.2470092773438, 449.2309875488281, 646.4660034179688], 'label': 'Date: (DD)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T199', 'type': 7, 'rect': [452.1579895019531, 636.2479858398438, 474.46600341796875, 646.4660034179688], 'label': 'Date: (YYYY)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T200', 'type': 7, 'rect': [481.5509948730469, 636.2470092773438, 502.1860046386719, 646.4660034179688], 'label': 'Date: (MM)', 'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n'}\n",
            "{'page': 4, 'name': 'T201', 'type': 7, 'rect': [507.2669982910156, 636.2470092773438, 527.9030151367188, 646.4660034179688], 'label': 'Date: (DD)', 'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n'}\n",
            "{'page': 4, 'name': 'T202', 'type': 7, 'rect': [530.9580078125, 636.2470092773438, 554.6389770507812, 646.4660034179688], 'label': 'Date: (YYYY)', 'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n'}\n",
            "{'page': 4, 'name': 'CB181', 'type': 2, 'rect': [52.666900634765625, 603.18701171875, 62.96879959106445, 613.7440185546875], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n'}\n",
            "{'page': 4, 'name': 'CB203', 'type': 2, 'rect': [22.673099517822266, 659.490966796875, 32.975101470947266, 670.0479736328125], 'label': 'Yes', 'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB204', 'type': 2, 'rect': [52.012298583984375, 659.4710083007812, 62.31420135498047, 670.0269775390625], 'label': 'No', 'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB205', 'type': 2, 'rect': [85.74980163574219, 671.2470092773438, 96.05130004882812, 681.8040161132812], 'label': 'Yes', 'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n'}\n",
            "{'page': 4, 'name': 'CB206', 'type': 2, 'rect': [115.375, 671.2260131835938, 125.677001953125, 681.7830200195312], 'label': 'No', 'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'T12', 'type': 7, 'rect': [20.796199798583984, 131.79498291015625, 164.39100646972656, 144.45697021484375], 'label': 'Patient First Name', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 5, 'name': 'T13', 'type': 7, 'rect': [169.26499938964844, 131.79498291015625, 348.5950012207031, 144.45697021484375], 'label': 'Patient Last Name', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 5, 'name': 'T19', 'type': 7, 'rect': [354.30499267578125, 131.79498291015625, 469.82598876953125, 144.45697021484375], 'label': 'Patient Phone', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 5, 'name': 'T14', 'type': 7, 'rect': [475.18701171875, 131.7960205078125, 592.4639892578125, 144.45697021484375], 'label': 'Patient DOB (MM/DD/YYYY)', 'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n'}\n",
            "{'page': 5, 'name': 'CB207', 'type': 2, 'rect': [249.6199951171875, 167.4429931640625, 259.9209899902344, 178.0], 'label': 'Mild', 'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB208', 'type': 2, 'rect': [282.375, 167.4429931640625, 292.6759948730469, 178.0], 'label': 'Moderate', 'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB209', 'type': 2, 'rect': [334.2569885253906, 167.4429931640625, 344.5580139160156, 178.0], 'label': 'Severe', 'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB210', 'type': 2, 'rect': [22.707700729370117, 177.44500732421875, 33.00960159301758, 188.00201416015625], 'label': 'Yes', 'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB211', 'type': 2, 'rect': [52.012298583984375, 177.4429931640625, 62.3140983581543, 188.0], 'label': 'No', 'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB212', 'type': 2, 'rect': [22.707700729370117, 188.08599853515625, 33.00960159301758, 198.64300537109375], 'label': 'Yes', 'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB213', 'type': 2, 'rect': [52.012298583984375, 188.05401611328125, 62.3140983581543, 198.61102294921875], 'label': 'No', 'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB214', 'type': 2, 'rect': [86.60260009765625, 198.60699462890625, 96.90440368652344, 209.16400146484375], 'label': 'Yes', 'block_context': '  Will Rituxan (rituximab) be used in combination with methotrexate? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB216', 'type': 2, 'rect': [191.60000610351562, 209.0369873046875, 201.90199279785156, 219.593994140625], 'label': 'ineffective', 'block_context': 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n'}\n",
            "{'page': 5, 'name': 'CB217', 'type': 2, 'rect': [246.1739959716797, 209.0369873046875, 256.4750061035156, 219.593994140625], 'label': 'not tolerated', 'block_context': 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n'}\n",
            "{'page': 5, 'name': 'CB218', 'type': 2, 'rect': [308.3710021972656, 209.0369873046875, 318.6719970703125, 219.593994140625], 'label': 'contraindicated', 'block_context': 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n'}\n",
            "{'page': 5, 'name': 'CB215', 'type': 2, 'rect': [116.39199829101562, 198.60699462890625, 126.69400024414062, 209.16400146484375], 'label': 'No', 'block_context': '  Will Rituxan (rituximab) be used in combination with methotrexate? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB223', 'type': 2, 'rect': [86.60260009765625, 221.36798095703125, 96.90440368652344, 231.92498779296875], 'label': 'Yes', 'block_context': 'Was treatment with another conventional DMARD ineffective? \\n Yes\\n'}\n",
            "{'page': 5, 'name': 'CB225', 'type': 2, 'rect': [191.07400512695312, 231.44598388671875, 201.37600708007812, 242.00299072265625], 'label': 'azathioprine', 'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB226', 'type': 2, 'rect': [251.9080047607422, 231.44598388671875, 262.2090148925781, 242.00299072265625], 'label': 'cyclosporine', 'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB227', 'type': 2, 'rect': [313.947998046875, 231.44598388671875, 324.2489929199219, 242.00299072265625], 'label': 'hydroxychloroquine', 'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB228', 'type': 2, 'rect': [399.94500732421875, 231.44598388671875, 410.2460021972656, 242.00299072265625], 'label': 'leflunomide', 'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB229', 'type': 2, 'rect': [458.1929931640625, 231.44598388671875, 468.4939880371094, 242.00299072265625], 'label': 'sulfasalazine', 'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n'}\n",
            "{'page': 5, 'name': 'CB224', 'type': 2, 'rect': [116.39199829101562, 221.36798095703125, 126.69400024414062, 231.92498779296875], 'label': 'No', 'block_context': 'Was treatment with another conventional DMARD ineffective? \\n Yes\\n'}\n",
            "{'page': 5, 'name': 'CB281', 'type': 2, 'rect': [22.707700729370117, 253.572021484375, 33.009498596191406, 264.1290283203125], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB282', 'type': 2, 'rect': [52.012298583984375, 253.58099365234375, 62.3140983581543, 264.13800048828125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB283', 'type': 2, 'rect': [22.707700729370117, 265.31402587890625, 33.009498596191406, 275.8709716796875], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'T285', 'type': 7, 'rect': [136.13800048828125, 285.8590087890625, 374.1789855957031, 296.2049865722656], 'label': 'Medication:', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T286', 'type': 7, 'rect': [404.0140075683594, 285.9859924316406, 424.6510009765625, 296.3320007324219], 'label': 'Date: (MM)', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T287', 'type': 7, 'rect': [428.8139953613281, 285.9859924316406, 449.45098876953125, 296.3320007324219], 'label': 'Date: (DD)', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T288', 'type': 7, 'rect': [453.23199462890625, 285.9859924316406, 476.1180114746094, 296.3320007324219], 'label': 'Date: (YYYY)', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T289', 'type': 7, 'rect': [482.5660095214844, 285.9859924316406, 504.2019958496094, 296.3320007324219], 'label': 'Date: (MM)', 'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n'}\n",
            "{'page': 5, 'name': 'T290', 'type': 7, 'rect': [506.7909851074219, 285.9859924316406, 528.427001953125, 296.3320007324219], 'label': 'Date: (DD)', 'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n'}\n",
            "{'page': 5, 'name': 'T291', 'type': 7, 'rect': [531.7750244140625, 285.9859924316406, 553.8289794921875, 296.3320007324219], 'label': 'Date: (YYYY)', 'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n'}\n",
            "{'page': 5, 'name': 'T292', 'type': 7, 'rect': [136.08299255371094, 296.54400634765625, 374.1239929199219, 306.8900146484375], 'label': 'Medication:', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T293', 'type': 7, 'rect': [404.32000732421875, 296.7300109863281, 424.99200439453125, 307.07598876953125], 'label': 'Date: (MM)', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T294', 'type': 7, 'rect': [428.8139953613281, 296.7300109863281, 449.4849853515625, 307.07598876953125], 'label': 'Date: (DD)', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T295', 'type': 7, 'rect': [453.0889892578125, 296.6719970703125, 475.9750061035156, 307.01800537109375], 'label': 'Date: (YYYY)', 'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n'}\n",
            "{'page': 5, 'name': 'T296', 'type': 7, 'rect': [482.197998046875, 296.6719970703125, 503.8340148925781, 307.01800537109375], 'label': 'Date: (MM)', 'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n'}\n",
            "{'page': 5, 'name': 'T297', 'type': 7, 'rect': [506.75, 296.6719970703125, 528.385986328125, 307.01800537109375], 'label': 'Date: (DD)', 'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n'}\n",
            "{'page': 5, 'name': 'T298', 'type': 7, 'rect': [531.7750244140625, 296.6719970703125, 553.8289794921875, 307.01800537109375], 'label': 'Date: (YYYY)', 'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n'}\n",
            "{'page': 5, 'name': 'CB284', 'type': 2, 'rect': [52.012298583984375, 265.322021484375, 62.3140983581543, 275.8790283203125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB299', 'type': 2, 'rect': [22.707700729370117, 320.2669982910156, 33.009498596191406, 330.8240051269531], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB300', 'type': 2, 'rect': [52.012298583984375, 320.2760009765625, 62.31420135498047, 330.8330078125], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB301', 'type': 2, 'rect': [22.707700729370117, 342.3320007324219, 33.0093994140625, 352.8890075683594], 'label': 'Yes', 'block_context': 'Does the patient have a documented diagnosis of Waldenström macroglobulinemia? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB302', 'type': 2, 'rect': [52.012298583984375, 342.3489990234375, 62.31420135498047, 352.906005859375], 'label': 'No', 'block_context': 'Does the patient have a documented diagnosis of Waldenström macroglobulinemia? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB303', 'type': 2, 'rect': [22.707700729370117, 365.67498779296875, 33.00960159301758, 376.23199462890625], 'label': 'Yes', 'block_context': 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n'}\n",
            "{'page': 5, 'name': 'CB304', 'type': 2, 'rect': [52.012298583984375, 365.6730041503906, 62.31399917602539, 376.2300109863281], 'label': 'No', 'block_context': 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n'}\n",
            "{'page': 5, 'name': 'T305', 'type': 7, 'rect': [225.25999450683594, 374.875, 512.3599853515625, 386.5299987792969], 'label': 'Please indicate the length of time on Rituxan (rituximab):', 'block_context': 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n'}\n",
            "{'page': 5, 'name': 'CB310', 'type': 2, 'rect': [353.3630065917969, 398.0530090332031, 363.66400146484375, 408.6099853515625], 'label': 'Mild', 'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB311', 'type': 2, 'rect': [386.1109924316406, 398.02301025390625, 396.4119873046875, 408.5799865722656], 'label': 'Moderate', 'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB312', 'type': 2, 'rect': [437.9490051269531, 398.02301025390625, 448.25, 408.5799865722656], 'label': 'Severe', 'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB306', 'type': 2, 'rect': [22.707700729370117, 408.30999755859375, 33.00960159301758, 418.86700439453125], 'label': 'Yes', 'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB307', 'type': 2, 'rect': [52.012298583984375, 408.2569885253906, 62.31420135498047, 418.8139953613281], 'label': 'No', 'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB308', 'type': 2, 'rect': [22.707700729370117, 419.2879943847656, 33.0093994140625, 429.8450012207031], 'label': 'Yes', 'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB309', 'type': 2, 'rect': [52.012298583984375, 419.2860107421875, 62.31399917602539, 429.8429870605469], 'label': 'No', 'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB313', 'type': 2, 'rect': [22.707700729370117, 441.96099853515625, 33.0093994140625, 452.51800537109375], 'label': 'Yes', 'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB314', 'type': 2, 'rect': [52.012298583984375, 441.9620056152344, 62.31420135498047, 452.5190124511719], 'label': 'No', 'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB315', 'type': 2, 'rect': [22.707700729370117, 453.41900634765625, 33.00960159301758, 463.97601318359375], 'label': 'Yes', 'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'CB316', 'type': 2, 'rect': [52.012298583984375, 453.43798828125, 62.31399917602539, 463.9949951171875], 'label': 'No', 'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n'}\n",
            "{'page': 5, 'name': 'T317', 'type': 7, 'rect': [508.2340087890625, 484.19500732421875, 531.7239990234375, 496.53900146484375], 'label': 'Date: (MM)', 'block_context': 'Request Completed By (Signature Required):\\n  Date: \\n'}\n",
            "{'page': 5, 'name': 'T318', 'type': 7, 'rect': [536.8720092773438, 484.19500732421875, 556.3619995117188, 496.53900146484375], 'label': 'Date: (DD)', 'block_context': ' \\n/ \\n/ \\n'}\n",
            "{'page': 5, 'name': 'T319', 'type': 7, 'rect': [561.8579711914062, 484.19500732421875, 584.239013671875, 496.53900146484375], 'label': 'Date: (YYYY)', 'block_context': ' \\n/ \\n/ \\n'}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Filling the Document\n"
      ],
      "metadata": {
        "id": "QoIREbHoe1EQ"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "def generate_field_prompt(block_context: str, referral_summary: str, label: str) -> str:\n",
        "    return (\n",
        "        f\"You are helping to fill out a prior authorization (PA) form.\\n\\n\"\n",
        "        f\"### Referral Summary:\\n{referral_summary}\\n\\n\"\n",
        "        f\"### Form Field Context:\\n{block_context}\\n\\n\"\n",
        "        f\"### Label:\\n{label}\\n\\n\"\n",
        "        f\"Based on the above, provide a clear and accurate answer to this field.\\n\"\n",
        "        f\"If a specific medication, date, diagnosis, or yes/no is requested, extract it directly from the summary.\\n\"\n",
        "        f\"If a label asks YYYY, only put in the year; if it asks for MM, only enter the month; and if it asks for DD only enter the day.\\n\"\n",
        "        f\"A single block context can have multiple fields, such as yes/no, multiple yes/nos, multiple fill-in lines, \"\n",
        "        f\"DD/MM/YYYY fields, or a combination of any or all field types mentioned beforehand.\"\n",
        "        f\"If you determine that a field does not need to be filled, do not return an answer at all\"\n",
        "    )"
      ],
      "metadata": {
        "id": "gP8tnP5-WOgw"
      },
      "execution_count": 95,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "from asyncio import Semaphore\n",
        "import random"
      ],
      "metadata": {
        "id": "YHOjMxvc5mJT"
      },
      "execution_count": 100,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "MODEL = \"models/gemini-2.0-flash\"\n",
        "MAX_RETRIES = 5\n",
        "RETRY_BASE_DELAY = 5\n",
        "semaphore = Semaphore(3)  # Limit to 3 concurrent LLM calls\n",
        "\n",
        "async def fill_single_field(field: Dict[str, Any], referral_summary: str, client) -> Dict[str, Any]:\n",
        "    prompt = generate_field_prompt(\n",
        "        block_context=field[\"block_context\"],\n",
        "        referral_summary=referral_summary,\n",
        "        label=field[\"label\"]\n",
        "    )\n",
        "\n",
        "    async with semaphore:\n",
        "        for attempt in range(1, MAX_RETRIES + 1):\n",
        "            try:\n",
        "                loop = asyncio.get_event_loop()\n",
        "                response = await loop.run_in_executor(\n",
        "                    None,\n",
        "                    lambda: client.models.generate_content(\n",
        "                        model=MODEL,\n",
        "                        contents=prompt\n",
        "                    )\n",
        "                )\n",
        "                answer = response.candidates[0].content.parts[0].text.strip()\n",
        "                return {**field, \"answer\": answer}\n",
        "            except Exception as e:\n",
        "                error_msg = str(e)\n",
        "                if \"RESOURCE_EXHAUSTED\" in error_msg or \"429\" in error_msg:\n",
        "                    wait_time = RETRY_BASE_DELAY * (2 ** (attempt - 1)) + random.uniform(0, 1)\n",
        "                    print(f\"Rate limit hit. Retrying field '{field['name']}' in {wait_time:.2f}s (attempt {attempt}/{MAX_RETRIES})...\")\n",
        "                    await asyncio.sleep(wait_time)\n",
        "                else:\n",
        "                    return {**field, \"answer\": f\"Error: {error_msg}\"}\n",
        "\n",
        "        return {**field, \"answer\": f\"Error: Max retries exceeded due to rate limit.\"}\n",
        "\n",
        "\n",
        "async def fill_pa_fields_from_summary(referral_summary: str, field_metadata: List[Dict[str, Any]], client) -> Dict[str, List[Dict[str, Any]]]:\n",
        "    tasks = [\n",
        "        fill_single_field(field, referral_summary, client)\n",
        "        for field in field_metadata\n",
        "    ]\n",
        "    results = await asyncio.gather(*tasks)\n",
        "    return {\"fields\": results}"
      ],
      "metadata": {
        "id": "A3QU_Q47Yg5l"
      },
      "execution_count": 101,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "response = await fill_pa_fields_from_summary(\n",
        "    referral_summary=summary_text,\n",
        "    field_metadata=labeled_blocks,\n",
        "    client=client\n",
        ")\n",
        "\n",
        "# Send response[\"fields\"] to your form-filling agent\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Qi95UWp3xoJq",
        "outputId": "92d736ef-354c-4fbf-bdd5-b3a4c2633f4e"
      },
      "execution_count": 102,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Rate limit hit. Retrying field 'CB1' in 5.38s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T3' in 5.06s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T2' in 5.23s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T3' in 10.02s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB1' in 10.83s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T2' in 10.35s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T3' in 20.07s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T2' in 20.94s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB1' in 20.03s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T16' in 5.65s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T17' in 5.51s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T18' in 5.41s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T17' in 10.20s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T16' in 10.10s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T18' in 10.99s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T16' in 20.82s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T17' in 20.43s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T18' in 20.50s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T17' in 40.67s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T16' in 40.25s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T18' in 40.13s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB31' in 5.91s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T33' in 5.26s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB32' in 5.01s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB32' in 10.13s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T33' in 10.55s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB31' in 10.99s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB32' in 20.66s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T33' in 20.28s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB31' in 20.39s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T52' in 5.66s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T53' in 5.75s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T54' in 5.66s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T52' in 10.08s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T53' in 10.07s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T55' in 5.37s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T55' in 10.14s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T52' in 20.40s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T53' in 20.66s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T55' in 20.08s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T52' in 40.27s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T53' in 40.03s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin T.9' in 5.06s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin T.9' in 10.35s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin T.9' in 20.12s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T52' in 80.36s (attempt 5/5)...\n",
            "Rate limit hit. Retrying field 'T53' in 80.61s (attempt 5/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin T.9' in 40.13s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin CB.25' in 5.99s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin CB.25' in 10.47s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin CB.25' in 20.07s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin CB.26' in 5.97s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin T.27' in 5.66s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T64' in 5.40s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T65' in 5.07s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin CB.25' in 40.86s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T64' in 10.44s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T65' in 10.97s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T64' in 20.15s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T65' in 20.84s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T64' in 40.02s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T65' in 40.57s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'Provider Admin CB.25' in 80.14s (attempt 5/5)...\n",
            "Rate limit hit. Retrying field 'T80' in 5.49s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T81' in 5.81s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T80' in 10.79s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T81' in 10.31s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T81' in 20.92s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T80' in 20.78s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB92' in 5.20s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB93' in 5.10s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB94' in 5.23s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB92' in 10.28s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB93' in 10.06s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB94' in 10.85s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB93' in 20.44s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB92' in 20.81s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB94' in 20.45s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB93' in 40.89s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB92' in 40.79s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB94' in 40.02s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB107z' in 5.53s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB108z' in 5.78s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB109z' in 5.74s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB107z' in 10.44s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB109z' in 10.58s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB108z' in 10.41s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB107z' in 20.88s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB108z' in 20.28s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB109z' in 20.63s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB120z' in 5.00s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB122z' in 5.35s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB123z' in 5.50s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB120z' in 10.05s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB122z' in 10.94s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB123z' in 10.61s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB120z' in 20.31s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB122z' in 20.78s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB123z' in 20.38s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB120z' in 40.10s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB122z' in 40.84s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB123z' in 40.91s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB104d' in 5.15s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB105' in 5.06s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB106' in 5.77s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB104d' in 10.50s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB105' in 10.08s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB106' in 10.33s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB105' in 20.69s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB104d' in 20.18s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB106' in 20.50s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB117' in 5.52s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB118' in 5.38s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB119' in 5.26s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB117' in 10.17s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB119' in 10.69s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB120' in 5.17s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB120' in 10.55s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB117' in 20.89s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB119' in 20.03s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB120' in 20.45s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB119' in 40.44s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB117' in 40.07s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB120' in 40.06s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB130' in 5.24s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB131' in 5.37s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB120' in 80.15s (attempt 5/5)...\n",
            "Rate limit hit. Retrying field 'CB130' in 10.84s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB131' in 10.19s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB131' in 20.04s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB130' in 20.32s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB146' in 5.74s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB147' in 5.12s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB147' in 10.21s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB146' in 10.81s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB138' in 5.94s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB148' in 6.00s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB138' in 10.05s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB148' in 10.91s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB138' in 20.04s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB148' in 20.71s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB149' in 5.22s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB163' in 5.29s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB164' in 5.60s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB148' in 40.27s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB163' in 10.28s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB164' in 10.03s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB163' in 20.18s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB164' in 20.63s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB163' in 41.00s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB164' in 40.68s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB148' in 80.30s (attempt 5/5)...\n",
            "Rate limit hit. Retrying field 'CB179' in 5.94s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB180' in 5.95s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB180' in 10.97s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB179' in 10.51s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB179' in 20.67s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB180' in 20.70s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T202' in 5.47s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB203' in 5.97s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB181' in 5.19s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB181' in 10.52s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T202' in 10.91s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB203' in 10.69s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB181' in 20.49s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T202' in 20.37s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB203' in 20.26s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB181' in 40.54s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T202' in 40.45s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB203' in 40.65s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB212' in 5.83s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB213' in 5.04s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB214' in 5.52s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB213' in 10.14s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB212' in 10.15s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB214' in 10.36s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB213' in 20.27s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB212' in 20.86s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB214' in 20.01s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB282' in 5.93s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB283' in 5.59s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T285' in 5.53s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T285' in 10.57s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB283' in 10.50s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB282' in 10.70s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB283' in 20.51s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T285' in 20.65s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB282' in 20.70s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB283' in 40.03s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB282' in 40.81s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T285' in 40.78s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB284' in 5.06s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB299' in 5.57s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB300' in 5.59s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB284' in 10.27s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB299' in 10.59s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB300' in 10.06s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB284' in 20.58s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB300' in 20.36s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB299' in 20.87s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB314' in 5.22s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB316' in 5.50s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'T317' in 5.41s (attempt 1/5)...\n",
            "Rate limit hit. Retrying field 'CB314' in 10.56s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB316' in 10.54s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'T317' in 10.06s (attempt 2/5)...\n",
            "Rate limit hit. Retrying field 'CB314' in 20.53s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'T317' in 20.77s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB316' in 20.51s (attempt 3/5)...\n",
            "Rate limit hit. Retrying field 'CB314' in 40.80s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'CB316' in 40.42s (attempt 4/5)...\n",
            "Rate limit hit. Retrying field 'T317' in 40.73s (attempt 4/5)...\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "response"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "R44bddX12lsx",
        "outputId": "b8e72fdb-c411-416f-946e-77e2749deeda"
      },
      "execution_count": 103,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'fields': [{'page': 2,\n",
              "   'name': 'CB1',\n",
              "   'type': 2,\n",
              "   'rect': [82.92900085449219,\n",
              "    110.4580078125,\n",
              "    93.23079681396484,\n",
              "    121.0150146484375],\n",
              "   'label': 'Start of treatment',\n",
              "   'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n',\n",
              "   'answer': 'May 22nd'},\n",
              "  {'page': 2,\n",
              "   'name': 'T2',\n",
              "   'type': 7,\n",
              "   'rect': [210.19700622558594,\n",
              "    109.281982421875,\n",
              "    231.8699951171875,\n",
              "    120.96099853515625],\n",
              "   'label': 'Start date: (MM)',\n",
              "   'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n',\n",
              "   'answer': '05'},\n",
              "  {'page': 2,\n",
              "   'name': 'T3',\n",
              "   'type': 7,\n",
              "   'rect': [236.83399963378906,\n",
              "    109.281982421875,\n",
              "    258.5069885253906,\n",
              "    120.96099853515625],\n",
              "   'label': 'Start date: (DD)',\n",
              "   'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 2,\n",
              "   'name': 'T4',\n",
              "   'type': 7,\n",
              "   'rect': [262.1719970703125,\n",
              "    109.281982421875,\n",
              "    285.8070068359375,\n",
              "    120.96099853515625],\n",
              "   'label': 'Start date: (YYYY)',\n",
              "   'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n',\n",
              "   'answer': '2024'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB5',\n",
              "   'type': 2,\n",
              "   'rect': [306.0480041503906,\n",
              "    110.03802490234375,\n",
              "    316.3500061035156,\n",
              "    120.594970703125],\n",
              "   'label': 'Continuation of therapy',\n",
              "   'block_context': 'Please indicate:\\n Start of treatment, start date:  \\n Continuation of therapy, date of last treatment: \\n',\n",
              "   'answer': 'There is no information about prior rituximab or biosimilar treatment.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T6',\n",
              "   'type': 7,\n",
              "   'rect': [502.3739929199219,\n",
              "    109.2760009765625,\n",
              "    524.0469970703125,\n",
              "    120.95501708984375],\n",
              "   'label': 'Date of last treatment: (MM)',\n",
              "   'block_context': '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n',\n",
              "   'answer': '/\\n/'},\n",
              "  {'page': 2,\n",
              "   'name': 'T7',\n",
              "   'type': 7,\n",
              "   'rect': [529.010986328125,\n",
              "    109.2760009765625,\n",
              "    550.6840209960938,\n",
              "    120.95501708984375],\n",
              "   'label': 'Date of last treatment: (DD)',\n",
              "   'block_context': '  \\n \\n      /     / \\n \\n/ \\n/ \\n \\n \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 2,\n",
              "   'name': 'T8',\n",
              "   'type': 7,\n",
              "   'rect': [554.9990234375,\n",
              "    109.2760009765625,\n",
              "    578.135986328125,\n",
              "    120.95501708984375],\n",
              "   'label': 'Date of last treatment: (YYYY)',\n",
              "   'block_context': '',\n",
              "   'answer': 'There is no specific information about the date of last treatment.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T9',\n",
              "   'type': 7,\n",
              "   'rect': [143.625, 122.6729736328125, 350.625, 134.35198974609375],\n",
              "   'label': 'Precertification Requested By:',\n",
              "   'block_context': 'Precertification Requested By: \\nPhone: \\nFax: \\n',\n",
              "   'answer': 'Erfan Rostami, BSN, RN'},\n",
              "  {'page': 2,\n",
              "   'name': 'T10',\n",
              "   'type': 7,\n",
              "   'rect': [386.3070068359375,\n",
              "    123.7030029296875,\n",
              "    480.1470031738281,\n",
              "    135.38201904296875],\n",
              "   'label': 'Phone:',\n",
              "   'block_context': 'Precertification Requested By: \\nPhone: \\nFax: \\n',\n",
              "   'answer': '615-343-1176'},\n",
              "  {'page': 2,\n",
              "   'name': 'T11',\n",
              "   'type': 7,\n",
              "   'rect': [501.19500732421875, 123.69598388671875, 593.594970703125, 135.375],\n",
              "   'label': 'Fax:',\n",
              "   'block_context': '',\n",
              "   'answer': '614-936-0065'},\n",
              "  {'page': 2,\n",
              "   'name': 'T12',\n",
              "   'type': 7,\n",
              "   'rect': [62.843101501464844,\n",
              "    150.93402099609375,\n",
              "    230.375,\n",
              "    162.61297607421875],\n",
              "   'label': 'Patient First Name',\n",
              "   'block_context': 'First Name:  \\nLast Name:  \\nDOB:  \\n',\n",
              "   'answer': 'Shakh'},\n",
              "  {'page': 2,\n",
              "   'name': 'T13',\n",
              "   'type': 7,\n",
              "   'rect': [277.2619934082031,\n",
              "    150.93402099609375,\n",
              "    501.9209899902344,\n",
              "    162.61297607421875],\n",
              "   'label': 'Patient Last Name',\n",
              "   'block_context': 'First Name:  \\nLast Name:  \\nDOB:  \\n',\n",
              "   'answer': 'Abdulla'},\n",
              "  {'page': 2,\n",
              "   'name': 'T14',\n",
              "   'type': 7,\n",
              "   'rect': [526.2670288085938,\n",
              "    150.93402099609375,\n",
              "    592.1160278320312,\n",
              "    162.61297607421875],\n",
              "   'label': 'Patient DOB (MM/DD/YYYY)',\n",
              "   'block_context': 'First Name:  \\nLast Name:  \\nDOB:  \\n',\n",
              "   'answer': '04/01/2001'},\n",
              "  {'page': 2,\n",
              "   'name': 'T15',\n",
              "   'type': 7,\n",
              "   'rect': [52.88520050048828,\n",
              "    164.8270263671875,\n",
              "    327.07598876953125,\n",
              "    176.5059814453125],\n",
              "   'label': 'Address:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': '425 Sherman Ave'},\n",
              "  {'page': 2,\n",
              "   'name': 'T16',\n",
              "   'type': 7,\n",
              "   'rect': [347.5299987792969,\n",
              "    164.8270263671875,\n",
              "    443.9800109863281,\n",
              "    176.5059814453125],\n",
              "   'label': 'City:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': 'Nashville'},\n",
              "  {'page': 2,\n",
              "   'name': 'T17',\n",
              "   'type': 7,\n",
              "   'rect': [469.6700134277344,\n",
              "    164.8270263671875,\n",
              "    501.9209899902344,\n",
              "    176.5059814453125],\n",
              "   'label': 'State:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': 'TN'},\n",
              "  {'page': 2,\n",
              "   'name': 'T18',\n",
              "   'type': 7,\n",
              "   'rect': [521.6199951171875,\n",
              "    164.8270263671875,\n",
              "    592.1160278320312,\n",
              "    176.5059814453125],\n",
              "   'label': 'ZIP:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': '37995'},\n",
              "  {'page': 2,\n",
              "   'name': 'T19',\n",
              "   'type': 7,\n",
              "   'rect': [69.14689636230469, 179.32098388671875, 151.4929962158203, 191.0],\n",
              "   'label': 'Patient Phone',\n",
              "   'block_context': 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n',\n",
              "   'answer': '865-395-3958'},\n",
              "  {'page': 2,\n",
              "   'name': 'T20',\n",
              "   'type': 7,\n",
              "   'rect': [201.93499755859375, 179.32098388671875, 286.2969970703125, 191.0],\n",
              "   'label': 'Work Phone:',\n",
              "   'block_context': 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n',\n",
              "   'answer': '614-936-0065'},\n",
              "  {'page': 2,\n",
              "   'name': 'T21',\n",
              "   'type': 7,\n",
              "   'rect': [332.29400634765625,\n",
              "    179.44097900390625,\n",
              "    421.7250061035156,\n",
              "    191.1199951171875],\n",
              "   'label': 'Cell Phone:',\n",
              "   'block_context': 'Home Phone:  \\nWork Phone:  \\nCell Phone:  \\nE-mail:\\n',\n",
              "   'answer': '865-395-0481'},\n",
              "  {'page': 2,\n",
              "   'name': 'T22',\n",
              "   'type': 7,\n",
              "   'rect': [450.6510009765625,\n",
              "    179.44097900390625,\n",
              "    592.1160278320312,\n",
              "    191.1199951171875],\n",
              "   'label': 'E-mail:',\n",
              "   'block_context': '',\n",
              "   'answer': 'This information is not available in the provided document.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T24',\n",
              "   'type': 7,\n",
              "   'rect': [78.66909790039062,\n",
              "    194.8740234375,\n",
              "    100.60900115966797,\n",
              "    206.552978515625],\n",
              "   'label': 'lbs',\n",
              "   'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n',\n",
              "   'answer': 'This field cannot be filled from the provided context.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T25',\n",
              "   'type': 7,\n",
              "   'rect': [128.6300048828125,\n",
              "    194.989990234375,\n",
              "    151.65899658203125,\n",
              "    206.66900634765625],\n",
              "   'label': 'kgs',\n",
              "   'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n',\n",
              "   'answer': 'Based on the information provided, the patient\\'s Body Surface Area (BSA) is listed as 1.85 m2, which was used to calculate the Rituximab dosage. To calculate the weight in kilograms (kgs) to determine if the BSA is accurate, we would need to use a BSA formula, such as the Mosteller formula: BSA (m2) = √ (Height(cm) x Weight(kg) / 3600) or the Haycock formula. Since height is not provided, calculating an accurate weight in kilograms from the BSA is not possible.\\n\\nTherefore, I cannot provide an answer to the field \"kgs\" without knowing the patient\\'s height.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T26',\n",
              "   'type': 7,\n",
              "   'rect': [216.36099243164062,\n",
              "    194.93597412109375,\n",
              "    239.2469940185547,\n",
              "    206.614990234375],\n",
              "   'label': 'inches',\n",
              "   'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n',\n",
              "   'answer': 'Height: inches'},\n",
              "  {'page': 2,\n",
              "   'name': 'T27',\n",
              "   'type': 7,\n",
              "   'rect': [280.114990234375,\n",
              "    194.85400390625,\n",
              "    303.5719909667969,\n",
              "    206.53302001953125],\n",
              "   'label': 'cms',\n",
              "   'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n',\n",
              "   'answer': 'Height: inches or **cms**'},\n",
              "  {'page': 2,\n",
              "   'name': 'T23',\n",
              "   'type': 7,\n",
              "   'rect': [363.9159851074219,\n",
              "    195.40802001953125,\n",
              "    592.1160278320312,\n",
              "    207.08697509765625],\n",
              "   'label': 'Allergies:',\n",
              "   'block_context': 'Current Weight:\\n lbs or \\n kgs \\nHeight:  \\ninches or\\ncms \\nAllergies:   \\n',\n",
              "   'answer': 'There is no mention of allergies in the provided text.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T28',\n",
              "   'type': 7,\n",
              "   'rect': [72.4458999633789,\n",
              "    222.19500732421875,\n",
              "    229.36099243164062,\n",
              "    232.90301513671875],\n",
              "   'label': 'Member ID #:',\n",
              "   'block_context': 'Member ID #:  \\nGroup #:  \\nInsured:  \\n',\n",
              "   'answer': 'This information is not available in the provided document.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T29',\n",
              "   'type': 7,\n",
              "   'rect': [55.536800384521484,\n",
              "    233.70098876953125,\n",
              "    229.41600036621094,\n",
              "    244.40899658203125],\n",
              "   'label': 'Group #:',\n",
              "   'block_context': 'Member ID #:  \\nGroup #:  \\nInsured:  \\n',\n",
              "   'answer': 'Based on the information provided, the Group # is not specified.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T30',\n",
              "   'type': 7,\n",
              "   'rect': [53.76750183105469,\n",
              "    244.69598388671875,\n",
              "    229.44700622558594,\n",
              "    254.6669921875],\n",
              "   'label': 'Insured:',\n",
              "   'block_context': 'Member ID #:  \\nGroup #:  \\nInsured:  \\n',\n",
              "   'answer': 'Shakh Abdulla'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB31',\n",
              "   'type': 2,\n",
              "   'rect': [386.09100341796875,\n",
              "    222.927978515625,\n",
              "    396.39300537109375,\n",
              "    233.4840087890625],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB32',\n",
              "   'type': 2,\n",
              "   'rect': [415.6910095214844,\n",
              "    222.906982421875,\n",
              "    425.99200439453125,\n",
              "    233.4630126953125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 2,\n",
              "   'name': 'T33',\n",
              "   'type': 7,\n",
              "   'rect': [304.1390075683594,\n",
              "    233.13201904296875,\n",
              "    386.218994140625,\n",
              "    244.40899658203125],\n",
              "   'label': 'If yes, provide ID#:',\n",
              "   'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n',\n",
              "   'answer': 'TC BLUE CARE NO COPAY'},\n",
              "  {'page': 2,\n",
              "   'name': 'T34',\n",
              "   'type': 7,\n",
              "   'rect': [440.7279968261719,\n",
              "    233.13201904296875,\n",
              "    588.68798828125,\n",
              "    244.40899658203125],\n",
              "   'label': 'Carrier Name:',\n",
              "   'block_context': '',\n",
              "   'answer': 'TC BLUE CARE NO COPAY'},\n",
              "  {'page': 2,\n",
              "   'name': 'T35',\n",
              "   'type': 7,\n",
              "   'rect': [266.8479919433594,\n",
              "    245.7550048828125,\n",
              "    588.68798828125,\n",
              "    256.031982421875],\n",
              "   'label': 'Insured:',\n",
              "   'block_context': 'Does patient have other coverage? \\n Yes\\n No \\nIf yes, provide ID#:  \\nCarrier Name: \\nInsured: \\n',\n",
              "   'answer': 'Shakh Abdulla'},\n",
              "  {'page': 2,\n",
              "   'name': 'T42',\n",
              "   'type': 7,\n",
              "   'rect': [61.66939926147461,\n",
              "    272.82098388671875,\n",
              "    231.23199462890625,\n",
              "    283.5010070800781],\n",
              "   'label': 'First Name:',\n",
              "   'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n',\n",
              "   'answer': 'Hao'},\n",
              "  {'page': 2,\n",
              "   'name': 'T43',\n",
              "   'type': 7,\n",
              "   'rect': [277.4209899902344,\n",
              "    272.81097412109375,\n",
              "    395.2850036621094,\n",
              "    283.4909973144531],\n",
              "   'label': 'Last Name:',\n",
              "   'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n',\n",
              "   'answer': 'Gu'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB44',\n",
              "   'type': 2,\n",
              "   'rect': [453.2449951171875,\n",
              "    271.9940185546875,\n",
              "    463.5469970703125,\n",
              "    282.5509948730469],\n",
              "   'label': 'M.D.',\n",
              "   'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n',\n",
              "   'answer': 'First Name: Hao H\\nLast Name: Gu\\n[X] M.D.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB45',\n",
              "   'type': 2,\n",
              "   'rect': [490.072998046875, 271.98297119140625, 500.375, 282.5400085449219],\n",
              "   'label': 'D.O.',\n",
              "   'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n',\n",
              "   'answer': 'The provided information does not contain the first and last name of the physician to use to populate those fields.\\n\\nN.P.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB46',\n",
              "   'type': 2,\n",
              "   'rect': [526.3419799804688,\n",
              "    272.0040283203125,\n",
              "    536.6439819335938,\n",
              "    282.5610046386719],\n",
              "   'label': 'N.P.',\n",
              "   'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n',\n",
              "   'answer': 'Last Name: Rostami\\nFirst Name: Erfan'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB47',\n",
              "   'type': 2,\n",
              "   'rect': [561.6890258789062,\n",
              "    271.98297119140625,\n",
              "    571.9910278320312,\n",
              "    282.5400085449219],\n",
              "   'label': 'P.A.',\n",
              "   'block_context': 'First Name:\\nLast Name:  \\n(Check one): \\nM.D.\\nD.O.\\n N.P.  \\n P.A. \\n',\n",
              "   'answer': 'P.A.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T48',\n",
              "   'type': 7,\n",
              "   'rect': [52.40890121459961,\n",
              "    287.9179992675781,\n",
              "    326.39801025390625,\n",
              "    298.5979919433594],\n",
              "   'label': 'Address:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': '425 Sherman Ave'},\n",
              "  {'page': 2,\n",
              "   'name': 'T49',\n",
              "   'type': 7,\n",
              "   'rect': [347.1679992675781,\n",
              "    287.9179992675781,\n",
              "    443.7019958496094,\n",
              "    298.5979919433594],\n",
              "   'label': 'City:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': 'Nashville'},\n",
              "  {'page': 2,\n",
              "   'name': 'T50',\n",
              "   'type': 7,\n",
              "   'rect': [470.031005859375,\n",
              "    287.8869934082031,\n",
              "    502.8450012207031,\n",
              "    298.5669860839844],\n",
              "   'label': 'State:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': 'TN'},\n",
              "  {'page': 2,\n",
              "   'name': 'T51',\n",
              "   'type': 7,\n",
              "   'rect': [521.7979736328125,\n",
              "    287.8869934082031,\n",
              "    592.8610229492188,\n",
              "    298.5669860839844],\n",
              "   'label': 'ZIP:',\n",
              "   'block_context': 'Address:  \\nCity:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': '37995'},\n",
              "  {'page': 2,\n",
              "   'name': 'T52',\n",
              "   'type': 7,\n",
              "   'rect': [45.78519821166992,\n",
              "    302.1709899902344,\n",
              "    113.06099700927734,\n",
              "    312.85101318359375],\n",
              "   'label': 'Phone:',\n",
              "   'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n',\n",
              "   'answer': 'Error: Max retries exceeded due to rate limit.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T53',\n",
              "   'type': 7,\n",
              "   'rect': [132.92300415039062,\n",
              "    302.1709899902344,\n",
              "    209.58200073242188,\n",
              "    312.85101318359375],\n",
              "   'label': 'Fax:',\n",
              "   'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n',\n",
              "   'answer': 'Error: Max retries exceeded due to rate limit.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T54',\n",
              "   'type': 7,\n",
              "   'rect': [243.28700256347656,\n",
              "    302.1709899902344,\n",
              "    326.14599609375,\n",
              "    312.85101318359375],\n",
              "   'label': 'St Lic #:',\n",
              "   'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n',\n",
              "   'answer': 'Based on the provided information, the state license number (\"St Lic #:\") is not specified. Therefore, I will not provide an answer.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T55',\n",
              "   'type': 7,\n",
              "   'rect': [353.95098876953125,\n",
              "    302.1709899902344,\n",
              "    417.0400085449219,\n",
              "    312.85101318359375],\n",
              "   'label': 'NPI #:',\n",
              "   'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n',\n",
              "   'answer': 'Based on the information provided, I cannot fill out the NPI field because the NPI of the referring provider is not specified.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T56',\n",
              "   'type': 7,\n",
              "   'rect': [446.7349853515625,\n",
              "    302.1709899902344,\n",
              "    502.8450012207031,\n",
              "    312.85101318359375],\n",
              "   'label': 'DEA #:',\n",
              "   'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n',\n",
              "   'answer': 'Based on the provided information, the DEA # is not specified. Therefore, no answer is needed.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T57',\n",
              "   'type': 7,\n",
              "   'rect': [527.7540283203125,\n",
              "    302.1499938964844,\n",
              "    592.8610229492188,\n",
              "    312.8299865722656],\n",
              "   'label': 'UPIN:',\n",
              "   'block_context': 'Phone:  \\nFax:  \\nSt Lic #:  \\nNPI #:  \\nDEA #:  \\nUPIN:  \\n',\n",
              "   'answer': 'Based on the information provided in the referral summary, there is no UPIN listed for the referring provider.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T58.0',\n",
              "   'type': 7,\n",
              "   'rect': [74.67269897460938,\n",
              "    317.27301025390625,\n",
              "    209.50900268554688,\n",
              "    327.9530029296875],\n",
              "   'label': 'Provider Email:',\n",
              "   'block_context': 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n',\n",
              "   'answer': 'Based on the provided information, there is no Provider Email listed. Therefore, I will leave the field blank.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T58.1',\n",
              "   'type': 7,\n",
              "   'rect': [290.1669921875,\n",
              "    317.27301025390625,\n",
              "    417.0400085449219,\n",
              "    327.9530029296875],\n",
              "   'label': 'Office Contact Name:',\n",
              "   'block_context': 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n',\n",
              "   'answer': 'Erfan Rostami'},\n",
              "  {'page': 2,\n",
              "   'name': 'T59',\n",
              "   'type': 7,\n",
              "   'rect': [446.9049987792969,\n",
              "    317.27301025390625,\n",
              "    592.8610229492188,\n",
              "    327.9530029296875],\n",
              "   'label': 'Phone:',\n",
              "   'block_context': 'Provider Email:  \\nOffice Contact Name:  \\nPhone:  \\n',\n",
              "   'answer': '614-936-0065'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.1',\n",
              "   'type': 2,\n",
              "   'rect': [22.34000015258789,\n",
              "    352.0459899902344,\n",
              "    32.375999450683594,\n",
              "    362.5190124511719],\n",
              "   'label': 'Self-administered',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.2',\n",
              "   'type': 2,\n",
              "   'rect': [107.87300109863281,\n",
              "    352.0790100097656,\n",
              "    117.90899658203125,\n",
              "    362.552001953125],\n",
              "   'label': 'Physician’s Office',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'Yes'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.3',\n",
              "   'type': 2,\n",
              "   'rect': [194.05499267578125,\n",
              "    352.0790100097656,\n",
              "    204.09100341796875,\n",
              "    362.552001953125],\n",
              "   'label': 'Home',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': ''},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.4',\n",
              "   'type': 2,\n",
              "   'rect': [22.34000015258789,\n",
              "    362.49700927734375,\n",
              "    32.375999450683594,\n",
              "    372.9700012207031],\n",
              "   'label': 'Outpatient Infusion Center',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'Based on the information provided, I am unable to populate the \"Outpatient Infusion Center\" section of the form. The PA summary report does not specify the name, address, phone number, fax number, TIN, PIN, or NPI of the outpatient infusion center.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.5',\n",
              "   'type': 7,\n",
              "   'rect': [157.18699645996094,\n",
              "    362.43499755859375,\n",
              "    320.2829895019531,\n",
              "    373.0169982910156],\n",
              "   'label': 'Name:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'Outpatient Infusion Center Name: Better Life Multiple Sclerosis Center'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.7',\n",
              "   'type': 2,\n",
              "   'rect': [22.34000015258789,\n",
              "    372.5169982910156,\n",
              "    32.375999450683594,\n",
              "    382.989990234375],\n",
              "   'label': 'Home Infusion Center',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'There is no information about the Home Infusion Center in the provided document.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.6',\n",
              "   'type': 7,\n",
              "   'rect': [165.0959930419922,\n",
              "    373.2980041503906,\n",
              "    320.2829895019531,\n",
              "    383.8800048828125],\n",
              "   'label': 'Phone:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': '615-343-1176'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.8',\n",
              "   'type': 7,\n",
              "   'rect': [111.47799682617188,\n",
              "    383.5799865722656,\n",
              "    320.2829895019531,\n",
              "    394.1619873046875],\n",
              "   'label': 'Agency Name:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'Better Life Multiple Sclerosis Center'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.10',\n",
              "   'type': 2,\n",
              "   'rect': [22.34000015258789,\n",
              "    393.0249938964844,\n",
              "    32.375999450683594,\n",
              "    403.49798583984375],\n",
              "   'label': 'Administration code(s)',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': '96365, 96367, J9312'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.9',\n",
              "   'type': 7,\n",
              "   'rect': [143.82699584960938,\n",
              "    393.6579895019531,\n",
              "    320.2829895019531,\n",
              "    404.239990234375],\n",
              "   'label': 'CPT:',\n",
              "   'block_context': '',\n",
              "   'answer': 'No answer is needed. CPT codes are not provided in the referral summary.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.11A',\n",
              "   'type': 7,\n",
              "   'rect': [56.31019973754883,\n",
              "    403.95599365234375,\n",
              "    320.2829895019531,\n",
              "    414.5379943847656],\n",
              "   'label': 'Address:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': '425 Sherman Ave'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.13',\n",
              "   'type': 7,\n",
              "   'rect': [40.63639831542969,\n",
              "    415.3280029296875,\n",
              "    167.3459930419922,\n",
              "    425.9100036621094],\n",
              "   'label': 'City:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'Nashville'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.14',\n",
              "   'type': 7,\n",
              "   'rect': [193.09100341796875,\n",
              "    415.3280029296875,\n",
              "    229.23599243164062,\n",
              "    425.9100036621094],\n",
              "   'label': 'State:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'TN'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.15',\n",
              "   'type': 7,\n",
              "   'rect': [246.7010040283203,\n",
              "    415.7640075683594,\n",
              "    320.2829895019531,\n",
              "    426.34600830078125],\n",
              "   'label': 'ZIP:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': '37995'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.16',\n",
              "   'type': 7,\n",
              "   'rect': [49.74549865722656,\n",
              "    425.79998779296875,\n",
              "    167.3459930419922,\n",
              "    436.3819885253906],\n",
              "   'label': 'Phone:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': '615-343-1176'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.17A',\n",
              "   'type': 7,\n",
              "   'rect': [189.15499877929688,\n",
              "    425.79998779296875,\n",
              "    320.2829895019531,\n",
              "    436.3819885253906],\n",
              "   'label': 'Fax:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': '615-343-1219'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.18',\n",
              "   'type': 7,\n",
              "   'rect': [39.92729949951172,\n",
              "    437.27301025390625,\n",
              "    167.3459930419922,\n",
              "    447.8550109863281],\n",
              "   'label': 'TIN:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'There is no TIN provided in the referral summary.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.19',\n",
              "   'type': 7,\n",
              "   'rect': [189.15499877929688,\n",
              "    437.27301025390625,\n",
              "    320.2829895019531,\n",
              "    447.8550109863281],\n",
              "   'label': 'PIN:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'Based on the information provided, I cannot answer this question. The referral summary does not contain the PIN.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.20',\n",
              "   'type': 7,\n",
              "   'rect': [39.86439895629883,\n",
              "    448.2250061035156,\n",
              "    320.2829895019531,\n",
              "    458.8070068359375],\n",
              "   'label': 'NPI:',\n",
              "   'block_context': ' Self-administered \\n Physician’s Office \\n Home \\n Outpatient Infusion Center Name:   \\n Home Infusion Center \\nPhone:   \\nAgency Name:   \\n Administration code(s) (CPT): \\nAddress: \\nCity: \\nState:  \\nZIP:  \\nPhone:\\n  Fax:  \\nTIN:\\nPIN:  \\nNPI: \\n',\n",
              "   'answer': 'Since the referring provider is Hao H Gu, MD, from Better Life Multiple Sclerosis Center, we need to find the NPI for this provider or practice. The PA summary report does not include the NPI. Therefore, I cannot provide a value for this field.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.21',\n",
              "   'type': 2,\n",
              "   'rect': [331.30499267578125,\n",
              "    352.072998046875,\n",
              "    341.34100341796875,\n",
              "    362.5459899902344],\n",
              "   'label': 'Outpatient Dialysis Center',\n",
              "   'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "   'answer': 'Outpatient Dialysis Center'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.22',\n",
              "   'type': 2,\n",
              "   'rect': [448.74798583984375,\n",
              "    352.0220031738281,\n",
              "    458.78399658203125,\n",
              "    362.4949951171875],\n",
              "   'label': 'Physician’s Office',\n",
              "   'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "   'answer': 'Physician’s Office'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.23.0.0',\n",
              "   'type': 2,\n",
              "   'rect': [331.2909851074219,\n",
              "    363.12799072265625,\n",
              "    341.3269958496094,\n",
              "    373.60101318359375],\n",
              "   'label': 'Retail Pharmacy',\n",
              "   'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "   'answer': 'Retail Pharmacy'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.24.0.0',\n",
              "   'type': 2,\n",
              "   'rect': [448.6730041503906,\n",
              "    363.12799072265625,\n",
              "    458.7090148925781,\n",
              "    373.60101318359375],\n",
              "   'label': 'Specialty Pharmacy',\n",
              "   'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "   'answer': 'Specialty Pharmacy'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.25',\n",
              "   'type': 2,\n",
              "   'rect': [331.2909851074219,\n",
              "    374.8550109863281,\n",
              "    341.3269958496094,\n",
              "    385.3280029296875],\n",
              "   'label': 'Mail Order',\n",
              "   'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "   'answer': 'Error: Max retries exceeded due to rate limit.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin CB.26',\n",
              "   'type': 2,\n",
              "   'rect': [448.6730041503906,\n",
              "    374.8550109863281,\n",
              "    458.7090148925781,\n",
              "    385.3280029296875],\n",
              "   'label': 'Other:',\n",
              "   'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "   'answer': 'Better Life Multiple Sclerosis Center'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.27',\n",
              "   'type': 7,\n",
              "   'rect': [484.71099853515625,\n",
              "    374.8219909667969,\n",
              "    591.8259887695312,\n",
              "    385.8489990234375],\n",
              "   'label': 'Other:',\n",
              "   'block_context': ' Outpatient Dialysis Center \\n Physician’s Office \\n Retail Pharmacy \\n Specialty Pharmacy \\n Mail Order \\n Other:  \\n',\n",
              "   'answer': 'Better Life Multiple Sclerosis Center'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.28',\n",
              "   'type': 7,\n",
              "   'rect': [356.0669860839844,\n",
              "    386.92401123046875,\n",
              "    591.8259887695312,\n",
              "    398.0429992675781],\n",
              "   'label': 'Name:',\n",
              "   'block_context': 'Name: \\n',\n",
              "   'answer': 'Shakh Abdulla'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.29a',\n",
              "   'type': 7,\n",
              "   'rect': [363.8489990234375,\n",
              "    399.135009765625,\n",
              "    591.8259887695312,\n",
              "    410.2539978027344],\n",
              "   'label': 'Address:',\n",
              "   'block_context': 'Address:  \\n',\n",
              "   'answer': '425 Sherman Ave, Nashville TN 37995'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.30a',\n",
              "   'type': 7,\n",
              "   'rect': [349.0429992675781,\n",
              "    411.1409912109375,\n",
              "    448.72601318359375,\n",
              "    422.1679992675781],\n",
              "   'label': 'City:',\n",
              "   'block_context': 'City:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': 'Nashville'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.31',\n",
              "   'type': 7,\n",
              "   'rect': [476.072998046875,\n",
              "    411.2590026855469,\n",
              "    513.3820190429688,\n",
              "    422.1679992675781],\n",
              "   'label': 'State:',\n",
              "   'block_context': 'City:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': 'TN'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.32',\n",
              "   'type': 7,\n",
              "   'rect': [533.135009765625,\n",
              "    411.2590026855469,\n",
              "    591.8259887695312,\n",
              "    422.1679992675781],\n",
              "   'label': 'ZIP:',\n",
              "   'block_context': 'City:  \\nState:  \\nZIP:  \\n',\n",
              "   'answer': '37995'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.33',\n",
              "   'type': 7,\n",
              "   'rect': [359.12799072265625,\n",
              "    423.7099914550781,\n",
              "    466.9100036621094,\n",
              "    434.6189880371094],\n",
              "   'label': 'Phone:',\n",
              "   'block_context': 'Phone:  \\n Fax:  \\n',\n",
              "   'answer': '614-936-0065'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.34',\n",
              "   'type': 7,\n",
              "   'rect': [488.0799865722656,\n",
              "    423.7099914550781,\n",
              "    591.8259887695312,\n",
              "    434.6189880371094],\n",
              "   'label': 'Fax:',\n",
              "   'block_context': 'Phone:  \\n Fax:  \\n',\n",
              "   'answer': '615-343-1219'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.35',\n",
              "   'type': 7,\n",
              "   'rect': [349.09100341796875,\n",
              "    436.05499267578125,\n",
              "    466.9100036621094,\n",
              "    446.9639892578125],\n",
              "   'label': 'TIN:',\n",
              "   'block_context': 'TIN: \\n PIN:  \\n',\n",
              "   'answer': 'Based on the information provided, there is no Taxpayer Identification Number (TIN) listed for either the referring provider or the practice. Therefore, I cannot answer this question.'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.36',\n",
              "   'type': 7,\n",
              "   'rect': [488.08099365234375,\n",
              "    436.05499267578125,\n",
              "    591.8259887695312,\n",
              "    446.9639892578125],\n",
              "   'label': 'PIN:',\n",
              "   'block_context': 'TIN: \\n PIN:  \\n',\n",
              "   'answer': '(No answer needed)'},\n",
              "  {'page': 2,\n",
              "   'name': 'Provider Admin T.37',\n",
              "   'type': 7,\n",
              "   'rect': [349.0989990234375,\n",
              "    447.89801025390625,\n",
              "    591.8259887695312,\n",
              "    458.8070068359375],\n",
              "   'label': 'NPI:',\n",
              "   'block_context': '',\n",
              "   'answer': 'The NPI is not specified in the provided document.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB60',\n",
              "   'type': 2,\n",
              "   'rect': [82.12529754638672,\n",
              "    475.0929870605469,\n",
              "    92.31230163574219,\n",
              "    485.68701171875],\n",
              "   'label': 'Riabni (rituximab-arrx)',\n",
              "   'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n',\n",
              "   'answer': 'No answer is needed for this field.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB61',\n",
              "   'type': 2,\n",
              "   'rect': [188.06199645996094,\n",
              "    475.0929870605469,\n",
              "    198.24899291992188,\n",
              "    485.68701171875],\n",
              "   'label': 'Rituxan (rituximab)',\n",
              "   'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n',\n",
              "   'answer': 'Based on the PA Summary Report, the answer is:\\n\\nNo answer needed.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB62',\n",
              "   'type': 2,\n",
              "   'rect': [281.27899169921875,\n",
              "    475.177001953125,\n",
              "    291.46600341796875,\n",
              "    485.77099609375],\n",
              "   'label': 'Ruxience (rituximab-pvvr)',\n",
              "   'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n',\n",
              "   'answer': 'No answer needed.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB63',\n",
              "   'type': 2,\n",
              "   'rect': [398.927001953125,\n",
              "    475.177001953125,\n",
              "    409.114013671875,\n",
              "    485.77099609375],\n",
              "   'label': 'Truxima (rituximab-abbs)',\n",
              "   'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n',\n",
              "   'answer': 'Truxima (rituximab-abbs)'},\n",
              "  {'page': 2,\n",
              "   'name': 'T64',\n",
              "   'type': 7,\n",
              "   'rect': [45.61000061035156,\n",
              "    487.57000732421875,\n",
              "    225.343994140625,\n",
              "    498.47900390625],\n",
              "   'label': 'Dose:',\n",
              "   'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n',\n",
              "   'answer': '694 mg IVPB'},\n",
              "  {'page': 2,\n",
              "   'name': 'T65',\n",
              "   'type': 7,\n",
              "   'rect': [308.4649963378906,\n",
              "    487.57000732421875,\n",
              "    459.3169860839844,\n",
              "    498.47900390625],\n",
              "   'label': 'Directions for Use:',\n",
              "   'block_context': 'Request is for: \\n Riabni (rituximab-arrx)\\n Rituxan (rituximab)\\n Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs)\\nDose: \\nDirections for Use: \\nHCPCS Code: \\n',\n",
              "   'answer': 'Days 1, 15 Load Then Once Every 24 Weeks. Initial Dose: Every 2 weeks, 2/2 remaining week of 5/19/2024. Maintenance Dose: Every 24 weeks, starting Mon 11/4/2024.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T66',\n",
              "   'type': 7,\n",
              "   'rect': [524.906005859375,\n",
              "    487.57000732421875,\n",
              "    589.9249877929688,\n",
              "    498.47900390625],\n",
              "   'label': 'HCPCS Code:',\n",
              "   'block_context': '',\n",
              "   'answer': 'J1745'},\n",
              "  {'page': 2,\n",
              "   'name': 'T67',\n",
              "   'type': 7,\n",
              "   'rect': [97.97879791259766,\n",
              "    518.5599975585938,\n",
              "    270.3380126953125,\n",
              "    529.259033203125],\n",
              "   'label': 'Primary ICD Code:',\n",
              "   'block_context': 'Primary ICD Code: \\n Other ICD Code: \\n',\n",
              "   'answer': 'G35'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB68',\n",
              "   'type': 2,\n",
              "   'rect': [292.47198486328125,\n",
              "    518.5599975585938,\n",
              "    302.77398681640625,\n",
              "    529.259033203125],\n",
              "   'label': 'Other ICD Code:',\n",
              "   'block_context': 'Primary ICD Code: \\n Other ICD Code: \\n',\n",
              "   'answer': 'G35'},\n",
              "  {'page': 2,\n",
              "   'name': 'T69',\n",
              "   'type': 7,\n",
              "   'rect': [370.33099365234375,\n",
              "    518.5599975585938,\n",
              "    589.5579833984375,\n",
              "    529.259033203125],\n",
              "   'label': 'Other ICD Code:',\n",
              "   'block_context': '',\n",
              "   'answer': 'G35'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB70',\n",
              "   'type': 2,\n",
              "   'rect': [22.825700759887695,\n",
              "    584.4249877929688,\n",
              "    33.12770080566406,\n",
              "    594.9819946289062],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Has the patient had prior therapy with the requested product within the last 365 days? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB71',\n",
              "   'type': 2,\n",
              "   'rect': [52.699501037597656,\n",
              "    584.6510009765625,\n",
              "    62.623199462890625,\n",
              "    594.9819946289062],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Note: Riabni and Rituxan are non-preferred. Ruxience and Truxima are the preferred biosimilars for most indications. \\nFor rheumatoid arthritis, all Rituxan and biosimilar products are non-preferred. Inflectra, Renflexis and Simponi Aria are preferred for MA plans. \\nEnbrel, Humira, Idacio, Rinvoq, Tyenne SC and Xeljanz/Xeljanz XR are preferred for MAPD plans. \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB72',\n",
              "   'type': 2,\n",
              "   'rect': [52.699501037597656,\n",
              "    596.738037109375,\n",
              "    62.623199462890625,\n",
              "    607.0689697265625],\n",
              "   'label': 'No',\n",
              "   'block_context': ' No \\n',\n",
              "   'answer': 'This field does not require an answer based on the provided information.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB73',\n",
              "   'type': 2,\n",
              "   'rect': [81.47090148925781,\n",
              "    606.9550170898438,\n",
              "    91.65750122070312,\n",
              "    617.5490112304688],\n",
              "   'label': 'Ruxience (rituximab-pvvr)',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n',\n",
              "   'answer': 'There is no information about a trial and failure of Ruxience (rituximab-pvvr) in the provided text.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB74',\n",
              "   'type': 2,\n",
              "   'rect': [190.92300415039062,\n",
              "    606.9550170898438,\n",
              "    201.11000061035156,\n",
              "    617.5490112304688],\n",
              "   'label': 'Truxima (rituximab-abbs)',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr)  \\n Truxima (rituximab-abbs) \\nWhen was the member’s trial and failure of the preferred drug? \\n',\n",
              "   'answer': 'There is no information in the provided text to answer when the member had a trial and failure of a preferred drug.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T75',\n",
              "   'type': 7,\n",
              "   'rect': [315.31298828125,\n",
              "    617.7750244140625,\n",
              "    585.489013671875,\n",
              "    628.6840209960938],\n",
              "   'label': 'When was the member’s trial and failure of the preferred drug?',\n",
              "   'block_context': '',\n",
              "   'answer': 'There is no mention of a trial and failure of a preferred drug in the provided summary.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T76',\n",
              "   'type': 7,\n",
              "   'rect': [315.31298828125, 630.634033203125, 585.489013671875, 641.54296875],\n",
              "   'label': 'Please describe the nature of the failure of the preferred drug',\n",
              "   'block_context': '',\n",
              "   'answer': 'Not applicable. Rituximab is being considered as a first-line treatment. The provided information does not indicate a failure of a preferred drug.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB77',\n",
              "   'type': 2,\n",
              "   'rect': [52.699501037597656,\n",
              "    642.22998046875,\n",
              "    63.001399993896484,\n",
              "    652.7869873046875],\n",
              "   'label': 'No',\n",
              "   'block_context': ' No\\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB78',\n",
              "   'type': 2,\n",
              "   'rect': [81.47090148925781,\n",
              "    653.0399780273438,\n",
              "    91.65750122070312,\n",
              "    663.634033203125],\n",
              "   'label': 'Ruxience (rituximab-pvvr)',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n',\n",
              "   'answer': \"Since the question is related to an adverse reaction to Ruxience (rituximab-pvvr) and there's no mention of the patient having taken this medication or experiencing an adverse reaction, the field should be left blank.\"},\n",
              "  {'page': 2,\n",
              "   'name': 'CB79',\n",
              "   'type': 2,\n",
              "   'rect': [190.92300415039062,\n",
              "    653.0399780273438,\n",
              "    201.11000061035156,\n",
              "    663.634033203125],\n",
              "   'label': 'Truxima (rituximab-abbs)',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n',\n",
              "   'answer': 'This field does not need to be filled based on the information provided. There is no indication that the patient had an adverse reaction to a preferred drug, only that Rituximab or its biosimilar is being considered.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T80',\n",
              "   'type': 7,\n",
              "   'rect': [315.31298828125,\n",
              "    664.2340087890625,\n",
              "    585.489013671875,\n",
              "    675.1430053710938],\n",
              "   'label': 'When was the member’s adverse reaction to the preferred drug?',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr) \\n Truxima (rituximab-abbs) \\nWhen was the member’s adverse reaction to the preferred drug?  \\n',\n",
              "   'answer': 'There is no indication in the provided documentation that the member had an adverse reaction to a preferred drug. Therefore, this question does not need to be answered.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T81',\n",
              "   'type': 7,\n",
              "   'rect': [342.1499938964844,\n",
              "    676.0919799804688,\n",
              "    585.489013671875,\n",
              "    687.0009765625],\n",
              "   'label': 'Please describe the nature of the adverse reaction to the preferred drug',\n",
              "   'block_context': '',\n",
              "   'answer': 'No adverse reaction to a preferred drug is mentioned in the provided summary.'},\n",
              "  {'page': 2,\n",
              "   'name': 'T84',\n",
              "   'type': 7,\n",
              "   'rect': [22.731800079345703,\n",
              "    720.555908203125,\n",
              "    585.489013671875,\n",
              "    731.4649047851562],\n",
              "   'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n',\n",
              "   'answer': 'No contraindications or other medical reasons are apparent in the provided documentation that would prevent the patient from using preferred rituximab biosimilar products.'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB82',\n",
              "   'type': 2,\n",
              "   'rect': [22.825700759887695,\n",
              "    708.5637817382812,\n",
              "    33.12770080566406,\n",
              "    719.1207885742188],\n",
              "   'label': 'Ruxience (rituximab-pvvr)',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n',\n",
              "   'answer': 'Truxima (rituximab-abbs)'},\n",
              "  {'page': 2,\n",
              "   'name': 'CB83',\n",
              "   'type': 2,\n",
              "   'rect': [131.9810028076172,\n",
              "    708.4747924804688,\n",
              "    141.90499877929688,\n",
              "    718.8057861328125],\n",
              "   'label': 'Truxima (rituximab-abbs)',\n",
              "   'block_context': ' Ruxience (rituximab-pvvr)\\n Truxima (rituximab-abbs) \\n',\n",
              "   'answer': 'Truxima (rituximab-abbs)'},\n",
              "  {'page': 3,\n",
              "   'name': 'T12',\n",
              "   'type': 7,\n",
              "   'rect': [19.95840072631836,\n",
              "    128.02301025390625,\n",
              "    164.60400390625,\n",
              "    140.68499755859375],\n",
              "   'label': 'Patient First Name',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': 'Shakh'},\n",
              "  {'page': 3,\n",
              "   'name': 'T13',\n",
              "   'type': 7,\n",
              "   'rect': [168.7469940185547,\n",
              "    128.02301025390625,\n",
              "    348.12200927734375,\n",
              "    140.68499755859375],\n",
              "   'label': 'Patient Last Name',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': 'Abdulla'},\n",
              "  {'page': 3,\n",
              "   'name': 'T19',\n",
              "   'type': 7,\n",
              "   'rect': [353.4530029296875,\n",
              "    128.02301025390625,\n",
              "    465.8210144042969,\n",
              "    140.68499755859375],\n",
              "   'label': 'Patient Phone',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': '865-395-3958'},\n",
              "  {'page': 3,\n",
              "   'name': 'T14',\n",
              "   'type': 7,\n",
              "   'rect': [470.8710021972656,\n",
              "    128.02301025390625,\n",
              "    591.301025390625,\n",
              "    140.68499755859375],\n",
              "   'label': 'Patient DOB (MM/DD/YYYY)',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': '04/01/2001'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB86',\n",
              "   'type': 2,\n",
              "   'rect': [81.38929748535156,\n",
              "    178.2750244140625,\n",
              "    91.69129943847656,\n",
              "    188.83197021484375],\n",
              "   'label': 'Inflectra (infliximab-dyyb)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n',\n",
              "   'answer': 'This information is not available in the provided document.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB87',\n",
              "   'type': 2,\n",
              "   'rect': [188.22500610351562,\n",
              "    178.3590087890625,\n",
              "    198.26100158691406,\n",
              "    188.83197021484375],\n",
              "   'label': 'Renflexis (infliximab-abda)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n',\n",
              "   'answer': 'There is no information in the provided PA summary regarding a trial and failure of Renflexis (infliximab-abda).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB88',\n",
              "   'type': 2,\n",
              "   'rect': [300.7449951171875,\n",
              "    178.3590087890625,\n",
              "    310.781005859375,\n",
              "    188.83197021484375],\n",
              "   'label': 'Simponi Aria (golimumab)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n',\n",
              "   'answer': 'Based on the provided PA summary report, there is no mention of Simponi Aria (golimumab) being a preferred drug or a trial/failure of this medication. Therefore, this field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T89',\n",
              "   'type': 7,\n",
              "   'rect': [314.85101318359375,\n",
              "    189.10797119140625,\n",
              "    582.4080200195312,\n",
              "    199.8070068359375],\n",
              "   'label': 'When was the member’s trial and failure of the preferred drug?',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)  \\n Renflexis (infliximab-abda) \\n Simponi Aria (golimumab)  \\nWhen was the member’s trial and failure of the preferred drug? \\n',\n",
              "   'answer': 'There is no information in the provided PA summary report regarding a trial and failure of a preferred drug.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T90',\n",
              "   'type': 7,\n",
              "   'rect': [314.85101318359375,\n",
              "    201.96600341796875,\n",
              "    582.4080200195312,\n",
              "    212.66497802734375],\n",
              "   'label': 'Please describe the nature of the failure of the preferred drug',\n",
              "   'block_context': '',\n",
              "   'answer': 'Not applicable. Rituximab is being considered and no preferred drug failure is mentioned.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB85',\n",
              "   'type': 2,\n",
              "   'rect': [52.34349822998047,\n",
              "    168.1290283203125,\n",
              "    62.64540100097656,\n",
              "    178.68597412109375],\n",
              "   'label': 'No',\n",
              "   'block_context': ' No\\n',\n",
              "   'answer': 'This field does not require an answer based on the provided information.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB92',\n",
              "   'type': 2,\n",
              "   'rect': [81.38929748535156,\n",
              "    223.86602783203125,\n",
              "    91.69129943847656,\n",
              "    234.4229736328125],\n",
              "   'label': 'Inflectra (infliximab-dyyb)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n',\n",
              "   'answer': 'This field cannot be answered from the given context.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB93',\n",
              "   'type': 2,\n",
              "   'rect': [188.552001953125,\n",
              "    223.95001220703125,\n",
              "    198.58799743652344,\n",
              "    234.4229736328125],\n",
              "   'label': 'Renflexis (infliximab-abda)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n',\n",
              "   'answer': \"Based on the provided PA summary, there's no mention of an adverse reaction to Renflexis (infliximab-abda). Therefore, I cannot answer the question.\"},\n",
              "  {'page': 3,\n",
              "   'name': 'CB94',\n",
              "   'type': 2,\n",
              "   'rect': [301.4179992675781,\n",
              "    223.95001220703125,\n",
              "    311.4540100097656,\n",
              "    234.4229736328125],\n",
              "   'label': 'Simponi Aria (golimumab)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n',\n",
              "   'answer': 'Based on the provided information, there is no mention of the member having an adverse reaction to Simponi Aria (golimumab). Therefore, this question should not be answered.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T95',\n",
              "   'type': 7,\n",
              "   'rect': [314.85101318359375,\n",
              "    235.56597900390625,\n",
              "    582.4080200195312,\n",
              "    246.2650146484375],\n",
              "   'label': 'When was the member’s adverse reaction to the preferred drug?',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab)  \\nWhen was the member’s adverse reaction to the preferred drug? \\n',\n",
              "   'answer': 'The provided PA summary does not mention any adverse reaction to a preferred drug. Therefore, this question does not need to be answered.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T96a',\n",
              "   'type': 7,\n",
              "   'rect': [342.0140075683594,\n",
              "    247.42401123046875,\n",
              "    582.4080200195312,\n",
              "    258.12298583984375],\n",
              "   'label': 'Please describe the nature of the adverse reaction to the preferred drug',\n",
              "   'block_context': '  \\n',\n",
              "   'answer': 'Not applicable. The patient has not had any adverse reactions to preferred drugs. The patient is being started on Rituximab-abbs (Truxima).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB91',\n",
              "   'type': 2,\n",
              "   'rect': [52.34349822998047,\n",
              "    214.0479736328125,\n",
              "    62.64540100097656,\n",
              "    224.60498046875],\n",
              "   'label': 'No',\n",
              "   'block_context': ' No\\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB98a',\n",
              "   'type': 2,\n",
              "   'rect': [81.38929748535156,\n",
              "    269.666015625,\n",
              "    91.69129943847656,\n",
              "    280.2229919433594],\n",
              "   'label': 'Enbrel (etanercept)',\n",
              "   'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB99a',\n",
              "   'type': 2,\n",
              "   'rect': [168.93499755859375, 269.75, 178.9709930419922, 280.2229919433594],\n",
              "   'label': 'Humira (adalimumab)',\n",
              "   'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB100a',\n",
              "   'type': 2,\n",
              "   'rect': [263.5639953613281, 269.75, 273.6000061035156, 280.2229919433594],\n",
              "   'label': 'Idacio (adalimumab-aacf)',\n",
              "   'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB101a',\n",
              "   'type': 2,\n",
              "   'rect': [371.9209899902344, 269.75, 381.9570007324219, 280.2229919433594],\n",
              "   'label': 'Rinvoq (upadacitinib)',\n",
              "   'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled. The patient is being prescribed Rituximab, not Rinvoq.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB102a',\n",
              "   'type': 2,\n",
              "   'rect': [465.09600830078125, 269.75, 475.1319885253906, 280.2229919433594],\n",
              "   'label': 'Tyenne SC (tocilizumab-aazg)',\n",
              "   'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled based on the information provided. The requested medication is Rituximab-abbs (Truxima), not Tyenne SC (tocilizumab-aazg).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB103a',\n",
              "   'type': 2,\n",
              "   'rect': [81.38929748535156,\n",
              "    280.92999267578125,\n",
              "    91.69129943847656,\n",
              "    291.48699951171875],\n",
              "   'label': 'Xeljanz/Xeljanz XR (tofacitinib)',\n",
              "   'block_context': ' Enbrel (etanercept) \\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib)\\n Tyenne SC (tocilizumab-aazg)  \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field should not be filled based on the provided information.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T104',\n",
              "   'type': 7,\n",
              "   'rect': [314.85101318359375,\n",
              "    294.3110046386719,\n",
              "    582.4080200195312,\n",
              "    305.010009765625],\n",
              "   'label': 'When was the member’s trial and failure of the preferred drug?',\n",
              "   'block_context': '',\n",
              "   'answer': 'There is no information in the provided referral summary regarding a trial and failure of a preferred drug.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T105',\n",
              "   'type': 7,\n",
              "   'rect': [314.85101318359375,\n",
              "    306.16900634765625,\n",
              "    582.4080200195312,\n",
              "    316.8680114746094],\n",
              "   'label': 'Please describe the nature of the failure of the preferred drug',\n",
              "   'block_context': '',\n",
              "   'answer': 'Not applicable, Rituximab is being considered, not a failure of a preferred drug.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB97',\n",
              "   'type': 2,\n",
              "   'rect': [52.34349822998047,\n",
              "    260.1939697265625,\n",
              "    62.64540100097656,\n",
              "    270.7509765625],\n",
              "   'label': 'No',\n",
              "   'block_context': ' No\\n',\n",
              "   'answer': 'This field does not require an answer based on the provided information.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB107z',\n",
              "   'type': 2,\n",
              "   'rect': [81.38929748535156,\n",
              "    328.5570068359375,\n",
              "    91.69129943847656,\n",
              "    339.114013671875],\n",
              "   'label': 'Enbrel (etanercept)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled based on the context provided.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB108z',\n",
              "   'type': 2,\n",
              "   'rect': [168.93499755859375,\n",
              "    328.6409912109375,\n",
              "    178.9709930419922,\n",
              "    339.114013671875],\n",
              "   'label': 'Humira (adalimumab)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB109z',\n",
              "   'type': 2,\n",
              "   'rect': [263.5639953613281,\n",
              "    328.6409912109375,\n",
              "    273.6000061035156,\n",
              "    339.114013671875],\n",
              "   'label': 'Idacio (adalimumab-aacf)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled. The patient is being prescribed Rituximab-abbs (Truxima), not Idacio (adalimumab-aacf).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB110z',\n",
              "   'type': 2,\n",
              "   'rect': [371.9209899902344,\n",
              "    328.6409912109375,\n",
              "    381.9570007324219,\n",
              "    339.114013671875],\n",
              "   'label': 'Rinvoq (upadacitinib)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB111z',\n",
              "   'type': 2,\n",
              "   'rect': [465.0780029296875,\n",
              "    328.6409912109375,\n",
              "    475.114013671875,\n",
              "    339.114013671875],\n",
              "   'label': 'Tyenne SC (tocilizumab-aazg)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled. The requested medication is Rituximab-abbs (Truxima), not Tyenne SC (tocilizumab-aazg).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB112z',\n",
              "   'type': 2,\n",
              "   'rect': [81.38929748535156,\n",
              "    339.8210144042969,\n",
              "    91.69129943847656,\n",
              "    350.37799072265625],\n",
              "   'label': 'Xeljanz/Xeljanz XR (tofacitinib)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab)\\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T113',\n",
              "   'type': 7,\n",
              "   'rect': [314.85101318359375,\n",
              "    352.33599853515625,\n",
              "    582.4080200195312,\n",
              "    363.0360107421875],\n",
              "   'label': 'When was the member’s adverse reaction to the preferred drug?',\n",
              "   'block_context': '   \\n',\n",
              "   'answer': 'This information is not available in the provided referral summary.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T114',\n",
              "   'type': 7,\n",
              "   'rect': [342.34100341796875,\n",
              "    364.19500732421875,\n",
              "    582.4080200195312,\n",
              "    374.8940124511719],\n",
              "   'label': 'Please describe the nature of the adverse reaction to the preferred drug',\n",
              "   'block_context': '',\n",
              "   'answer': 'There is no information in the provided summary regarding a previous adverse reaction to a preferred drug.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB106z',\n",
              "   'type': 2,\n",
              "   'rect': [52.34349822998047,\n",
              "    318.0840148925781,\n",
              "    62.64540100097656,\n",
              "    328.6419982910156],\n",
              "   'label': 'No',\n",
              "   'block_context': ' No\\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T118',\n",
              "   'type': 7,\n",
              "   'rect': [22.0226993560791,\n",
              "    409.406005859375,\n",
              "    582.4080200195312,\n",
              "    420.85198974609375],\n",
              "   'label': 'Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?',\n",
              "   'block_context': '',\n",
              "   'answer': 'No contraindications are apparent from the provided information.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB115z',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    397.3210144042969,\n",
              "    32.70389938354492,\n",
              "    407.87799072265625],\n",
              "   'label': 'Inflectra (infliximab-dyyb)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB116z',\n",
              "   'type': 2,\n",
              "   'rect': [129.55799865722656,\n",
              "    397.4049987792969,\n",
              "    139.593994140625,\n",
              "    407.87799072265625],\n",
              "   'label': 'Renflexis (infliximab-abda)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n',\n",
              "   'answer': 'Based on the provided information, Renflexis (infliximab-abda) is NOT being considered. The medication being considered is Rituximab-abbs (Truxima). Therefore, this field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB117z',\n",
              "   'type': 2,\n",
              "   'rect': [241.75100708007812,\n",
              "    397.4049987792969,\n",
              "    251.78700256347656,\n",
              "    407.87799072265625],\n",
              "   'label': 'Simponi Aria (golimumab)',\n",
              "   'block_context': ' Inflectra (infliximab-dyyb)\\n Renflexis (infliximab-abda)\\n Simponi Aria (golimumab) \\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'T125',\n",
              "   'type': 7,\n",
              "   'rect': [22.0226993560791,\n",
              "    464.6180114746094,\n",
              "    582.4080200195312,\n",
              "    476.0639953613281],\n",
              "   'label': 'Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?',\n",
              "   'block_context': '',\n",
              "   'answer': 'There are no contraindications or other medical reasons listed in the provided information that would prevent the patient from using preferred products.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB119z',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    441.5849914550781,\n",
              "    32.70389938354492,\n",
              "    452.1409912109375],\n",
              "   'label': 'Enbrel (etanercept)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field should not be filled. The PA is for Rituximab-abbs (Truxima), not Enbrel (etanercept).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB120z',\n",
              "   'type': 2,\n",
              "   'rect': [109.67500305175781,\n",
              "    441.5469970703125,\n",
              "    119.86100006103516,\n",
              "    452.1409912109375],\n",
              "   'label': 'Humira (adalimumab)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB121z',\n",
              "   'type': 2,\n",
              "   'rect': [201.76400756835938,\n",
              "    441.5469970703125,\n",
              "    211.9499969482422,\n",
              "    452.1409912109375],\n",
              "   'label': 'Idacio (adalimumab-aacf)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled. The provided information concerns Rituximab-abbs (Truxima), which is unrelated to Idacio (adalimumab-aacf).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB122z',\n",
              "   'type': 2,\n",
              "   'rect': [310.4049987792969,\n",
              "    441.5379943847656,\n",
              "    320.5840148925781,\n",
              "    452.1409912109375],\n",
              "   'label': 'Rinvoq (upadacitinib)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'Based on the provided PA summary report, there is no information about the use of Rinvoq (upadacitinib). Therefore, this field does not need to be filled.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB123z',\n",
              "   'type': 2,\n",
              "   'rect': [401.4320068359375,\n",
              "    441.5379943847656,\n",
              "    411.6109924316406,\n",
              "    452.1409912109375],\n",
              "   'label': 'Tyenne SC (tocilizumab-aazg)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB124z',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    452.5150146484375,\n",
              "    32.58890151977539,\n",
              "    463.1090087890625],\n",
              "   'label': 'Xeljanz/Xeljanz XR (tofacitinib)',\n",
              "   'block_context': ' Enbrel (etanercept)\\n Humira (adalimumab) \\n Idacio (adalimumab-aacf)\\n Rinvoq (upadacitinib) \\n Tyenne SC (tocilizumab-aazg) \\n Xeljanz/Xeljanz XR (tofacitinib) \\n',\n",
              "   'answer': 'This field does not need to be filled based on the PA summary report provided. The requested medication is Rituximab-abbs (Truxima), not Xeljanz/Xeljanz XR (tofacitinib).'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB96.4.0',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    489.9960021972656,\n",
              "    32.58890151977539,\n",
              "    500.5899963378906],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB98',\n",
              "   'type': 2,\n",
              "   'rect': [52.02109909057617,\n",
              "    490.0329895019531,\n",
              "    62.323001861572266,\n",
              "    500.5899963378906],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB99.0',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    512.27001953125,\n",
              "    32.70389938354492,\n",
              "    522.8270263671875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB100.0',\n",
              "   'type': 2,\n",
              "   'rect': [52.02109909057617,\n",
              "    512.6729736328125,\n",
              "    61.89899826049805,\n",
              "    522.8060302734375],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB101.0',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    523.8699951171875,\n",
              "    32.70389938354492,\n",
              "    534.427001953125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB102.0',\n",
              "   'type': 2,\n",
              "   'rect': [52.02109909057617,\n",
              "    523.8699951171875,\n",
              "    62.323001861572266,\n",
              "    534.427001953125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB103',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    546.2080078125,\n",
              "    32.703800201416016,\n",
              "    556.7650146484375],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB104',\n",
              "   'type': 2,\n",
              "   'rect': [52.02109909057617,\n",
              "    546.218017578125,\n",
              "    62.323001861572266,\n",
              "    556.7750244140625],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB104a',\n",
              "   'type': 2,\n",
              "   'rect': [238.76499938964844,\n",
              "    568.7449951171875,\n",
              "    249.0659942626953,\n",
              "    579.301025390625],\n",
              "   'label': 'Wegener granulomatosis',\n",
              "   'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n',\n",
              "   'answer': 'Based on the provided information, there is no indication of Wegener granulomatosis.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB104b',\n",
              "   'type': 2,\n",
              "   'rect': [351.2770080566406,\n",
              "    568.7249755859375,\n",
              "    361.5780029296875,\n",
              "    579.281005859375],\n",
              "   'label': 'Churg-Strauss syndrome',\n",
              "   'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB104c',\n",
              "   'type': 2,\n",
              "   'rect': [238.77499389648438,\n",
              "    579.343017578125,\n",
              "    249.0760040283203,\n",
              "    589.8989868164062],\n",
              "   'label': 'microscopic polyangiitis',\n",
              "   'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB104d',\n",
              "   'type': 2,\n",
              "   'rect': [351.2860107421875,\n",
              "    579.3330078125,\n",
              "    361.5880126953125,\n",
              "    589.8890380859375],\n",
              "   'label': 'pauci-immune glomerulonephritis',\n",
              "   'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n',\n",
              "   'answer': \"Based on the provided information, it's impossible to determine if the patient has pauci-immune glomerulonephritis.\"},\n",
              "  {'page': 3,\n",
              "   'name': 'CB105',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    591.3099975585938,\n",
              "    32.703800201416016,\n",
              "    601.865966796875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB106',\n",
              "   'type': 2,\n",
              "   'rect': [52.02109909057617,\n",
              "    591.3410034179688,\n",
              "    62.323001861572266,\n",
              "    601.89697265625],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Anti-neutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitides  \\nPlease indicate which of the following applies to the patient:\\n Wegener granulomatosis \\n Churg-Strauss syndrome \\n microscopic polyangiitis \\n pauci-immune glomerulonephritis \\n Will Rituxan (rituximab) be given in conjunction with glucocorticoids? \\n Yes \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB106a',\n",
              "   'type': 2,\n",
              "   'rect': [22.401899337768555,\n",
              "    613.6580200195312,\n",
              "    32.703800201416016,\n",
              "    624.2139892578125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': ' Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB107',\n",
              "   'type': 2,\n",
              "   'rect': [234.27999877929688,\n",
              "    623.35400390625,\n",
              "    244.58099365234375,\n",
              "    633.9100341796875],\n",
              "   'label': 'pemphigus vulgaris',\n",
              "   'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n',\n",
              "   'answer': 'None of the above'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB108',\n",
              "   'type': 2,\n",
              "   'rect': [321.2820129394531,\n",
              "    623.343017578125,\n",
              "    331.5830078125,\n",
              "    633.9000244140625],\n",
              "   'label': 'pemphigus folliaceus',\n",
              "   'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n',\n",
              "   'answer': 'None of the above'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB109',\n",
              "   'type': 2,\n",
              "   'rect': [414.0069885253906,\n",
              "    623.3370361328125,\n",
              "    424.3080139160156,\n",
              "    633.8930053710938],\n",
              "   'label': 'bullous pemphigoid',\n",
              "   'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n',\n",
              "   'answer': 'None of the above'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB110',\n",
              "   'type': 2,\n",
              "   'rect': [501.04901123046875,\n",
              "    623.322998046875,\n",
              "    511.3500061035156,\n",
              "    633.8800048828125],\n",
              "   'label': 'cicatricial pemphigoid',\n",
              "   'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n',\n",
              "   'answer': 'None of the above'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB111',\n",
              "   'type': 2,\n",
              "   'rect': [234.29100036621094,\n",
              "    633.9869995117188,\n",
              "    244.5919952392578,\n",
              "    644.5440063476562],\n",
              "   'label': 'epidermolysis bullosa acquisita',\n",
              "   'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n',\n",
              "   'answer': 'None of the above'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB112',\n",
              "   'type': 2,\n",
              "   'rect': [362.60101318359375,\n",
              "    633.9970092773438,\n",
              "    372.9020080566406,\n",
              "    644.5540161132812],\n",
              "   'label': 'paraneoplastic pemphigus',\n",
              "   'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n',\n",
              "   'answer': 'None of the above'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB113',\n",
              "   'type': 2,\n",
              "   'rect': [473.9859924316406,\n",
              "    633.9830322265625,\n",
              "    484.2869873046875,\n",
              "    644.5390014648438],\n",
              "   'label': 'None of the above',\n",
              "   'block_context': 'Please select which applies to the patient: \\n pemphigus vulgaris\\n pemphigus folliaceus\\n bullous pemphigoid\\n cicatricial pemphigoid \\n epidermolysis bullosa acquisita\\n paraneoplastic pemphigus\\n None of the above \\n',\n",
              "   'answer': 'None of the above'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB106b',\n",
              "   'type': 2,\n",
              "   'rect': [52.02109909057617,\n",
              "    613.66796875,\n",
              "    62.323001861572266,\n",
              "    624.2249755859375],\n",
              "   'label': 'No',\n",
              "   'block_context': ' Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB114',\n",
              "   'type': 2,\n",
              "   'rect': [175.54200744628906,\n",
              "    655.4459838867188,\n",
              "    185.843994140625,\n",
              "    666.0029907226562],\n",
              "   'label': 'AIDS-related B-cell lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the provided PA summary, none of the B-cell lymphoma options apply to the patient. The patient has multiple sclerosis. Therefore, this field should be left blank.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB115',\n",
              "   'type': 2,\n",
              "   'rect': [301.32501220703125,\n",
              "    655.4459838867188,\n",
              "    311.62701416015625,\n",
              "    666.0029907226562],\n",
              "   'label': 'Burkitt lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the provided PA summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not provide an answer.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB116',\n",
              "   'type': 2,\n",
              "   'rect': [380.8210144042969,\n",
              "    655.4459838867188,\n",
              "    391.12298583984375,\n",
              "    666.0029907226562],\n",
              "   'label': 'Diffuse large B-cell lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the provided information, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, this question should not be answered.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB117',\n",
              "   'type': 2,\n",
              "   'rect': [505.20098876953125,\n",
              "    655.4459838867188,\n",
              "    515.5029907226562,\n",
              "    666.0029907226562],\n",
              "   'label': 'Follicular lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the provided PA summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not provide an answer.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB118',\n",
              "   'type': 2,\n",
              "   'rect': [175.54200744628906,\n",
              "    665.8720092773438,\n",
              "    185.843994140625,\n",
              "    676.4290161132812],\n",
              "   'label': 'Gastric MALT lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the information provided, none of the B-cell lymphoma options apply to the patient, as the patient has multiple sclerosis. Therefore, I will not provide an answer.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB119',\n",
              "   'type': 2,\n",
              "   'rect': [281.6090087890625,\n",
              "    665.8720092773438,\n",
              "    291.9110107421875,\n",
              "    676.4290161132812],\n",
              "   'label': 'High-grade B-Cell lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the provided referral summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not provide an answer.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB120',\n",
              "   'type': 2,\n",
              "   'rect': [403.06201171875,\n",
              "    665.8720092773438,\n",
              "    413.364013671875,\n",
              "    676.4290161132812],\n",
              "   'label': 'Mantle cell lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Error: Max retries exceeded due to rate limit.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB121',\n",
              "   'type': 2,\n",
              "   'rect': [175.54200744628906,\n",
              "    676.5670166015625,\n",
              "    185.843994140625,\n",
              "    687.1240234375],\n",
              "   'label': 'Nodal marginal zone lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the provided PA summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not answer this question.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB122',\n",
              "   'type': 2,\n",
              "   'rect': [306.08599853515625,\n",
              "    676.5670166015625,\n",
              "    316.38800048828125,\n",
              "    687.1240234375],\n",
              "   'label': 'Nongastric MALT lymphoma',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Based on the provided PA Summary Report, none of the listed B-cell lymphomas apply to the patient, Shakh Abdulla. The patient has been diagnosed with Multiple sclerosis in pediatric patient.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB123',\n",
              "   'type': 2,\n",
              "   'rect': [425.44000244140625,\n",
              "    676.5670166015625,\n",
              "    435.74200439453125,\n",
              "    687.1240234375],\n",
              "   'label': 'Primary cutaneous B-cell lymphomas',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB124',\n",
              "   'type': 2,\n",
              "   'rect': [175.54200744628906,\n",
              "    687.93701171875,\n",
              "    185.843994140625,\n",
              "    698.4945068359375],\n",
              "   'label': 'Splenic marginal zone lymphoma',\n",
              "   'block_context': ' Splenic marginal zone lymphoma\\n Other: \\n',\n",
              "   'answer': 'This field does not need to be filled. The patient has multiple sclerosis, not splenic marginal zone lymphoma.'},\n",
              "  {'page': 3,\n",
              "   'name': 'CB125',\n",
              "   'type': 2,\n",
              "   'rect': [311.91900634765625,\n",
              "    688.2860107421875,\n",
              "    322.22100830078125,\n",
              "    698.8427124023438],\n",
              "   'label': 'Other:',\n",
              "   'block_context': ' Splenic marginal zone lymphoma\\n Other: \\n',\n",
              "   'answer': 'Multiple sclerosis in pediatric patient'},\n",
              "  {'page': 3,\n",
              "   'name': 'T126',\n",
              "   'type': 7,\n",
              "   'rect': [347.5450134277344,\n",
              "    688.0380249023438,\n",
              "    585.0689697265625,\n",
              "    698.70947265625],\n",
              "   'label': 'Other:',\n",
              "   'block_context': 'B-cell lymphomas\\nPlease select which applies to the patient:\\n AIDS-related B-cell lymphoma\\n Burkitt lymphoma \\n Diffuse large B-cell lymphoma\\n Follicular lymphoma \\n Gastric MALT lymphoma\\n High-grade B-Cell lymphoma\\n Mantle cell lymphoma\\n Nodal marginal zone lymphoma \\n Nongastric MALT lymphoma \\n Primary cutaneous B-cell lymphomas \\n',\n",
              "   'answer': 'Multiple sclerosis in pediatric patient (CMS/HCC)'},\n",
              "  {'page': 4,\n",
              "   'name': 'T12',\n",
              "   'type': 7,\n",
              "   'rect': [20.796199798583984,\n",
              "    131.79498291015625,\n",
              "    164.06300354003906,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient First Name',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': 'Shakh'},\n",
              "  {'page': 4,\n",
              "   'name': 'T13',\n",
              "   'type': 7,\n",
              "   'rect': [168.93800354003906,\n",
              "    131.79498291015625,\n",
              "    348.9230041503906,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient Last Name',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': 'Abdulla'},\n",
              "  {'page': 4,\n",
              "   'name': 'T19',\n",
              "   'type': 7,\n",
              "   'rect': [354.30499267578125,\n",
              "    131.79498291015625,\n",
              "    469.82598876953125,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient Phone',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': '865-395-3958'},\n",
              "  {'page': 4,\n",
              "   'name': 'T14',\n",
              "   'type': 7,\n",
              "   'rect': [475.18701171875,\n",
              "    131.79498291015625,\n",
              "    592.4639892578125,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient DOB (MM/DD/YYYY)',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': '04/01/2001'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB127',\n",
              "   'type': 2,\n",
              "   'rect': [22.673200607299805,\n",
              "    167.864013671875,\n",
              "    32.975101470947266,\n",
              "    178.4210205078125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of multicentric Castleman’s disease (angiofollicular lymph node hyperplasia)? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB128',\n",
              "   'type': 2,\n",
              "   'rect': [52.01240158081055,\n",
              "    167.87298583984375,\n",
              "    62.31420135498047,\n",
              "    178.42999267578125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of multicentric Castleman’s disease (angiofollicular lymph node hyperplasia)? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB129',\n",
              "   'type': 2,\n",
              "   'rect': [173.50999450683594,\n",
              "    190.15802001953125,\n",
              "    183.81199645996094,\n",
              "    200.71502685546875],\n",
              "   'label': 'leptomeningeal metastases from lymphoma',\n",
              "   'block_context': 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB130',\n",
              "   'type': 2,\n",
              "   'rect': [346.9599914550781,\n",
              "    190.15802001953125,\n",
              "    357.2619934082031,\n",
              "    200.71502685546875],\n",
              "   'label': 'primary CNS lymphoma',\n",
              "   'block_context': 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB131',\n",
              "   'type': 2,\n",
              "   'rect': [449.24700927734375,\n",
              "    190.15802001953125,\n",
              "    459.54901123046875,\n",
              "    200.71502685546875],\n",
              "   'label': 'none of the above',\n",
              "   'block_context': 'Central nervous system lymphomas \\nPlease select which applies to the patient:\\n leptomeningeal metastases from lymphoma\\n primary CNS lymphoma\\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB132',\n",
              "   'type': 2,\n",
              "   'rect': [173.1649932861328,\n",
              "    212.5050048828125,\n",
              "    183.4669952392578,\n",
              "    223.06201171875],\n",
              "   'label': 'chronic lymphocytic leukemia (CLL)',\n",
              "   'block_context': 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB133',\n",
              "   'type': 2,\n",
              "   'rect': [317.5360107421875,\n",
              "    212.5050048828125,\n",
              "    327.8380126953125,\n",
              "    223.06201171875],\n",
              "   'label': 'small lymphocytic leukemia',\n",
              "   'block_context': 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB134',\n",
              "   'type': 2,\n",
              "   'rect': [432.5050048828125,\n",
              "    212.5050048828125,\n",
              "    442.8070068359375,\n",
              "    223.06201171875],\n",
              "   'label': 'none of the above',\n",
              "   'block_context': 'Chronic or small lymphocytic leukemia \\nPlease select which applies to the patient:\\n chronic lymphocytic leukemia (CLL)\\n small lymphocytic leukemia\\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB135',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    235.28399658203125,\n",
              "    32.975101470947266,\n",
              "    245.84100341796875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB136',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    235.27197265625,\n",
              "    62.31420135498047,\n",
              "    245.8289794921875],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB139',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    246.739990234375,\n",
              "    32.975101470947266,\n",
              "    257.2969970703125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB140',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    246.739990234375,\n",
              "    62.31420135498047,\n",
              "    257.2969970703125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of cryoglobulinemia? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB144',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    268.89697265625,\n",
              "    32.975101470947266,\n",
              "    279.4539794921875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB145',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    269.38201904296875,\n",
              "    62.31420135498047,\n",
              "    279.93902587890625],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB141',\n",
              "   'type': 2,\n",
              "   'rect': [173.4029998779297,\n",
              "    291.9289855957031,\n",
              "    183.7050018310547,\n",
              "    302.4859924316406],\n",
              "   'label': 'relapsed hairy cell leukemia',\n",
              "   'block_context': 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB142',\n",
              "   'type': 2,\n",
              "   'rect': [290.2030029296875,\n",
              "    291.91900634765625,\n",
              "    300.5050048828125,\n",
              "    302.47601318359375],\n",
              "   'label': 'refractory hairy cell leukemia',\n",
              "   'block_context': 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB143',\n",
              "   'type': 2,\n",
              "   'rect': [410.20599365234375,\n",
              "    291.90899658203125,\n",
              "    420.50799560546875,\n",
              "    302.46600341796875],\n",
              "   'label': 'none of the above',\n",
              "   'block_context': 'Hairy cell leukemia \\nPlease select which applies to the patient:\\n relapsed hairy cell leukemia\\n refractory hairy cell leukemia \\n none of the above \\n',\n",
              "   'answer': 'none of the above'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB137',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    313.6650085449219,\n",
              "    32.975101470947266,\n",
              "    324.22198486328125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB146',\n",
              "   'type': 2,\n",
              "   'rect': [239.57899475097656,\n",
              "    334.8080139160156,\n",
              "    249.88099670410156,\n",
              "    345.364990234375],\n",
              "   'label': 'heart transplant recipient',\n",
              "   'block_context': ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB147',\n",
              "   'type': 2,\n",
              "   'rect': [345.38299560546875,\n",
              "    334.7669982910156,\n",
              "    355.68499755859375,\n",
              "    345.3240051269531],\n",
              "   'label': 'other solid organ transplant recipient',\n",
              "   'block_context': ' Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with \\n antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB138',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    313.67401123046875,\n",
              "    62.31420135498047,\n",
              "    324.2309875488281],\n",
              "   'label': 'No',\n",
              "   'block_context': ' No \\n',\n",
              "   'answer': 'This field does not need to be filled.'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB148',\n",
              "   'type': 2,\n",
              "   'rect': [293.14898681640625,\n",
              "    357.11199951171875,\n",
              "    303.45098876953125,\n",
              "    367.66900634765625],\n",
              "   'label': 'Bavencio (avelumab)',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': 'Error: Max retries exceeded due to rate limit.'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB149',\n",
              "   'type': 2,\n",
              "   'rect': [386.4150085449219,\n",
              "    357.11199951171875,\n",
              "    396.7170104980469,\n",
              "    367.66900634765625],\n",
              "   'label': 'Imfinzi (durvalumab)',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': \"This field should not be filled. The patient's diagnosis is Multiple Sclerosis, and they are being prescribed Rituximab. There is no mention of immune checkpoint-inhibitor related encephalitis or any of the listed medications.\"},\n",
              "  {'page': 4,\n",
              "   'name': 'CB150',\n",
              "   'type': 2,\n",
              "   'rect': [476.68499755859375,\n",
              "    357.11199951171875,\n",
              "    486.98699951171875,\n",
              "    367.66900634765625],\n",
              "   'label': 'Keytruda (pembrolizumab)',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': 'This field does not need to be filled. The patient is being treated for multiple sclerosis, not immune checkpoint-inhibitor related encephalitis.'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB151',\n",
              "   'type': 2,\n",
              "   'rect': [293.14898681640625,\n",
              "    368.8280029296875,\n",
              "    303.45098876953125,\n",
              "    379.385009765625],\n",
              "   'label': 'Opdivo (nivolumab)',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': 'This field should not be filled. The patient does not have immune checkpoint-inhibitor related encephalitis, but instead has Multiple Sclerosis.'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB152',\n",
              "   'type': 2,\n",
              "   'rect': [380.1409912109375,\n",
              "    368.8280029296875,\n",
              "    390.4429931640625,\n",
              "    379.385009765625],\n",
              "   'label': 'Tecentriq (atezolizumab)',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': 'Based on the provided PA summary, the field \"Immune checkpoint-inhibitor related encephalitis\" should not be filled. The patient is being treated for Multiple Sclerosis, not encephalitis, and the medication being requested (Rituximab-abbs) is not an immune checkpoint inhibitor.'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB153',\n",
              "   'type': 2,\n",
              "   'rect': [486.5639953613281,\n",
              "    368.8280029296875,\n",
              "    496.8659973144531,\n",
              "    379.385009765625],\n",
              "   'label': 'Yervoy (ipilimumab)',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': \"This field should not be filled in, as the patient's diagnosis is Multiple Sclerosis, not Immune checkpoint-inhibitor related encephalitis.\"},\n",
              "  {'page': 4,\n",
              "   'name': 'CB154',\n",
              "   'type': 2,\n",
              "   'rect': [293.14898681640625,\n",
              "    380.08099365234375,\n",
              "    303.45098876953125,\n",
              "    390.63800048828125],\n",
              "   'label': 'Other:',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': 'Other: Rituximab-abbs (Truxima)'},\n",
              "  {'page': 4,\n",
              "   'name': 'T155',\n",
              "   'type': 7,\n",
              "   'rect': [327.6289978027344,\n",
              "    380.3970031738281,\n",
              "    584.3980102539062,\n",
              "    391.5920104980469],\n",
              "   'label': 'Other:',\n",
              "   'block_context': 'Immune checkpoint-inhibitor related encephalitis \\nPlease identify which immune check-point inhibitor caused the encephalitis:\\n Bavencio (avelumab)\\n Imfinzi (durvalumab)\\n Keytruda (pembrolizumab) \\n Opdivo (nivolumab)\\n Tecentriq (atezolizumab)\\n Yervoy (ipilimumab) \\n Other: \\n',\n",
              "   'answer': 'Multiple sclerosis in pediatric patient (CMS/HCC) \\\\[G35]'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB156',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    402.6449890136719,\n",
              "    32.975101470947266,\n",
              "    413.2019958496094],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB158',\n",
              "   'type': 2,\n",
              "   'rect': [90.4845962524414,\n",
              "    413.0060119628906,\n",
              "    100.78600311279297,\n",
              "    423.56201171875],\n",
              "   'label': 'refractory immune thrombocytopenic purpura',\n",
              "   'block_context': ' refractory immune thrombocytopenic purpura\\n idiopathic thrombocytopenic purpura (ITP) \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB159',\n",
              "   'type': 2,\n",
              "   'rect': [268.21099853515625,\n",
              "    413.0060119628906,\n",
              "    278.51300048828125,\n",
              "    423.56201171875],\n",
              "   'label': 'idiopathic thrombocytopenic purpura (ITP)',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB157',\n",
              "   'type': 2,\n",
              "   'rect': [51.7942008972168,\n",
              "    403.08099365234375,\n",
              "    62.96879959106445,\n",
              "    413.2019958496094],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?\\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB160',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    435.7309875488281,\n",
              "    32.975101470947266,\n",
              "    446.2879943847656],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB161',\n",
              "   'type': 2,\n",
              "   'rect': [52.66699981689453,\n",
              "    435.70098876953125,\n",
              "    62.96879959106445,\n",
              "    446.25799560546875],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB162',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    458.125,\n",
              "    32.975101470947266,\n",
              "    468.6820068359375],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin’s lymphoma? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB163',\n",
              "   'type': 2,\n",
              "   'rect': [52.666900634765625,\n",
              "    458.1050109863281,\n",
              "    62.96879959106445,\n",
              "    468.6619873046875],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin’s lymphoma? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB164',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    490.4849853515625,\n",
              "    32.975101470947266,\n",
              "    501.0419921875],\n",
              "   'label': 'Relapsing-remitting MS (RRMS)',\n",
              "   'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n',\n",
              "   'answer': 'Yes'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB165',\n",
              "   'type': 2,\n",
              "   'rect': [155.08900451660156,\n",
              "    490.4849853515625,\n",
              "    165.39100646972656,\n",
              "    501.0419921875],\n",
              "   'label': 'Secondary-progressive MS (SPMS)',\n",
              "   'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB166',\n",
              "   'type': 2,\n",
              "   'rect': [299.5010070800781,\n",
              "    490.65899658203125,\n",
              "    309.8030090332031,\n",
              "    501.21600341796875],\n",
              "   'label': 'Primary-progressive MS (PPMS)',\n",
              "   'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB167',\n",
              "   'type': 2,\n",
              "   'rect': [433.9739990234375,\n",
              "    490.7030029296875,\n",
              "    444.2760009765625,\n",
              "    501.260009765625],\n",
              "   'label': 'Progressive-relapsing MS (PRMS)',\n",
              "   'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB168',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    501.45001220703125,\n",
              "    32.975101470947266,\n",
              "    512.0069580078125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB169',\n",
              "   'type': 2,\n",
              "   'rect': [52.666900634765625,\n",
              "    501.47100830078125,\n",
              "    62.96879959106445,\n",
              "    512.0280151367188],\n",
              "   'label': 'No',\n",
              "   'block_context': ' Relapsing-remitting MS (RRMS)\\n Secondary-progressive MS (SPMS)\\n Primary-progressive MS (PPMS)\\n Progressive-relapsing MS (PRMS) \\n Has the patient discontinued other medications used for treating MS (not including Ampyra)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB170',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    523.8510131835938,\n",
              "    32.975101470947266,\n",
              "    534.407958984375],\n",
              "   'label': 'Yes',\n",
              "   'block_context': ' Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB172',\n",
              "   'type': 2,\n",
              "   'rect': [80.48059844970703,\n",
              "    536.14697265625,\n",
              "    90.78199768066406,\n",
              "    546.7039794921875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Has the patient had an unsatisfactory response to initial immunotherapy? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB173',\n",
              "   'type': 2,\n",
              "   'rect': [110.12899780273438,\n",
              "    536.136962890625,\n",
              "    120.43099975585938,\n",
              "    546.6939697265625],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Has the patient had an unsatisfactory response to initial immunotherapy? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB171',\n",
              "   'type': 2,\n",
              "   'rect': [52.666900634765625,\n",
              "    523.8510131835938,\n",
              "    62.96879959106445,\n",
              "    534.407958984375],\n",
              "   'label': 'No',\n",
              "   'block_context': ' Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB174',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    558.5859985351562,\n",
              "    32.975101470947266,\n",
              "    569.1430053710938],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB175',\n",
              "   'type': 2,\n",
              "   'rect': [52.666900634765625,\n",
              "    558.5250244140625,\n",
              "    62.96879959106445,\n",
              "    569.08203125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB176',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    569.6649780273438,\n",
              "    32.975101470947266,\n",
              "    580.2219848632812],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB177',\n",
              "   'type': 2,\n",
              "   'rect': [52.666900634765625,\n",
              "    569.614990234375,\n",
              "    62.96879959106445,\n",
              "    580.1719970703125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of neuromyelitis optica (Devic’s disease)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB178',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    591.4509887695312,\n",
              "    32.975101470947266,\n",
              "    602.0079956054688],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB179',\n",
              "   'type': 2,\n",
              "   'rect': [52.666900634765625,\n",
              "    591.4199829101562,\n",
              "    62.96879959106445,\n",
              "    601.9769897460938],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB180',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    603.18701171875,\n",
              "    32.975101470947266,\n",
              "    613.7440185546875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'T189',\n",
              "   'type': 7,\n",
              "   'rect': [135.4010009765625,\n",
              "    624.9459838867188,\n",
              "    373.4419860839844,\n",
              "    635.29296875],\n",
              "   'label': 'Medication:',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': 'Rituximab-abbs (Truxima)'},\n",
              "  {'page': 4,\n",
              "   'name': 'T190',\n",
              "   'type': 7,\n",
              "   'rect': [403.30499267578125,\n",
              "    625.0750122070312,\n",
              "    423.9419860839844,\n",
              "    635.29296875],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': 'Date: (MM) 05'},\n",
              "  {'page': 4,\n",
              "   'name': 'T191',\n",
              "   'type': 7,\n",
              "   'rect': [428.614013671875, 625.0750122070312, 449.25, 635.29296875],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 4,\n",
              "   'name': 'T192',\n",
              "   'type': 7,\n",
              "   'rect': [452.177001953125,\n",
              "    625.0750122070312,\n",
              "    474.48699951171875,\n",
              "    635.29296875],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': '2024'},\n",
              "  {'page': 4,\n",
              "   'name': 'T193',\n",
              "   'type': 7,\n",
              "   'rect': [481.57000732421875,\n",
              "    625.0750122070312,\n",
              "    502.2070007324219,\n",
              "    635.29296875],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': 'Date: (MM)\\n05'},\n",
              "  {'page': 4,\n",
              "   'name': 'T194',\n",
              "   'type': 7,\n",
              "   'rect': [507.2860107421875,\n",
              "    625.0750122070312,\n",
              "    527.9219970703125,\n",
              "    635.29296875],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 4,\n",
              "   'name': 'T195',\n",
              "   'type': 7,\n",
              "   'rect': [530.97802734375,\n",
              "    625.0750122070312,\n",
              "    554.6589965820312,\n",
              "    635.29296875],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n',\n",
              "   'answer': '2024'},\n",
              "  {'page': 4,\n",
              "   'name': 'T196',\n",
              "   'type': 7,\n",
              "   'rect': [135.4010009765625,\n",
              "    636.1209716796875,\n",
              "    373.4419860839844,\n",
              "    646.4660034179688],\n",
              "   'label': 'Medication:',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': 'Medication: Rituximab-abbs (Truxima)\\nDates: \\n- 05/22/2024 -'},\n",
              "  {'page': 4,\n",
              "   'name': 'T197',\n",
              "   'type': 7,\n",
              "   'rect': [403.28399658203125,\n",
              "    636.2470092773438,\n",
              "    423.9219970703125,\n",
              "    646.4660034179688],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': 'Date: (MM)\\n05'},\n",
              "  {'page': 4,\n",
              "   'name': 'T198',\n",
              "   'type': 7,\n",
              "   'rect': [428.593994140625,\n",
              "    636.2470092773438,\n",
              "    449.2309875488281,\n",
              "    646.4660034179688],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 4,\n",
              "   'name': 'T199',\n",
              "   'type': 7,\n",
              "   'rect': [452.1579895019531,\n",
              "    636.2479858398438,\n",
              "    474.46600341796875,\n",
              "    646.4660034179688],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': 'There is no information about prior medications in the provided summary. Therefore, this field should be left blank.'},\n",
              "  {'page': 4,\n",
              "   'name': 'T200',\n",
              "   'type': 7,\n",
              "   'rect': [481.5509948730469,\n",
              "    636.2470092773438,\n",
              "    502.1860046386719,\n",
              "    646.4660034179688],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': 'Please provide the names and date ranges of medications tried: \\nMedication:  \\n  Dates:\\n - \\nMedication: \\n  Dates: \\n - \\n',\n",
              "   'answer': 'May'},\n",
              "  {'page': 4,\n",
              "   'name': 'T201',\n",
              "   'type': 7,\n",
              "   'rect': [507.2669982910156,\n",
              "    636.2470092773438,\n",
              "    527.9030151367188,\n",
              "    646.4660034179688],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 4,\n",
              "   'name': 'T202',\n",
              "   'type': 7,\n",
              "   'rect': [530.9580078125,\n",
              "    636.2470092773438,\n",
              "    554.6389770507812,\n",
              "    646.4660034179688],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': '      \\n      /     /     \\n     / \\n/ \\n       \\n     /     /     \\n     / \\n/ \\n',\n",
              "   'answer': '2024'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB181',\n",
              "   'type': 2,\n",
              "   'rect': [52.666900634765625,\n",
              "    603.18701171875,\n",
              "    62.96879959106445,\n",
              "    613.7440185546875],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma? \\n Yes\\n No \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB203',\n",
              "   'type': 2,\n",
              "   'rect': [22.673099517822266,\n",
              "    659.490966796875,\n",
              "    32.975101470947266,\n",
              "    670.0479736328125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB204',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    659.4710083007812,\n",
              "    62.31420135498047,\n",
              "    670.0269775390625],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB205',\n",
              "   'type': 2,\n",
              "   'rect': [85.74980163574219,\n",
              "    671.2470092773438,\n",
              "    96.05130004882812,\n",
              "    681.8040161132812],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 4,\n",
              "   'name': 'CB206',\n",
              "   'type': 2,\n",
              "   'rect': [115.375, 671.2260131835938, 125.677001953125, 681.7830200195312],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'T12',\n",
              "   'type': 7,\n",
              "   'rect': [20.796199798583984,\n",
              "    131.79498291015625,\n",
              "    164.39100646972656,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient First Name',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': 'Shakh'},\n",
              "  {'page': 5,\n",
              "   'name': 'T13',\n",
              "   'type': 7,\n",
              "   'rect': [169.26499938964844,\n",
              "    131.79498291015625,\n",
              "    348.5950012207031,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient Last Name',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': 'Abdulla'},\n",
              "  {'page': 5,\n",
              "   'name': 'T19',\n",
              "   'type': 7,\n",
              "   'rect': [354.30499267578125,\n",
              "    131.79498291015625,\n",
              "    469.82598876953125,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient Phone',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': '865-395-3958'},\n",
              "  {'page': 5,\n",
              "   'name': 'T14',\n",
              "   'type': 7,\n",
              "   'rect': [475.18701171875,\n",
              "    131.7960205078125,\n",
              "    592.4639892578125,\n",
              "    144.45697021484375],\n",
              "   'label': 'Patient DOB (MM/DD/YYYY)',\n",
              "   'block_context': 'Patient First Name \\nPatient Last Name \\nPatient Phone \\nPatient DOB \\n',\n",
              "   'answer': '04/01/2001'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB207',\n",
              "   'type': 2,\n",
              "   'rect': [249.6199951171875, 167.4429931640625, 259.9209899902344, 178.0],\n",
              "   'label': 'Mild',\n",
              "   'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n',\n",
              "   'answer': 'Based on the information provided, there is no mention of Rheumatoid Arthritis in the PA summary report. Therefore, this question does not need to be answered.'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB208',\n",
              "   'type': 2,\n",
              "   'rect': [282.375, 167.4429931640625, 292.6759948730469, 178.0],\n",
              "   'label': 'Moderate',\n",
              "   'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n',\n",
              "   'answer': 'I cannot answer this question, as the provided patient information pertains to multiple sclerosis (MS), not rheumatoid arthritis.'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB209',\n",
              "   'type': 2,\n",
              "   'rect': [334.2569885253906, 167.4429931640625, 344.5580139160156, 178.0],\n",
              "   'label': 'Severe',\n",
              "   'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n',\n",
              "   'answer': 'Based on the provided information, the patient has Multiple Sclerosis, not Rheumatoid Arthritis. Therefore, this question does not need to be answered.'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB210',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    177.44500732421875,\n",
              "    33.00960159301758,\n",
              "    188.00201416015625],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n',\n",
              "   'answer': 'Yes'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB211',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375, 177.4429931640625, 62.3140983581543, 188.0],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB212',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    188.08599853515625,\n",
              "    33.00960159301758,\n",
              "    198.64300537109375],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n',\n",
              "   'answer': 'Yes'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB213',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    188.05401611328125,\n",
              "    62.3140983581543,\n",
              "    198.61102294921875],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Rheumatoid Arthritis \\nPlease indicate the severity of the patient’s rheumatoid arthritis: \\n Mild \\n Moderate\\n Severe \\nIs there evidence that the disease is active? \\n Yes \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB214',\n",
              "   'type': 2,\n",
              "   'rect': [86.60260009765625,\n",
              "    198.60699462890625,\n",
              "    96.90440368652344,\n",
              "    209.16400146484375],\n",
              "   'label': 'Yes',\n",
              "   'block_context': '  Will Rituxan (rituximab) be used in combination with methotrexate? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB216',\n",
              "   'type': 2,\n",
              "   'rect': [191.60000610351562,\n",
              "    209.0369873046875,\n",
              "    201.90199279785156,\n",
              "    219.593994140625],\n",
              "   'label': 'ineffective',\n",
              "   'block_context': 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB217',\n",
              "   'type': 2,\n",
              "   'rect': [246.1739959716797,\n",
              "    209.0369873046875,\n",
              "    256.4750061035156,\n",
              "    219.593994140625],\n",
              "   'label': 'not tolerated',\n",
              "   'block_context': 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB218',\n",
              "   'type': 2,\n",
              "   'rect': [308.3710021972656,\n",
              "    209.0369873046875,\n",
              "    318.6719970703125,\n",
              "    219.593994140625],\n",
              "   'label': 'contraindicated',\n",
              "   'block_context': 'Was treatment with methotrexate ineffective, not tolerated or contraindicated? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB215',\n",
              "   'type': 2,\n",
              "   'rect': [116.39199829101562,\n",
              "    198.60699462890625,\n",
              "    126.69400024414062,\n",
              "    209.16400146484375],\n",
              "   'label': 'No',\n",
              "   'block_context': '  Will Rituxan (rituximab) be used in combination with methotrexate? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB223',\n",
              "   'type': 2,\n",
              "   'rect': [86.60260009765625,\n",
              "    221.36798095703125,\n",
              "    96.90440368652344,\n",
              "    231.92498779296875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Was treatment with another conventional DMARD ineffective? \\n Yes\\n',\n",
              "   'answer': '.'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB225',\n",
              "   'type': 2,\n",
              "   'rect': [191.07400512695312,\n",
              "    231.44598388671875,\n",
              "    201.37600708007812,\n",
              "    242.00299072265625],\n",
              "   'label': 'azathioprine',\n",
              "   'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB226',\n",
              "   'type': 2,\n",
              "   'rect': [251.9080047607422,\n",
              "    231.44598388671875,\n",
              "    262.2090148925781,\n",
              "    242.00299072265625],\n",
              "   'label': 'cyclosporine',\n",
              "   'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB227',\n",
              "   'type': 2,\n",
              "   'rect': [313.947998046875,\n",
              "    231.44598388671875,\n",
              "    324.2489929199219,\n",
              "    242.00299072265625],\n",
              "   'label': 'hydroxychloroquine',\n",
              "   'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB228',\n",
              "   'type': 2,\n",
              "   'rect': [399.94500732421875,\n",
              "    231.44598388671875,\n",
              "    410.2460021972656,\n",
              "    242.00299072265625],\n",
              "   'label': 'leflunomide',\n",
              "   'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB229',\n",
              "   'type': 2,\n",
              "   'rect': [458.1929931640625,\n",
              "    231.44598388671875,\n",
              "    468.4939880371094,\n",
              "    242.00299072265625],\n",
              "   'label': 'sulfasalazine',\n",
              "   'block_context': 'Please select:\\n azathioprine\\n cyclosporine \\n hydroxychloroquine\\n leflunomide\\n sulfasalazine \\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB224',\n",
              "   'type': 2,\n",
              "   'rect': [116.39199829101562,\n",
              "    221.36798095703125,\n",
              "    126.69400024414062,\n",
              "    231.92498779296875],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Was treatment with another conventional DMARD ineffective? \\n Yes\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB281',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    253.572021484375,\n",
              "    33.009498596191406,\n",
              "    264.1290283203125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB282',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    253.58099365234375,\n",
              "    62.3140983581543,\n",
              "    264.13800048828125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB283',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    265.31402587890625,\n",
              "    33.009498596191406,\n",
              "    275.8709716796875],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'T285',\n",
              "   'type': 7,\n",
              "   'rect': [136.13800048828125,\n",
              "    285.8590087890625,\n",
              "    374.1789855957031,\n",
              "    296.2049865722656],\n",
              "   'label': 'Medication:',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': 'Medication: methylprednisolone sod succinate (SOLU-Medrol)\\nDates: 5/22/2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'T286',\n",
              "   'type': 7,\n",
              "   'rect': [404.0140075683594,\n",
              "    285.9859924316406,\n",
              "    424.6510009765625,\n",
              "    296.3320007324219],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': '11'},\n",
              "  {'page': 5,\n",
              "   'name': 'T287',\n",
              "   'type': 7,\n",
              "   'rect': [428.8139953613281,\n",
              "    285.9859924316406,\n",
              "    449.45098876953125,\n",
              "    296.3320007324219],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': 'Medication: methylprednisolone sod succinate (SOLU-Medrol)\\nDates: 05/22/2024\\n-\\nMedication: Rituximab-abbs (Truxima)\\nDates: 05/22/2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'T288',\n",
              "   'type': 7,\n",
              "   'rect': [453.23199462890625,\n",
              "    285.9859924316406,\n",
              "    476.1180114746094,\n",
              "    296.3320007324219],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': 'Medication: methylprednisolone sod succinate (SOLU-Medrol)\\nDates: 05/22/2024\\n-\\nMedication: Rituximab-abbs (Truxima)\\nDates: 05/22/2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'T289',\n",
              "   'type': 7,\n",
              "   'rect': [482.5660095214844,\n",
              "    285.9859924316406,\n",
              "    504.2019958496094,\n",
              "    296.3320007324219],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n',\n",
              "   'answer': '05'},\n",
              "  {'page': 5,\n",
              "   'name': 'T290',\n",
              "   'type': 7,\n",
              "   'rect': [506.7909851074219,\n",
              "    285.9859924316406,\n",
              "    528.427001953125,\n",
              "    296.3320007324219],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 5,\n",
              "   'name': 'T291',\n",
              "   'type': 7,\n",
              "   'rect': [531.7750244140625,\n",
              "    285.9859924316406,\n",
              "    553.8289794921875,\n",
              "    296.3320007324219],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n',\n",
              "   'answer': '2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'T292',\n",
              "   'type': 7,\n",
              "   'rect': [136.08299255371094,\n",
              "    296.54400634765625,\n",
              "    374.1239929199219,\n",
              "    306.8900146484375],\n",
              "   'label': 'Medication:',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': 'Medication: methylprednisolone sod succinate (SOLU-Medrol)\\nDates: 5/22/2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'T293',\n",
              "   'type': 7,\n",
              "   'rect': [404.32000732421875,\n",
              "    296.7300109863281,\n",
              "    424.99200439453125,\n",
              "    307.07598876953125],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': 'Date: (MM)\\n05'},\n",
              "  {'page': 5,\n",
              "   'name': 'T294',\n",
              "   'type': 7,\n",
              "   'rect': [428.8139953613281,\n",
              "    296.7300109863281,\n",
              "    449.4849853515625,\n",
              "    307.07598876953125],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': 'Medication: methylprednisolone sod succinate (SOLU-Medrol)\\n Dates: 05/22/2024\\n-\\nMedication: Rituximab-abbs (Truxima)\\n Dates: 05/22/2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'T295',\n",
              "   'type': 7,\n",
              "   'rect': [453.0889892578125,\n",
              "    296.6719970703125,\n",
              "    475.9750061035156,\n",
              "    307.01800537109375],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': 'Please provide the names and dates of the corticosteroids and other immunosuppressive agents used: \\nMedication:   \\n Dates:  \\n-\\nMedication: \\n  Dates: \\n-\\n',\n",
              "   'answer': 'Medication: methylprednisolone sod succinate (SOLU-Medrol)\\nDates: 2024\\n-\\nMedication: acetaminophen (TYLENOL)\\nDates: 2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'T296',\n",
              "   'type': 7,\n",
              "   'rect': [482.197998046875,\n",
              "    296.6719970703125,\n",
              "    503.8340148925781,\n",
              "    307.01800537109375],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n',\n",
              "   'answer': '05'},\n",
              "  {'page': 5,\n",
              "   'name': 'T297',\n",
              "   'type': 7,\n",
              "   'rect': [506.75, 296.6719970703125, 528.385986328125, 307.01800537109375],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 5,\n",
              "   'name': 'T298',\n",
              "   'type': 7,\n",
              "   'rect': [531.7750244140625,\n",
              "    296.6719970703125,\n",
              "    553.8289794921875,\n",
              "    307.01800537109375],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': '     \\n \\n    /     / \\n/\\n/ \\n       \\n     /     / \\n/\\n/ \\n',\n",
              "   'answer': '2024'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB284',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    265.322021484375,\n",
              "    62.3140983581543,\n",
              "    275.8790283203125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Sjögren’s syndrome? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB299',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    320.2669982910156,\n",
              "    33.009498596191406,\n",
              "    330.8240051269531],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB300',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    320.2760009765625,\n",
              "    62.31420135498047,\n",
              "    330.8330078125],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB301',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    342.3320007324219,\n",
              "    33.0093994140625,\n",
              "    352.8890075683594],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Waldenström macroglobulinemia? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB302',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    342.3489990234375,\n",
              "    62.31420135498047,\n",
              "    352.906005859375],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Does the patient have a documented diagnosis of Waldenström macroglobulinemia? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB303',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    365.67498779296875,\n",
              "    33.00960159301758,\n",
              "    376.23199462890625],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB304',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    365.6730041503906,\n",
              "    62.31399917602539,\n",
              "    376.2300109863281],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'T305',\n",
              "   'type': 7,\n",
              "   'rect': [225.25999450683594, 374.875, 512.3599853515625, 386.5299987792969],\n",
              "   'label': 'Please indicate the length of time on Rituxan (rituximab):',\n",
              "   'block_context': 'Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)? \\n Yes\\n No \\nPlease indicate the length of time on Rituxan (rituximab): \\n',\n",
              "   'answer': \"Since the patient is being considered for Rituximab-abbs (Truxima), which is a biosimilar, and there's no mention of prior Rituxan (rituximab) use, the answer is not applicable. Therefore, I will not provide an answer.\"},\n",
              "  {'page': 5,\n",
              "   'name': 'CB310',\n",
              "   'type': 2,\n",
              "   'rect': [353.3630065917969,\n",
              "    398.0530090332031,\n",
              "    363.66400146484375,\n",
              "    408.6099853515625],\n",
              "   'label': 'Mild',\n",
              "   'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'This field should not be answered, as it is specific to rheumatoid arthritis, and the patient has multiple sclerosis.'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB311',\n",
              "   'type': 2,\n",
              "   'rect': [386.1109924316406,\n",
              "    398.02301025390625,\n",
              "    396.4119873046875,\n",
              "    408.5799865722656],\n",
              "   'label': 'Moderate',\n",
              "   'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'Based on the provided information, this field should not be populated. The form specifies this section is \"For rheumatoid arthritis only,\" and the patient\\'s diagnosis is Multiple Sclerosis.'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB312',\n",
              "   'type': 2,\n",
              "   'rect': [437.9490051269531, 398.02301025390625, 448.25, 408.5799865722656],\n",
              "   'label': 'Severe',\n",
              "   'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'Based on the provided information, this field should not be answered as it is specific to rheumatoid arthritis and the patient has multiple sclerosis.'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB306',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    408.30999755859375,\n",
              "    33.00960159301758,\n",
              "    418.86700439453125],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB307',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    408.2569885253906,\n",
              "    62.31420135498047,\n",
              "    418.8139953613281],\n",
              "   'label': 'No',\n",
              "   'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB308',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    419.2879943847656,\n",
              "    33.0093994140625,\n",
              "    429.8450012207031],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB309',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    419.2860107421875,\n",
              "    62.31399917602539,\n",
              "    429.8429870605469],\n",
              "   'label': 'No',\n",
              "   'block_context': 'For rheumatoid arthritis only: \\nPlease indicate the severity of the disease at baseline (pretreatment with Rituxan (rituximab):\\n Mild  \\n Moderate\\n Severe \\n  Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB313',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    441.96099853515625,\n",
              "    33.0093994140625,\n",
              "    452.51800537109375],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'Yes'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB314',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    441.9620056152344,\n",
              "    62.31420135498047,\n",
              "    452.5190124511719],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB315',\n",
              "   'type': 2,\n",
              "   'rect': [22.707700729370117,\n",
              "    453.41900634765625,\n",
              "    33.00960159301758,\n",
              "    463.97601318359375],\n",
              "   'label': 'Yes',\n",
              "   'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'CB316',\n",
              "   'type': 2,\n",
              "   'rect': [52.012298583984375,\n",
              "    453.43798828125,\n",
              "    62.31399917602539,\n",
              "    463.9949951171875],\n",
              "   'label': 'No',\n",
              "   'block_context': 'Is there clinical documentation supporting disease stability? \\n Yes\\n No\\n',\n",
              "   'answer': 'No'},\n",
              "  {'page': 5,\n",
              "   'name': 'T317',\n",
              "   'type': 7,\n",
              "   'rect': [508.2340087890625,\n",
              "    484.19500732421875,\n",
              "    531.7239990234375,\n",
              "    496.53900146484375],\n",
              "   'label': 'Date: (MM)',\n",
              "   'block_context': 'Request Completed By (Signature Required):\\n  Date: \\n',\n",
              "   'answer': '05'},\n",
              "  {'page': 5,\n",
              "   'name': 'T318',\n",
              "   'type': 7,\n",
              "   'rect': [536.8720092773438,\n",
              "    484.19500732421875,\n",
              "    556.3619995117188,\n",
              "    496.53900146484375],\n",
              "   'label': 'Date: (DD)',\n",
              "   'block_context': ' \\n/ \\n/ \\n',\n",
              "   'answer': '22'},\n",
              "  {'page': 5,\n",
              "   'name': 'T319',\n",
              "   'type': 7,\n",
              "   'rect': [561.8579711914062,\n",
              "    484.19500732421875,\n",
              "    584.239013671875,\n",
              "    496.53900146484375],\n",
              "   'label': 'Date: (YYYY)',\n",
              "   'block_context': ' \\n/ \\n/ \\n',\n",
              "   'answer': '2024'}]}"
            ]
          },
          "metadata": {},
          "execution_count": 103
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from io import BytesIO"
      ],
      "metadata": {
        "id": "GeT2k_PoEswh"
      },
      "execution_count": 115,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def fill_pdf_form_fields(pdf_path: str, field_values: list, output_file=None):\n",
        "    doc = fitz.open(pdf_path)\n",
        "\n",
        "    for page in doc:\n",
        "        for w in page.widgets() or []:\n",
        "            # Find the matching field dictionary by 'name'\n",
        "            data = next((f for f in field_values if f[\"name\"] == w.field_name), None)\n",
        "\n",
        "            if data is None:\n",
        "                continue\n",
        "\n",
        "            answer = data.get(\"answer\", \"\")\n",
        "            print(f\"Filling {w.field_name}: {answer}\")\n",
        "\n",
        "            if w.field_type == fitz.PDF_WIDGET_TYPE_CHECKBOX:\n",
        "              if (w.field_label == \"Yes\" and answer == \"Yes\") or (w.field_label == \"No\" and answer == \"No\"):\n",
        "                  w.field_value = w.field_label  # set to \"Yes\" or \"No\"\n",
        "              else:\n",
        "                  w.field_value = \"Off\"\n",
        "            else:\n",
        "                w.field_value = str(answer)\n",
        "\n",
        "            w.update()\n",
        "\n",
        "    if output_file:\n",
        "        doc.save(output_file, deflate=True, encryption=fitz.PDF_ENCRYPT_KEEP)\n",
        "    else:\n",
        "        from io import BytesIO\n",
        "        buf = BytesIO()\n",
        "        doc.save(buf, deflate=True, encryption=fitz.PDF_ENCRYPT_KEEP)\n",
        "        return buf\n",
        "\n",
        "    doc.close()\n",
        "\n"
      ],
      "metadata": {
        "id": "Gy_G1MI3DaDv"
      },
      "execution_count": 144,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "fill_pdf_form_fields(\"PA.pdf\", response['fields'], \"filled_form.pdf\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "QFU6c9yiIFLF",
        "outputId": "d81334dc-298b-4fbb-e389-4299c0dbc1f2"
      },
      "execution_count": 145,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Filling CB1: May 22nd\n",
            "Filling T2: 05\n",
            "Filling T3: 22\n",
            "Filling T4: 2024\n",
            "Filling CB5: There is no information about prior rituximab or biosimilar treatment.\n",
            "Filling T6: /\n",
            "/\n",
            "Filling T7: 22\n",
            "Filling T8: There is no specific information about the date of last treatment.\n",
            "Filling T9: Erfan Rostami, BSN, RN\n",
            "Filling T10: 615-343-1176\n",
            "Filling T11: 614-936-0065\n",
            "Filling T12: Shakh\n",
            "Filling T13: Abdulla\n",
            "Filling T14: 04/01/2001\n",
            "Filling T15: 425 Sherman Ave\n",
            "Filling T16: Nashville\n",
            "Filling T17: TN\n",
            "Filling T18: 37995\n",
            "Filling T19: 865-395-3958\n",
            "Filling T20: 614-936-0065\n",
            "Filling T21: 865-395-0481\n",
            "Filling T22: This information is not available in the provided document.\n",
            "Filling T24: This field cannot be filled from the provided context.\n",
            "Filling T25: Based on the information provided, the patient's Body Surface Area (BSA) is listed as 1.85 m2, which was used to calculate the Rituximab dosage. To calculate the weight in kilograms (kgs) to determine if the BSA is accurate, we would need to use a BSA formula, such as the Mosteller formula: BSA (m2) = √ (Height(cm) x Weight(kg) / 3600) or the Haycock formula. Since height is not provided, calculating an accurate weight in kilograms from the BSA is not possible.\n",
            "\n",
            "Therefore, I cannot provide an answer to the field \"kgs\" without knowing the patient's height.\n",
            "Filling T26: Height: inches\n",
            "Filling T27: Height: inches or **cms**\n",
            "Filling T23: There is no mention of allergies in the provided text.\n",
            "Filling T28: This information is not available in the provided document.\n",
            "Filling T29: Based on the information provided, the Group # is not specified.\n",
            "Filling T30: Shakh Abdulla\n",
            "Filling CB31: No\n",
            "Filling CB32: No\n",
            "Filling T33: TC BLUE CARE NO COPAY\n",
            "Filling T34: TC BLUE CARE NO COPAY\n",
            "Filling T35: Shakh Abdulla\n",
            "Filling T42: Hao\n",
            "Filling T43: Gu\n",
            "Filling CB44: First Name: Hao H\n",
            "Last Name: Gu\n",
            "[X] M.D.\n",
            "Filling CB45: The provided information does not contain the first and last name of the physician to use to populate those fields.\n",
            "\n",
            "N.P.\n",
            "Filling CB46: Last Name: Rostami\n",
            "First Name: Erfan\n",
            "Filling CB47: P.A.\n",
            "Filling T48: 425 Sherman Ave\n",
            "Filling T49: Nashville\n",
            "Filling T50: TN\n",
            "Filling T51: 37995\n",
            "Filling T52: Error: Max retries exceeded due to rate limit.\n",
            "Filling T53: Error: Max retries exceeded due to rate limit.\n",
            "Filling T54: Based on the provided information, the state license number (\"St Lic #:\") is not specified. Therefore, I will not provide an answer.\n",
            "Filling T55: Based on the information provided, I cannot fill out the NPI field because the NPI of the referring provider is not specified.\n",
            "Filling T56: Based on the provided information, the DEA # is not specified. Therefore, no answer is needed.\n",
            "Filling T57: Based on the information provided in the referral summary, there is no UPIN listed for the referring provider.\n",
            "Filling T58.0: Based on the provided information, there is no Provider Email listed. Therefore, I will leave the field blank.\n",
            "Filling T58.1: Erfan Rostami\n",
            "Filling T59: 614-936-0065\n",
            "Filling Provider Admin CB.1: No\n",
            "Filling Provider Admin CB.2: Yes\n",
            "Filling Provider Admin CB.3: \n",
            "Filling Provider Admin CB.4: Based on the information provided, I am unable to populate the \"Outpatient Infusion Center\" section of the form. The PA summary report does not specify the name, address, phone number, fax number, TIN, PIN, or NPI of the outpatient infusion center.\n",
            "Filling Provider Admin T.5: Outpatient Infusion Center Name: Better Life Multiple Sclerosis Center\n",
            "Filling Provider Admin CB.7: There is no information about the Home Infusion Center in the provided document.\n",
            "Filling Provider Admin T.6: 615-343-1176\n",
            "Filling Provider Admin T.8: Better Life Multiple Sclerosis Center\n",
            "Filling Provider Admin CB.10: 96365, 96367, J9312\n",
            "Filling Provider Admin T.9: No answer is needed. CPT codes are not provided in the referral summary.\n",
            "Filling Provider Admin T.11A: 425 Sherman Ave\n",
            "Filling Provider Admin T.13: Nashville\n",
            "Filling Provider Admin T.14: TN\n",
            "Filling Provider Admin T.15: 37995\n",
            "Filling Provider Admin T.16: 615-343-1176\n",
            "Filling Provider Admin T.17A: 615-343-1219\n",
            "Filling Provider Admin T.18: There is no TIN provided in the referral summary.\n",
            "Filling Provider Admin T.19: Based on the information provided, I cannot answer this question. The referral summary does not contain the PIN.\n",
            "Filling Provider Admin T.20: Since the referring provider is Hao H Gu, MD, from Better Life Multiple Sclerosis Center, we need to find the NPI for this provider or practice. The PA summary report does not include the NPI. Therefore, I cannot provide a value for this field.\n",
            "Filling Provider Admin CB.21: Outpatient Dialysis Center\n",
            "Filling Provider Admin CB.22: Physician’s Office\n",
            "Filling Provider Admin CB.23.0.0: Retail Pharmacy\n",
            "Filling Provider Admin CB.24.0.0: Specialty Pharmacy\n",
            "Filling Provider Admin CB.25: Error: Max retries exceeded due to rate limit.\n",
            "Filling Provider Admin CB.26: Better Life Multiple Sclerosis Center\n",
            "Filling Provider Admin T.27: Better Life Multiple Sclerosis Center\n",
            "Filling Provider Admin T.28: Shakh Abdulla\n",
            "Filling Provider Admin T.29a: 425 Sherman Ave, Nashville TN 37995\n",
            "Filling Provider Admin T.30a: Nashville\n",
            "Filling Provider Admin T.31: TN\n",
            "Filling Provider Admin T.32: 37995\n",
            "Filling Provider Admin T.33: 614-936-0065\n",
            "Filling Provider Admin T.34: 615-343-1219\n",
            "Filling Provider Admin T.35: Based on the information provided, there is no Taxpayer Identification Number (TIN) listed for either the referring provider or the practice. Therefore, I cannot answer this question.\n",
            "Filling Provider Admin T.36: (No answer needed)\n",
            "Filling Provider Admin T.37: The NPI is not specified in the provided document.\n",
            "Filling CB60: No answer is needed for this field.\n",
            "Filling CB61: Based on the PA Summary Report, the answer is:\n",
            "\n",
            "No answer needed.\n",
            "Filling CB62: No answer needed.\n",
            "Filling CB63: Truxima (rituximab-abbs)\n",
            "Filling T64: 694 mg IVPB\n",
            "Filling T65: Days 1, 15 Load Then Once Every 24 Weeks. Initial Dose: Every 2 weeks, 2/2 remaining week of 5/19/2024. Maintenance Dose: Every 24 weeks, starting Mon 11/4/2024.\n",
            "Filling T66: J1745\n",
            "Filling T67: G35\n",
            "Filling CB68: G35\n",
            "Filling T69: G35\n",
            "Filling CB70: No\n",
            "Filling CB71: No\n",
            "Filling CB72: This field does not require an answer based on the provided information.\n",
            "Filling CB73: There is no information about a trial and failure of Ruxience (rituximab-pvvr) in the provided text.\n",
            "Filling CB74: There is no information in the provided text to answer when the member had a trial and failure of a preferred drug.\n",
            "Filling T75: There is no mention of a trial and failure of a preferred drug in the provided summary.\n",
            "Filling T76: Not applicable. Rituximab is being considered as a first-line treatment. The provided information does not indicate a failure of a preferred drug.\n",
            "Filling CB77: This field does not need to be filled.\n",
            "Filling CB78: Since the question is related to an adverse reaction to Ruxience (rituximab-pvvr) and there's no mention of the patient having taken this medication or experiencing an adverse reaction, the field should be left blank.\n",
            "Filling CB79: This field does not need to be filled based on the information provided. There is no indication that the patient had an adverse reaction to a preferred drug, only that Rituximab or its biosimilar is being considered.\n",
            "Filling T80: There is no indication in the provided documentation that the member had an adverse reaction to a preferred drug. Therefore, this question does not need to be answered.\n",
            "Filling T81: No adverse reaction to a preferred drug is mentioned in the provided summary.\n",
            "Filling T84: No contraindications or other medical reasons are apparent in the provided documentation that would prevent the patient from using preferred rituximab biosimilar products.\n",
            "Filling CB82: Truxima (rituximab-abbs)\n",
            "Filling CB83: Truxima (rituximab-abbs)\n",
            "Filling T12: Shakh\n",
            "Filling T13: Abdulla\n",
            "Filling T19: 865-395-3958\n",
            "Filling T14: 04/01/2001\n",
            "Filling CB86: This information is not available in the provided document.\n",
            "Filling CB87: There is no information in the provided PA summary regarding a trial and failure of Renflexis (infliximab-abda).\n",
            "Filling CB88: Based on the provided PA summary report, there is no mention of Simponi Aria (golimumab) being a preferred drug or a trial/failure of this medication. Therefore, this field does not need to be filled.\n",
            "Filling T89: There is no information in the provided PA summary report regarding a trial and failure of a preferred drug.\n",
            "Filling T90: Not applicable. Rituximab is being considered and no preferred drug failure is mentioned.\n",
            "Filling CB85: This field does not require an answer based on the provided information.\n",
            "Filling CB92: This field cannot be answered from the given context.\n",
            "Filling CB93: Based on the provided PA summary, there's no mention of an adverse reaction to Renflexis (infliximab-abda). Therefore, I cannot answer the question.\n",
            "Filling CB94: Based on the provided information, there is no mention of the member having an adverse reaction to Simponi Aria (golimumab). Therefore, this question should not be answered.\n",
            "Filling T95: The provided PA summary does not mention any adverse reaction to a preferred drug. Therefore, this question does not need to be answered.\n",
            "Filling T96a: Not applicable. The patient has not had any adverse reactions to preferred drugs. The patient is being started on Rituximab-abbs (Truxima).\n",
            "Filling CB91: This field does not need to be filled.\n",
            "Filling CB98a: This field does not need to be filled.\n",
            "Filling CB99a: .\n",
            "Filling CB100a: .\n",
            "Filling CB101a: This field does not need to be filled. The patient is being prescribed Rituximab, not Rinvoq.\n",
            "Filling CB102a: This field does not need to be filled based on the information provided. The requested medication is Rituximab-abbs (Truxima), not Tyenne SC (tocilizumab-aazg).\n",
            "Filling CB103a: This field should not be filled based on the provided information.\n",
            "Filling T104: There is no information in the provided referral summary regarding a trial and failure of a preferred drug.\n",
            "Filling T105: Not applicable, Rituximab is being considered, not a failure of a preferred drug.\n",
            "Filling CB97: This field does not require an answer based on the provided information.\n",
            "Filling CB107z: This field does not need to be filled based on the context provided.\n",
            "Filling CB108z: .\n",
            "Filling CB109z: This field does not need to be filled. The patient is being prescribed Rituximab-abbs (Truxima), not Idacio (adalimumab-aacf).\n",
            "Filling CB110z: .\n",
            "Filling CB111z: This field does not need to be filled. The requested medication is Rituximab-abbs (Truxima), not Tyenne SC (tocilizumab-aazg).\n",
            "Filling CB112z: This field does not need to be filled.\n",
            "Filling T113: This information is not available in the provided referral summary.\n",
            "Filling T114: There is no information in the provided summary regarding a previous adverse reaction to a preferred drug.\n",
            "Filling CB106z: This field does not need to be filled.\n",
            "Filling T118: No contraindications are apparent from the provided information.\n",
            "Filling CB115z: This field does not need to be filled.\n",
            "Filling CB116z: Based on the provided information, Renflexis (infliximab-abda) is NOT being considered. The medication being considered is Rituximab-abbs (Truxima). Therefore, this field does not need to be filled.\n",
            "Filling CB117z: This field does not need to be filled.\n",
            "Filling T125: There are no contraindications or other medical reasons listed in the provided information that would prevent the patient from using preferred products.\n",
            "Filling CB119z: This field should not be filled. The PA is for Rituximab-abbs (Truxima), not Enbrel (etanercept).\n",
            "Filling CB120z: .\n",
            "Filling CB121z: This field does not need to be filled. The provided information concerns Rituximab-abbs (Truxima), which is unrelated to Idacio (adalimumab-aacf).\n",
            "Filling CB122z: Based on the provided PA summary report, there is no information about the use of Rinvoq (upadacitinib). Therefore, this field does not need to be filled.\n",
            "Filling CB123z: .\n",
            "Filling CB124z: This field does not need to be filled based on the PA summary report provided. The requested medication is Rituximab-abbs (Truxima), not Xeljanz/Xeljanz XR (tofacitinib).\n",
            "Filling CB96.4.0: No\n",
            "Filling CB98: No\n",
            "Filling CB99.0: No\n",
            "Filling CB100.0: No\n",
            "Filling CB101.0: No\n",
            "Filling CB102.0: No\n",
            "Filling CB103: No\n",
            "Filling CB104: No\n",
            "Filling CB104a: Based on the provided information, there is no indication of Wegener granulomatosis.\n",
            "Filling CB104b: No\n",
            "Filling CB104c: No\n",
            "Filling CB104d: Based on the provided information, it's impossible to determine if the patient has pauci-immune glomerulonephritis.\n",
            "Filling CB105: No\n",
            "Filling CB106: No\n",
            "Filling CB106a: No\n",
            "Filling CB107: None of the above\n",
            "Filling CB108: None of the above\n",
            "Filling CB109: None of the above\n",
            "Filling CB110: None of the above\n",
            "Filling CB111: None of the above\n",
            "Filling CB112: None of the above\n",
            "Filling CB113: None of the above\n",
            "Filling CB106b: No\n",
            "Filling CB114: Based on the provided PA summary, none of the B-cell lymphoma options apply to the patient. The patient has multiple sclerosis. Therefore, this field should be left blank.\n",
            "Filling CB115: Based on the provided PA summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not provide an answer.\n",
            "Filling CB116: Based on the provided information, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, this question should not be answered.\n",
            "Filling CB117: Based on the provided PA summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not provide an answer.\n",
            "Filling CB118: Based on the information provided, none of the B-cell lymphoma options apply to the patient, as the patient has multiple sclerosis. Therefore, I will not provide an answer.\n",
            "Filling CB119: Based on the provided referral summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not provide an answer.\n",
            "Filling CB120: Error: Max retries exceeded due to rate limit.\n",
            "Filling CB121: Based on the provided PA summary, none of the listed B-cell lymphomas apply to the patient. The patient has multiple sclerosis. Therefore, I will not answer this question.\n",
            "Filling CB122: Based on the provided PA Summary Report, none of the listed B-cell lymphomas apply to the patient, Shakh Abdulla. The patient has been diagnosed with Multiple sclerosis in pediatric patient.\n",
            "Filling CB123: .\n",
            "Filling CB124: This field does not need to be filled. The patient has multiple sclerosis, not splenic marginal zone lymphoma.\n",
            "Filling CB125: Multiple sclerosis in pediatric patient\n",
            "Filling T126: Multiple sclerosis in pediatric patient (CMS/HCC)\n",
            "Filling T12: Shakh\n",
            "Filling T13: Abdulla\n",
            "Filling T19: 865-395-3958\n",
            "Filling T14: 04/01/2001\n",
            "Filling CB127: No\n",
            "Filling CB128: No\n",
            "Filling CB129: none of the above\n",
            "Filling CB130: none of the above\n",
            "Filling CB131: none of the above\n",
            "Filling CB132: none of the above\n",
            "Filling CB133: none of the above\n",
            "Filling CB134: none of the above\n",
            "Filling CB135: No\n",
            "Filling CB136: No\n",
            "Filling CB139: No\n",
            "Filling CB140: No\n",
            "Filling CB144: No\n",
            "Filling CB145: No\n",
            "Filling CB141: none of the above\n",
            "Filling CB142: none of the above\n",
            "Filling CB143: none of the above\n",
            "Filling CB137: No\n",
            "Filling CB146: No\n",
            "Filling CB147: No\n",
            "Filling CB138: This field does not need to be filled.\n",
            "Filling CB148: Error: Max retries exceeded due to rate limit.\n",
            "Filling CB149: This field should not be filled. The patient's diagnosis is Multiple Sclerosis, and they are being prescribed Rituximab. There is no mention of immune checkpoint-inhibitor related encephalitis or any of the listed medications.\n",
            "Filling CB150: This field does not need to be filled. The patient is being treated for multiple sclerosis, not immune checkpoint-inhibitor related encephalitis.\n",
            "Filling CB151: This field should not be filled. The patient does not have immune checkpoint-inhibitor related encephalitis, but instead has Multiple Sclerosis.\n",
            "Filling CB152: Based on the provided PA summary, the field \"Immune checkpoint-inhibitor related encephalitis\" should not be filled. The patient is being treated for Multiple Sclerosis, not encephalitis, and the medication being requested (Rituximab-abbs) is not an immune checkpoint inhibitor.\n",
            "Filling CB153: This field should not be filled in, as the patient's diagnosis is Multiple Sclerosis, not Immune checkpoint-inhibitor related encephalitis.\n",
            "Filling CB154: Other: Rituximab-abbs (Truxima)\n",
            "Filling T155: Multiple sclerosis in pediatric patient (CMS/HCC) \\[G35]\n",
            "Filling CB156: No\n",
            "Filling CB158: No\n",
            "Filling CB159: No\n",
            "Filling CB157: No\n",
            "Filling CB160: No\n",
            "Filling CB161: No\n",
            "Filling CB162: No\n",
            "Filling CB163: No\n",
            "Filling CB164: Yes\n",
            "Filling CB165: No\n",
            "Filling CB166: No\n",
            "Filling CB167: No\n",
            "Filling CB168: No\n",
            "Filling CB169: No\n",
            "Filling CB170: No\n",
            "Filling CB172: No\n",
            "Filling CB173: No\n",
            "Filling CB171: No\n",
            "Filling CB174: No\n",
            "Filling CB175: No\n",
            "Filling CB176: No\n",
            "Filling CB177: No\n",
            "Filling CB178: No\n",
            "Filling CB179: No\n",
            "Filling CB180: No\n",
            "Filling T189: Rituximab-abbs (Truxima)\n",
            "Filling T190: Date: (MM) 05\n",
            "Filling T191: 22\n",
            "Filling T192: 2024\n",
            "Filling T193: Date: (MM)\n",
            "05\n",
            "Filling T194: 22\n",
            "Filling T195: 2024\n",
            "Filling T196: Medication: Rituximab-abbs (Truxima)\n",
            "Dates: \n",
            "- 05/22/2024 -\n",
            "Filling T197: Date: (MM)\n",
            "05\n",
            "Filling T198: 22\n",
            "Filling T199: There is no information about prior medications in the provided summary. Therefore, this field should be left blank.\n",
            "Filling T200: May\n",
            "Filling T201: 22\n",
            "Filling T202: 2024\n",
            "Filling CB181: No\n",
            "Filling CB203: No\n",
            "Filling CB204: No\n",
            "Filling CB205: No\n",
            "Filling CB206: No\n",
            "Filling T12: Shakh\n",
            "Filling T13: Abdulla\n",
            "Filling T19: 865-395-3958\n",
            "Filling T14: 04/01/2001\n",
            "Filling CB207: Based on the information provided, there is no mention of Rheumatoid Arthritis in the PA summary report. Therefore, this question does not need to be answered.\n",
            "Filling CB208: I cannot answer this question, as the provided patient information pertains to multiple sclerosis (MS), not rheumatoid arthritis.\n",
            "Filling CB209: Based on the provided information, the patient has Multiple Sclerosis, not Rheumatoid Arthritis. Therefore, this question does not need to be answered.\n",
            "Filling CB210: Yes\n",
            "Filling CB211: No\n",
            "Filling CB212: Yes\n",
            "Filling CB213: No\n",
            "Filling CB214: No\n",
            "Filling CB216: No\n",
            "Filling CB217: No\n",
            "Filling CB218: No\n",
            "Filling CB215: No\n",
            "Filling CB223: .\n",
            "Filling CB225: No\n",
            "Filling CB226: No\n",
            "Filling CB227: No\n",
            "Filling CB228: No\n",
            "Filling CB229: No\n",
            "Filling CB224: No\n",
            "Filling CB281: No\n",
            "Filling CB282: No\n",
            "Filling CB283: No\n",
            "Filling T285: Medication: methylprednisolone sod succinate (SOLU-Medrol)\n",
            "Dates: 5/22/2024\n",
            "Filling T286: 11\n",
            "Filling T287: Medication: methylprednisolone sod succinate (SOLU-Medrol)\n",
            "Dates: 05/22/2024\n",
            "-\n",
            "Medication: Rituximab-abbs (Truxima)\n",
            "Dates: 05/22/2024\n",
            "Filling T288: Medication: methylprednisolone sod succinate (SOLU-Medrol)\n",
            "Dates: 05/22/2024\n",
            "-\n",
            "Medication: Rituximab-abbs (Truxima)\n",
            "Dates: 05/22/2024\n",
            "Filling T289: 05\n",
            "Filling T290: 22\n",
            "Filling T291: 2024\n",
            "Filling T292: Medication: methylprednisolone sod succinate (SOLU-Medrol)\n",
            "Dates: 5/22/2024\n",
            "Filling T293: Date: (MM)\n",
            "05\n",
            "Filling T294: Medication: methylprednisolone sod succinate (SOLU-Medrol)\n",
            " Dates: 05/22/2024\n",
            "-\n",
            "Medication: Rituximab-abbs (Truxima)\n",
            " Dates: 05/22/2024\n",
            "Filling T295: Medication: methylprednisolone sod succinate (SOLU-Medrol)\n",
            "Dates: 2024\n",
            "-\n",
            "Medication: acetaminophen (TYLENOL)\n",
            "Dates: 2024\n",
            "Filling T296: 05\n",
            "Filling T297: 22\n",
            "Filling T298: 2024\n",
            "Filling CB284: No\n",
            "Filling CB299: No\n",
            "Filling CB300: No\n",
            "Filling CB301: No\n",
            "Filling CB302: No\n",
            "Filling CB303: No\n",
            "Filling CB304: No\n",
            "Filling T305: Since the patient is being considered for Rituximab-abbs (Truxima), which is a biosimilar, and there's no mention of prior Rituxan (rituximab) use, the answer is not applicable. Therefore, I will not provide an answer.\n",
            "Filling CB310: This field should not be answered, as it is specific to rheumatoid arthritis, and the patient has multiple sclerosis.\n",
            "Filling CB311: Based on the provided information, this field should not be populated. The form specifies this section is \"For rheumatoid arthritis only,\" and the patient's diagnosis is Multiple Sclerosis.\n",
            "Filling CB312: Based on the provided information, this field should not be answered as it is specific to rheumatoid arthritis and the patient has multiple sclerosis.\n",
            "Filling CB306: No\n",
            "Filling CB307: No\n",
            "Filling CB308: No\n",
            "Filling CB309: No\n",
            "Filling CB313: Yes\n",
            "Filling CB314: No\n",
            "Filling CB315: No\n",
            "Filling CB316: No\n",
            "Filling T317: 05\n",
            "Filling T318: 22\n",
            "Filling T319: 2024\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#Additional Testing"
      ],
      "metadata": {
        "id": "KT-SkfCXLsPd"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import fitz  # PyMuPDF\n",
        "import matplotlib.pyplot as plt\n",
        "import matplotlib.patches as patches\n",
        "\n",
        "# Open PDF and get dimensions\n",
        "doc = fitz.open(\"PA.pdf\")\n",
        "page = doc[1]\n",
        "page_width = page.mediabox.width\n",
        "page_height = page.mediabox.height\n",
        "\n",
        "# Block rectangles (red)\n",
        "blocks = [\n",
        "    {'rect': [20.4, 122.12, 524.49, 133.75], 'label': 'patient info header'},\n",
        "    {'rect': [22.56, 159.03, 372.96, 189.43], 'label': 'rheumatoid arthritis question'},\n",
        "    {'rect': [22.56, 388.72, 476.93, 420.13], 'label': 'second question'}\n",
        "]\n",
        "\n",
        "# Field rectangles (green)\n",
        "fields = [\n",
        "    {'rect': [249.62, 167.44, 259.92, 178.0]},\n",
        "    {'rect': [282.375, 167.44, 292.676, 178.0]},\n",
        "    {'rect': [334.257, 167.44, 344.558, 178.0]},\n",
        "    {'rect': [20.80, 131.79, 164.39, 144.46]},\n",
        "    {'rect': [169.26, 131.79, 348.60, 144.46]},\n",
        "    {'rect': [354.30, 131.79, 469.83, 144.46]},\n",
        "    {'rect': [22.71, 419.29, 33.01, 429.85]}\n",
        "]\n",
        "\n",
        "# Create plot\n",
        "fig, ax = plt.subplots(1)\n",
        "ax.set_xlim(0, page_width)\n",
        "ax.set_ylim(0, page_height)\n",
        "ax.invert_yaxis()  # Match PDF coordinate space\n",
        "\n",
        "# Plot block rectangles\n",
        "for block in blocks:\n",
        "    x0, y0, x1, y1 = block['rect']\n",
        "    ax.add_patch(patches.Rectangle((x0, y0), x1 - x0, y1 - y0, linewidth=1, edgecolor='r', facecolor='none'))\n",
        "    ax.text(x0, y0, block['label'], fontsize=8, color='blue', verticalalignment='bottom')\n",
        "\n",
        "# Plot field rectangles\n",
        "for field in fields:\n",
        "    x0, y0, x1, y1 = field['rect']\n",
        "    ax.add_patch(patches.Rectangle((x0, y0), x1 - x0, y1 - y0, linewidth=1, edgecolor='g', facecolor='none'))\n",
        "\n",
        "# Show plot\n",
        "plt.title(\"PDF Field & Block Mapping\")\n",
        "plt.show()"
      ],
      "metadata": {
        "id": "KIPBXgwFEvcW"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}